Angelopoulou Maria English Cv July 2015

MARIA K ANGELOPOULOU HEMATOLOGIST

CURRICULUM VITAE

Candidate for the Position of Ass οciate Professor

JULY 2015

LIST OF CONTENTS CHAPTER PAGE

A. PERSONAL DATA 3 B. GRADUATE/POSTGRADUATE TRAINING AND 3 SCIENTIFIC CAREER C. EDUCATIONAL QUALIFICATIONS AND CERTIFICATES 5 D. TEACHING EXPERIENCE 6 E. CLINICAL AND LABORATORY EXPERIENCE 6 F. ADMINISTRATIVE AND ORGANIZING EXPERIENCE 9 G. RESEARCH WORK 9 H. AWARDS 15 I. INVITED SPEAKER 15 J. EDITORIAL WORK 19 K. PUBLICATIONS 21 K1. SUMMARY OF PUBLICATIONS 21 K2. IMPACT FACTOR FOR ENGLISH PUBLICATIONS 22 K3. OVERVIEW OF ENGLISH PUBLICATIONS 25 K4. FULL LIST OF ENGLISH PUBLICATIONS IN SCI 28 JOURNALS K5. FULL LIST OF ENGLISH PUBLICATIONS IN NON-SCI 69 JOURNALS K6. CHAPTERS IN ENGLISH BOOKS OR INTERNATIONAL 79 MEETING PROCEEDINGS K7. FULL LIST OF ABSTRACTS IN INTERNATIONAL 83 MEETINGS K8. OVERVIEW OF GREEK PUBLICATIONS 176 K9. SUMMARY OF PUBLICATIONS 177

A. PERSONAL DATA

NAME: Maria K Angelopoulou DATE OF BIRTH: 06/18/1966 BIRTHPLACE: Athens ADDRESS: 8 Monastiriou Street, Thrakomakedones, Attiki, 11527 SPECIALTY : Hematologist MARITAL STATUS: Married to Fotios Mitropoulos, Cardiothoracic Surgeon, 2 children (ages 10 and 14 years) CURRENT POSITION : Assistant Professor in Hematology, National and Kapodistrian University of Athens, Department of Hematology and Bone Marrow Transplantation

B. GRADUATE AND POSTGRADUATE TRAINING, SCIENTIFIC CAREER

I graduated with honors from the German School of Athens and I began my medical studies at the National and Kapodistrian University of Athens, School of Medicine in 1984. I graduated in 1990 with honors. I performed my compulsory rural practice at the Dialysis Unit in the Chalkida Hospital. Subsequently, I worked for a year at the of Hematology Section of the First Department of Internal Medicine of the National and Kapodistrian University of Athens, Laikon General Hospital. From 1993 to 1995 I did my residency in Internal Medicine at the Athens Chest Diseases Hospital "Sotiria", a part of which I served in the Center of Respiratory Failure. From 1995 to 1998 I did my fellowship in Hematology at the First Department of Internal Medicine, National and Kapodistrian University of Athens, Laikon General Hospital of Athens. From 1998 to 2001 I completed the residency program in Clinical Pathology and Laboratory Medicine, at Yale University Yale New Haven Hospital, New Haven, Connecticut, USA. During that time I have completed my training in Laboratory Hematology, Transfusion Medicine and Coagulation, Biochemistry, Immunology, Flow Cytometry, Microbiology, Virology and Molecular Biology. In the period 2000-2001 under the residency of Laboratory Medicine, I worked as a researcher at the Hematopoietic Stem Cell Laboratory (Supervisor:

Professor Diane S Krause), where I studied the engraftment of human hematopoietic and mesenchymal stem cells. Then I attended the Program of Hematology and Bone Marrow Transplantation at the Department of Hematology and Bone Marrow Transplantation, City of Hope National Medical Center, Duarte, California, USA, for 2 years (2001-2003): initially, as a visiting physician for a year and then as a fellow/staff member with full salary and benefits. There, I was trained in hematopoietic stem cell mobilization, autologous and allogeneic stem cell transplantation in one of the oldest and largest centers of Bone Marrow Transplantation in the United States In conclusion, my postgraduate training in the United States includes: (i) one month in the Flow Cytometry Laboratory of the Memorial Sloan Kettering Cancer Center, New York, USA (1995) (ii) three years residency in Clinical Pathology/Laboratory Medicine, focusing mainly in Laboratory Hematology, Transfusion Medicine and Stem Cells Biology, including one year of basic research at Yale University, New Haven, CT (1998-2001) (iii) two years in Bone Marrow Transplantation in the Department of Hematology and Bone Marrow Transplantation , City of Hope National Medical Center, Duarte, California, USA (2001-2003). I received my PhD with Honors at the University of Athens in September 2003. The title of my thesis was: "Expression of Adhesion Molecules in Chronic Lymphocytic Leukemia and low-grade non-Follicular Leukemic Lymphomas". From 1.1.2004 to 31.8.2005, I worked as a Scientific Associate in the First Department of Internal Medicine, National and Kapodistrian University of Athens (Director: Professor Gerassimos A. Pangalis) I was elected Lecturer in Hematology in June 2004 and I was appointed to that position in September 2005. From September 2005 until May 2008, I served as a Lecturer in Hematology at the First Department of Internal Medicine, National and Kapodistrian University of Athens (Director: Professor Gerassimos A. Pangalis), where I was responsible for a large number of patients with benign and malignant

4 hematologic diseases and where I expanded the Autologous Stem Cell Transplantation Unit (Supervisor: Associate Professor: G. Rompos). I was transferred to the Department of Hematology and Bone Marrow Transplantation upon its foundation on 15.5.2008 (Directors: Prof. Gerassimos A. Pangalis to 31.8.2008, Associate Professor Konstantinos Konstantopoulos, from 1.9.2008 to 15.12.2009, Professor Photis Beris, from 16.12.2009 to 31.12.2010, Professor John Meletis from 1.1.2011 to 31.8.2013, Professor K. Konstantopoulos from 01.09.2013 to today), where I am serving until today. I was elected Assistant Professor in Hematology on March 9, 2010 and I was appointed to this position on May 7, 2010.

C. EDUCATIONAL QUALIFICATIONS AND CERTIFICATES

Foreign Languages • English: excellent, Proficiency Certificate, Cambridge University, UK, Proficiency Teaching License • German: excellent, Proficiency Certificate: Grosses Deutsches Sprachdiplom, Proficiency Teaching License Licenses and Certificates ° Medical Degree: National and Kapodistrian University of Athens, School of Medicine, Dean: K. Dimopoulos, 31.1.1991, Grades: Excellent ° United States Medical Licensing Examination-USMLE Certificate, Part II, 20.4.1995, score: 84, Certificate number: 0-529-661-1. ° United States Medical Licensing Examination-USMLE Certificate, Part I, 10.12.1996, βαθµός : score: 84, Certificate number: 0-529-661-1. ° United States Medical Licensing Examination-USMLE Certificate, Part III, 16.1.2002, score: 81, Certificate number: 0-529-661-1. ° Advanced Cardiac Life Support Certificate, 17.6.2002, University of Southern California, Los Angeles, California, USA. ° Greek Medical Profession Practicing License, 11.2.1991, Athens, #: 4897 ° Greek Boards in Hematology: 4.10.2001, #: 11245/2001 ° California Medical License, California, USA, 14.6.2002, #: Α79459

D. TEACHING EXPERIENCE Throughout the course of my medical career, I have been actively involved in the education of students both in Athens and Yale University, as well as in all educational activities with case presentations, journal clubs and educational lectures. I participate actively in the annual undergraduate program of elective courses in “Hematology” from 2005 to today. I also participate in the undergraduate program for students of two Internal Medicine Departments of our Hospital, both with lectures and bedside training. As a Lecturer and Assistant Professor I have been actively participating in the training of Hematology Fellows through everyday clinical practice, lectures and courses. During the last 10 years (2005-2015), I have given approximately 50 lectures on various subjects of hematology for medical students and Hematology fellows in Hospital lectures and courses, at the annual Educational Meetings of the Hellenic Society of Hematology, the Lymphoma Working Party of the Hellenic Society of Hematology and the Hematopoietic Stem Cell Transplantation Working Party of the Hellenic Society of Hematology. I also participate regularly in the annual postgraduate seminar “Neoplastic Disease in the human. Modern clinicopathologic diagnosis and research” organized by the University Pathology Department.

E. CLINICAL AND LABORATORY EXPERIENCE Throughout the course of my medical career, clinical – mainly - and laboratory work - to a lesser extent - were the focus of my interest, in order to provide health services to patients according to the respective positions I held. In all positions, I have fully participated in the On-Call program. I have been responsible for the diagnosis and treatment of a significant number of in- and outpatients with a wide variety of hematologic diseases. During my compulsatory rural practice, I worked in the Hemodialysis Unit of Chalkida Hospital and Gained experience on taking care of patients with chronic renal failure, as well as patients with end stage renal disease treated

6 with dialysis. I was the responsible physician for the afternoon shift under the supervision of the Director Dr Solomakou. During my residency in Internal Medicine in Sotiria Hospital, I gained expertise on treating critically ill patients in the Intermediate Care Unit and on patients with various diseases within the Internal medicine ward. I fully particiapated in the on-call schedule. During my fellowship in Hematology I was responsible for a significant number of inpatients with acute leukemia and various complications of hematological diseases. I was trained particularly in the field of lymphoproliferative disorders under the supervision of professor GA Pangalis. I also gained experience in the field of hematopathology, namely in interpreting blood, bone marrow, lymph node smears, cytochemistry and flow cytometry. More specifically, I was responsible for setting up and performing the flow cytometry studies in patients with lympgoproliferative disorders. During my residency in Clinical Pathology and Laboratory Medicine at Yale University, I have fully participated in all clinical activities and the On-Call program. I was responsible for the interpretation of various diagnostic laboratory tests for patients and for troubleshooting both technical and clinical problems. More specifically, during that time, I practiced in the following areas: A. Blood Bank: blood donation, collection of autologous blood, hematopoietic stem cell collection and patients’ monitoring, erythrocytophereseis in patients with sickle cell anemia, plasmapheresis in patients with thrombotic thrombocytopenic purpura, myasthenia Gravis and other diseases, recording and investigation of transfusion reactions, blood crossmatch and immunohematology, laboratory investigation and monitoring of the hemolytic disease of the newborn. B. Hematology Laboratory: I participated in the investigation and diagnosis of hemoglobinopathies and thalassemia, various coagulation disorders (lupus anticoagulant, clotting factors inhibitors, hemophilia, etc.), hypercoagulability states (antithrombin deficiency, protein S and C, etc), and platelet disorders with platelet aggregation tests. Moreover I gained experience in the interpretation of blood / marrow / lymph node smears and flow cytometry, as well as I resolved problems of automatic blood 7

analyzers. I was also involved in the interpretation of specialized tests, such as Kleihauer-Betke, etc. C. Chemistry Laboratory: I learned the operating principles and troubleshooting of automatic analyzers, methods of determination of all biochemical tests, while I have gained significant experience in toxicology, both in the laboratory and in the clinic, since this department was a reference toxicology laboratory. D. Microbiology Laboratory: I practiced on identification and culture of various microorganisms. E. Virology Laboratory: I practiced on methods for identification of various viruses, by cell culture, immunofluorescence, ELISA and Western Blot, viral load for hepatitis C virus and HIV. F. Molecular Biology Laboratory: I dealt with the interpretation of various molecular tests, such as immunoglobulin heavy chain and T-cell receptor rearrangement, cystic fibrosis, factor V Leiden, etc. During my work in the Department of Bone Marrow Transplantation at the City of Hope National Medical Center, I had the opportunity to be exposed to multiple and specific issues of hematopoietic stem cell transplantation. I gained experience in the process of stem cell collection, cryopreservation, and photopheresis for chronic graft – versus - host disease and cutaneous T - cell lymphomas. I have participated in the process of bone marrow collection from related and volunteer donors, since City of Hope was a Volunteer Donor Marrow Collection Center. I also attended meetings of the selection program of unrelated donors according to HLA- compatibility, since a section of the NMDP (National Marrow Donor Program), was established in the Institution where I worked. I was also briefly exposed to the methodology and interpretation of karyotyping, fluorescent in situ hybridization, HLA-typing by molecular techniques (SSOP, SSP, and sequencing) and chimerism studies with the technique of short tandem repeats. In my present position, I take care of a significant number of outpatients (80 patients per week), and inpatients. I am also responsible for the Stem Cell Collection and Autologous Transplantation Program and the Stem Cell Laboratory in our Hospital. During working hours, my time is shared between clinical and educational activities. My institution has not assigned any 8 dedicated protected academic time for research/writing to me. Thus, my research and academic work is peeformed after my official hours.

F. ADMINISTRATIVE AND ORGANIZING EXPERIENCE I have been a member of the Organizing Committee of: • the 7th International Chronic Lymphocytic Leukemia Working Group • the Postgraduate Seminar of the European School of Oncology on Leukemia and Lymphoma in 1997 • the 2013 International Athens Lymphoma Seminar in October 2013. I am the main organizer of the upcoming 2015 International Athens Lymphoma Seminar in October 2015. During my residency at the Department of Laboratory Medicine, Yale University, I was assigned the Chief Resident position. In my current position, I organized and expanded the Mobilization, Collection and Autologous Hematopoietic Stem Cell Program, the Stem Cell Laboratory and the electronic patient database. I have been recently appointed as the Scientific Head of the Transplanation Unit.

G. RESEARCH WORK 1. Research Laboratories 1. May 1992 - May 1998: Research Laboratory, First Department of Internal Medicine, National and Kapodistrian University of Athens. I participated as a researcher in the study of the biology and diagnosis of lymphoproliferative diseases (Coordinator: Professor Gerassimos A Pangalis). During this period, I was trained in various techniques such as cytochemistry, immunocytochemistry, cell separation and cryopreservation, flow cytometry, and molecular techniques including isolation of DNA, RNA, PCR, RT- PCR. I introduced and expanded both at the research and diagnostic level, flow cytometry in the study of lymphoproliferative diseases. 2. January 2000 - June 2001: Stem Cell Research Laboratory, Department of Laboratory Medicine, Yale University, School of Medicine, New Haven, Connecticut, USA. (Supervisor: Professor Diane S Krause, MD, PhD). During that time I completed a project related to the study of human hematopoiesis.

Specifically I studied the engraftment of human hematopoietic and mesenchymal stem cells in a xenotransplantation model of immunocompromised animals (NOD/SCID mice) and I had the opportunity to learn a variety of techniques. This work led me to the production of two publications in the form of original papers with about 180 citations in the International literature and two awards at medical conferences. During that time I received training on Ethics related to experimental animals and license on the use of radiation. I gained experience on maintaining and handling immunosuppressed mice, blood collection, sampling of bone marrow and other organs from animals, infusion of human cells in mice, liquid and semi- solid cultures of cells, culture and expansion of mesenchymal stem cells, flow cytometry and Southern blot. 2. January 2004 - Today: Laboratory of the First Department of Internal Medicine and Department of Hematology, National and Kapodistrian University of Athens: I have participated, supervised and developed various projects related to the study of the biology of lymphoproliferative diseases and hematopoietic stem cells. These projects included i) the study of the molecule survivin in aggressive B -cell and mantle cell lymphoma in the context of an EU-cofunded program (OP Pythagoras II). ii) the study of bone metabolism in the mobilization and engraftment of human hematopoietic stem cells iii) the study of genomic instability after autologous hematopoietic stem cell transplantation, iv) the correlation of the abcb6 molecule and chemoresistance in acute myeloid leukemia. . 2. Participation in Funded Research Programs 1. Epidemiologic, Immunologic and Molecular Study of Familial Lymph proliferative Diseases. Principal Investigator: G.A. Pangalis Coinvestigators: C. Karkantaris M.K. Angelopoulou Funding: National Ministry of Health 2. Study of Adhesion Molecules in B-Chronic Lymphoproliferative Syndroms. Principal Investigator: M.K. Angelopoulou Coinvestigators: E. Kapiri G.A. Pangalis 10

Funding: National and Kapodistrian University of Athens 3. Expression and Role of Survivin in Lymphoproliferative Diseases and its Evaluation as a Potential Therapeutic Target. Principal Investigator: G.A. Pangalis Coinvestigators: P. Panayiotidis M.K. Angelopoulou Funding: Pithagoras II 3. Clinical Trials 1. Coinvestigator in: PRI/EPO-INT-10 Protocol: Double Blind Controlled Placebo Trial for the Evaluation of the Effectiveness of preemptive treatment of epoetin alpha in anemia of patients with malignancies treated with chemotherapy with non-platinum based regimens. 2. Principal Investigator in: Study of the incidence of medium-severe mucositis in patients who undergo high dose therapy and autologous hematopoietic stem cell transplantation. 3. Coinvestigator in: OMB110911 – GLAXO: “Open randomized multi- institutional phase III clinical trial of Ofatumumab in combination with chlorambucil vs chlorambucil monotherapy as 1 st line treatment in patients with chronic lymphocytic leukemia”. 4. Coinvestigator in: OMB110913 – GLAXO: “Open International randomized phase III clinical trial of Ofatumumab in combination with fludarabine and cyclophosphamide vs fludarabine and cyclophosphamide in patients with relapsed chronic lymphocytic leukemia” 5. Coinvestigators in: B1931008 – PFIZER: “ Open randomized phase III clinical trial of inotuzumab ozogamycin in combination with rituximab vs Investigator’s choice in patients with relapsed/refractory CD22+ aggressive non-Hodgkin lymphoma, who are not candidates for high dose therapy”.

6. Principal Investigator in: GS-EU-131-0247 Gilead Sciences International Ltd. “Double Blind multi-institutional randomized phase III, placebo controlled clinical trial for the Evaluation of the Effectiveness, Safety and Tolerability of liposomal amphotericin B (AmBisome®) for the prevention of invasive fungal infections (IFI) in patients with acute lymphoblastic leukemia receiving induction chemotherapy for remission induction”.

7. Principal Investigator in: OMB110928 GLAXO: “Open randomized phase III clinical trial of Ofatumumab in combination with DHAP chemotherapy vs rituximab in combination with DHAP in patients with relapsed/refractory CD20 positive aggressive B cell non-Hodgkin lymphoma”.

8. Principal Investigator in the Clinical Trial 115523 (ZOSTER-002) with the title: “A randomized, double blind, placebo-controlled multicentric clinical phase III trial for the evaluation of the prophylactic efficacy, safety and immunogenicity of the candidate vaccine gE/AS01B of GSK Biologicals against herpes zoster, given intramuscularly in two doses in adults recei ing autologous hematopoietic stem cell transplantation (HCT)”. 9. Principal Investigator in the non-invasive trial Arroven (PASS) with the title “An Observational Cohort Study of the Safety of Brentuximab Vedotin in the Treatment of Relapsed or Refractory CD30+ Hodgkin Lymphoma and Relapsed or Refractory Systemic Anaplastic Large Cell Lymphoma – ARROVEN”

10. Subinvestigator in the phase 3 clinical trial B3281006 with the title: “A Study Of PF-05280586 (Rituximab-Pfizer) Or MabThera® (Rituximab-EU) For The First-Line Treatment Of Patients With CD20- Positive, Low Tumor Burden, Follicular Lymphoma”

11. Principal Investigator in the interventional clinical phase II/III trial ΑΒ 1004 with the title: “ A multicenter, randomised, open-label, three- parallel groups, phase 2-3 study to evaluate the efficacy and safety of masitinib with dexamethasone, gemcitabine with dexamethasone and the combination of masitinib, gemcitabine and dexamethasone in patients with relapsed or refractory peripheral T-cell lymphoma”. 8.

4. PhD Thesis "Expression of Adhesion Molecules in Chronic Lymphocytic Leukemia and low-grade non-Follicular Leukemic Lymphomas". (Supervisor: Professor

G.A. Pangalis). I received my PhD with Honors at the University of Athens in September 2003.

5.Supervision of Theses/Dissertations Member of the 3-member Scientific Committee of the following theses: 1. “Study of bone metabolism in the mobilization of hematopoietic stem cells”. Candidate: P. Tsirkinidis 2. “Study of genomic instability in lymphoma/myeloma patients who undergo autologous stem cell transplantation”. Candidate: M. Moschogianni. 3. “Marginal Zone Lymphomas. Clinical and Laboratory Study”. Doctor: C. Kalpadakis. Supervisor of the following theses: 1. “Study of bone metabolism in the engraftment process in patients who undergo autologous hematopoietic stem cell transplantation”. Candidate: G. Boutsikas. 2. “PET scan in Hodgkin lymphoma”. Candidate: E. Mosa 3. “Study of cellular subpopulations in hematopoietic stem cell grafts collected from patients with hematologic malignancies”. Candidate: E. Lalou. 4. “Study of the intracellular transduction pathways BRAF/MEK/ERK and AKT/mTOR in hairy cell leukemia”. Candidate PhD: Eleftheria lakiotaki, MD. 5. “Study on the fertility of patients with lymphoma, undergoing chemotherapy”. Candidate PhD: Andreas Giannakou, MD.

6. Description of Research My research work includes two axes: The first axis focuses on clinical and laboratory studies in lymphoproliferative disorders and stem cell transplantation in these diseases. My involvement in clinical research in lymphoproliferative diseases is evident from the respective publications, which form the great bulk of my published work.

The second axis focuses on a) the biology of lymphoproliferative diseases and b) the biology of hematopoietic progenitor cells, as indicated by my doctoral thesis, the respective publications and the theses that I supervise.

H. AWARDS 1. In Greece: 5 2. Abroad: 3 ° 2000 Paul E. Strandjord, Young Investigator Award for the paper: «DOSE RESPONSE RELATIONSHIP BETWEEN THE NUMBER OF CD34+ PERIPHERAL BLOOD STEM CELLS (PBSC) ADMINISTERED AND HUMAN PLATELET ENGRAFTEMENT IN NOD/SCID MICE». Αngelopoulou MK, Perez L, Rinder H, Krause DS, 35 th Annual Meeting of the Academy of Clinical Pathology and Laboratory Medicine Doctors and Scientists, June, 8-10, Salt Lake City, Utah, USA. ° 1st Award for Best Oral Presentation with the title: “HUMAN MESENCHYMAL STEM CELLS ENHANCE HUMAN HEMATOPOIETIC STEM CELL ENGRAFTMENT IN NOD/SCID MICE”. Angelopoulou MK, Rinder H, Grove J, Krause DS. Annual Meeting of the International Society for Hematotherapy and Graft Engineering (ISHAGE), Toronto, Canada, June 2001. ° 1st Award for Best Poster Presentation for the paper: ‘‘RITUXIMAB- CHOP (R-CHOP) AND RADIOTHERAPY (RT) FOR PRIMARY MEDIASTINAL LARGE B-CELL LYMPHOMA (PMLBCL)’’. Vassilakopoulos TP, Angelopoulou MK , Galani Z, et al., Mabthera Expert Forum, Valencia, 6-8 October 2006.

I. INVITED SPEAKER IN : 1. Postgraduate Seminar of the Hellenic School of Hematology with the title: Immunophenotypic Classification of chronic lymphoproliferative diseases”, Athens,1995 . 2. Flow Cytometry Seminar with the title: “Immunophenotypic Study of chronic lymphoproliferative diseases with flow cytometry” Athens,1995.

3. 10 th Meeting of the Mediterranean Blood Club with the title “Adhesion Molecules in chronic lymphoproliferative diseases”, Thessaloniki, June 1997. 4. Postgraduate Seminar of the European School of Oncology (ESO) in Leukemias/Lymphomas with the title: “Adhesion Molecules in Leukemias and Lymphomas”, Vouliagmeni, Attiki, October 1997. 5. Educational Program of the 15 th Annual Meeting of the Hellenic Hematology Association with the title: “Peripheral T cell Lymphomas: Classification and Treatment”, Athens, November 2004. 6. Annual Meeting of the Lymphoma Working Party of the Hellenic Hematology Association with the title “Autologous Stem Cell Transplantation in Follicular and Aggressive B-Cell Lymphomas”, Athens, March 2005. 7. 31 st Panhellenic Medical Meeting with the title “Lymphopenia and Lymphocytosis”, Athens, May 2005. 8. Annual Meeting of the Hellenic Transplantation Organization with the title “Advances in Autologous Stem Cell Transplantation in Hematologic Diseases”, Athens, 2005. 9. Annual Meeting of the Lymphoma Working Party of the Hellenic Hematology Association with the title ‘‘Treatment of Relapsed Chronic Lymphocytic Leukemia”, Athens, September 2006. 10. Annual Meeting of the Hematopoietic Stem Cell Transplantation Working Party of the Hellenic Hematology Association with the title “Mantle Cell Lymphoma. Pathogenesis, Cytogenetic and Molecular Aberrations”, Karpenisi, October 2006. 11. Round Table at the 17 th annual meeting of the Panhellenic Hematology Association with the title “Applications of targeted therapies in autologous stem cell transplantation in low grade B cell non-Hodgkin lymphomas”, Athens, November 2006 12. Annual Meeting of the Lymphoma Working Party of the Hellenic Hematology Association with the title “Mantle Cell Lymphoma. Pathogenesis and Treatment”, Athens, April 2007.

13. Educational Program of the 18 th Annual Meeting of the Hellenic Hematology Association with the title: “Initial Treatment of T-Cell non- Hodgkin Lymphomas”, Thessaloniki, November 2007 14. Educational Program of the 19 th Annual Meeting of the Hellenic Hematology Association with the title: «The role of the Microenvironment in low grade non-follicular non-Hodgkin Lymphomas”, Athens, November 2008 15. Annual Meeting of the Lymphoma Working Party of the Hellenic Hematology Association with the title “Salvage Treatment of Hodgkin Lymphoma”, Athens, January 2009. 16. Educational Program of the 21 st Annual Meeting of the Hellenic Hematology Association with the title: “Malignant Lymphoproliferations of Innate Immunity: Neoplasms originating from NK, T/NK and γδ Τ cells”, Thessaloniki, 2010. 17. Annual Meeting of the Lymphoma Working Party of the Hellenic Hematology Association with the title: “Treatment of Refractory Peripheral T Cell Lymphomas”, Santorini, October 2010. 18. Annual Meeting of the Lymphoma Working Party of the Hellenic Hematology Association with the title: “Treatment of Very-High Risk Chronic Lymphocytic Leukemia”, Lefkada, May 2011. 19. Combined Meeting of the Foundation of the Hellenic Hematology Association and the Department of Hematology of the University of Crete: Clinical and Laboratory Education in Hematology, 2011: Lymphomas with the title: “Treatment of Peripheral T Cell lymphomas”, Heraklion, Crete, September 2011. 20. International Meeting on Chronic Lymphocytic Leukemia organized by the Department of Hematology of the University of Crete with the title: “Treatment of Relapsed/Refractory CLL”, Heraklion, Crete, October 2012. 21. Combined Meeting of the Foundation of the Hellenic Hematology Association and the Department of Hematology of the University of Crete: Clinical and Laboratory Education in Hematology, 2012: Acute Myelogenous Leukemia, with the title: “Management of Special Situations in AML: Leukostasis, CNS Involvement”, Heraklion, Crete, September 2012. 17

22. Annual Meeting of the Hematopoietic Stem Cell Transplantation Working Party of the Hellenic Hematology Association with the title “The role of PET/CT in the follow-up Lymphoma patients after autologous stem cell transplantation”, Athens, October 2012. 23. International Educational Symposium on Marginal Zone Lymhomas during the 16 th Annual Meeting of the Working Party of the International Extranodal Lymphoma Study Group (IELSG) with the title: “Nodal Marginal Zone Lymphomas”, Athens, February 2013 24. International Educational Athens Lymphoma Seminar with the title: “Treatment of Chronic Lymphocytic Leukemia”, October 2013. 25. International Educational Athens Lymphoma Seminar with the title: “Treatment of T Cell Lymphomas”, October 2013. 26. Eduacational Meeting organized by the 2 nd Propedeutic Department of Internal Medicine of the University of Athens on High Grade Diffuse Large B Cell lymphomas with the title: “Advances in the application of monoclonal antibodies”, Athens, May 2013. 27. Educational Meeting of the Hellenic Society of Oral/Maxillofacial Medicine: with the title: “Oral Manifestations in Hematologic Diseases”, Athens, June 2013. 28. Annual Meeting of the Hematopoietic Stem Cell Transplantation Working Party of the Hellenic Hematology Association with the title: “Hematopoietic Stem Cell Transplantation in Hodgkin Lymphoma”, Athens, October 2013. 29. Educational Meeting on Chronic Myelogenous Leukemia, organized by the Hellenic Corporation of Molecular Research in Cancer with the title: “Treatment of CML in accelerated phase”, Athens, October 2013. 30. Educational Meeting on Chronic Lymphocytic Leukemia, organized by the Hellenic Corporation of Molecular Research in Cancer with the title: “Treatment of Refractory CLL”, Athens, December 2013. 31. Satellite symposium sponsored by Roche during the Meeting of the Lymphoma Working Party of the Hellenic Hematology Association with the title “New Era for MabThera”, Volos Thessalia, June 2014.

32. Educational Meeting organized by Takeda with the title “New Therapeutic Developments in T-cell lymphomas”, Chania Crete, September 2014. 33. Arzerra Launch Event organized by Glaxo Smithkline with the title “What is next for the relapsed/refractory CLL patient?”, Athens, September 2014. 34. Educational Meeting organized by the 2 nd Propedeutic Internal Medicine Department “Low grade B cell non-Hodgkin Lymphomas” with the title “New Drugs in the Treatment of Chronic Lymphocytic Leukemia”, Athens, November the 1 st 2014. 35. Satellite symposium organized by Glaxo Smithkline “Developments in ITP and CLL” with the title “New therapeutic strategies in the 1 st line treatment of CLL” during the 25 th Panhellenic Hematology Meeting, Thessaloniki, Novemeber 13-15, 2014. 36. Educational Meeting on chronic lymphocytic leukemia organized by Glaxo Smithkline “Preceptorship in CLL with the title “Treatment Options in relapsed/refractory CLL”, Athens and Thessaloniki, December 2014. 37. Educational Meeting organized by Amgen with the title “Bite: Biotechnology in the treatment of acute lymphoblastic leukemia”, Athens, December 2014. 31. Central Greece educational meeting “Evolving Therapeutic Choices in Hematology” with the title “New therapeutic options in ALL”, Larissa Thessalia, February 13-14, 2015.

J. EDITORIAL WORK ° Member of the Editorial Board of the Journal of the Hellenic Society of Hematology “Haema” in the past. ° Reviewer of the submitted abstracts to the Annual Meeting of the Hellenic Society of Hematology in 2007, 2008, 2010-2014. ° Guest Editor in the Journal of the Hellenic Society of Hematology “Haema” with the subject “Autologous Stem Cell Transplantation”, Volume 4 (issue 3), September 2014. ° Reviewer in of the Journal of the Hellenic Society of Hematology “Haema” 19

° Reviewer in the Leukemia and Lymphoma Journal ° Reviewer in Case Reports in Hematology ° Reviewer in BioMed Research International ° Reviewer in Open Medicine ° Reviewer in Futture Oncology

Author of Educational Books • Συγγραφή εκπαιδευτικών κειµένων α.PANGALIS GA, VASSILAKOPOULOS TP, DIMOPOULOU MN, SIAKANTARIS MP, ANGELOPOULOU MK. Malignant Lymphomas and Chronic Lymphocytic Leukemia. . In: Internal Medicine by Chatzigiannis S, Mavrikakis M, Moundokalakis Th, Nana-Anastasiou M, Pangalis GA, Papadogiannis D, Chalevelakis G (eds), Scientific and Educational Staff Of the Internal Medicine Section, National and aKapodistrian University of Athens, Paschalidis Editions, Athens, pp:1289-1301, 2002. β. ANGELOPOULOU MK, TSIRIGOTIS P. Acute Leukemias In: Internal Medicine by Pekatsidis K (ed), Scientific and Educational Staff Of the Internal Medicine Section, National and aKapodistrian University of Athens, Paschalidis Editions, Athens, 2015, under publication. γ. TSIRIGOTIS P, ANGELOPOULOU MK. Hematopoietic Stem Cell Transplantation In: Internal Medicine by Pekatsidis K (ed), Scientific and Educational Staff Of the Internal Medicine Section, National and aKapodistrian University of Athens, Paschalidis Editions, Athens, 2015, under publication. δ. VASSILAKOPOULOS TP, DIMOPOULOU MN, SIAKANTARIS MP, ANGELOPOULOU MK. Malignant Lymphomas and Chronic Lymphocytic Leukemia. In: Internal Medicine by Pekatsidis K (ed), Scientific and Educational Staff Of the Internal Medicine Section, National and aKapodistrian University of Athens, Paschalidis Editions, Athens, 2015, under publication.

K. PUBLICATIONS

1.SUMMARY OF PUBLICATIONS Number Impact Factor Citations Α. ENGLISH PUBLICATIONS Papers in SCI Journals 104 388.459 2474 Papers in non -SCI Journals 26 1.5 24 Chapters in Books or Meeting Proceedings 19 - 23 Abstracts Presented in International Meetings 297 - 14 4 Β. GREEK PUBLICATIONS Papers in Greek Journals 8 - - Chapters in Books or Meeting Proceedings 32 - Abstracts Presented in Greek Mee tings 260 - 16 Total 389.959 2681

2. IMPACT FATOR OF ENGLISH PUBLICATIONS Journal Impact Number of Total Factor Publications Impact Factor SCI JOURNALS Acta Haematologica 1.116 3 3.348 Advances in Hematology - 1 - Annals of Hematology 2.634 3 7.902 AntiCancer Research 1. 826 7 12.782 Biology of Blood and 3.404 1 3.404 Marrow Transplantation Biomed Research 1.579 4 6.316 International Blood 10.452 3 31.356 Bone Marrow 3.570 1 3.570 Transplantation British Journal of 4.711 3 14.133 Hematology Cancer Genetics 2.975 1 2.975 Cytogenetics Clinical Biochemistry 2.275 1 2.275 Clinical Cancer Research 8.722 2 17.444 Clinical Lymphoma 2.020 3 6.06 Clinical Microbiology and 5.768 1 5.768 Infection Current Hematologic 2.200 1 2.200 Malignancy Reports Current Topics in Medicinal 3. 402 1 3.402 Chemistry European Journal of 2. 066 4 8.264 Hematology Experimental Hematology 2. 475 1 2.475 Haematologia - 1 - Haematologica 5. 814 6 34.884 Hellenic Journal of 1.229 1 1.229 Cardiology Hematological Oncology 3.084 4 12.336

Hematology 1.253 1 1.253 Histopathology 3.453 2 6.906 International Journal of 2.449 1 2.449 Colorectal Disease International Journal of 4.258 1 4.258 Radiation, Oncology, Biology, Physics International Journal of 1.819 1 1.819 Laboratory Hematology International Journal of 1.918 1 1.918 Hematology Journal of the American 4.449 1 4.449 Society of Dermatology Journal of Balkanic Union 0.741 1 0.741 of Oncology Journal of Clinical 18.428 2 36.856 Oncology Leukemia 10.431 3 31.293 Leukemia and Lymphoma 2.891 20 57.82 Leukemia Research 2.351 2 4.702 Medical Oncology 2.634 2 5.268 Medicine (Baltimore) 5.723 1 5.723 MEMO (Magazine of - 1 - European Medical Oncology) Modern Pathology 6.187 1 6.187 Medical Science Monitor 1.433 1 1.433 Oncologist 4. 865 3 14.595 Seminars in Hematology 3.274 3 9.822 Seminars in Oncology 3.898 1 3.898 Transfusion 3.225 1 3.225 West Indian Medical 0. 332 1 0.332 Journal Total Impact Factor 104 388.459 Mean Impact Factor 101 * 3.846

NON -SCI JOURN ALS Progress in Growth Factors - 1 - Haema - 7 - Anemia in Oncology - 1 - Asia-Pacific Journal of - 1 - Oncology and Hematology Archives of Hellenic - 12 - Medicine American Journal of - 1 - Medicine and Medical Sciences Current Angiogenesis 1.5 1 1.5 Current Cancer Therapy 2 Reviews Total Impact Factor 130 389.959 Mean Impact Factor 101 * 3.846

*The table includes 104 papers published in SCI Journals and 26 in non-SCI Journals. The impact factor has been calculated for the 104 publications in SCI Journals, that have a measurable 2015 impact factor.

3. ENGLISH PUBLICATIONS - OVERVIEW Α. PUBLICATIONS IN SCI JOURNALS Total Number: 104

Topics • Hodgkin Lymphoma: 21 • Non-Hodgkin Lymphomas: 34 • Chronic Lymphocytic Leukemia: 16 • Hematopoietic stem cell Transplantation: 7 • Waldenstrom Macroglobulinemia: 5 • Multiple Myeloma: 6 • Hairy cell Leukemia: 2 • Myelodysplastic Syndromes/Acute Leukemia:6 • Myeloproliferative Syndromes: 1 • Hematologic Malignancies in general: 1 • Cytogenetics: 1 • General Hematology:3 • Infections: 1

Methodology • Experimental studies: 3 • Retrospective Clinical Studies: 26 • Prospective Clinical Trials: 6 • Prospective Randomized Clinical Trials: 1 • Clinical/Laboratory Studies: 40 • Multi-institutional Studies: 1 • Reviews: 15 • Letters to the editor: 1 • Case Reports: 9 • Correspondence: 1 • Editorials: 1

Rank between the Authors

• 1st in: 11 • 2nd in: 17 • 3d in: 16 • Last in: 16 • Other rank in: 44

Β. PUBLICATIONS IN NON-SCI JOURNALS Total Number: 26 Topics: • Hodgkin Lymphoma: 4 • Chronic Lymphocytic Leukemia: 3 • Non-Hodgkin Lymphomas: 5 • Multiple Myeloma: 4 • Hematologic Malignancies in general: 1 • General Hematology: 8 • Acute Leukemia: 1 Methodology • Retrospective Clinical Studies: 5 • Prospective Clinical Trials: 1 • Reviews: 7 • Clinical / Laboratory Studies: 1 • Case Reports: 12 Rank between the Authors • 1st in: 1 • 2nd in: 5 • Last in: 3 • Other rank in: 17

C. IMPACT FACTOR • Total Score: 389.959 • Median: 3.846

D. CITATIONS:

1. For papers published in SCI Journals : • Total: 2474 • Self Citations: 231 2. For papers published in non-SCI Journals : 24 3. Total Citation Number of English papers: 2498

4. FULL LIST OF ENGLISH PUBLICATIONS IN SCI JOURNALS

1. ANGELOPOULOU MK , LAFIONATIS SN, PANGALIS GA. Low Grade Non-Hodgkin’s Lymphomas. Disease Control With Mitoxan- throne Monotherapy In Patients Refractory To Conventional Chemo- therapy. Leukemia and Lymphoma 12:253-258, 1994 Topic: non-Hodgkin Lymphomas Methodology: Retrospective Clinical Study Number of Patients: 14 Citations: 6 Impact Factor: 2.891

2. PANGALIS GA, POZIOPOULOS CH, ANGELOPOULOU MK , SIAKA- NTARIS M, PANAYIOTIDIS P. Εffective Treatment Of Disease Related Anemia In Β-Chronic Lymphocytic Leukemia Patients With Recombinant Human Erythropoietin. British Journal of Hematology 89:627-629, 1995 Topic: Chronic Lymphocytic Leukemia Methodology : Prospective Clinical Trial Number of Patients: 9 Citations: 43 Impact Factor: 4.711

3. ANGELOPOULOU MK , POZIOPOULOS CH, BOUSSIOTIS VA, PAN- GALIS GA. Fludarabine Monophosphate In Refractory To Conventional Chemotherapy B-Chronic Lymphocytic Leukemia: Maintenance May Be Significant To Sustain Response. Leukemia and Lymphoma 21:321-324, 1996 Topic: Chronic Lymphocytic Leukemia Methodology: Retrospective Clinical Study

Number of Patients: 20 Citations:22 Impact Factor: 2.891

4. KONSTANTOPOULOS ΚK, KANELLOPOULOU G, ANGELOPOULOU MK , HATZIDIMITRIOU D, ANDROULAKI A, PATSOURIS S, YATAGANAS X, PANGALIS GA. Leukemia Cutis Proceeding Acute Myelomonocytic Leukemia. Haematologia 28:169-172, 1997. Topic: Acute Leukemia Methodology: Case Report Number of Patients: 1 Citations: -

5. KORKOLOPOULOU P, ANGELOPOULOU MK , KONTOPIDOU F, TSENGA A, PATSOURIS E, THOMAS-TSAGLI E, KITTAS CH, PANGALIS GA. Prognostic Relevance Of Apoptotic Cell Death In Non-Hodgkin’s Lymphomas. A Multivariate Survival Analysis Including Ki-67 And P53 Oncoprotein Expression. Histopathology 33: 240-247, 1998 Topic: non-Hodgkin Lymphomas Methodology: Clinical/Laboratory Study Number of Patients: 92 Citations: 25 Impact Factor: 3.453

6. KORKOLOPOULOU P, ANGELOPOULOU MK , KONTOPIDOU F, TSENGAS A, PATSOURIS E, KITTAS CH, PANGALIS GA. Prognostic Implication Of Proliferating Cell Nuclear Antigen (PCNA) AgNORs and p53 In Non-Hodgkin’s Lymphomas. Leukemia and Lymphoma; 30:625-636, 1998 Topic: non-Hodgkin Lymphomas Methodology: Clinical/Laboratory Study 29

Number of Patients: 91 Citations:19 Impact Factor: 2.891

7. PANGALIS GA, ANGELOPOULOU MK , VASSILAKOPOULOS THP, SIAKANTARIS MP, KITTAS CH. B-Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, And Lymphoplasmacytic Lymphoma, Including Waldenstrom’s Macroglobulinemia: A Clinical, Morphologic And Biologic Spectrum Of Similar Disorders. Seminars in Hematology, 36: 104-114, 1999 Topic: Non-Hodgkin Lymphomas and Chronic Lymphocytic Leukemia Methodology: Review Number of Patients: - Citations: 153 Impact Factor: 3.274

8. ANGELOPOULOU MK , KONTOPIDOU FN, PANGALIS GA. Adhesion Molecules In B-Chronic Lymphoproliferative Disorders. Seminars in Hematology, 36: 178-197, 1999 Topic: Chronic Lympoproliferative Diseases Methodology: Clinical/Laboratory Study and Review Number of Patients: 65 Citations: 62 Impact Factor: 3.274

9. GUENOVA M, RASSIDAKIS GZ, GORGOULIS VG, ANGELOPOULOU MK , SIAKANTARIS MP, KANAVAROS P, PANGALIS GA, KITTAS CH. p16 INKA Is Regularly Expressed And Tightly Related To Retinoblastoma Protein In Hodgkin’s Disease: Comparison With P53, And Mdm2 Protein Status And The Presence Of Epstein-Barr Virus. Modern Pathology 12: 1062-1071, 1999 Topic: Hodgkin Lymphoma Methodology: Clinical/Laboratory Study 30

Number of Patients: 44 Citations: 16 Impact Factor: 6.187

10. KAMPER EF, PAPAPHYLLIS AD, ANGELOPOULOU MK , KOPEIKINA LT, SIAKANTARIS MP, PANGALIS GA, STAVRIDIS JC. Serum Levels Of Tetranectin, Adhesion Molecule-1 And Interleukin-10 In B- Chronic Lymphocytic Leukemia. Clinical Biochemistry 32: 639-645, 1999 Topic: Chronic Lymphocytic Leukemia Methodology: Clinical/Laboratory Study Number of Patients: 53 Citations:26 Impact Factor: 2.275

11. TERPOS E, ANGELOPOULOU MK , VARIAMI E, MELETIS JC, VAIO- POULOS G. Sjogren’s Syndrome Associated With Multiple Myeloma. Annals of Hematology 79: 449-451, 2000 Topic: Multiple Myeloma Methodology: Case Report Number of Patients: 1 Citations:23 Impact Factor: 2.634

12. PANGALIS GA, DIMOPOULOU MN, ANGELOPOULOU MK , TSEKOURAS CH, SIAKANTARIS MP. Campath-1H In B-Chronic Lymphocytic Leukemia. Report Of A Case Treated Thrice In A 3-Year Period. Medical Oncology 17: 70-73, 2000 Topic: Chronic Lymphocytic Leukemia Methodology: Case Report Number of Patients: 1 Citations: 20 31

Impact Factor: 2.634

13. ANGELOPOULOU MK , VASSILAKOPOULOS THP, SIAKANTARIS MP, KONTOPIDOU FN, BOUSSIOTIS VA, PAPAVASSILIOU C, KITTAS CH, PANGALIS GA. EBVD Combination Chemotherapy Plus Low Dose Involved Field Radiation Is A Highly Effective Treatment Modality For Early Stage Hodgkin’s Disease. Leukemia and Lymphoma 37: 131-143, 2000. Topic: Hodgkin Lymphoma Methodology: Retrospective Clinical Study Number of Patients: 148 Citations: 29 Impact Factor: 2.891

14. MITROPOULOS FA, ANGELOPOULOU MK , SIAKANTARIS MP, RASSIDAKIS G, PAPALAMPROS E, KALOVIDOURIS A, VAIOPOULOS G, PANGALIS GA. Primary Non-Hodgkin’s Lymphoma Of The Gallbladder. Report Of A Case And Review Of The Literature. Leukemia and Lymphoma 40: 123-131, 2000 Topic: non-Hodgkin Lymphomas Methodology: Case Report Number of Patients: 1 Citations: 28 Impact Factor: 2.891

15. SIAKANTARIS MP, ANGELOPOULOU MK , VASSILAKOPOULOS THP, DIMOPOULOU MN, KONTOPIDOU FN, PANGALIS GA. Correction Of Disease Related Anemia Of B-Chronic Lymphoproliferative Disorders By Recombinant Human Erythopoietin. Maintenance Is Necessary To Sustain Response. Leukemia and Lymphoma 40: 141-147, 2000, Topic: Non-Hodgkin Lymphomas and Chronic Lymphocytic Leukemia 32

Methodology: Retrospective Clinical Study Number of Patients: 33 Citations: 41 Impact Factor: 2.891

16. KORKOROPOULOU PA, ANGELOPOULOU MK , KONTOPIDOU FN, TSENGA AG, PATSOURIS EV, CHRISTODOULOU PN, KITTAS CH, PANGALIS GA. Retinoblastoma Gene Product And p21 (WAF 1, C1P1) Protein Expression In Non-Hodgkin’s Lymphomas. A Multivariate Analysis. Leukemia and Lymphoma 40: 647-658, 2001 Topic: non-Hodgkin Lymphomas Methodology: Clinical/Laboratory Study Number of Patients: 93 Citations: 11 Impact Factor: 2.891

17. KORKOLOPOULOU P, ANGELOPOULOU MK , SIAKANTARIS MP, MITROPOULOS F, VASSILAKOPOULOS THP, ZORZOS H, RASSIDAKIS G, ANDROULAKI A, PATSOURIS E, KITTAS CH, DAVARIS P, PANGALIS GA. Evaluation Of DNA Topoisomerase Iia Expression In Non-Hodgkin’s Lymphomas. Histopathology 38: 45-53, 2001 Topic: Non-Hodgkin Lymphomas and Chronic Lymphocytic Leukemia Methodology: Clinical/Laboratory Study Number of Patients: 153 Citations: 16 Impact Factor: 3.453

18. KYRTSONIS MC, ANGELOPOULOU MK , KONTOPIDOU FN, SIAKA- NTARIS MP, DIMOPOULOU MN, MITROPOULOS F, KALOVIDOURIS A, VAIOPOULOS GA, PANGALIS GA.

Primary Lung Involvement In Waldenstrom’s Macroglobulinemia. Report Of Two Cases And Review Of The Literature.

Acta Haematologica 105: 92-96, 2001 Topic: non-Hodgkin Lymphomas Methodology: Case Report Number of Patients: 2 Citations: 21 Impact Factor: 1.116

19. VASSILAKOPOULOS TP, NADALI G, ANGELOPOULOU MK , SIAKA- NTARIS MP, DIMOPOULOU MN, KONTOPIDOU FN, RASSIDAKIS G, DOUSSIS-ANAGNOSTOPOULOU I, HATZIOANNOU M, VAIOPOULOS G, KITTAS CH, SARRIS AH, PIZZOLO G, PANGALIS GA. Serum Interleukin10 Levels Are An Independent Prognostic Factor For Patients With Hodgkin’s Lymphoma. Haematologica 88: 274-281, 2001. Topic: Hodgkin Lymphoma Methodology: Clinical/Laboratory Study Number of Patients: 122 Citations: 74 Impact Factor: 5.814

20. PANGALIS GA, DIMOPOULOU MN, ANGELOPOULOU MK , TSEKOU- RAS CH, VASSILAKOPOULOS THP, SIAKANTARIS MP. Campath-1H (Anti-CD52) Monoclonal Antibody Therapy In Lympho- proliferative Disorders. A Review. Medical Oncology 18: 99-107, 2001. Topic: Non-Hodgkin Lymphomas and Chronic Lymphocytic Leukemia Methodology: Review Number of Patients: - Citations: 80 Impact Factor: 2.634

21. KYRTSONIS M-C, VASSILAKOPOULOS TP, ANGELOPOULOU MK , SIAKANTARIS MP, KONTOPIDOU FN, DIMOPOULOU MN, BOUSSIOTIS V, GRIBABIS DA, KONSTANTOPOULOS K, VAIOPOULOS GA, FESSAS P, KITTAS CH, PANGALIS GA. Waldenstrom’s Macroglobulinemia: Clinical Course And Prognostic Factors In 60 Patients. Annals of Hematology 80: 722-727, 2001 Topic: non-Hodgkin Lymphomas Methodology: Retrospective Clinical Study Number of Patients: 60 Citations: 80 Impact Factor: 2.634

22. VASSILAKOPOULOS TP, ANGELOPOULOU MK , SIAKANTARIS MP, KONTOPIDOU FN, DIMOPOULOU MN, BARBOUNIS A, GRIGORAKIS V, KARKANTARIS C, ANARGYROU K, CHATZIIOANOOU M, ROMBOS J, BOUSSIOTIS VA, VAIOPOULOS GA, KITTAS CH, PANGALIS GA. Prognostic Factors In Advanced Stage Hodgkin’s Lymphoma: The Significance Of The Number Of Involved Anatomical Sites. European Journal of Hematology 67: 279-288, 2001 Topic: Hodgkin Lymphoma Methodology: Retrospective Clinical Study Number of Patients: 277 Citations: 41 Impact Factor: 2.066

23. RASSIDAKIS GZ, MEDEIROS LJ, VIVIANI S, BONFANTE V, NADALI G-P, VASSILAKOPOULOS TP, MESINA O, HERLING M, ANGELO- POULOU MK , GIARDINI R, CHILOSI M, KITTAS CH, MCLAUGHLIN P, RODRIGUEZ MA, ROMAGUERA J, BONADONNA G, GIANNI AM, PIZZOLO G, PANGALIS GA, CABANILLAS F, SARRIS AH. CD20 Expression In Hodgkin And Reed-Sternberg Cells Of Classical Hodgkin’s Disease: Association With Presenting Features And Clinical Outcome. 35

Journal of Clinical Oncology 20: 1278-1287, 2002 Topic: Hodgkin Lymphoma Methodology: Clinical/Laboratory Study Number of Patients: 598 Citations: 86 Impact Factor: 18.428

24. ANGELOPOULOU MK , SIAKANTARIS MP, VASSILAKOPOULOS TP, KONTOPIDOU FN, RASSIDAKIS G, DIMOPOULOU MN, KITTAS CH, PANGALIS GA. The Splenic Form Of Mantle Cell Lymphoma. European Journal of Hematology 68: 12-21, 2002. Topic: non-Hodgkin Lymphomas Methodology: Clinical/Laboratory Study Number of Patients: 7 Citations: 44 Impact Factor: 2.066

25. PANGALIS GA, SIAKANTARIS MP, ANGELOPOULOU MK , VASSI- LAKOPOULOS TP, DIMOPOULOU MN, KYRTSONIS MC, KONSTA- NTOPOULOS K, TSAFTARIDIS P, VAIOPOULOS GA, KONTOPIDOU FN. Downstaging Rai Stage III B-Chronic Lymphocytic Leukemia Patients With The Administration Of Recombinant Human Erythropoietin. Haematologica. 87:500-6, 2002 Topic: Chronic Lymphocytic Leukemia Methodology: Retrospective Clinical Study Number of Patients: 25 Citations: 38 Impact Factor: 5.814

26. VASSILAKOPOULOS TP, NADALI G, ANGELOPOULOU MK , SIAKA- NTARIS MP, DIMOPOULOU MN, KONTOPIDOU FN, KOKORIS SI, GIANNAKAKIS A, KYRTSONIS M-C, TSAFTARIDIS P, KITTAS C, PIZZO- LO G, PANGALIS GA. 36

The Prognostic Significance Of Β2-Microglobulin In Patients With Hodgkin’s Lymphoma.

Haematologica 87:701-8; discussion 708, 2002 Topic: Hodgkin Lymphoma Methodology: Clinical/Laboratory Study Number of Patients: 232 Citations: 36 Impact Factor: 5.814

27. VASSILAKOPOULOS TP, ANGELOPOULOU MK , SIAKANTARIS MP, KONTOPIDOU FN, DIMOPOULOU MN, KARKANTARIS C, KOKORIS SI, GIANNAKAKIS A, KYRTSONIS M-C, PANGALIS GA. Hodgkin’s Lymphoma In First Relapse Following Chemotherapy Or Combined Modality Therapy: Analysis Of Outcome And Prognostic Factors After Conventional Salvage Therapy. European Journal of Hematology 68:289-98, 2002 Topic: Hodgkin Lymphoma Methodology: Retrospective Clinical Study Number of Patients: 113 Citations: 20 Impact Factor: 2.066

28. PANGALIS GA, VASSILAKOPOULOS THP, SIAKANTARIS MP, DI- MOPOULOU MN, KONTOPIDOU FN, ANGELOPOULOU MK . B-Chronic Lymphocytic Leukemia In The Year 2001. Practical Aspects. Hematological Oncology 20:103-46, 2002. Topic: B-CLL Methodology: Review Number of Patients: - Citations: 57 Impact Factor: 3.084

29. RASSIDAKIS GZ, MEDEIROS LJ, VIVIANI S, BONFANTE V, NADALI G-P, VASSILAKOPOULOS TP, HERLING M, ANGELOPOULOU MK, GIARDINI R, CHILOSI M, KITTAS C, MCDONNELL TJ, BONNADONA G, GIANNI M, PIZZOLO G, PANGALIS GA, CABANILLAS F, SARRIS AH. BCL-2 Expression In Hodgkin And Reed-Sternberg Cells Of Classical Hodgkin’s Disease Predicts A Poorer Prognosis In Patients Treated With ABVD Or Equivalent Regimens. Blood 100:3935-41, 2002 Topic: Hodgkin Lymphoma Methodology: Clinical/Laboratory Study Number of Patients: 707 Citations: 110 Impact Factor: 10.452

30. ZINZANI PL, MARTELLI M, BERTINI M, GIANNI AM, DEVIZZI L, FEDERICO M, PANGALIS G, MICHELS J, ZUCCA E, CANTONETTI M, CORTELAZZO S, WOTHERSPOON A, FERRERI AJ, ZAJA F, LAURIA F, DE RENZO A, LIBERATI MA, FALINI B, BALZAROTTI M, CALDERONI A, ZACCARIA A, GENTILINI P, FATTORI PP, PAVONE E, ANGELO- POULOU MK , ALINARI L, BRUGIATELLI M, DI RENZO N, BONIFAZI F, PILERI SA, CAVALLI F; INTERNATIONAL EXTRANODAL LYMPHOMA STUDY GROUP (IELSG). Induction Chemotherapy Strategies For Primary Mediastinal Large B-Cell Lymphoma With Sclerosis: A Retrospective Multinational Study On 426 Previously Untreated Patients. Haematologica 87:1258-64, 2002. Topic: non-Hodgkin Lymphomas Methodology: Multi-institutional Retrospective Clinical Study Number of Patients: 426 Citations: 114 Impact Factor: 5.814

31. PANGALIS GA, KYRTSONIS MC, KONTOPIDOU FN, VASSILA- KOPOULOS TP, SIAKANTARIS MP, DIMOPOULOU MN, KITTAS C, ANGELOPOULOU MK . Differential Diagnosis Of Waldenstrom's Macroglobulinemia From Other Low-Grade B-Cell Lymphoproliferative Disorders. Seminars in Oncology 30:201-5, 2003 Topic: non-Hodgkin Lymphomas Methodology: Review Number of Patients: - Citations: 24 Impact Factor: 3.898

32. VASSILAKOPOULOS TP, DOUSSIS-ANAGNOSTOPOULOU I, AN- GELOPOULOU MK , SIAKANTARIS MP, KITTAS C, PANGALIS GA. Correspondence re: M. Provencio, et al. The topoisomerase IIa expression correlates with survival in patients with advanced Hodgkin's lymphoma. Clin. Cancer Res., 9: 1406-1411, 2003. Clinical Cancer Research 9:5430-5431, 2003; author reply 5431. Topic: Hodgkin Lymphoma Methodology: Clinical/Laboratory Study Number of Patients: 59 Citations: 4 Impact Factor: 8.722

33. ANGELOPOULOU MK , NOVELLI E, GROVE JE, RINDER HM, CIVIN C, CHENG L, KRAUSE DS. Cotransplantation Of Human Mesenchymal Stem Cells Enhances Human Myelopoiesis And Megakaryocytopoiesis In NOD/SCID Mice. Experimental Hematology 31:413-20, 2003 Topic: Hematopoietic stem cell Transplantation Methodology: Experimental Study Number of Patients: - Citations: 176 Impact Factor: 2.475 39

34. PANGALIS GA, VASSILAKOPOULOS TP, MICHALIS E, ROUSSOU P, VRAKIDOU E, REPOUSIS P, ANGELOPOULOU MK , SIAKANTARIS MP, KORANTZIS J, SYMEONIDIS A, GRIGORAKIS V, STEFANOUDAKIS E, STAMATELLOU M, BOURANTAS KL, KALMANTIS TH 1, CHRISTO- POULOS G, KOKKINIS G , MICHALAKEAS I, PAPAYIANNIS A FOR THE HELLENIC COOPERATIVE LYMPHOMA GROUP. A Randomized Trial Comparing Intensified CNOP Versus CHOP In Patients With Aggressive Non-Hodgkin’s Lymphoma. Leukemia and Lymphoma 44:635-44, 2003 Topic: non-Hodgkin Lympomas Methodology: Prospective Randomized Clinical Trial Number of Patients: 143 Citations: 12 Impact Factor: 2.891

35. KORKOLOPOULOU P, GRIBABIS D, KAVANTZAS N, ANGELOPOULOU MK , SIAKANTARIS MP, PATSOURIS E, ANDROULAKI A, THYMARA I, KOKORIS SI, KYRTSONIS M-C, KITTAS C, PANGALIS GA. A Morphometric Study Of Bone Marrow Angiogenesis In Hairy Cell Leukemia With Clinicopathological Correlations British journal of Hematology 2003, 122: 900-910. Topic: Hairy cell Leukemia Methodology: Clinical/Laboratory Study Number of Patients: 44 Citations: 13 Impact Factor: 4.711

36. KYRTSONIS M-C, VASSILAKOPOULOS TP, KOKORIS SI, GRIBABIS DA, DIMOPOULOU MN, ANGELOPOULOU MK , PANGALIS GA. Serum Syndecan-1, Basic Fibroblast Growth Factor and Osteoprotegerin in Myeloma Patients at Diagnosis and During the Course of the Disease. European Journal of Hematology, 72: 252-258, 2004. 40

Topic: Multiple Myeloma Methodology: Clinical/Laboratory Study Number of Patients: 32 Citations: 44 Impact Factor: 2.066

37. VASSILAKOPOULOS TP, ANGELOPOULOU MK , SIAKANTARIS MP, KONTOPIDOU FN, DIMOPOULOU MN, KOKORIS SI, KYRTSONIS M-C, TSAFTARIDIS P, KARKANTARIS C, ANARGYROU K, BOUTSIS DE, VARIAMIS E, MICHALOPOULOS T, BOUSSIOTIS VA, PANAYIOTIDIS P, PAPAVASSILIOU C, PANGALIS GA. Eighteen-Year Experience of Combination Chemotherapy Plus Low Dose Involved Field Radiation Therapy for Early Clinical Stage Hodgkin’s Lymphoma. International Journal of Radiation, Oncology, Biology, Physics, 59 (3): 765- 781, 2004. Topic: Hodgkin Lymphoma Methodology: Retrospective Clinical Study Number of Patients: 368 Citations: 40 Impact Factor: 4.258

38. ANGELOPOULOU MK , RINDER H, WANG C, BURTNESS B, COOPER DL AND KRAUSE DS. A preclinical xenotransplantation animal model to assess human hematopoietic stem cell engraftment. Transfusion. 2004;44:555-66 . Topic: Hematopoietic stem cell Transplantation Methodology: Experimental Study Number of Patients: - Citations: 11 Impact Factor: 3.225

39. RODRIGUEZ R, PARKER P, NADEMANEE A, SMITH D, O'DONNELL MR, STEIN A, SNYDER DS, FUNG HC, KRISHNAN AY, POPPLEWELL L, COHEN S, SOMLO G, ANGELOPOULOU M , AL-KADHIMI Z, FALK PM, SPIELBERGER R, KOGUT N, SAHEBI F, SENITZER D, SLOVAK M, SCHRIBER J, FORMAN SJ. Cyclosporine and mycophenolate mofetil prophylaxis with fludarabine and melphalan conditioning for unrelated donor transplantation: a prospective study of 22 patients with hematologic malignancies. Bone Marrow Transplant, 2004;33:1123-9. Topic: Hematopoietic stem cell Transplantation Methodology: Prospective Clinical Trial Number of Patients: 22 Citations: 24 Impact Factor: 3.570

40. VASSILAKOPOULOS TP, ANGELOPOULOU MK , CONSTANTINOU N, KARMIRIS T, REPOUSSIS P, ROUSSOU P, SIAKANTARIS MP, KORKOLOPOULOU P, KYRTSONIS M-C, KOKORIS SI, DIMOPOULOU MN, VARIAMIS E, VINIOU NA, KONSTANTOPOULOS K, DIMITRIADOU EM, ANDROULAKI A, PATSOURIS E, DOUSSIS-ANAGNOSTOPOULOU IA, PANAYIOTIDIS P, BOUSSIOTIS VA, KITTAS CH, PANGALIS GA. Development and validation of a clinical prediction rule for bone marrow involvement in patients with Hodgkin’s lymphoma. Blood, 105 (5): 1875-1880, 2005. Topic: Hodgkin Lymphoma Methodology: Retrospective Clinical Study- Development of Prognostic Model Number of Patients: 1480 Citations: 40 Impact Factor: 10.452

,٭ MOLINA Α, ZAIN J, ARBER DA, ANGELOPOLOU MK .41 O’DONNELL M, MURATA-COLLINSJ, FORMAN SJ, NADEMANEE A. .Name written as Angelopolou instead of Angelopou lou ٭ 42

Durable Clinical, Cytogenetic, and Molecular Remissions After Allogeneic Hematopoietic Cell Transplantation for Refractory Sezary Syndrome and Mycosis Fungoides J Clin Oncol 2005 23:6163-6171. Topic: Hematopoietic stem cell Transplantation Methodology: Retrospective Clinical Study Number of Patients: 8 Citations: 92 Impact Factor: 18.428

42. PANGALIS GA, KYRTSONIS MC, KONTOPIDOU FN, SIAKANTARIS MP, DIMOPOULOU MN, VASSILAKOPOULOS TP, TZENOU T, KOKORIS S, DIMITRIADOU E, KALPADAKIS C, TSALIMALMA K, TSAFTARIDIS P, PANAYIOTIDIS P, ANGELOPOULOU MK . Differential diagnosis of Waldenstrom's Macroglobulinemia and other B-cell disorders. Clinical Lymphoma, 5(4): 235-240, 2005. Topic: non-Hodgkin Lymphomas Methodology: Review Number of Patients: - Citations: 25 Impact Factor: 2.020

43. KORKOLOPOULOU P, THYMARA I, KAVANTZAS N, VASSILA- KOPOULOS TP, ANGELOPOULOU MK , KOKORIS SI, DIMITRIADOU E, SIAKANTARIS MP, ANARGYROU K, PANAYIOTIDIS P, TSENGA A, ANDROULAKI A, DOUSSIS-ANAGNOSTOPOULOU I, PATSOURIS E, PANGALIS GA. Angiogenesis in Hodgkin's lymphoma: A morphometric approach in 286 patients with prognostic implications. Leukemia, 19(6): 894-900, 2005 Topic: Hodgkin Lymphoma Methodology: Clinical/Laboratory Study Number of Patients: 286 43

Citations: 38 Impact Factor: 10.431

44. PANGALIS GA, VASSILAKOPOULOS TP, KALPADAKIS C, KYR- TSONIS M-C, KOKORIS SI, ANGELOPOULOU MK , PANAYIOTIDIS P. Treatment of indolent lymphomas: from watch and wait to high dose therapy. Hematology, 10 (Suppl.1): 6-9, 2005. Topic: non-Hodgkin Lympomas Methodology: Review Number of Patients: - Citations: 7 Impact Factor: 1.253

45. VASSILAKOPOULOS TP, KYRTSONIS M-C, PAPADOGIANNIS A, NADALI G, ANGELOPOULOU MK , TZENOU T, DIMOPOULOU MN, SIAKANTARIS MP, KONTOPIDOU FN, CALPADAKIS C, KOKORIS SI, DIMITRIADOU EM, TSAFTARIDIS P, PIZZOLO G, PANGALIS GA. Serum levels of soluble syndecan-1 in Hodgkin’s lymphoma. Anticancer Research, 25 (6C): 4743-4746, 2005. Topic: Hodgkin Lymphoma Methodology: Clinical/Laboratory Study Number of Patients: 66 Citations: 20 Impact Factor: 1.826

46. VASSILAKOPOULOS TP, NADALI G, ANGELOPOULOU MK , DIMO- POULOU MN, SIAKANTARIS MP, KONTOPIDOU FN, KARKANTARIS C, KOKORIS SI, DIMITRIADOU EM, CALPADAKI C, SARANTOPOULOS A, GALANI Z, SACHANAS S, KYRTSONIS M-C, TSAFTARIDIS P, VARIAMIS E, PANAYIOTIDIS P, PIZZOLO G, SARRIS AH, PANGALIS GA.

β2-microglobulin in Hodgkin’s lymphoma: Prognostic significance in patients treated with ABVD or equivalent regimens. Journal of the Balcanic Union of Oncology, 10: 59-69, 2005. 44

Topic: Hodgkin Lymphoma Methodology: Clinical/Laboratory Study Number of Patients: 379 Citations: 2 Impact Factor: 0.741

47. VASSILAKOPOULOS TP, ANGELOPOULOU MK , SIAKANTARIS MP, KONSTANTINOU N, SYMEONIDIS A, KARMIRIS TH, REPOUSSIS P, ROUSSOU PA, DIMOPOULOS MA, KOKORIS SI, DIMITRIADOU EM, KYRTSONIS MC, DIMOPOULOU MN, TSATALAS K, KOKKINIS G, VRAKIDOU E, GRIGORAKIS V, POZIOPOULOS CH, STAMATELOU M, LIAPIS D, GEORGIOU G, PANAYIOTIDIS P, PANGALIS GA. Pure infradiaphragmatic Hodgkin’s lymphoma: Clinical features, prognostic factors and comparison with supradiaphragmatic disease. Haematologica, 91: 32-39, 2006. Topic: Hodgkin Lymphoma Methodology: Retrospective Clinical Study Number of Patients: 131 Citations: 19 Impact Factor: 5.814

48. LILAKOS K, VINIOU NA, MAVROGIANNIS D, VASSILAKOPOULOS TP, DIMOPOULOU MN, PLATA E, ANGELOPOULOU MK , VARIAMIS E, STAVROGIANNI N, LIAPIS D, XILOURIS I, GALANOPOULOS A, AGELOUDIS M, PANAYIOTIDIS P, VOULGARELIS M, ROMBOS J, MELETIS J, YATAGANAS X, PANGALIS GA. FLT3 over expression in APL patients without detectable FLT3-ITD or codon 835-836 mutations: a pilot study. Anticancer Research, 26 (2 Α): 1201-1207, 2006. Topic: Acute Leukemia Methodology: Clinical/Laboratory Study Number of Patients: 16 Citations: 2 Impact Factor: 1.826 45

49. KRISHNAN A, NADEMANEE A, FUNG H, ANGELOPOULOU M, MOLINA A, GAAL K, DAGIS A, PALMER J, ALVARNAS J, SLOVAK M, KOGUT N, POPPLEWELL L, RODRIGUEZ R, SCHRIBER J, WANG S, FORMAN SJ. Does follicularity in large cell lymphoma predict outcome after autologous stem cell transplantation?\ Biol Blood Marrow Transplant. 2006;12:641-7 Topic: Hematopoietic stem cell Transplantation Methodology: Retrospective Clinical Study Number of Patients: 332 Citations: 9 Impact Factor: 3.404

50. PANGALIS GA, KYRTSONIS M-C, VASSILAKOPOULOS TP, DIMO- POULOU MN, SIAKANTARIS MP, EMMANOUILIDES C, DOUFEXIS D, SACHANAS S, KONTOPIDOU FN, KALPADAKIS C, ANGELOPOULOU MK , DIMITRIADOU EM, KOKORIS SI, PANAYIOTIDIS P. Immunotherapeutic and immunoregulatory drugs in haematologic malignancies. Current Topics in Medicinal Chemistry, 6: 1657-1686, 2006. Topic: Hematologic Malignancies Methodology: Review Number of Patients: - Citations: 24 Impact Factor: 3.402

51. VASSILAKOPOULOS TP, ANGELOPOULOU MK , PANGALIS GA. Treatment strategies for pediatric nodular lymphocyte predominant Hodgkin’s lymphoma. Leukemia and Lymphoma, 47: 1450-1451, 2006. Topic: Hodgkin Lymphoma Methodology: Correspondence Number of Patients: -

Citations: 5 Impact Factor: 2.891

52. KYRTSONIS MC, VASSILAKOPOULOS TP, KAFASI N, SACHANAS S, TZENOU T, PAPADOGIANNIS A, GALANIS Z, KALPADAKIS C, DIMOU M, KYRIAKOU E, ANGELOPOULOU MK , DIMOPOULOU MN, SIAKANTARIS MP, DIMITRIADOU EM, KOKORIS SI, PANAYIOYIDIS P, PANGALIS GA. Prognostic value of serum free light chain ratio (FLCR) at diagnosis in multiple myeloma (MM). British Journal of Haematology, 137(3), 240-243, 2007. Topic: Multiple Myeloma Methodology: Clinical/Laboratory Study Number of Patients: 94 Citations: 95 Impact Factor: 4.711

53. KALPADAKIS C, PANGALIS GA, DIMOPOULOU MN, VASSILAKO- POULOS TP, KYRTSONIS M-C, KORKOLOPOULOU P, KONTOPIDOU FN, SIAKANTARIS MP, DIMITRIADOU EM, KOKORIS SI, TSAFTARIDIS P, PLATA E, ANGELOPOULOU MK . Rituximab monotherapy is highly effective in splenic marginal zone lymphoma. Hematological Oncology, 25, 127-131, 2007. Topic: Non-Hodgkin Lymphomas Methodology: Retrospective Clinical Study Number of Patients: 16 Citations: 61 Impact Factor: 3.084

54. ANARGYROU K, TERPOS E, VASSILAKOPOULOS TP, POULI A, SACHANAS S, TZENOU T, MASOURIDIS S, CHRISTOULAS D, ANGE- LOPOULOU MK , DIMITRIADOU EM, KALPADAKIS C, TSIONOS K, PANAYIOTIDIS P, DIMOPOULOS MA, PANGALIS GA, KYRTSONIS M-C. 47

Normalization of the serum angiopoietin-1 to angiopoietin-2 ratio reflects response in refractory/resistant multiple myeloma patients treated with bortezomib.

Haematologica/The Hematology Journal, 93: 451-454, 2008 Topic: Multiple Myeloma Methodology: Clinical/Laboratory Study Number of Patients: 35 Citations: 26 Impact Factor: 5.814

55. DOUSSIS-ANAGNOSTOPOULOU IA, VASSILAKOPOULOS TP, THY- MARA I, KORKOLOPOULOU P, ANGELOPOULOU MK , SIAKANTARIS MP, KOKORIS SI, DIMITRIADOU EM, KALPADAKIS C, MATZOURANIS M, KAKLAMANIS L, PANAYIOTIDIS P, KYRTSONIS MC, ANDROULAKI A, PATSOURIS E, KITTAS C, PANGALIS GA. Topoisomerase II α expression as an independent prognostic factor in Hodgkin’s lymphoma. Clinical Cancer Research, 14: 1759-1766, 2008 Topic: Hodgkin Lymphoma Methodology: Clinical/Laboratory Study Number of Patients: 238 Citations: 18 Impact Factor: 8.722

56. ANGELOPOULOU MK , PANGALIS GA, SACHANAS S, KOKORIS SI, ANARGYROU K, GALANI Z, KALPADAKIS C, VASSILAKOPOULOS TP. Outcome and toxicity in relapsed hairy cell leukemia patients treated with rituximab. Leukemia Lymphoma, 49: 1817-1820, 2008 Topic: Hairy cell Leukemia Methodology: Letter to the editor Number of Patients: 12 Citations: 11

Impact Factor: 2.891

57. KALPADAKIS C, PANGALIS GA, VASSILAKOPOULOS TP, KYRTSONIS MC, SIAKANTARIS MP, KONTOPIDOU FN, KORKOLOPOULOU P, BOBOTSIS P, SAHANAS S, TZENOU T, ANAGNOSTOU D, DIMITRIADOU E, YIAKOUMIS X, PATSOURIS E, ROUSSOU P, PANAYIOTIDIS P, PAPADAKI E, ANGELOPOULOU MK . Non-gastric MALT lymphomas – a single center experience on 76 patients. Leukemia Lymphoma, 2008;49:2308-15 Topic: non-Hodgkin Lymphomas Methodology: Retrospective Clinical Study Number of Patients: 76 Citations: 20 Impact Factor: 2.891

58. MANOLA KN, GEORGAKAKOS VN, STAVROPOULOU C, SPYRIDONIDIS A, ANGELOPOULOU MK , VLACHADAMI I, KATSIGIANNIS A, ROUSSOU P, PANTELIAS GE, SAMBANI C. Jumping translocations in hematological malignancies: a cytogenetic study of five cases.

Cancer Genet Cytogenet. 2008;187:85-94 . Topic: Cytogenetics Methodology: Clinical/Laboratory Study Number of Patients: 5 Citations: 13 Impact Factor: 2.975

59. SIAKANTARIS MP, PANGALIS GA, DIMITRIADOU E, KONTOPIDOU FN, VASSILAKOPOULOS TP, KALPADAKIS C, SACHANAS S, YIAKOUMIS X, KORKOLOPOULOU P, KYRTSONIS MC, BOBOTSIS P, ANDROULAKIS A, PATSOURIS E, PANAYIOTIDIS P, ANGELOPOULOU MK . Early stage gastric MALT lymphoma. Is it a true localized disease? Oncologist, 2009 ; 14: 148-54 Topic: non-Hodgkin Lymphomas 49

Methodology: Clinical/Laboratory Study Number of Patients: 62 Citations: 10 Impact Factor: 4.865

60. KALPADAKIS C, PANGALIS GA, DIMITRIADOU E, SIAKANTARIS MP, KYRTSONIS MC, XIMERIS M, TZENOU T, SAHANAS S, YIAKOUMIS X, PAPADAKI EA, PANAYIOTIDIS P, ANGELOPOULOU MK , VASSILAKO- POULOS TP. Mutation analysis of IgVH genes in splenic marginal zone lymphomas: Correlation with clinical characteristics and outcome. Anticancer Research, 2009: 29:1811-6 Topic: non-Hodgkin Lymphoma Methodology: Clinical/Laboratory Study Number of Patients: 23 Citations: 12 Impact Factor: 1.826

61. TSOPRA O, ZIROS PG, LAGADINOU ED, SYMEONIDIS A, KOU- RAKLIS-SYMEONIDIS A, THANOPOULOU E, ANGELOPOULOU MK, VASSILAKOPOULOS TP, PANGALIS GA, ZOUMBOS NC. Disease-related anemia in chronic lymphocytic leukemia is not due to intrinsic defects of erythroid precursors: a possible pathogenetic role for tumour necrosis factor-α. Acta Haematologica, 2009: 121:187-95 Topic: Chronic Lymphocytic Leukemia Methodology: Experimental Study Number of Patients: 29 Citations: 7 Impact Factor: 1.116

62. MICHAIL OP, TSIRKINIDIS P, ANDROULAKI A, GEORGIOU C, ANGELOPOULOU M , GRINIATSOS J. Retroperitoneal pararenal Castleman's disease.

West Indian Med J. 2009 Jan;58:61-4. Topic: Lymphoproliferative Syndromes Methodology: Case Report Number of Patients: 1 Citations: - Impact Factor: 0.332

63. ANARGYROU K, VASSILAKOPOULOS TP, ANGELOPOULOU MK , TERPOS E. Incorporating novel agents in the treatment of myelodysplastic syndromes.

Leuk Res. 2010;34:6-17 Topic: Myelodysplastic Syndromes Methodology: Review Number of Patients: - Citations: 12 Impact Factor: 2.351

64. TSAGARAKIS NJ, KENTROU NA, PAPADIMITRIOU KA, PAGONI M, KOKKINI G, PAPADAKI H, PAPPA V, MARINAKIS T, ANAGNOSTOPOULOS NI, VADIKOLIA C,ANAGNOSTOPOULOS A, ANGELOPOULOU MK , TERPOS E, POZIOPOULOS C, ANARGYROU K, RONTOGIANNI D, PAPADAKI T, PSARRA A, KONTOPIDOU FN, SKOUMI D, PAPADHIMITRIOU SI, PATERAKIS G, for the Hellenic Dendritic Cell Leukemia Study Group. Acute lymphoplasmacytoid dendritic cell (DC2) leukemia: Results from the Hellenic Dendritic Cell Leukemia Study Group.

Leuk Res. 2010;34:438-446 Topic: Acute Dendritic Leukemia Methodology: Clinical/Laboratory Study Number of Patients: 22 Citations: 31 Impact Factor: 2.351

65. KYRTSONIS MC, LEVIDOU G, KORKOLOPOULOU P, KOULIERIS E, BARTZI V, MALTEZAS D, PANGALIS GA, KALPADAKIS C, DIMOU M, GEORGIOU G, VASSILAKOPOULOS TP, ANGELOPOULOU MK , SALPEAS V, TSAFTARIDIS P, PATSOURIS E, PANAYIOTIDIS P, TZENOU TK. CD138 expression helps distinguishing Waldenström's macroglobulinemia (WM) from splenic marginal zone lymphoma (SMZL). Clin Lymphoma Myeloma Leuk. 2011;11:99-102. Topic: non-Hodgkin Lymphomas Methodology: Clinical/Laboratory Study Number of Patients: 69 Citations: 7 Impact Factor: 2.020

49. SACHANAS S, PANGALIS GA, VASSILAKOPOULOS TP, KORKOLOPOULOU P, KONTOPIDOU FN, ATHANASOULIA M, YIAKOUMIS X, KALPADAKIS C. GEORGIOU G, MASOURIDIS S, MOSCHOGIANNIS M, TSIRKINIDIS P, PAPPIS V, KOKORIS S, SIAKANTARIS MP, PANAYIOTIDIS P, ANGELOPOULOU MK . Combination of rituximab with chlorambucil as first line treatment in patients with mantle cell lymphoma: a highly effective regimen. Leuk Lymphoma. 2011 Mar;52:387-93. Topic: non Hodgkin Lymphomas Methodology: Clinical/Laboratory Study Number of Patients: 20 Citations: 18 Impact Factor: 2.891

66. MARNERIDES A, VASSILAKOPOULOS TP, BOLTETSOU E, LEVIDOU G, ANGELOPOULOU MK , THYMARA I, KYRTSONIS M-C, PAPPI V, TSOPRA O, PANAYOTIDIS P, BERIS P, PATSOURIS E, KORKOLOPOULOU P.

Immunohistochemical expression and prognostic significance of CCND3, MCM2, MCM7 in Hodgkin Lymphoma. Anticancer Research 2011;31: 3585-94 Topic: Hodgkin Lymphoma Methodology: Clinical/Laboratory Study Number of Patients: 138 Citations: 10 Impact Factor: 1.826

67. GEORGIOU G, EFTHYMIOU A, VARDOUNIOTI A, BOUTSIKAS G, ANGELOPOULOU MK , VASSILAKOPOULOS TP, KYRTSONIS M-C, PLATA E, TOFAS P, BITSANI A, BARTZI V, PESSACH I, DIMOU M, PANAYIOTIDIS P. Development of Acute Myeloid Leukemia with NPM1 mutation, in Ph- negative clone, during treatment of CML with Imatinib. Leukemia 26: 824-826, 2012. Topic: Acute Leukemia Methodology: Case Report and Clinical/Laboratory Study Number of Patients: 1 Citations: 4 Impact Factor: 10.431

68. . VASSILAKOPOULOS TP, PANGALIS GA, KATSIGIANNIS A, PAPAGEORGIOU S, CONSTANTINOU N, TERPOS E, ZORBALA A, VRAKIDOU E, REPOUSSIS P, POZIOPOULOS C, GALANI Z, DIMOPOULOU MN, KOKORIS SI, SACHANAS S, KALPADAKIS C, DIMITRIADOU EM, SIAKANTARIS MP, KYRTSONIS MC, DERVENOULAS J, DIMOPOULOS MA, MELETIS J, ROUSSOU P, PANAYIOTIDIS P, BERIS P, ANGELOPOULOU MK. Rituximab, cyclophosphamide, doxorubicine, vincristine and prednisone with or without radiotherapy in primary mediastinal large B- cell lymphoma: The emerging standard therapy. Oncologist, 17: 239-249, 2012.

Topic: Primary Mediastinal large B-cell Lympoma Methodology: Retrospective Clinical Study Number of Patients: 121 Citations: 40 Impact Factor: 4.865

69. DIMOU M, ANGELOPOULOU MK , PANGALIS GA, GEORGIOU G, KALPADAKIS C, PAPPI V, TSOPRA O, KOUTSOUKOS K, ZOGRAFOS E, BOUTSIKAS G, MOSCHOGIANNI M, VARDOUNIOTI I, PETEVI K, KARALI V, KANELLOPOULOS A, DALAGEORGOS T, YIAKOUMIS X, BARTZI V, BITSANI C, PESSACH E, EFTHIMIOU A, KORKOLOPOULOU P, RASSIDAKIS GZ, KYRTSONIS M-C, PATSOURIS E, MELETIS J, PANAYIOTIDIS P, VASSILAKOPOULOS TP. Autoimmune hemolytic anemia and autoimmune thrombocytopenia at diagnosis and during follow-up of Hodgkin Lymphoma. Leukemia and Lymphoma, 53: 1481-1487, 2012. Topic: Hodgkin Lymphoma Methodology: Retrospective Clinical Study Number of Patients: 1029 Citations: 7 Impact Factor: 2.891

70. PAPAGEORGIOU SG, DIAMANTOPOULOS P, LEVIDOU G, ANGELOPOULOU MK , ECONOMOPOULOU P, EFTHIMIOU A, CONSTANTINOU N, KATSIGIANNIS A, KORKOLOPOULOU P, PAPPA V, ECONOMOPOULOU C, GEORGIOU G, DIMOU M, TSIRIGOTIS P, KYRTSONIS MC, KOTSIANIDIS I, KALPADAKIS C, DIMOPOULOS MA, BERIS F, MELETIS J, PANGALIS GA, DERVENOULAS J, PANAYIOTIDIS P, VASSILAKOPOULOS TP. Isolated central nervous system relapses in primary mediastinal large B-cell lymphoma after CHOP-like chemotherapy with or without rituximab. Hematological Oncology, 31:10-17, 2013. Topic: non-Hodgkin Lymphomas Methodology: Retrospective Clinical Study

Number of Patients: 145 Citations: 10 Impact Factor: 3.084

71. KALPADAKIS C, PANGALIS GA, ANGELOPOULOU MK , SACHANAS S, KONTOPIDOU FN, YIAKOUMIS X, KOKORIS SI, DIMITRIADOU EM, DIMOPOULOU MN, MOSCHOGIANNIS M, TSAFTARIDIS P, PLATA E, PAPADAKI HE, VASSILAKOPOULOS TP. Treatment of splenic marginal zone lymphoma with rituximab monotherapy: Progress report and comparison with splenectomy. Oncologist, 18: 190-197, 2013. Topic: non Hodgkin Lympoma Methodology: Retrospective Clinical Study Number of Patients: 85 Citations: 17 Impact Factor: 4.865

72. VASSILAKOPOULOS TP, ANGELOPOULOU MK . Advanced and relapsed/refractory Hodgkin Lymphoma: What has been achieved during the last 50 years. Seminars in Hematology, 50: 4-14, 2013. Topic: Hodgkin Lymphoma Methodology: Review Number of Patients: - Citations: 7 Impact Factor: 3.274

73. MALTEZAS D, DIMOPOULOS MA, KATODRITOU I, REPOUSIS P, POULI A, TERPOS E, PANAYIOTIDIS P, DELIMPASI S, MICHALIS E, ANARGYROU K, GAVRIATOPOULOU M, STEFANOUDAKI A, TZENOU T, KOULIERIS E, SACHANAS S, DIMOU M, VASSILAKOPOULOS TP, ANGELOPOULOU MK , PANGALIS GA, KYRTSONIS MC.

Reevaluation of prognostic markers including staging, serum free light chains (sFLC) or their ratio (sFLCR), and serum lactate dehydrogenase (LDH) in multiple myeloma (MM) patients receiving novel agents. Hematological Oncology, 31; 356-362, 2013. Topic: Multiple Myeloma Methodology: Retrospective Clinical Study Number of Patients: 305 Citations: 10 Impact Factor: 3.084

74. DIAMANTOPOULOS PT, KALOTYCHOU V, POLONYFI K, SOFOTASIOU M, ANASTASOPOULOU A, GALANOPOULOS A, SPANAKIS N, VASSILAKOPOULOS T, ANGELOPOULOU M, SIAKANTARIS M, VARIAMI E, POZIOPOULOS C, TERPOS E, KOLLIA P, VINIOU NA. Correlation of Fc-gamma RIIA Polymorphisms with Latent EBV infection and LMP1 Expression in Patients with Low Grade B-Cell Lymphomas. Leukemia and Lymphoma, 54: 2030-2034, 2013. Topic: non Hodgkin Lympomas Methodology: Clinical/Laboratory Study Number of Patients: 40 Citations: 6 Impact Factor: 2.891

75. PAPANIKOLAOU X, REPOUSIS P, TZENOU T, MALTEZAS D, KOTSOPOULOU M, MEGALAKAKI K, ANGELOPOULOU M , DIMITRAKOLOULOU E, KOULIERIS E, BARTZIS V, PANGALIS G, PANAYOTIDIS P, KYRTSONIS MC. Incidence, clinical features, laboratory findings and outcome of patients with multiple myeloma presenting with extramedullary relapse. Leuk Lymphoma. 54:1459-1464, 2013. Topic: Multiple Myeloma Methodology: Retrospective Clinical Study Number of Patients: 303

Citations: 7 Impact Factor: 2.891 . 76. LEVIDOU G, SIAKANTARIS M, PAPADAKI T, PAPADAVID E, VASSILAKOPOULOS TP, ANGELOPOULOU MK , MARINOS L, NIKOLAOU V, ECONOMIDI A, ANTONIOU C, PATSOURIS E, KORKOLOPOULOU P. A comprehensive immunohistochemical approach of AKT/MTOR pathway and p-STAT3 in mycosis fungoides. Journal of the American Academy of Dermatology, 69: 375-384, 2013. Topic: non-Hodgkin Lymphomas Methodology: Clinical/Laboratory Study Number of Patients: 50 Citations: 3 Impact Factor: 4.449

77. SACHANAS S, LEVIDOU G, ANGELOPOULOU MK , MOSCHOYIANNIS M, YIAKOUMIS X, KALPADAKIS C, VASSILAKOPOULOS TP, KONTOPIDOU F, TSIRKINIDIS P, DIMITRAKOPOULOU A, KOKORIS S, DIMITRIADOU E, KYRTSONIS MC, PANAYIOTIDIS P, PAPADAKI H, PATSOURIS E, KORKOLOPOULOU P, PANGALIS GA. Apoptotic and proliferative characteristics of proliferation centers in lymph node sections of chronic lymphocytic leukemia patients. Leukemia and Lymphoma, 55:571-582, 2014 Topic: B-CLL Methodology: Clinical/Laboratory Study Number of Patients: . Citations: 3 Impact Factor: 2.891

79. GAMALETSOU MN, WALSH TJ, ZAOUTIS T, PAGONI M, KOTSOPOULOU M, VOULGARELIS M, PANAYIOTIDIS P,

VASSILAKOPOULOS T, ANGELOPOULOU MK , MARANGOS M, SPYRIDONIDIS A, KOFTERIDIS D, POULI A, SOTIROPOULOS D, MATSOUKA P, ARGYROPOULOU A, PERLORETZOU S, LECKERMAN K, MANAKA A, OIKONOMOPOULOS P, DAIKOS G, PETRIKKOS G, SIPSAS NV. A prospective cohort, multicentre study of candidaemia in hospitalized adult patients with haematologic malignancies.

Clinical Microbiology and Infection,Clin Microbiol Infect. 20:O50-57, 2014. Topic: Infections Methodology: Prospective Clinical Trial Number of Patients: 1.160.804. Citations: 8 Impact Factor: 5.768

80. ILIAKIS T, PAPADOPOULOU V, DIAMANTOPOULOS PT, PANAYIOTIDIS P, ZERVAKIS K, GIANNAKOPOULOU N, TILIMIDOS G, ANGELOPOULOU M , SIAKANTARIS MP, PANGALIS G, MANTZOURANI M, VARIAMI E, VINIOU NA. Cessation of tyrosine kinase inhibitors in patients with chronic-phase chronic myelogenous leukemia following durable complete molecular response: a single center facing the dilemma. Anticancer Res;33:3509-3514, 2013. Topic: Myeloproliferative Diseases Methodology: Retrospective Clinical Study Number of Patients: 50 Citations: - Impact Factor: 1.826

81. ANGELOPOULOU MK , KALPADAKIS C, PANGALIS GA, KYRTSONIS MC, VASSILAKOPOULOS TP. Nodal marginal zone lymphoma. Leukemia and Lymphoma;55: 1240-1250, 2014. Topic: Non-Hodgkin Lymphomas Methodology: Review

Number of Patients: 0 Citations: 5 Impact Factor: 2.891

82. KALPADAKIS C, PANGALIS GA, VASSILAKOPOULOS TP, SACHANAS S, ANGELOPOULOU MK . Treatment of splenic marginal zone lymphoma: Should splenectomy be abandoned? Leukemia and Lymphoma;55: 1463-1470, 2014. Topic: Non-Hodgkin Lymphomas Methodology: Review Number of Patients:0 Citations: 6 Impact Factor: 2.891

83. SOTIROPOULOS GC, CHARALAMPOUDIS P, ANGELOPOULOU MK , KOURAKLIS G. Acute leukemoid reaction associated with liver surgery for metastatic colorectal cancer. Int J Colorectal Dis. 2014 Jan;29(1):137-8. Topic: General Hematology Methodology: Case Report Number of Patients:1 Citations: - Impact Factor: 2.449

84. DIAMANTOPOULOS PT, POLONYFI K, SOFOTASIOU M, MANTZOURANI M, GALANOPOULOS A, SPANAKIS N, PAPADOPOULOU V, KALALA F, ILIAKIS T, ZAREIFI DS, KODANDREOPOULOU E, VASSILAKOPOULOS T, ANGELOPOULOU M , SIAKANTARIS M, TERPOS E, VARIAMI E, KOLLIA P, VAIOPOULOS G, PANGALIS G, VINIOU NA.

Survivin Messenger RNA Levels in Epstein-Barr Virus-Positive Patients With Leukemic Low-Grade B-Cell Lymphomas Expressing the Latent Membrane Protein 1: Evidence of Apoptotic Function? Clinical Lymphoma Myeloma Leukemia, 14:56-60, 2014. . Topic: Non-Hodgkin Lymphomas Methodology: Clinical/Laboratory Study Number of Patients: 64 Citations: 1 Impact Factor: 2.020

85. SARRIS K, MALTEZAS D, KOULIERIS E, BARTZIS V, TZENOU T, SACHANAS S, NIKOLAOU E, EFTHYMIOU A, BITSANI K, DIMOU M, VASSILAKOPOULOS TP, SIAKANTARIS M, ANGELOPOULOU MK , KONTOPIDOU F, TSAFTARIDIS P, KAFASI N, PANGALIS GA, PANAYIOTIDIS P, Harding S, KYRTSONIS MC. Prognostic significance of serum free light chains in chronic lymphocytic leukemia (CLL). Advances in Hematology, 2013, 359071, 2013 Topic: Chronic Lymphocytic Leukemia Methodology: Clinical/Laboratory Study Number of Patients: 143 Citations: - Impact Factor: -

86. XOCHELLI A, KALPADAKIS C, GARDINER A, BALIAKAS P, VASSILAKOPOULOS TP, MOULD S, DAVIS Z, STALIKA E, KANELLIS G, ANGELOPOULOU MK , McIVER-BROWN N, IBBOTSON R, SACHANAS S, KORKOLOPOULOU P, ATHANASIADOU A, ANAGNOSTOPOULOS A, PAPADAKI HA, PAPADAKI T, STAMATOPOULOS K, PANGALIS GA, OSCIER D. Clonal B-cell lymphocytosis exhibiting immunophenotypic features consistent with a marginal zone origin: is this a distinct entity? Blood, 2013 Dec 3. [Epub ahead of print] Topic: Lymphoproliterative Diseases

Methodology: Clinical/Laboratory Study Number of Patients: 102 Citations: 12 Impact Factor: 10.452

87. DIAMANTOPOULOS PT, POLONYFI K, SOFOTASIOU M, PAPADOPOULOU V, KALALA F, ILIKIS T, ZERVAKIS K, TSILIMIDOS G, KOUZIS P, KYRTSONIS MC, VASSILAKOPOULOS T, ANGELOPOULOU M, SIAKANTARIS M, VAYOPOULOS G, KOLLIA P, PANGALIS G, VINIOU NA. Rituximab in the treatment of EBV-positive low-grade B-cell lymphoma. Anticancer Research,33: 5693-5698, 2013. Topic: Non-Hodgkin Lymphomas Methodology: Retrospective Clinical Study Number of Patients: 44 Citations: 1 Impact Factor: 1.826

88. ASIMAKOPOULOS JV, TERPOS E, PAPAGEORGIOU L, KAMPOUROPOULOU O, CHRISTOULAS D, GIAKOUMIS A, SAMARKOS M, VAIOPOULOS G, KONSTANTOPOULOS K, ANGELOPOULOU MK, VASSILAKOPOULOS TP, MELETIS J. The presence of CD55- and/or CD59-deficient erythrocytic populations in patients with rheumatic diseases reflects an immune-mediated bone- marrow derived phenomenon. Med Sci Monit. 2014;20:123-139 Topic: Connective Tissue Diseases Methodology: Clinical/Laboratory Study Number of Patients: 244 Citations: - Impact Factor: 1.433

89. DASKALAKI MI, MOYSSAKIS I, VASSILAKOPOULOS T, MAKRIS T, SIAKANTARIS M, ANGELOPOULOU M , VAIOPOULOS G, PANGALIS G.

Effects of anthracyclines on aortic distensibility in patients with lymphomas: a prospective study. Hellenic Journal of Cardiology, 2014 (accepted for publication, ID: HJC_A864) Topic: non-Hodgin Lympomas Methodology: Prospective Clinical Trial Number of Patients: 70 Citations: - Impact Factor: 1.229

90. KANELLOPOULOS A, KOUTSI K, GEORGIOU G, NTALAGIORGOS T, PETEVI K, BOUTSIKAS G, PAPAGEORGIOU L, GAINARU G, FLEVARI P, ANGELOPOULOU MK , MELETIS J, VASSILAKOPOULOS TP. Pure red cell aplasia complicating the course of long-standing mantle cell lymphoma. International Journal of Hematology, 2014. (accepted for publication) Topic: non-Hodgkin Lympomas Methodology: Case Report Number of Patients: 1 Citations: - Impact Factor: 1.918

91. KALPADAKIS C, PANGALIS GA, ANGELOPOULOU MK , SACHANAS S, KONTOPIDOU F, MOSCHOGIANNIS M, XIMERI M, TSIRKINIDIS P, YIAKOUMIS X, PAPADAKI HA, VASSILAKOPOULOS TP. Validation of the simplified prognostic score for splenic marginal zone lymphoma of the Splenic Marginal Zone Lymphoma Study Group. Leukemia and Lymphoma, 2014 (accepted for publication). Topic: Non-Hodgkin Lymphomas Methodology: Retrospective Clinical Study Number of Patients: 120 Citations: 1 Impact Factor: 2.891

92. PALAIOLOGOU D, PANAYIOTIDIS P, PAPANIKOLAOU G, GEORGIOU G, BOUTSIKAS G, HATZINICOLAOU S-L, PANGALIS GA, SAKELLAROPOULOS N, VASSILAKOPOULOS TP, ANGELOPOULOU MK. International Journal of Laboratory Hematology 2015 Feb;37(1):e7-e10. Topic: Acute Leukemia Methodology: Clinical/Laboratory Study Number of Patients: 49 Citations: - Impact Factor: 1.819

93. LEVIDOU G, SACHANAS S, PANGALIS GA, KALPADAKIS C, YIAKOUMIS X, MOSCHOGIANNIS M, SEPSA A, LAKIOTAKI E, MILIONIS V, KYRTSONIS MC, VASSILAKOPOULOS TP, TSIRKINIDIS P, KONTOPIDOU F, KOKORIS S, SIAKANTARIS M, ANGELOPOULOU M , PAPADAKI H, KAVANTZAS N, PANAYIOTIDIS P, PATSOURIS E, KORKOLOPOULOU P.

Immunohistochemical analysis of IL-6, IL-8/CXCR2 axis, Tyr p-STAT-3, and SOCS-3 in lymph nodes from patients with chronic lymphocytic leukemia: correlation between microvascular characteristics and prognostic significance.

Biomed Research International. 2014;2014:251479 . TopicChronic Lymphocytic Leukemia Methodology: Clinical/Laboratory Study Number of Patients: 62 Citations: - Impact Factor: 1.579

94. KYRTSONIS MC, SARRIS K, KOULIERIS E, MALTEZAS D, NIKOLAOU E, ANGELOPOULOU MK , BARTZIS V, TZENOU T, DIMOU M, SIAKANDARIS MP, VINIOU NA, SACHANAS S, KALPADAKIS C, SFIKAKIS PP, PANGALIS GA, PANAYIOTIDIS P.

Serum soluble TACI, a BLyS receptor, is a powerful prognostic marker of outcome in chronic lymphocytic leukemia.

Biomed Research International. 2014;2014: 159632. Topic: Chronic Lymphocytic Leukemia Methodology: Clinical/Laboratory Study Number of Patients: 73 Citations: 1 Impact Factor: 1.579

95. ANGELOPOULOU MK , TSIRKINIDIS P, BOUTSIKAS G, VASSILAKOPOULOS TP, TSIRIGOTIS P.

New insights in the mobilization of hematopoietic stem cells in lymphoma and multiple myeloma patients.

Biomed Research International. 2014;2014: 835138 Θεµατολογία : Hematopoietic Stem Cell Mobilization/Transplantation Μεθοδολογία : Review Number of Patients: - Citations: - Impact Factor: 1.579

96. KALPADAKIS C, PANGALIS GA, SACHANAS S, VASSILAKOPOULOS TP, KYRIAKAKI S, KORKOLOPOULOU P, KOULIERIS E, MOSCHOGIANNIS M, YIAKOUMIS X, TSIRKINIDIS P, KYRTSONIS MC, LEVIDOU G, PAPADAKI HA, PANAYIOTIDIS P, ANGELOPOULOU MK .

New insights into monoclonal B-cell lymphocytosis.

Biomed Research International. 2014;2014 : 258917 Topic: Chronic Lymphocytic Leukemia Methodology: Review Number of Patients: - Citations: - Impact Factor: 1.579

97. KALPADAKIS C, PANGALIS GA, VASSILAKOPOULOS TP, KYRIAKAKI S, YIAKOUMIS X, SACHANAS S, MOSCHOGIANNIS M, TSIRKINIDIS P, KORKOLOPOULOU P, PAPADAKI HA, ANGELOPOULOU MK.

Clinical aspects of malt lymphomas.

Current Hematologic Malignancy Reports. 2014;9:262-72 Topic: non Hodgkin Lymphomas Methodology: Review Number of Patients: - Citations: 1 Impact Factor: 2.200

98. PAPAGEORGIOU SG, SACHANAS S, PANGALIS GA, TSOPRA O, LEVIDOU G, FOUKAS P, RONDOGIANNI P, SOTIROPOULOS V, IOANNIDOU HD, GASSIAMIS A, ILIAKIS T, KORKOLOPOULOU P, ANGELOPOULOU MK , PAPPA V, KONSTANTOPOULOS K, VASSILAKOPOULOS TP.

Gastric involvement in patients with primary mediastinal large B-cell lymphoma.

Anticancer Research 2014;34:6717-23. Topic: non Hodgkin Lymphomas Methodology: Retrospective Study Number of Patients: 204 Citations: - Impact Factor: 1.826

99. ANGELOPOULOU MK.

Transformed nodal marginal zone lymphoma versus diffuse large B cell lymphoma: the microRNA aspect.

Acta Haematologica. 2015;133:212-3. Topic: non Hodgkin Lymphomas Methodology: Editorial

Number of Patients: - Citations: - Impact Factor: 1.116

100. SACHANAS S, PANGALIS GA, KALPADAKIS C, LEVIDOU G, YIAKOUMIS X, MOSCHOGIANNIS M, KYRTSONIS MC, VASSILAKOPOULOS TP, TSIRKINIDIS P, SIAKANTARIS M, SPILIADI C, KARAGIANNI E, KORKOLOPOULOU P, RONTOGIANNI D, PAPADAKI H, PANAYIOTIDIS P, ANGELOPOULOU M.

Extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue (MALT) with concurrent high grade component at diagnosis: clinicopathologic features and treatment strategy. Leukemia & Lymphoma. 2015 May 12:1-3 [Epub ahead of print] . Topic: non Hodgkin Lymphomas Methodology: Clinical/Laboratory Study Number of Patients: 25 Citations: - Impact Factor: 2.891

101. VASSILAKOPOULOS TP, PANGALIS GA, CHATZIIOANNOU S, PAPAGEORGIOU S, ANGELOPOULOU MK, GALANI Z, KOURTI G, PRASSOPOULOS V, LEONIDOPOULOU T, TERPOS E, DIMOPOULOU MN, SACHANAS S, KALPADAKIS C, KONSTANTINIDOU P, BOUTSIS D, STEFANOUDAKI E, KYRIAZOPOULOU L, SIAKANTARIS MP, KYRTSONIS MC, VARIAMI E, KOTSIANIDIS I, SYMEONIDIS A, MICHALI E, KATODRITOU E, KOKKINI G, TSATALAS C, PAPADAKI H, DIMOPOULOS MA, SOTIROPOULOS V, PAPPA V, KARMIRIS T, MELETIS J, APOSTOLIDIS J, DATSERIS I, PANAYIOTIDIS P, KONSTANTOPOULOS K, ROUSSOU P, RONDOGIANNI P.

PET/CT in primary mediastinal large B-cell lymphoma responding to rituximab-CHOP: An analysis of 106 patients regarding prognostic significance and implications for subsequent radiotherapy.

Leukemia. 2015 May 14. doi: 10.1038/leu.2015.120. [Epub ahead of print]

Topic: non Hodgkin Lymphomas Methodology: Retrospective Study Number of Patients: 106 Citations: - Impact Factor: 10.431

102. KYRITSI EM, YIAKOUMIS X, PANGALIS GA, PONTIKOGLOU C, PYROVOLAKI K, KALPADAKIS C, MAVROUDI I, KOUTALA H, MASTRODEMOU S, VASSILAKOPOULOS TP, VAIOPOULOS G, DIAMANTI-KANDARAKIS E, PAPADAKI HA, ANGELOPOULOU MK.

High Frequency of Thyroid Disorders in Patients Presenting With Neutropenia to an Outpatient Hematology Clinic STROBE-Compliant Article.

Medicine (Baltimore). 2015 Jun;94(23):e886. doi: 10.1097/MD.0000000000000886. Topic: General Hematology Methodology: Prospective Study Number of Patients: 95 Citations: - Impact Factor: 5.723

103. SAKELLARI I, ANGELOPOULOU M, TSOPRA O, DERVENOULAS I, TSIRIGOTIS P, SPYRIDONIDIS A, LIGA M, TSIONOS K, ANARGYROU K, POULI A, ANAGNOSTOPOULOS A. A prospective study of incidence, clinical and quality of life consequences of oral mucositis post palifermin prophylaxis in patients undergoing high- dose chemotherapy and autologous hematopoietic cell transplantation. Annals of Hematology, accepted for publication, manuscript number: AOHE-D-15-00102R2 Topic: Hematopoietic Stem Cell Transplantation Methodology: Prospective Study Number of Patients: 39 Citations: -

Impact Factor: 2.634

104. VASSILAKOPOULOS TP, PRASSOPOULOS V, RONDOGIANNI P, CHATZIIOANNOU S, KONSTANTOPOULOSK, ANGELOPOULOU MK. Role of FDG-PET/CT in staging and first-line treatment of Hodgkin and aggressive B-cell lymphomas. MEMO – Magazine of European Medical Oncology, online first article, 16 Jun 2015 Topic: Hodgkin and non Hodgkin Lymphomas Methodology: Review Number of Patients: - Citations: - Impact Factor: -

FULL LIST OF ENGLISH PUBLICATIONS IN NON-SCI JOURNALS

Total Number: 26 Citations: 24 Self-Citations: 14 1. PANGALIS GA, POZIOPOULOS CH, ANGELOPOULOU MK , SIAKA- NTARIS M, PANAYIOTIDIS P. Εffective Treatment Of Disease Related Anemia In Β-Chronic Lymphocytic Leukemia Patients With Recombinant Human Erythropoietin. Progress in Growth Factors 1:13, 1995. Topic: Chronic Lymphocytic Leukemia Methodology: Prospective Clinical Trial Number of Patients: 9 Citations: - Impact Factor: -

2. SIAKANTARIS MP, SAMARAS IT, ANGELOPOULOU MK , KONTOPIDOU F, PANGALIS GA. The use of cytokines in the supportive care of oncology patients. Haema, 2: 64-82, 1999. Topic: Hematologic Malignancies Methodology: Review Number of Patients: - Citations: - Impact Factor: -

3. VASSILAKOPOULOS THP, ANGELOPOULOU MK , KONTOPIDOU FN, SIAKANTARIS MP, BARBOUNIS A, HADJIOANNOU M, BOUSSIOTIS VA, KITTAS CH, PANGALIS GA. Pure Infradiaphragmatic Hodgkin’s Disease. Analysis Of Twenty Five Patients And Review Of The Literature. Haema, 2: 90-100, 1999. Topic: Hodgkin Lymphoma Methodology: Retrospective Clinical Study 69

Number of Patients: 25 Citations: 4 Impact Factor: -

4. PANGALIS GA, SIAKANTARIS MP, ANGELOPOULOU MK . Treatment Of Disease Related Anemia In B-Chronic Lymphoproliferative Disorders With Recombinant Human Erythropoietin. Anemia in Oncology, 2: 2-3, 1999 Topic: Chronic Lymphocytic Leukemia Methodology: Retrospective Clinical Study Number of Patients: 33 Citations: - Impact Factor: -

5. VASSILAKOPOULOS TP, ANGELOPOULOU MK , SIAKANTARIS MP, BARBOUNIS A, DIMOPOULOU MN, KONTOPIDOU FN, KARKANTARIS C, CHATZIIOANNOU M, BOUSSIOTIS VA, VARIAMIS E, VAIOPOULOS GA, KITTAS CH, PANGALIS GA. Validation Of The International Prognostic Score In Patients With Advanced Hodgkin’s Lymphoma In A Single Hematology Unit. Haema 4: 230-235, 2001. Topic: Hodgkin Lymphoma Methodology: Retrospective Clinical Study Number of Patients: 308 Citations: 7 Impact Factor: -

6. VASSILAKOPOULOS TP, ANGELOPOULOU MK , SIAKANTARIS MP, KOKORIS SI, PANGALIS GA. Hodgkin’s lymphoma: Treatment and prognosis. Haema, 7 (Suppl. 1): S53-S63, 2004. Topic: Hodgkin Lymphoma Methodology: Review Number of Patients: - 70

Citations: 9 Impact Factor: -

7. ANGELOPOULOU MK , VASSILAKOPOULOS TP, SIAKANTARIS MP, DIMITRIADOU E, PANGALIS GA. Classification and treatment of mature T-cell non-Hodgkin’s lymphomas. Haema, 7 (Suppl. 1): S64-S75, 2004. Topic: Non-Hodgkin Lymphomas Methodology: Review Number of Patients: - Citations: 2 Impact Factor: -

8. SIAKANTARIS MP, ANGELOPOULOU MK , VASSILAKOPOULOS TP, KALPADAKI C, PANGALIS GA. Marginal zone non-Hodgkin’s lymphomas of the MALT type. Haema, (Suppl.): S117-S120, 2006. Topic: Non-Hodgkin Lymphomas Methodology: Review Number of Patients: - Citations: 1 Impact Factor: -

9. VASSILAKOPOULOS TP, PANGALIS GA, DIMITRIADOU EM, KOKORIS SI, SIAKANTARIS MP, KONTOPIDOU FN, KALPADAKIS C, KYRTSONIS MC, DIMOPOULOU MN, ANGELOPOULOU MK. Management of advanced stage Hodgkin Lymphoma. Haema, 10 ( Suppl 2): 90-98, 2007. Topic: Hodgkin Lymphoma Methodology: Review Number of Patients: - Citations: - Impact Factor: -

10. KYRTSONIS M-C, MALTEZAS D, KOULIERIS E, ZAROULIS C, TZENOU T, SACHANAS S, BARTZIS V, GEORGIOU G, DIMOU M, SIAKAVELLAS S, VASSILAKOPOULOS T, ANGELOPOULOU MK , KOUTRA E, MOUZAKI A, PANGALIS GA, PANAYIOTIDIS P. Response to Bortezomib in Refractory/Relapsed Multiple Myeloma Patients: A Single Center Experience with Discussion on Specific Issues. Asia Pasific Journal of Oncology and Hematology 2010;2:29-39 Topic: Multiple Myeloma Methodology: Retrospective Clinical Study Citations: - Impact Factor: -

11. VASSILAKOPOULOS TP, ZOGRAFOS E, PAPAGEORGIOU L, KARALI V, BOUTSIKAS G, PETEVI K, DALAGIORGOS TH, KANELLOPOULOS A, GAINAROU G, FLEVARI P, KOUTSI E, GALANI Z, BILALIS A, GEORGIOU G, ANGELOPOULOU MK , MELETIS J. Hematology Quiz – Case 26. Archives of Hellenic Medicine, 28: 718-719, 2011. Topic: Plasmacytoid Dendritic cell Neoplasias Methodology: Case Report Number of Patients: 1 Citations: - Impact Factor: -

12. PAPAGEORGIOU L, KARALI V, KANELLOPOULOS A, GAINAROU G, FLEVARI P, BOUTSIKAS G, PETEVI K, DALAGIORGOS T, KOUTSI E, TELONIS V, GALANI Z, BILALIS A, SINNI E, GEORGIOU G, ANGELOPOULOU MK , VASSILAKOPOULOS TP, MELETIS J. Hematology Quiz – Case 27. Archives of Hellenic Medicine, 28: 856-857, 2011. Topic: Non-Hodgkin Lymphomas Methodology: Case Report Number of Patients: 1 72

Citations: - Impact Factor: -

13. VASSILAKOPOULOS TP, PETEVI K, BOUTSIKAS G, KANELLOPOULOS A, BILALIS A, SINNI E, NTALAGIORGOS TH, GAINAROU G, KOUTSI E, PAPAGEORGIOU L, FLEVARI P, TELONIS V, GEORGIOU G, GALANI Z, ANGELOPOULOU MK , MELETIS J. Hematology Quiz – Case 28. Archives of Hellenic Medicine, 29: 130-131, 2012. Topic: Lympadeopathies Methodology: Case Report Number of Patients: 1 Citations: - Impact Factor: -

14. ΝΤ ALAGIORGOS T Η, GAINAROU G, KOUTSI E, PETEVI K, BOUTSIKAS G, PAPAGEORGIOU L, KANELLOPOULOS A, FLEVARI P, BOUTSIKAS G, TELONIS V, GALANI Z, BILALIS A, SINNI E, GEORGIOU G, ANGELOPOULOU MK , VASSILAKOPOULOS TP, MELETIS J. Internal Medicine Quiz – Case 18. Archives of Hellenic Medicine, 29: 136-137, 2012. Topic: Aplastic anemia - Systemic Fungal Infections Methodology: Case Report Number of Patients: 1 Citations: - Impact Factor: -

15. KANELLOPOULOS A, VASSILAKOPOULOS TP, MIKOS N, PETEVI K, BOUTSIKAS G, PAPAGEORGIOU L, GAINAROU G, FLEVARI P, KOUTSI E, TELONIS V, ZANNOU A, PANOU M, GALANI Z, BILALIS A, SINNI E, ANGELOPOULOU MK , MELETIS J. Hematology Quiz – Case 29. Archives of Hellenic Medicine, 29: 379-380, 2012. Topic: Hypereosinophilic Syndrome 73

Methodology: Case Report Number of Patients: 1 Citations: - Impact Factor: -

16. KOUTSI K, VASSILAKOPOULOS TP, PETEVI K, GAINARU G, BOUTSIKAS G, KANELLOPOULOS A, PAPAGEORGIOU L, FLEVARI P, TELONIS V, ZANNOU A, PANOU M, BILALIS A, SINNI E, TSAFTARIDIS P, ANGELOPOULOU MK , MELETIS J. Hematology Quiz – Case 30. Archives of Hellenic Medicine, 29: 511-512, 2012. Topic: Multiple Myeloma Methodology: Case Report Number of Patients: 1 Citations: - Impact Factor: -

17. GAINAROU G, VASSILAKOPOULOS TP, KOUTSI E, PAPAGEORGIOU L, PETEVI K, BOUTSIKAS G, KANELLOPOULOS A, FLEVARI P, TELONIS V, ZANNOU A, BILALIS A, SINNI E, PAPAKOSTAS E, TSAFTARIDIS P, ANGELOPOULOU MK , MELETIS J. Hematology Quiz – Case 31. Archives of Hellenic Medicine, 29: 638-639, 2012. Topic: Metastatic Neoplasms Methodology: Case Report Number of Patients: 1 Citations: - Impact Factor: -

18. DALAGIORGOS T, VASSILAKOPOULOS TP, DIMITRAKOPOULOU A, RONDOGIANNI PH, PAPAGEORGIOU L, KOUTSI E, SINNI E, PETEVI K, BOUTSIKAS G, KANELLOPOULOS A, GAINAROU G, FLEVARI P, TELONIS V, ZANNOU A, BILALIS A, PAPAKOSTAS AE, TSAFTARIDIS P, ANGELOPOULOU MK , MELETIS J. 74

Hematology Quiz – Case 32. Archives of Hellenic Medicine, 29: 761-765, 2012. Topic: Non-Hodgkin Lymphomas Methodology: Case Report Number of Patients: 1 Citations: - Impact Factor: -

19. VASSILAKOPOULOS TP, BILALIS A, PAPAGEORGIOU L, KOUTSI E, PETEVI K, BOUTSIKAS G, KANELLOPOULOS A, GAINAROU G, FLEVARI P, TELONIS V, ZANNOU A, PAPAKOSTAS AE, TSAFTARIDIS P, PLATA E, ANGELOPOULOU MK , MELETIS J. Hematology Quiz – Case 33. Archives of Hellenic Medicine, 30: 246-247, 2013. Topic: Metastatic Neoplasms Methodology: Case Report Number of Patients: 1 Citations: - Impact Factor:-

20. KYRTSONIS MC, KOULIERIS E, MALTEZAS D, TZENOU T, HARDING S, KASTRITIS E, KAFASSI N, BARTZIS V, EFTHYMIOU A, BITSANIS K, GAVRIATOPOULOU M, TERPOS E, KALPADAKIS C, ANGELOPOULOU MK , VASSILAKOPOULOS TP, BRADWELL AR, BERIS PH, PANGALIS GA, PANAYIOTIDIS P, DIMOPOULOS MA. Prognostic contribution of the new immunoglobulin (Ig) biomarkers (Freelite TM and Heavylite TM ) in Waldenstrom’s Macroglobulinemia (WM). American Journal of Medicine and Medical Sciences, 2: 136-143, 2012. Topic: Multiple Myeloma Methodology: Retrospective Clinical Study Citations: 1 Impact Factor: -

21. L. PAPAGEORGIOU, E. KOUTSI, K. PETEVI, G. BOUTSIKAS, A. KANELLOPOULOS, G. GAINAROU, P. FLEVARI, V. TELONIS, A. BILALIS, A. ZANNOU, A.E. PAPAKOSTAS, P. TSAFTARIDIS, E. PLATA, T.P. VASSILAKOPOULOS, M.K. ANGELOPOULOU , J. MELETIS. Hematology Quiz – Case 34. Archives of Hellenic Medicine, 30: 378-379, 2013. Topic: General Hematology Methodology: Case Report Number of Patients: 1 Citations: - Impact Factor:-

22. SACHANAS S, ANGELOPOULOU M , KORKOLOPOULOU M, KALPADAKIS C, TSIRKINIDIS P, MOSCHOGIANNIS M, YIAKOUMIS X, DIMITRAKOPOULOU A, VASSILAKOPOULOS TP, PANGALIS GA. Angiogenesis in chronic lymphocytic leukemia. Current Angiogenesis 2013;2: 96-103. Topic: Chronic Lymphocytic Leukemia Methodology: Rerview Number of Patients: - Citations: - Impact Factor: 1.5

23. SACHANAS S, PANGALIS GA, KALPADAKIS C, YIAKOUMIS X, MOSCHOGIANNIS M, KYRTSONIS MC, VASSILAKOPOULOS TP, TSIRKINIDIS P, KONTOPIDOU F, KOKORIS S, SIAKANTARIS M, VINIOU NA, KORKOLOPOULOU P, PAPADAKI H, PANAYIOTIDIS P, ANGELOPOULOU M . Composite lymphomas. A challenging entity? Current Cancer Therapy Reviews 2014;10: 80-89. Topic: non Hodgkin Lymphomas Methodology: Rerview Number of Patients: - Citations: - 76

Impact Factor: -

24. NIKOLAOU E, KOULIERIS E, MALTEZAS D, SARRI A, ILIAKIS T, VINIOU NA, VARDOUNIOTI I, KARALI V, PESSACH I, EFTHYMIOU A, BITSANI A, BARTZIS V, TZENOU T, DIMOU M, VASSILAKOPOULOS TP, ANGELOPOULOU M , TSAFTARIDIS P, TSALIMALMA K, KAFASSI N, PANAYIOTIDIS P, KYRTSONIS MC. Aberrant immunoglobulin variations as indicators of eventual clonal changes in symptomatic multiple myeloma patients' course. Current Cancer Therapy Reviews, 10: 90-96, 2014. Topic: Multiple Myeloma Methodology: Clinical / Laboratory Study Number of Patients: 234 Citations: - Impact Factor: -

25. ASIMAKOPOULOS J, PAPAGEORGIOU L, PETEVI K, BOUTSIKAS G, GAINAROU G, FLEVARI P, KOUTSI E, TELONIS V, ZANNOU A, TSAFTARIDIS P, PLATA E, VASSILAKOPOULOS TP, ANGELOPOULOU MK, KONSTANTOPOULOS K, MELETIS J. Hematology Quiz – Case 38. Archives of Hellenic Medicine 2015;32: 114-115. Topic: General Hematology Methodology: Case Report Number of Patients: 1 Citations: - Impact Factor:-

26. PAPAGEORGIOU L, ASIMAKOPOULOS J, PETEVI K, BOUTSIKAS G, GAINAROU G, FLEVARI P, KOUTSI E, TELONIS V, ZANNOU A, TSAFTARIDIS P, PLATA E, VASSILAKOPOULOS TP, ANGELOPOULOU MK , KONSTANTOPOULOS K, MELETIS J. Hematology Quiz – Case 39. Archives of Hellenic Medicine 2015;32: 253-254 77

Topic: General Hematology Methodology: Case Report Number of Patients: 1 Citations: - Impact Factor:-

6. CHAPTERS IN ENGLISH BOOKS AND MEETINGS’ PROCEEDINGS

Total Number: 19 Citations: 23 a. Chapters in Books 1. ANGELOPOULOU MK , PANGALIS GA. Treatment Of Low Grade Non-Hodgkin’s Lymphomas. In Malignant Lymphomas. Biology and Treatment: An Update. GA Pangalis Ed., Springer- Verlag ,Berlin, Heidelberg, New York,pp 75-102,1995.

2. PANGALIS GA, ANGELOPOULOU MK , POZIOPOULOS CH, POLLIACK A, GILLIS S. Fludarabine Monophosphate: An Effective New Agent In Leukemia And Lymphomas. In Malignant Lymphomas. Biology and Therapy: An Update. GA Pangalis Ed. Springer- Verlag, Berlin, Heidelberg, New York,pp 151-162,1995.

3. ANGELOPOULOU MK , KONTOPIDOU F, PANGALIS GA. Mantle Cell Lymphoma: Clinical Features, Diagnosis, Biology, Treatment And Prognosis. In Malignant Lymphomas. Biology and Treatment. An Update. GA Pangalis Ed. Springer- Verlag, Berlin, Heidelberg, New York, pp 151-162,1995.

b. Chapters in Meeting Proceedings 1. PANGALIS GA, ANGELOPOULOU MK , POZIOPOULOS CH. Fludarabine Monophosphate In Leukemias And Lymphomas. In New Drugs in Cancer Therapy, N. Pavlidis Ed. European School of Oncology, Monograph, pp 191-210, Corfu, Greece, 1993.

2. ANGELOPOULOU MK , PANGALIS GA. Treatment Of Low Grade Non-Hodgkin’s Lymphomas.

In Postgraduate Athens lymphoma Course, GA Pangalis and A Polliack Eds European School of Oncology, Monograph pp 309-337,Vouliagmeni, Attiki, Greece, 1993.

3. PANGALIS GA, ANGELOPOULOU MK . Cytology Of Malignant Lymphomas. In Postgraduate Athens Lymphoma Course, GA Pangalis and A Polliack Eds.European School of Oncology, Monograph pp 69-74, Vouliagmeni, Attiki, Greece, 1993.

4. ANGELOPOULOU MK , KONTOPIDOU F, VASSILAKOPOULOS TH, PANGALIS GA. B-Chronic Lymphocytic Leukaemia. Present Status. In Postgraduate Athens Leukemia-Lymphoma Course, Pangalis GA and Polliack A Eds, European School of Oncology/ European School of Hematology, Monograph, pp 285-315, Vouliagmeni, Attiki, Greece, 1995, αρ . Αναφορών : 2.

5. ANGELOPOULOU MK , DIMOPOULOU MN, SIAKANTARIS MP, KONTOPIDOU FN, RASSIDAKIS G, VASSILAKOPOULOS THP, KITTAS CH, PANGALIS GA. Μantle Cell And Nodal Monocytoid Β-Cell Lymphoma. In Kenoyer G, Mc Arthur JR, Kansu F, eds. ISH/AED (International Society of Hematology/ African And European Division) Education and Symposium Programme, pp 182-185, Durban, South Africa, 18-23 September 1999, αρ . Αναφορών : 2 .

6. ANGELOPOULOU MK , VASSILAKOPOULOS TP, DIMOPOULOU MN, SIAKANTARIS MP, KONTOPIDOU FN, CITTAS C, PANGALIS GA. B-Chronic Lymphocytic Leukemia In: UpDate In Lymphomas Educational Course, European School of Oncology, Monograph, pp. 50-52, Izmir, Turkey, 24-28 October 2000

7. ANGELOPOULOU MK , DIMOPOULOU MN, SIAKANTARIS MP, VASSILA- KOPOULOS THP, KONTOPIDOU FN, KITTAS CH, PANGALIS GA. Mantle Cell Lymphoma. In: 3 rd PanArab Cancer Congress, pp.45-48, Beirut, Lebanon, 27-30 April 2000.

8. ANGELOPOULOU MK , VASSILAKOPOULOS THP, DIMOPOULOU MN, SIAKANTARIS MP, KONTOPIDOU FN, KITTAS CH, PANGALIS GA. B-Chronic Lymphocytic Leukemia. In: 3 rd PanArab Cancer Congress, pp.50-53, Beirut, Lebanon, 27-30 April 2000.

9. ANGELOPOULOU MK , DIMOPOULOU MN, SIAKANTARIS MP, VASSI- LAKOPOULOS THP, KONTOPIDOU FN, KITTAS CH, PANGALIS GA. Nodal Monocytoid B-Cell Lymphoma. In: 3 rd PanArab Cancer Congress, pp.59-60, Beirut, Lebanon, 27-30 April 2000.

10. ANGELOPOULOU MK, VASSILAKOPOULOS TP, DIMOPOULOU MN, SIAKANTARIS MP, PANGALIS GA. B-Chronic Lymphocytic Leukemia: Biology And Treatment. Kairo 2002.

11. ANGELOPOULOU MK , VASSILAKOPOULOS TP, SIAKANTARIS MP, DIMITRIADOU E, PANGALIS GA. Classification and treatment of mature T-cell non-Hodgkin’s lymphomas. Haema, 7 (Suppl. 1): S64-S75, 2004, Αρ . Αναφορών : 2

12. VASSILAKOPOULOS TP, ANGELOPOULOU MK , SIAKANTARIS MP, KOKORIS SI, PANGALIS GA. Ηodgkin’s lymphoma: Treatment and prognosis. Haema, 7 (Suppl. 1): S53-S63, 2004, αρ . Αναφορών : 8

13. SIAKANTARIS MP, ANGELOPOULOU MK, VASSILAKOPOULOS TP , KALPADAKI C, PANGALIS GA. 81

Marginal zone non-Hodgkin’s lymphomas of the MALT type. Haema S117-120, 2006.

14. PANGALIS GA, TZENOU T, KALPADAKIS C, VASSILAKOPOULOS TP, DIMITRIADOU EM, SACHANAS S, PETRIKKOS L, ANGELOPOULOU MK , SIAKANTARIS MP, DIMOPOULOU MN, KOKORIS SI, TSA- FTARIDIS P, PANAYIOTIDIS P, KYRTSONIS MC. Biologic and clinical overlap of IgM-secreting lymphomas; focus on Waldenstrom’s Macroglobulinemia. XIth International Myeloma Workshop and IVth International Workshop on Waldenstrom’s Macroglobulinemia, June 25-30, 2007, Kos Island, Greece. Haematologica/The Hematology Journal, 92 (6, Suppl 2): 74-77, 2007.

15. VASSILAKOPOULOS TP, PANGALIS GA, DIMITRIADOU EM, KOKO- RIS SI, SIAKANTARIS MP, KONTOPIDOU FN, KALPADAKIS C, KYR- TSONIS MC, DIMOPOULOU MN, ANGELOPOULOU MK . Management of advanced stage Hodgkin Lymphoma. Haema, 10 ( Suppl 2): 90-98, 2007 .

16. PANGALIS GA, VASSILAKOPOULOS TP, KALPADAKIS C, ANGELOPOULOU MK , PANAYIOTIDIS P. B-chronic lymphocytic leukemia and small lymphocytic lymphoma. XXVII International Congress of the International Academy of Pathology, October 12-17, 2008, Athens, Greece. Citations: 1

7. ABSTRACTS PRESENTED IN INTERNATIONAL MEETINGS Total number: 297 Rank between the Authors: • 1st in: 58 • 2nd in: 57 • Last in: 41 • Other rank in: 149 Citations: 144 Slf-Citations: 80

LIST OF ABSTRACTS PRESENTED IN INTERNATIONAL MEETINGS 1. ANGELOPOULOU MK , LAFIONATIS S, PANGALIS GA. Low Grade Non-Hodgkin’s Lymphomas (LGNHL): Disease Control With Mitoxanthrone Monotherapy In Patients Refractory To Conventional Therapy. XII Meeting of the ISH (European And African Division), Abstract# 636, p. 160, Vienna, Austria, 1993.

2. PANGALIS GA, TSEKOURAS CH, BOUSSIOTIS VA, POZIOPOULOS CH, ANGELOPOULOU MK , GRIBABIS DA, KITTAS CH. Treatment Of Low Grade Non-Hodgkin’s Lymphomas With Chlorambucil

And a 2b -Interferon. 8th Meeting of the Mediteranean Blood Club, Abstract book, Jerusalem, Israel, 1993.

3. PANGALIS GA, POZIOPOULOS CH, PANAYIOTIDIS P, ANGELOPOU- LOU MK . Treatment Of Anemia In B-Chronic Lymphocytic Leukemia (B-CLL) With Recombinant Human Erythropoietin (r-HuEPO). Blood 82 (Suppl. 1), p. 574a,1993, αρ . Ανφορών : 3.

4. PANGALIS GA, PATERAKIS G, BOUSSIOTIS VA, POZIOPOULOS CH, ANGELOPOULOU MK , GRIBABIS DA, KITTAS CH.

Treatment Of Low Grade Non-Hodgkin’s Lymphomas (LGNHL) With

Chlorambucil And a-2b -Interferon (a-2b -IFN). 5th International Conference on Malignant Lymphomas, Lugano, p83, June 1993.

5. PANGALIS GA, PATERAKIS G, BOUSSIOTIS VA, PANAYIOTIDIS P, LAFIONATIS S, ANGELOPOULOU MK , KITTAS CH, PAPAVASSILIOU K. Lymphoblastic Lymphoma (LBL): Curable Disease With Intensive Treat- ment. 5th International Conference on Malignant Lymphomas, Lugano, Abstract# T244, p83, June 1993.

6. ANGELOPOULOU MK , VASILAKOPOULOS TP, PANGALIS GA. Hodgkin’s Disease Stage I And II. Implication Of Prognostic Factors In The Outcome Of 180 Patients. Br J Haematol 87 (Suppl. 1),Abstract# 805, p. 208, First Meeting of the European Haematology Association, Brussels , 1994.

7. POZIOPOULOS CH, PANAYIOTIDIS P, ANGELOPOULOU MK , PANGA- LIS GA. Treatment Of Anaemia In B-Chronic Lymphocytic Leukemia (B-CLL) With Recombinant Human Erythropoietin (R-HuEPO). Br J Haematol 87 (Suppl 1), Abstract# 901, 232, 1994.

8. TSEKOURAS CH, ANGELOPOULOU MK , PANGALIS GA. Treatment Of B-Chronic Lymphocytic Leukemia (B-CLL) With The Mono- clonal Antibody Campath-1H. Br J Haematol 87 (Suppl 1), Abstract# 920, p.237, 1994.

9. POZIOPOULOS C, PANAYIOTIDIS P, ANGELOPOULOU MK , SIAKA- NTARIS M, PANGALIS GA. Effective Treatment Of Disease Related Anaemia In B-Chronic Lympho- cytic Leukaemia Patients With Recombinant Human Erythropoietin (R- Huepo). 84

Supportive Care in Haematological Oncology, Prague, Czech Republic, Galen Press, p 120-121, Sept. 1994.

10. ANGELOPOULOU MK , SIAKANTARIS M, KONTOPIDOU F, PANGALIS GA. Mitoxanthrone Monotherapy. An Effective Treatment For Refractory To Conventional Therapy Of Low Grade Non-Hodgkin’s Lymphomas. 13 th Meeting of the International Society of Haematology (European and African Division), Istambul, Turkey, Abstract #198, 3-8 September 1995.

11. ANGELOPOULOU MK , KONTOPIDOU F, GRIBABIS DA, HATZIIOAN- NOU M, SIALKANTARIS M, PANGALIS GA. Combination Chemotherapy With Mitoxanthrone, Etoposide, Vindezine And Bleomycin As Salvage Therapy For Patients With Hodgkin’s Disease. Third International Symposium on Hodgkin’s Lymphoma, Koln, Germany, Absrtact #122, p.142, Sept. 18-23 1995, αρ . Αναφορών : 1.

12. VASSILAKOPOULOS TP, ANGELOPOULOU MK , GRIGORAKIS V, BOUSSIOTIS VA, KITTAS CH, PAPAVASSILIOU K, FESSAS PH, PANAGLIS GA. Clinical Features Of 455 Patients With Hodgkin’s Disease: A 15 Year Experience Of A Single Haematology Unit. Third International Symposium on Hodgkin’s Lymphoma., Koln, Germa- ny, Absrtact #104, p.122, Sept. 18-23, 1995, αρ . Αναφορών : 1 .

13. ANGELOPOULOU MK , SIAKANTARIS MP, KONTOPIDOU FN, PAN- GALIS GA. Mitoxanthrone Monotherapy: An Effective Treatment For Refractory Low Grade Non-Hodgkin’s Lymphomas (LGNHL) With Follicular Histology. Blood 86 (Suppl 1) 807a, 1995.

14. ANGELOPOULOU MK , SIAKANTARIS MP, PANAYIOTIDIS P, KONTO- PIDOU FN, KITTAS CH, PANGALIS GA. 85

Tonsilar Involvement In Rai 0 B-Chronic Lymphocytic Leukemia (B-CLL) Patients. A Histologic, Immunophenotypic And Adhesion Molecule Study. Blood 86 (Suppl 1) 828a, 1995, αρ Αναφορών : 3.

15. ANGELOPOULOU MK , SIAKANTARIS MP, PANGALIS GA.

A-2-Interferon ( Α-IFN) In Lymphoproliferative Diseases. New Insights in Hematology, Third Spring Meeting, Abstract p 58-59, Venice, Italy, May 1-4, 1996,.

16. VASSILAKOPOULOS THP, ANGELOPOULOU MK , PANGALIS GA. Intravenous Immunoglobulin (IVIG) Administration In B-Chronic Lypho- cytic Leukemia (B-CLL). Impact On Disease Activity. Blood 88 (Suppl 1) 222b,1996.

17. SIAKANTARIS MP, ANGELOPOULOU MK , HATZIIOANNOU M, KONTO- PIDOU F, PANAYIOTIDIS P, VAYIOPOULOS G, PANGALIS GA. Primary Sjogren’s Syndrome In B-Chronic Lymphoproliferative Disorders Br J Haematol 93 (Suppl 2) Abstract# 410, p. 105, Paris, France, 29 May- 1 June 1996.

18. VASSILAKOPOULOS THP, BARBOUNIS A, ANGELOPOULOU MK , BOUSSIOTIS VA, HATZIIOANNOU M, KONTOPIDOU F, FESSAS PH, KITTAS CH, PANGALIS GA. Prognostic Factors For Advanced Stage Hodgkin’s Disease. Br J Haematol 93 (Suppl 2) Abstract# 411, p.106, Paris, France, 29 May- 1 June 1996, αρ . Αναφορών : 1 .

19. VASSILAKOPOULOS THP, ANGELOPOULOU MK , GRIBABIS DA, SIA- KANTARIS MP, BOUSSIOTIS VA, PANGALIS GA. Immunoglobulin Disorders At Diagnosis And Course Of B-Chronic Lymphocytic Leukemia (B-CLL) Patients. Br J Haematol 93 (Suppl 2) Abstract# 457, p.117, Paris, France, 29 May- 1 June 1996, αρ . Αναφορών : 5.

20. ANGELOPOULOU MK , SIAKANTARIS MP, KONTOPIDOU FN, KITTAS CH, PANGALIS GA. Mitoxanthrone Monotherapy: Effective Treatment For Refractory Follicular Low Grade Non-Hodgkin’s Lymphomas (LGNHL). Br J Haematol 93 (Suppl 2) Abstract# 1398, p. 369, Paris, France, 29 May-1 June 1996.

21. ANGELOPOULOU MK , SIAKANTARIS MP, KOURTIS I, PANAYIOTIDIS P, KONTOPIDOU FN, KITTAS CH, PANGALIS GA. An Adhesion Molecule (AM) Study Of Blood And Tonsilar Lymphocytes In Rai 0 B-Chronic Lymphocytic Leukemia (B-CLL). Br J Haematol 93 (Suppl 2) Abstract#: 1088, p:287, Paris, France, 29 May-1 June 1996, αρ . Αναφορών : 2.

22. BARBOUNIS A, VASSILAKOPOULOS THP, ANGELOPOULOU MK , KO- NTOPIDOU F, HATZIIOANNOU M, BOUSSIOTIS VA, PANGALIS GA Comparison of alternating MOPP/A(E)BVD and hybrid MOPP/A(E)BV in the treatment of advanced Hodgkin’s disease. Annals of Oncology, 7(Suppl.3):114, Sixth International Conference on Malignant Lymphoma, Lugano, Switzerland, 1996.

23. ANGELOPOULOU MK , VASSILAKOPOULOS THP, KONTOPIDOU F, BOUSSIOTIS VA, PANGALIS GA. Comparison Of MOPP And A(E)BVD Regimens In Stage IA And IIA Hodgkin’s Disease. Annals of Oncology, 7(Suppl.3):110, Sixth International Conference on Malignant Lymphoma, Lugano, Switzerland, 1996.

24. ANGELOPOULOU MK, VASSILAKOPOULOS THP, KONTOPIDOU F, BOUSSIOTIS VA, PANGALIS GA. Prognostic Factors For Early Stage Hodgkin’s Disease. Annals of Oncology, 7(Suppl.3):109, Sixth International Conference on Malignant Lymphoma, Lugano, Switzerland, 1996, αρ . Αναφορών : 1.

25. VASSILAKOPOULOS THP, ANGELOPOULOU MK , PANGALIS GA. Intravenous Immunoglobulin (IVIG) Administration In B-Chronic Lymphocytic Leukemia (B-CLL): Impact On Disease Activity. Fourth International Symposium on IVIG, Interlaken, Switzerland, 1996.

26. VASSILAKOPOULOS TP, ANGELOPOULOU MK , GRIBABIS DA, ROUSSOU PA, PANGALIS GA. The Evolution Of Immunoglobulin Disorders In B-Chronic Lymphocytic Leukemia (B-CLL). VII International Workshop On CLL, Abstract Book: 024, and Hematol Cell Ther 39(Suppl 1): S101,Crete, Greece, 2-4 May 1997.

27. SIAKANTARIS MP, ANGELOPOULOU MK , KONTOPIDOU FN, POZIO- POULOS C, PANAYIOTIDIS P, PANGALIS GA. Effective Treatment Of Disease Related Anaemia With Recombinant Human Erythropoietin (r-HuEPO) In B-Chronic Lymphocytic Leukemia (B- CLL) Patients. VII International Workshop On CLL, Abstract Book: 085, and Hematol Cell Ther 39 (Suppl 1) S 95, Crete, Greece, 2-4 May 1997.

28. ANGELOPOULOU MK , SIAKANTARIS MP, KONTOPIDOU FN, BOUS- SIOTIS VA, PANGALIS GA. Treatment Of B-Chronic Lymphocytic Leukemia (B-CLL) With Chlorambucil And α2b-Interferon ( α2b-IFN). VII International Workshop On CLL, Abstract Book: 101, and Hematol Cell Ther 39(Suppl 1): S101, Crete, Greece, 2-4 May 1997.

29. TSEKOURAS C, ANGELOPOULOU MK , PANGALIS GA. Treatment Of B-Chronic Lymphocytic Leukemia With Monoclonal Antibodies. VII International Workshop On CLL, Abstract Book: 103, and Hematol Cell Ther 39(Suppl 1): S102, Crete, Greece, 2-4 May 1997.

30. ANGELOPOULOU MK , SIAKANTARIS MP, KONTOPIDOU FN, BOUS- SIOTIS VA, PANGALIS GA. Treatment Of B-Chronic Lymphocytic Leukemia (B-CLL) With Chlorambucil And α2b-Interferon ( α2b-IFN). 10 th Meeting of the Mediterranean Blood Club, Thessaloniki, Greece, Abstract# 11, p.67, June 12-15, 1997 .

31. SIAKANTARIS MP, ANGELOPOULOU MK , KONTOPIDOU F, POZIO- POULOS CH, PANAYIOTIDIS P, PANGALIS GA. Effective Treatment Of Disease Related Anaemia With Recombinant Human Erythropoietin (rHuEPO) In Patients With B-Chronic Lymphoproliferative Diseases (BCLD). 10 th Meeting of the Mediterranean Blood Club, Thessaloniki, Greece, Abstract# 35, p.91, June 12-15, 1997 .

32. ANGELOPOULOU MK , KAPIRIS E, KOURTIS I, SIAKANTARIS MP, KITTAS CH, PANGALIS GA. The Adhesion Molecule Profile Of Mantle Cell Lymphoma (MCL) Vs B- Chronic Lymphocytic Leukemia (B-CLL). Blood 90 (Suppl 1, Part 1) 522a 1997, αρ . Αναφορών : 4.

33. ANGELOPOULOU MK , KAPIRIS E, KOURTIS I, SIAKANTARIS MP, KITTAS CH, PANGALIS GA. The Adhesion Molecule (AM) Profile Of B-Chronic Lymphocytic Leukemia (B-CLL). Correlation With Disease Activity. Blood 90 (Suppl 1, Part 2) 294b 1997, αρ Αναφορών : 3.

34. ANGELOPOULOU MK , VASSILAKOPOULOS THP, SIAKANTARIS MP, KONTOPIDOU FN, BOUSSIOTIS VA,PAPAVASSILIOU C, KITATS CH, PANGALIS GA. EBVD Combination Chemotherapy Plus Low Dose Involved Field Radiation Therapy For The Treatment Of Early Clinical Stage (CS) Hodgkin’s Disease (HD). Leukemia and Lymphoma, 29(Suppl 1): p62, 1998, αρ . Αναφορών : 1. 89

35. VASSILAKOPOULOS THP, ANGELOPOULOU MK , KONTOPIDOU F, BOUSSIOTIS VA, KITATS CH, PANGALIS GA. Pure Infradiafragmatic Hodgkin’s Disease: Treatment With Chemotherapy With Or Without Radiation Therapy. Leukemia and Lymphoma, 29(Suppl 1): P74, 1998.

36. VASSILAKOPOULOS THP, ANGELOPOULOU MK , SIAKANTARIS MP, KONTOPIDOU F, BOUSSIOTIS VA, PANGALIS GA. Hodgkin’s Disease In First Relapse, After Complete Remission Achieved By Chemotherapy ± Radiation Therapy: An Analysis Of Outcome And Prognostic Factors. Leukemia and Lymphoma, 29(Suppl 1): P156, 1998, αρ . Αναφορών : 2.

37. ANGELOPOULOU MK , SIAKANTARIS MP, KONTOPIDOU F, RASSI- DAKIS G, VOSKARIDOU E, KITTAS CH, PANGALIS GA. The Splenic Form Of Mantle Cell Lymphoma. Blood, 92 (Suppl. 1): 241a, 1998, αρ . Αναφορών : 4.

38. ANGELOPOULOU MK , SIAKANTARIS MP, PANGALIS GA. Downstaging Rai Stage III B-Chronic Lymphocytic Leukemia (B-CLL) Pa- tients By The Successful Administration Of Recombinant Human Erythropoietin (R-HuEPO) Could Change The Natural History Of The Disease. Blood, 92 (Suppl. 1): 273b, 1998, αρ . Αναφορών : 2.

39. VASSILAKOPOULOS THP, BARBOUNIS A, ANGELOPOULOU MK , SIA- KANTARIS MP, HADGIIOANNOU M, BOUSSIOTIS VA, KITTAS CH, PANGALIS GA. Validation Of The Prognostic Score Derived From The International Prognostic Factors Project (IPFP) For Advanced Hodgkin’s Disease In Patients From A Single Hematology Unit. Ann Oncol 10 (Suppl. 3): 586, Lugano, Switzerland, 2-5 June 1999.

40. GUENOVA M, RASIDAKIS GZ, ANGELOPOULOU MK , GORGOULIS VG, SIAKANTARIS MP, KANAVAROS P, KITTAS C, PANGALIS GA. P16 INK4A Is Regularly Expressed And Related To Retinoblastoma Protein In Hodgin’s Disease: Comparison With p53 And MDM2 Protein Status And The Presence Of Epstein-Barr Virus. Ann Oncol 10 (Suppl. 3): 585, Lugano, Switzerland, 2-5 June 1999.

41. MICHALIS E, SIAKANTARIS MP, ANGELOPOULOU MK , NODAROS K, KITTAS CH, PANGALIS GA. Administration Of The Chimeric Anti-CD20 Monoclonal Antibody (Rituximab®) In Patients With Low Grade Follicular Lymphomas. Haematologica, 84 (EHA-4 Abstract):14, 1999 .

42. VASSILAKOPOULOS THP, ANGELOPOULOU MK , SYMEONIDIS A, KARMIRIS TH, REPOUSIS P, GRIGORAKIS V, KOKKINIS G, KONSTA- NTINOU N, POZIOPOULOS CH, STAMATELOU M, VRAKIDOU E, DIMOPOULOS A-M, LIAPIS D, ROUSSOU PA, PANGALIS GA Pure Infradiaphragmatic Hodgkin’s Disease (IDHD): The Experience Of The Hellenic Cooperative Lymphoma Group. Blood 94(Suppl.1, Part 2): 256b, 1999.

43. ANGELOPOULOU MK , PEREZ L, RINDER H, KRAUSE DS Dose Response Relationship Between The Number Of CD34+ Peripheral Blood Stem Cells (PBSC) Administered And Human Platelet Enlargement In NOD/SCID mice. 35 th Annual Meeting ACLPS (Academy of Clinical Laboratory Physicians and Scientists), June 8-10, Marriott Pavle Hotel, Salt Lake City, Utah, USA, 2000

44. RASSIDAKIS GZ, VASSILAKOPOULOS THP, ANGELOPOULOU MK, BALASKAS C, SIAKANTARIS MP, DIMOPOULOU MN, GUENOVA M,

DOUSSIS-ANAGNOSTOPOULOU I, GORGOULIS VG, KITTAS CH, PANGALIS GA. Expression Of p27 kip1 In Hodgkin’s Disease: Relation To Proliferative Activity And EBV Status. The Hematology Journal, 1(Suppl 1 - EHA-5 Abstracts): 678, Birmingham, UK, 2000, αρ . Αναφορών : 2.

45. KYRTSONIS M-C, ANGELOPOULOU MK , SIAKANTARIS MP, KONTO- PIDOU FN, DIMOPOULOU MN, VASSILAKOPOULOS THP, MARKAKIS K, KITTAS CH, PANGALIS GA. Waldenstrom’s Macroglobulinaemia (WM): Clinical Course And Prognostic Factors In 60 Patients. The Hematology Journal, 1(Suppl 1 - EHA-5 Abstracts): 697, Birmingham, UK, 2000.

46. VASSILAKOPOULOS THP, SARRIS AH, ANGELOPOULOU MK , SY- MEONIDES A, KARMIRIS TH, REPOUSSIS P, KONSTANTINOU N, GRIGORAKIS V, KOKKINIS G, DIMOPOULOS MA, POZIOPOULOS CH, STAMATELOU M, VRAKIDOU E, LIAPIS D, POUSSOU PA, CABA- NILLAS F, PANGALIS GA. A Cooperative Retrospective Study Of Pure Infradiaphragmatic Hodgkin’s Disease (IDHD) The Hematology Journal, 1(Suppl 1 - EHA-5 Abstracts): 701, Birmingham, UK, 2000.

47. KORKOLOPOULOU P, ANGELOPOULOU MK , SIAKANTARIS MP, VAS- SILAKOPOULOS THP, ZORZOS H, DIMOPOULOU MN, PATSOURIS E, KITTAS CH, PANGALIS GA. Prognostic Relevance Of DNA Topoisomerase II α Expression In Non- Hodgkin’s Lymphomas. The Hematology Journal, 1(Suppl 1 - EHA-5 Abstracts): 709, Birmingham, UK, 2000.

48. DIMOPOULOU MN, VASSILAKOPOULOS THP, ANGELOPOULOU MK, SIAKANTARIS MP, ANTONIADES M, KONTOPIDOU FN, PATERAKIS G, VARIAMIS E, VINIOU N-A, BOUSSIOTIS VA, VAIOPOULOS G, KIT- TAS CH, PANGALIS GA. Treatment Of Lymphoblastic Lymphoma (LBL) With The L-17M Protocol Of The MSKCC. Experience From A Single Haematology Unit In 40 Patients. The Hematology Journal, 1(Suppl 1 - EHA-5 Abstracts): 721, Birmingham, UK, 2000.

49. ANGELOPOULOU MK , MICHALIS E, VASSILAKOPOULOS THP, SIA- KANTARIS MP, KONTOPIDOU FN, DIMOPOULOU MN, KITTAS CH, PANGALIS GA. Primary Mediastinal Large B-Cell Lymphoma (PMLBL) With Sclerosis. Experience Of A Single Haematology Unit. The Hematology Journal, 1(Suppl 1 - EHA-5 Abstracts): 723, Birmingham, UK, 2000.

50. PANGALIS GA, DIMOPOULOU MN, ANGELOPOULOU MK , TSEKOU- RAS C, SIAKANTARIS MP. Campath-1H Administration For The Treatment Of B-Chronic Lymphocytic Leukemia And Low Grade Non-Hodgkin’s Lymphomas. Haematolgica 85 (Suppl. 7), p:22, Venice, Italy, July 9-12, 2000.

51. SIAKANTARIS MP, GONIS NK, ANGELOPOULOU MK , KOURTIS I, KONTOPIDOU FN, DIMOPOULOU MN, VASSILAKOPOULOS THP, KITTAS CH, PANGALIS GA. Low Grade Gastric MALT Lymphoma (LGGMALT) Clinical Stage I. A Seemingly Localized Disease. Blood 96(11): 329a, 2000, αρ . Αναφορών : 7.

52. VASSILAKOPOULOS THP, NADALI G, ANGELOPOULOU MK , SIA- KANTARIS MP, DIMOPOULOU MN, KONTOPIDOU FN, RASSIDAKIS

GZ, DOUSSIS-ANAGNOSTOPOULOU IA, HATZIOANNOU M, KITTAS CH, SARRIS AH, PIZZOLO G, PANGALIS GA Serum Interleukin-10 (sIL-10) Levels Are A Potent, Independent Progno- stic Factor For Hodgkin’s Lymphoma (HL), Treated With Standard Chemotherapy Regimens. Blood 96(11): 727a, 2000

53. SARRIS AH, MEDEIROS LJ, RASSIDAKIS GZ, NADALI G, VIVIANI S, VASSILAKOPOULOS THP, GIARDINI R, CHILOSI M, KITTAS CH, ANGELOPOULOU MK , HERLING M, HAGEMEISTER FB, RODRIGUEZ MA, ROMAGUERA J, MCLAUGHLIN P, FORD R, GIANNI M, BOBA- DONNA G, PANGALIS GA, PIZZOLO G, CABANILLAS F. Bcl-2 Expression In Hodgkin-Reed-Sternberg Cells (HRS) Of Patients (PTS) With Classical Hodgkin’s Disease (CHD) Is Associated With Lower Progression-Free Survival (PFS). Blood 96(11): 725a, 2000, αρ . Αναφορών : 9

54. DIMOPOULOU MN, SIAKANTARIS MP, KONTOPIDOU FN, ANGELO- POULOU MK , DOUSSIS-ANAGNOSTOPOULOU IA, KORKOLOPOU- LOU P, KITATS CH, PANGALIS GA. Anti-CD20 Monoclonal Antibody (MabThera®) Administration Post Chlorambucil In Mantle Cell Lymphoma (MCL) Patients Leads To Eradication Of Minimal Residual Disease. Blood 96(11): 236b, 2000

55. VASSILAKOPOULOS TP, NADALI G, ANGELOPOULOU MK , SIAKA- NTARIS MP, DIMOPOULOU MN, KONTOPIDOU FN, CHATZIIOANNOU M, KITTAS CH, PANGALIS GA. The Significance Of Beta-2 Microglobulin In Hodgkin’s Lymphoma. The Hematology Journal, 1 (Suppl 1 - EHA-6 Abstracts): 561, Frankfurt, Germany, 2001.

56. SIAKANTARIS MP, VASSILAKOPOULOS TP, ANGELOPOULOU MK, DIMOPOULOU MN, BARBOUNIS A, GRIBABIS DA, KONTOPIDOU FN, CHATZIIOANNOU M, BOUSSIOTIS VA, KITTAS C, PANGALIS GA. MOPP/ABVD(E) Alternating And Hybrid Regimens In The Treatment Of Advanced Hodgkin’s Lymphoma. The Hematology Journal, 1(Suppl 1 - EHA-6 Abstracts): 564, Frankfurt, Germany, 2001.

57. VASSILAKOPOULOS TP, ANGELOPOULOU MK , SIAKANTARIS MP, KONTOPIDOU FN, DIMOPOULOU MN, BARBOUNIS A, CHATZIIOAN- NOU M, BOUSSIOTIS VA, KITTAS C, PANGALIS GA. Prognostic Factors In Advanced Stage Hodgkin’s Lymphoma (HL): The Significance Of The Number Of Involved Sites (NIS). The Hematology Journal, 1 (Suppl 1 - EHA-6 Abstracts): 569, Frankfurt, Germany, 2001.

58. SIAKANTARIS MP, GONIS NK, ANGELOPOULOU MK , KOURTIS I, KONTOPIDOU FN, DIMOPOULOU MK, VASSILAKOPOULOS TP, KORKOLOPOULOU P, KITTAS C, PANGALIS GA. Low Grade Gastric MALT Lymphoma Clinical Stage I. A Seemingly Localized Disease? B Cell Lymphoproliferative Disorders II, Amsterdam, The Netherlands, Abstarct# 38, June 2-5 2001.

59. ANGELOPOULOU MK , RINDER H, GROVE J, KRAUSE DS. Human Mesenchymal Stem Cells Enhance Human Hematopoietic Stem Cell Engraftment In NOD/SCID Mice. ISHAGE, Toronto, Canada, June 2001 ( Βραβείο Καλύτερης Προφορικής Παρουσίασης ).

60. VASSILAKOPOULOS THP, NADALI G, ANGELOPOULOU MK , SIAKA- NTARIS MP, DIMOPOULOU MN, PANGALIS GA.

The Prognostic Significance Of Β2-Microglobulin In Hodgkin’s Lymphoma. Leukemia and Lymphoma 42 (Suppl.2): P-172, 2001, αρ . Αναφορών : 2 95

61. VASSILAKOPOULOS THP, SARRIS AH, NADALI G, ANGELOPOULOU MK , SYMEONIDES A, KONSTANTINOU N, KARMIRIS TH, ZANOTTI R, REPOUSSSIS P, TSATALAS C, GRIGORAKIS V, KOKKINIS G, DIMOPOULOS MA, POZIOPOULOS CH, STAMATELOU M, VRAKIDOU E, LIAPIS D, ROUSSOU PA, PIZZOLO G, CABANILLAS F, PANGALIS GA. A Cooperative Retrospective Study Of Pure Infradiaphragmatic Hodgkin’s Lymphoma (IDHL). Leukemia and Lymphoma 42 (Suppl.2): P-92, 2001.

62. SIAKANTARIS MP, ANGELOPOULOU MK , VASSILAKOPOULOS TP, DIMOPOULOU MN, KYRTSONIS M-C, TSAFTARIDIS P, KONTOPIDOU FN, PANGALIS GA. “Downstaging” Rai Stage III B-Chronic Lymphocytic Leukemia Patients With The Administration Of Recombinant Human Erythropoietin. Blood 98(11): 634a, 2001, αρ . Αναφορών : 1.

63. ANGELOPOULOU MK , RINDER H, BURTNESS B, COOPER D, KRAUSE DS. Preclinical Xenotransplantation Model To Assess Human Hematopoietic Stem Cell Engraftment. Blood 98(11): 643a, 2001 .

64. KYRTSONIS M-C, SIAKANTARIS MP, VASSILAKOPOULOS TP, KO- KORIS SI, GIANNAKAKIS A, ANGELOPOULOU MK , PANGALIS GA. Longtudinal Study Of Serum Vascular Endothelial Growth Factor (VEGF), Basic Fibroblast Factor (bFGF) And Syndecan-1 In Patients With Multiple Myeloma. Blood 98(11): 299b, 2001.

65. KONTOPIDOU FN, KYRTSONIS M-C, ANGELOPOULOU MK , SIAKA- NTARIS MP, DIMOPOULOU MN, VASSILAKOPOULOS TP, KORKOLO- POULOU P, KOKORIS SI, TSAFTARIDIS P, KITTAS C, PANGALIS GA. 96

Immunophenotypic Findings In Lymphoplasmacytic Lymphoma, Including Waldenstrom’s Macroglobulinemia (WM) And Non-IgM Secreting Cases (LPL). Proceedings Of The Second International Workshop On Waldenstrom’s Macroglobulinemia, p. 62, Athens, 2002, αρ . Αναφορών : 1.

66. KYRTSONIS M-C, ANGELOPOULOU MK , VASSILAKOPOULOS TP, KONTOPIDOU FN, SIAKANTARIS MP, DIMOPOULOU MN, KORKOLO- POULOU P, KOKORIS SI, TSAFTARIDIS P, KITTAS C, PANGALIS GA. Waldenstrom’s Macroglobulinemia (WM) And Non-IgM Secreting Lymphoplasmacytic Lymphoma (LPL): Comparative Study In 108 Patients From A Single Institution. Proceedings Of The Second International Workshop On Waldenstrom’s Macroglobulinemia, p. 63, Athens, 2002, αρ . Αναφορών : 2.

67. PANGALIS GA, KYRTSONIS M-C, VASSILAKOPOULOS TP, SIAKA- NTARIS MP, KONTOPIDOU FN, KITTAS C, ANGELOPOULOU MK. Differential Diagnosis Of Waldenstrom’s Macroglobulinemia WM From Other B-Chronic Lymphoproliferative Disorders (LPDS). Proceedings Of The Second International Workshop On Waldenstrom’s Macroglobulinemia, p. 64, Athens, 2002.

68. KYRTSONIS M-C, VASSILAKOPOULOS TP, ANGELOPOULOU MK , REPOUSIS P, PANAYIOTIDIS P, SIAKANTARIS MP, KONTOPIDOU FN, VRAKIDOU E, DIMOPOULOU MN, KORKOLOPOULOU P, GIAN- NOULIS S, KITTAS C, PANGALIS GA. Prognostic Factors In Waldenstrom’s Macroglobulinemia (WM). Proceedings Of The Second International Workshop On Waldenstrom’s Macroglobulinemia, p. 65, Athens, 2002.

69. VASSILAKOPOULOS TP, SIAKANTARIS MP, ANGELOPOULOU MK, KONTOPIDOU FN, DIMOPOULOU MN, CHATZIIOANNOU M, BARBOU- NIS A, VARIAMIS E, BOUSSIOTIS VA, KITTAS C, PAPAVASSILIOU K, VAIOPOULOS G, FESSAS PH, PANGALIS GA. 97

Hodgkin’s Lymphoma (HL) In First Relapse Following Chemotherapy ± Radiotherapy (CT ±RT): Prognostic Factors For The Outcome Of Conventional Salvage Therapy. The Hematology Journal, 3 (Suppl 1 – EHA 7 Abstracts): 561, Florence, Italy, 6-9 June 2002.

70. VASSILAKOPOULOS TP, ANGELOPOULOU MK , SIAKANTARIS MP, DIMOPOULOU MN, KORKOLOPOULOU P, KONTOPIDOU FN, KARKA- NTARIS C, KOKORIS SI, GIANNAKAKIS A, BARBOUNIS A, KONSTA- NTOPOULOS K , VARIAMIS E, ROMBOS J, ANARGYROU K, BOUTSIS D, BOUSSIOTIS VA, FESSAS PH, KITTAS C, PANGALIS GA. Prediction Of Bone Marrow Involvement On The Basis Of Clinical And Laboratory Characteristics Of Patients With Hodgkin’s Lymphoma. The Hematology Journal, 3 (Suppl 1 – EHA 7 Abstracts): 849, Florence, Italy, 6-9 June 2002.

71. VASSILAKOPOULOS TP, ANGELOPOULOU MK , SIAKANTARIS MP, DIMOPOULOU MN, KORKOLOPOULOU P, KONTOPIDOU FN, KARKA- NTARIS C, KOKORIS SI, GIANNAKAKIS A, BARBOUNIS A, KONSTA- NTOPOULOS K , VARIAMIS E, ROMBOS J, ANARGYROU K, BOUTSIS D, BOUSSIOTIS VA, FESSAS PH, KITTAS C, PANGALIS GA. Prediction Of Bone Marrow Involvement On The Basis Of Clinical And Laboratory Characteristics Of Patients With Hodgkin’s Lymphoma. Ann Oncol 13(Suppl 2):205, Lugano, Switzerland, 12-15 June 2002.

72. KARMIRIS T, VASSILAKOPOULOS TP, ANGELOPOULOU MK , BALTA- DAKIS J, SIAKANTARIS MP, KONTOPIDOU FN, GRIGORIOU E, KON- STANTINOU N, CHRISTAKIS J, REPOUSIS P, STEFANOUDAKI E, NI- KIFORAKIS E, KITTAS C, PAPVASSILIOU K, PANGALIS GA, for THE HELLENIC COOPERATIVE LYMPHOMA GROUP. Bulky Mediastinal Hodgkin’s Disease: A Decade Experience With A Combined Modality Approach. Ann Oncol 13(Suppl 2): 407 Lugano, Switzerland, 12-15 June 2002.

73. VASSILAKOPOULOS TP, SIAKANTARIS MP, ANGELOPOULOU MK, KONTOPIDOU FN, DIMOPOULOU MN, CHATZIIOANNOU M, BARBOU- NIS A, VARIAMIS E, BOUSSIOTIS VA, KITTAS C, PAPAVASSILIOU K, VAIOPOULOS G, FESSAS PH, PANGALIS GA. Hodgkin’s Lymphoma (HL) In First Relapse Following Chemotherapy ± Radiotherapy (CT ±RT): Prognostic Factors For The Outcome Of Conventional Salvage Therapy. Ann Oncol 13(Suppl 2): 416 Lugano, Switzerland, 12-15 June 2002.

74. VASSILAKOPOULOS TP, ANGELOPOULOU MK , SIAKANTARIS MP, GRIGORAKI V, DIMOPOULOU MN, KONTOPIDOU FN, GRIBABIS D, BARBOUNIS A, KARKANTARIS C, KOKORIS SI, ANARGYROU K, KYRTSONIS M-C, TSAFTARIDIS P, BOUTSIS DE, VARIAMIS E, KONSTANTOPOULOS K , ROMBOS J, VAIOPOULOS G, BOUSSIOTIS VA, KITTAS C, PANGALIS GA. Secondary Malignancies (SM) After Treatment of Hodgkin’s Lymphoma (HL): A Single Center Study Of Patients Predominantly Treated with Chemotherapy (CT) +/- Limited Field And Dose Radiotherapy (RT) Blood 100 (11): 274b, 2002.

75. KYRTSONIS M-C, VASSILAKOPOULOS TP, KONTOPIDOU FN, ANGE- LOPOULOU MK , SIAKANTARIS MP, DIMOPOULOU MN, KOKORIS SI, TSAFTARIDIS P, KORKOLOPOULOU P, KITTAS C, PANGALIS GA. Clinical And Laboratory Features In Lymphoplasmacytic Lymphoma(LPL): Study Of 108 Patients With Either Waldenstrom’s Macroglobulinemia (WM) Or Non-IgM Secreting LPL. Blood 100 (11): 281b, 2002.

76. VASSILAKOPOULOS THP, SARRIS AH, NADALI G, VIVIANI S, ANGE- LOPOULOU MK , KONSTANTINOU N, SYMEONIDIS A, SIAKANTARIS MP, KARMIRIS TH, REPOUSSIS P, ROUSSOU PA, DIMOPOULOS MA, TSATALAS K, KOKKINIS G, VRAKIDOU E, GRIGORAKIS V, ZANNOTI

R, POZIOPOULOS CH, STAMATELOU M, LIAPIS D, PIZZOLO G, CABANILLAS F, PANGALIS GA. Pure Infradiaphragmatic (ID) Hodgkin’s Lymphoma (HL): Amulticenter Study. Blood 100 (11): 772a, 2002.

77. VASSILAKOPOULOS TP, ANGELOPOULOU MK , SIAKANTARIS MP, DIMOPOULOU MN, KORKOLOPOULOU P, KONTOPIDOU FN, KAR- KANTARIS C, KOKORIS SI, GIANNAKAKIS A, BARBOUNIS A, KON- STANTOPOULOS K , VARIAMIS E, ROMBOS J, ANARGYROU K, BOUTSIS D, BOUSSIOTIS VA, FESSAS PH, KITTAS C, PANGALIS GA. Prediction Of Bone Marrow Involvement On The Basis Of Clinical And Laboratory Characteristics Of Patients With Hodgkin’s Lymphoma. Blood 100 (11): 772a, 2002.

78. SIAKANTARIS MP, KONTOPIDOU FN, KYRTSONIS M-C, VASSILAKO- POULOS TP, KOKORIS SI, DIMOPOULOU MN, DIMITRIADOU EM, ANGELOPOULOU MK , PANGALIS GA. VH Analysis In Familial Chronic Lymphocytic Leukemia (B-CLL). X International Workshop on CLL, S 38, Stresa, Lake Maggiore, Italy, 10- 12 October 2003.

79. PANGALIS GA, ANGELOPOULOU MK , SIAKANTARIS MP, TSITSIKAS A, VASSILAKOPOULOS TP, KONTOPIDOU FN, KYRTSONIS M-C, TZENOU T, KORKOLOPOULOU P, PANAYIOTIDIS P. Tonsilar Involvement In B-Chronic Lymphocytic Leukemia (B-CLL): Experience On 19 Patients. X International Workshop on CLL, S 38, Stresa, Lake Maggiore, Italy, 10- 12 October 2003.

80. KONTOPIDOU FN, ANGELOPOULOU MK , KYRTSONIS M-C, VASSILA- KOPOULOS TP, SIAKANTARIS MP, KOKORIS SI, DIMITRIADOU EM, DIMOPOULOU MN, DIMITRAKOPOULOU A, TSAFTARIDIS P, VARIA- MIS E, PANGALIS GA. 100

CD38 Expression As A Marker Of Disease Progression in Patients With Binet Stage A B-Chronic Lymphocytic Leukemia (B-CLL). X International Workshop on CLL, S 39, Stresa, Lake Maggiore, Italy, 10- 12 October 2003.

81. ANGELOPOULOU MK , NADEMANEE A, DAGIS A, MOLINA A, FUNG HC, PARKER PM, O’DONNELL MR, STEIN A, FALK P, KRISHNAN A, KOGUT N, RODRIGUEZ R, SAHEBI F, SMITH EP, SNYDER D, SPIELBERGER R, ZAIN J, POPPLEWELL L, SMITH D, FORMAN SJ. Comparison Of Outcome Of High Dose Chemotreapy (HDT) And Autologous Stem Cell Transplantation (ASCT) In Peripheral T Cell Lymphoma (PTCL) Vs Diffuse Large B Cell Lymphoma (B-DLCL). Blood, 102:247a, Forty-fifth Annual Meeting of the American Society of Hematology), San Diego, California, USA, December 6-9, 2003, (oral presentation).

82. VASSILAKOPOULOS TP, ANGELOPOULOU MK , SIAKANTARIS MP, KYRTSONIS M-C, KONTOPIDOU FN, DIMOPOULOU MN, KOKORIS SI, DIMITRIADOU E, TSAFTARIDIS P, VARIAMIS E, ZAMBATIS C, MICHALOPOULOS E, BOUSSIOTIS VA, PANAGIOTIDIS P, PAPA- VASSILEIOU K, PANGALIS GA. Fifteen Year Experience Of A(E)BVD Chemotherapy Plus Low Dose Involved Field Radiation Therapy For Early Clinical Stage Hodgkin’s Lymphoma (HL). Does Radiation Dose Affect Patients’ Outcome? Blood 102:405a, Forty-fifth Annual Meeting of the American Society of Hematology), San Diego, California, USA, December 6-9, 2003.

83. MOLINA A, ZAIN J, ARBER DA, ANGELOPOULOU M , O’DONNELL MR, PARKER P, MURATA-COLLINS J, FUNG H, POPPLEWELL L, KRISH- NAN A, RAUBITSCHECK A, RODRIGUEZ R, FORMAN SJ, NADEMA- NEE A. Is allogeneic Hematopoietic Stem Cell Transplantation (AHSCT) Pote- ntially Curative In A Group Of Refractory Cutaneius T-Cell Lymphomas

101

(CTCLs)? Durable Clinical, Cytogenetic And Molecular Remissions After AHSCT For Refractory Sezary Syndrome And Mycosis Fungoides. Blood, 102: 476a, Forty-fifth Annual Meeting of the American Society of Hematology), San Diego, California, USA, December 6-9, 2003.

84. SIAKANTARIS MP, KONTOPIDOU FN, KYRTSONIS M-C, VASSILAKO- POULOS TP, KOKORIS SI, DIMOPOULOU MN, DIMITRIADOU EM, ANGELOPOULOU MK , PANGALIS GA. VH Analysis In Familial Chronic Lymphocytic Leukemia (B-CLL). Blood 102: 670a, Forty-fifth Annual Meeting of the American Society of Hematology), San Diego, California, USA, December 6-9, 2003.

85. KRISHNAN A, FUNG H, ANGELOPOULOU M , MOLINA A, GAAL K, KOGUT N, NADEMANEE A, POPPLEWELL L, RAUBITSCHECK A, RODRIGUEZ R, SMITH D, FORMAN SJ. Does Follicularity In Large Cell lymphoma Predict Outcome Following Autologous Stem Cell Transplantation (ASCT)? Blood 102:733a, Forty-fifth Annual Meeting of the American Society of Hematology), San Diego, California, USA, December 6-9, 2003.

86. KYRTSONIS M-C, DIMOPOULOS MA, VASSILAKOPOULOS TP, ANGELOPOULOU MK , REPOUSSIS P, ZERVAS K, PANAGIOTIDIS P, SIAKANTARIS MP, DIMOPOULOU MN, SYMEONIDIS A, BOURANTAS K, VRAKIDOU E, XYLOURI E, PANGALIS GA. Development And Validation Of A Prognostic Model For Waldenstrom’s Macroglobulinemia (MW). Blood 102:273b, Forty-fifth Annual Meeting of the American Society of Hematology), San Diego, California, USA, December 6-9, 2003, αρ . Αναφορών : 1.

87. ANGELOPOULOU MK, NADEMANEE A, DAGIS A, MOLINA A, FUNG H, PARKER PM, O’DONNELL MR, STEIN A, FALK P, KRISHNAN A, KOGUT R, RODRIGUEZ R, SAHEBI F, SMITH EP, SNYDER D, SPIELBERGER R, ZAIN J, POPPLEWELL L, SMITH D, FORMAN SJ. 102

Comparison of outcome of diffuse large B-cell lymphoma vs peripheral T- cell lymphoma with high dose chemotherapy and autologous stem cell transplantation. 30 th Annual Meeting of the European Group for Blood and Marrow Transplantation, Barcelona, Spain, March 28-31, 2004, Bone Marrow Transplantation 33(Suppl 1), S36

88. VASSILAKOPOULOS TP, ANGELOPOULOU MK , CONSTANTINOU N, KARMIRIS T, REPOUSSIS P, ROUSSOU P, SIAKANTARIS MP, KORKOLOPOULOU P, KYRTSONIS M-C, KOKORIS SI, DIMOPOULOU MN, VARIAMIS E, DIMITRIADOU E, PANAYIOTIDIS P, KITTAS C, PANGALIS GA. Development and validation of a clinical prediction rule for bone marrow involvement (BMI) in patients with Hodgkin’s Lymphoma (HL). Nineth Congress of the European Haematology Association, June 10-13, 2004, Geneva, Switzerland. The Hematology Journal, 5 (Suppl 2): S117, 2004.

89. SIAKANTARIS MP, TZENOU T, VASSILAKOPOULOS TP, KYRTSONIS MC, ANGELOPOULOU MK , DIMOPOULOU MN, KOKORIS SI, DIMI- TRIADOU EM, KORKOLOPOULOU P, PATSOURIS E, VARIAMIS E, LA- SKARIS G, PANGALIS GA. Lymphoma of the oral cavity. Ten-year experience of a single Haematology Unit. Nineth Congress of the European Haematology Association, June 10-13, 2004, Geneva, Switzerland. The Hematology Journal, 5 (Suppl 2): S117, 2004.

90. VASSILAKOPOULOS TP, ANGELOPOULOU MK , SIAKANTARIS MP, KYRTSONIS M-C, KONTOPIDOU FN, DIMOPOULOU MN, KOKORIS SI, DIMITRIADOU E, TSAFTARIDIS P, VARIAMIS E, ZAMBATIS H, MICHA- LOPOULOS T, BOUSSIOTIS VA, PANAYIOTIDIS P, PAPAVASSILIOU K, PANGALIS GA.

103

A(E)BVD chemotherapy (CT) plus low dose involved field radiation therapy (RT) for early clinical stage Hodgkin’s Lymphoma (HL): The effect of radiation dose on relapse free survival (RFS). Nineth Congress of the European Haematology Association, June 10-13, 2004, Geneva, Switzerland. The Hematology Journal, 5 (Suppl 2): S122- S123, 2004.

91. SIAKANTARIS MP, KYRTSONIS MC, TZENOU T, DIMITRIADOU EM, DIMOPOULOU MN, ANGELOPOULOU MK , KOKORIS SI, VASSILAKO- POULOS TP, KORKOLOPOULOU P, GIANNAKAKIS A, PATSOURIS E, KATSAMBAS A, PANGALIS GA. Management of primary cutaneous T- and B-cell lymphoma with interferon alpha-2b (IFN-α). A single center experience. Nineth Congress of the European Haematology Association, June 10-13, 2004, Geneva, Switzerland. The Hematology Journal, 5 (Suppl 2): S123, 2004, αρ . Αναφορών : 1.

92. KORKOLOPOULOU P, THYMARA I, KAVANTZAS N, VASSILAKOPOU- LOS TP, ANGELOPOULOU MK , KOKORIS SI, DIMITRIADOU EM, SIA- KANTARIS MP, DIMOPOULOU MN, ANARGYROU K, PANAYIOTIDIS P, ANDROULAKIS A, DOUSSIS-ANAGNOSTOPOULOU IA, PATSOU- RIS E, PANGALIS GA. Angiogenesis in Hodgkin’s lymphoma: A morphometric approach in 286 patients with prognostic implications. Nineth Congress of the European Haematology Association, June 10-13, 2004, Geneva, Switzerland. The Hematology Journal, 5 (Suppl 2): S205, 2004 (oral presentation).

93. KORKOLOPOULOU P, THYMARA I, VASSILAKOPOULOS TP, KAVAN- TZAS N, ANGELOPOULOU MK , KOKORIS SI, ANDROULAKIS A, PA- TSOURIS E, PANGALIS GA. Prognostic implications of angiogenesis in Hodgkin's lymphoma: a morphometric approach.

104

Sixth International Symposium on Hodgkin’s Lymphoma, September 18- 21, 2004, Cologne, Germany. European Journal of Haematology, 73 (Suppl. 65): 31 (D09), 2004.

94. VASSILAKOPOULOS TP, DOUSSIS-ANAGNOSTOPOULOU IA, KA- RANDREA D, KORKOLOPOULOU P, ANGELOPOULOU MK , SIAKA- NTARIS MP, PATSOURIS E, KITTAS CH, PANGALIS GA. Topoisomerase II alpha expression in Hodgkin's lymphoma: correlations with clinicopathologic features and treatment outcome. Sixth International Symposium on Hodgkin’s Lymphoma, September 18- 21, 2004, Cologne, Germany. European Journal of Haematology, 73 (Suppl. 65): 35 (D19), 2004.

95. VASSILAKOPOULOS TP, ANGELOPOULOU MK , KONSTANTINOU N, KARMIRIS T, REPOUSSIS P, ROUSSOU P, KOKORIS SI, DIMITRIA- DOU EM, PANGALIS GA. Development and validation of a clinical prediction rule for bone marrow involvement (BMI) in patients with Hodgkin's lymphoma (HL) Sixth International Symposium on Hodgkin’s Lymphoma, September 18- 21, 2004, Cologne, Germany. European Journal of Haematology, 73 (Suppl. 65): 35 (D20), 2004 (oral presentation).

96. VASSILAKOPOULOS TP, KYRTSONIS M-C, PAPADOYIANNI A, SIAKA- NTARIS MP, DIMOPOULOU MN, KOKORIS SI, DIMITRIADOU EM, ANGELOPOULOU MK , PANGALIS GA. Serum levels of syndecan-1 in patients with Hodgkin's lymphoma (HL). Sixth International Symposium on Hodgkin’s Lymphoma, September 18- 21, 2004, Cologne, Germany. European Journal of Haematology, 73 (Suppl. 65): 35 (D21), 2004.

97. VASSILAKOPOULOS TP, ANGELOPOULOU MK , SIAKANTARIS MP, KYRTSONIS M-C, DIMOPOULOU MN, KOKORIS SI, DIMITRIADOU EM, PAPAVASSILIOU C, PANGALIS GA. 105

The effect of radiation dose on relapse free survival (RFS) of patients with early clinical stage Hodgkin's lymphoma (HL) after A(E)BVD chemotherapy. Sixth International Symposium on Hodgkin’s Lymphoma, September 18- 21, 2004, Cologne, Germany. European Journal of Haematology, 73 (Suppl. 65): 41 (E13), 2004 (oral presentation, αρ . Αναφορών : 1).

98. VASSILAKOPOULOS T, ANGELOPOULOU MK , SIAKANTARIS MP, PANGALIS GA. Conventional and biological prognostic factors in Hodgkin’s lymphoma. Proceedings / Educational Book, 5 th Congress of the Balkan Union of Oncology, 14-17 October 2004, Beograd, Serbia and Montenegro, p. A- 11, abstract OP43.

99. SIAKANTARIS MP, KYRTSONIS MC, TZENOU T, DIMITRIADOU EM, DIMOPOULOU MN, ANGELOPOULOU MK , KOKORIS SI, VASSILAKO- POULOS TP, KORKOLOPOULOU P, GIANNAKAKIS A, PLATA E, PA- TSOURIS E, KATSAMBAS A, PANGALIS GA. Interferon alpha-2b (IFN-α) is an efective agent for the treatment of primary cutaneous T- and B-cell lymphoma. Forty-sixth Annual Meeting of the American Society of Hematology, San Diego, California, USA, December 4-7, 2004. Blood 104: 723a, 2004, αρ . Αναφορών : 1.

100. SIAKANTARIS MP, TZENOU T, VASSILAKOPOULOS TP, KYRTSONIS MC, ANGELOPOULOU MK , DIMOPOULOU MN, KOKORIS SI, DIMI- TRIADOU EM, KORKOLOPOULOU P, PATSOURIS E, TSAFTARIDIS P, VARIAMIS E, LASKARIS G, PANGALIS GA. Lymphoma of the oral cavity. A rare entity with favorable prognosis. Ten- year experience of a single Hematology Unit. Forty-sixth Annual Meeting of the American Society of Hematology, San Diego, California, USA, December 4-7, 2004. Blood 104: 233b, 2004, αρ . Αναφορών : 1.

106

101. DIMOPOULOU MN, ANGELOPOULOU MK , VASSILAKOPOULOS TP, KYRTSONIS MC, KOUMBIS D, KONTOPIDOU FN, SIAKANTARIS MP, KALPADAKIS C, KOKORIS SI, DIMITRIADOU E, PANGALIS GA. B-chronic lymphocytic leukemia (B-CLL), small lymphocytic lymphoma (SLL) and Waldenstrom’s Macroglobulinemia (MW): A comparative FISH analysis. Forty-sixth Annual Meeting of the American Society of Hematology, San Diego, California, USA, December 4-7, 2004. Blood 104: 283b, 2004.

102. KYRTSONIS MC, VASSILAKOPOULOS TP, PAPADOGIANNIS A, TZE- NOU T, DIMOPOULOU MN, SIAKANTARIS MP, KOKORIS SI, DIMI- TRIADOU EM, ANGELOPOULOU MK , KALPADAKI C, PANGALIS GA. Serum soluble syndecan-1 levels correlate with erythropoietin and inversely with hemoglobin levels in untreated anaemic myeloma patients: Possible role of syndecan-1 in the mechanisms of chronic anaemia. Forty-sixth Annual Meeting of the American Society of Hematology, San Diego, California, USA, December 4-7, 2004. Blood 104: 303b, 2004 . 103. VASSILAKOPOULOS TP, DOUSSIS-ANAGNOSTOPOULOU IA, KA- RANDREA D, KORKOLOPOULOU P, ANGELOPOULOU MK , SIAKA- NTARIS MP, KOKORIS SI, DIMITRIADOU EM, DIMOPOULOU MN, KALPADAKI C, KYRTSONIS M-C, PATSOURIS E, KITTAS C, PAN- GALIS GA. High topoisomerase II α (topoII α) expression is an independent prognostic factor in Hodgkin's lymphoma treated with ABVD and equivalent regimens with or without radiotherapy (RT). Tenth Congress of the European Haematology Association, June 2-5, 2005, Stockholm, Sweden. Haematologica/The Hematology Journal, 90 (Suppl 2): 72, 2005. . 104. VASSILAKOPOULOS TP, ANGELOPOULOU MK , SIAKANTARIS MP, KOKORIS SI, DIMITRIADOU EM, DIMOPOULOU MN, KYRTSONIS M- C, TSAFTARIDIS P, KALPADAKI C, PRASSAS E, VARIAMIS E, VY- NIOU NA, ROMBOS Y, PANAYIOTIDIS P, MICHAIL P, PANGALIS GA. 107

Very late relapses in patients with Hodgkin's lymphoma. Tenth Congress of the European Haematology Association, June 2-5, 2005, Stockholm, Sweden. Haematologica/The Hematology Journal, 90 (Suppl 2): 72, 2005, αρ . Αναφορών : 1.

105. VASSILAKOPOULOS TP, GALANI Z, ANGELOPOULOU MK , SIAKA- NTARIS MP, DIMOPOULOU MN, KONTOPIDOU FN, KOKORIS SI, KALPADAKI C, SARANTOPOULOS A, SACHANAS S, KYRTSONIS M- C, TSAFTARIDIS P, KARKANTARIS C, VYNIOU NA, VARIAMIS E, PAN- GALIS GA. The prognostic significance of serum lactate dehydrogenase (LDH) levels in patients with Hodgkin's lymphoma (HL). Tenth Congress of the European Haematology Association, June 2-5, 2005, Stockholm, Sweden. Haematologica/The Hematology Journal, 90 (Suppl 2): 73, 2005.

106. VASSILAKOPOULOS TP, ANGELOPOULOU MK , KALPADAKI C, SIA- KANTARIS MP, KOKORIS SI, DIMITRIADOU EM, DIMOPOULOU MN, KONTOPIDOU FN, KYRTSONIS M-C, TSAFTARIDIS P, VARIAMIS E, VYNIOU NA, PANAYIOTIDIS P, PANGALIS GA. Hodgkin's lymphoma (HL) in the elderly: Outcome after treatment with anthracycline-based chemotherapy with or without radiotherapy (RT) and comparison with the subgroup of younger patients. Tenth Congress of the European Haematology Association, June 2-5, 2005, Stockholm, Sweden. Haematologica/The Hematology Journal, 90 (Suppl 2): 72, 2005.

107. VASSILAKOPOULOS TP, ANGELOPOULOU MK , GALANI Z, SACHA- NAS S, KATSIGIANNIS A, DIMOPOULOU MN, KOKORIS SI, MICHALI E, DIMITRIADOU EM, SIAKANTARIS MP, KONTOPIDOU F, KALPA- DAKI C, SARANTOPOULOS A, KORKOLOPOULOU P, ROUSSOU P, PANGALIS GA.

108

Primary mediastinal (thymic) large B-cell lymphoma (PMLBCL): Excellent outcome with the combination of rituximab-CHOP (R-CHOP) and radiotherapy (RT). Tenth Congress of the European Haematology Association, June 2-5, 2005, Stockholm, Sweden. Haematologica/The Hematology Journal, 90 (Suppl 2): 103, 2005, αρ . Αναφορών : 3 .

108. VASSILAKOPOULOS TP, ANGELOPOULOU MK , SACHANAS S, ZOR- BALA A, SIAKANTARIS MP, KOKORIS SI, DIMITRIADOU EM, DIMO- POULOU MN, KALPADAKI C, KYRTSONIS M-C, TSAFTARIDIS P, MICHAIL P, PANAYIOTIDIS P, PANGALIS GA. Conventional prognostic factors in clinical stage IA/IIA Hodgkin's lymphoma (HL) after treatment with ABVD-based combined modality therapy (CMT). Tenth Congress of the European Haematology Association, June 2-5, 2005, Stockholm, Sweden. Haematologica/The Hematology Journal, 90 (Suppl 2): 141, 2005 (oral presentation).

109. DIMOPOULOU MN, KALPADAKIS C, DIMITRIADOU EM, KYRTSONIS M-C, KOKORIS SI, TSAFTARIDIS P, KONTOPIDOU FN, SIAKANTARIS MP, PLATA E, VASSILAKOPOULOS TP, ANGELOPOULOU MK , PANGALIS GA. Rituximab treatment for splenic marginal zone B-cell lymphomas (SMZL). Tenth Congress of the European Haematology Association, June 2-5, 2005, Stockholm, Sweden. Haematologica/The Hematology Journal, 90 (Suppl 2): 272, 2005, αρ . Αναφορών : 4.

110. KALPADAKIS C, SIAKANTARIS MP, KYRTSONIS M-C, VASSILAKO- POULOS TP, TZENOU T, DIMOPOULOU MN, KOKORIS SI, DIMITRIA- DOU EM, ANGELOPOULOU MK , MITROPOULOS F, KORKOLO- POULOU P, PANGALIS GA. Non-gastrointestinal extranodal marginal zone B-cell lymphomas (EMZL) : A single center experience.

109

Tenth Congress of the European Haematology Association, June 2-5, 2005, Stockholm, Sweden. Haematologica/The Hematology Journal, 90 (Suppl 2): 272, 2005, αρ . Αναφορών : 1.

111. DIMOPOULOU MN, ANGELOPOULOU MK , SIAKANTARIS MP, KYR- TSONIS MC, KOUMBI D, VASSILAKOPOULOS TP, KONTOPIDOU FN, KALPADAKIS C, PANGALIS GA. Fluorescence in situ hybridization (FISH) cytogenetic analysis of B- chronic lymphocytic leukemia (B-CLL), small lymphocytic lymphoma (SLL) and Waldenstrom’s Macroglobulinemia (MW). Tenth Congress of the European Haematology Association, June 2-5, 2005, Stockholm, Sweden. Haematologica/The Hematology Journal, 90 (Suppl 2): 465, 2005.

112. DIMOPOULOU MN, KONTOPIDOU FN, VASSILAKOPOULOS TP, SIA- KANTARIS MP, KYRTSONIS MC, DIMITRIADOU EM, PLATA E, KALPA- DAKIS C, KOKORIS SI, DIMITRAKOPOULOU A, SARANTOPOULOS A, KORKOLOPOULOU P, ANGELOPOULOU MK , PANGALIS GA. Immunophenotypic analysis of splenic marginal zone B-cell lymphomas (SMZL). Tenth Congress of the European Haematology Association, June 2-5, 2005, Stockholm, Sweden. Haematologica/The Hematology Journal, 90 (Suppl 2): 466, 2005.

113. BOBOTSI P, SIAKANTARIS MP, ANGELOPOULOU MK , DIMITRIADOU EM, DIMOPOULOU MN, KALPADAKI C, KOKORIS SI, KYRTSONIS MC, PLATA E, TSAFTARIDIS P, VASSILAKOPOULOS TP, SAKELLA- ROPOULOS N, TZIVRAS M, KORKOLOPOULOU P, PATSOURIS E, PANGALIS GA. Clinical outcome of patients (pts) with low grade gastric MALT lymhoma (LGGML). A single center experience. Gastroenterology, 128 (4 Suppl. 2): A294-A295, 2005.

110

114. VASSILAKOPOULOS TP, ANGELOPOULOU MK , GALANI Z, SACHA- NAS S, KATSIGIANNIS A, DIMOPOULOU MN, KOKORIS SI, MICHALIS E, DIMITRIADOU EM, SIAKANTARIS MP, KONTOPIDOU FN, KALPA- DAKI C, SARANTOPOULOS A, KORKOLOPOULOU P, ROUSSOU P, PANGALIS GA. Excellent outcome with rituximab-CHOP (R-CHOP) combined with radiotherapy (RT) in primary mediastinal large B-cell lymphoma (PMLBCL). Forty-seventh Annual Meeting of the American Society of Hematology, Atlanta, Georgia, USA, December 10-13, 2005. Blood 106: 275a, 2005, αρ . Αναφορών : 2.

115. VASSILAKOPOULOS TP, DOUSSIS-ANAGNOSTOPOULOU IA, KA- RANDREA D, KORKOLOPOULOU P, ANGELOPOULOU MK , SIAKA- NTARIS MP, KOKORIS SI, DIMITRIADOU EM, DIMOPOULOU MN, KALPADAKI C, KYRTSONIS M-C, THIMARA I, KAVANTZAS N, PA- NAYIOTIDIS P, PATSOURIS E, KITTAS C, PANGALIS GA. Topoisomerase II α (topoII α) expression in Hodgkin's lymphoma (HL): Correlations with conventional and biological markers and prognostic significance under treatment with ABVD or equivalent regimens with or without radiotherapy (RT). Forty-seventh Annual Meeting of the American Society of Hematology, Atlanta, Georgia, USA, December 10-13, 2005. Blood 106: 275a, 2005, αρ . Αναφορών : 1.

116. SIAKANTARIS MP, KYRTSONIS M-C, LILAKOS K, ANGELOPOULOU MK , VAVOURAKIS S, KONTOPIDOU FN, VASSILAKOPOULOS TP, KALPADAKIS C, KOKORIS SI, DIMITRIADOU EM, KILINDIREAS C, PANGALIS GA. Molecular analysis of VH gene usage in a familial case of Waldenstrom’s Macroglobulinemia. Forty-seventh Annual Meeting of the American Society of Hematology, Atlanta, Georgia, USA, December 10-13, 2005. Blood 106: 295a, 2005.

111

117. KYRTSONIS MC, VASSILAKOPOULOS TP, PAPADOGIANNIS A, TZE- NOU T, KALPADAKIS C, ANTONIADIS A, DIMOPOULOU MN, SIAKA- NTARIS MP, KOKORIS SI, DIMITRIADOU EM, ANGELOPOULOU MK , PLATA E, TSAFTARIDIS P, PANGALIS GA. Serum soluble syndecan-1 levels at diagnosis constitute an independent prognostic factor of survival in myeloma that may further differentiate patients within the ISS stages. Forty-seventh Annual Meeting of the American Society of Hematology, Atlanta, Georgia, USA, December 10-13, 2005. Blood 106: 951a, 2005.

118. KALPADAKIS C, SIAKANTARIS MP, KYRTSONIS M-C, VASSILAKO- POULOS TP, TZENOU T, DIMOPOULOU MN, DIMITRIADOU EM, KO- KORIS SI, ANGELOPOULOU MK , MITROPOULOS F, KORKOLOPOU- LOU P, PANGALIS GA. Retrospective analysis of 41 consecutive patients with non-gastrointestinal (GI) extranodal marginal zone B-cell lymphoma (EMZL) : Correla- tion of clinical characteristics and outcome with disease localization. Forty-seventh Annual Meeting of the American Society of Hematology, Atlanta, Georgia, USA, December 10-13, 2005. Blood 106: 276b, 2005, αρ . Αναφορών : 1.

119. DIMOPOULOU MN, KALPADAKIS C, DIMITRIADOU EM, KYRTSONIS M-C, KOKORIS SI, TSAFTARIDIS P, KONTOPIDOU FN, SIAKANTARIS MP, PLATA E, VASSILAKOPOULOS TP, ANGELOPOULOU MK , PAN- GALIS GA. Rituximab monotherapy is an effective treatment for splenic marginal zone B-cell lymphomas (SMZL). Forty-seventh Annual Meeting of the American Society of Hematology, Atlanta, Georgia, USA, December 10-13, 2005. Blood 106: 281b, 2005.

120. PAPADOGIANNIS A, KYRTSONIS MC, VASSILAKOPOULOS TP, TZE- NOU T, ANTONIADIS AG, KALPADAKIS C, SACHANAS S, DIMOPOU- LOU MN, SIAKANTARIS MP, KOKORIS SI, DIMITRIADOU EM, ANGE- LOPOULOU MK , PLATA E, TSAFTARIDIS P, PANGALIS GA. 112

Serum levels of OPG and MIP-1α in untreated multiple myeloma patients. Correlations with staging, survival and bone disease. Forty-seventh Annual Meeting of the American Society of Hematology, Atlanta, Georgia, USA, December 10-13, 2005. Blood 106: 350b, 2005.

121. KYRTSONIS MC, SACHANAS S, VASSILAKOPOULOS TP, KAFASSI N, TZENOU T, PAPADOGIANNIS A, KALPADAKIS C, ANTONIADIS AG, DIMOPOULOU MN, ANGELOPOULOU MK , SIAKANTARIS MP, DIMI- TRIADOU EM, KOKORIS SI, PLATA E, TSAFTARIDIS P, PANAYIO- TIDIS P, PANGALIS GA. Bortezomib in patients with relapsed-refractory multiple myeloma (MM). Clinical observations. Forty-seventh Annual Meeting of the American Society of Hematology, Atlanta, Georgia, USA, December 10-13, 2005. Blood 106: 382b, 2005, αρ . Αναφορών : 2.

122. VASSILAKOPOULOS TP, ANGELOPOULOU MK , GALANI Z, SACHA- NAS S, KATSIGIANNIS A, VRAKIDOU E, CONSTANTINOU N, DIMO- POULOU MN, KOKORIS SI, MICHALI E, DIMITRIADOU EM, SIAKA- NTARIS MP, PANAYIOTIDIS P, ROUSSOU P, PANGALIS GA. Rituximab-CHOP and radiotherapy for primary mediastinal large B-cell lymphoma: An update. Eleventh Congress of the European Haematology Association, June 15- 18, 2006, Amsterdam, the Netherlands. Haematologica/The Hematology Journal, 91 (Suppl 1): 260, 2006, αρ . Αναφορών : 3.

123. SACHANAS S, KYRTSONIS MC, GALANIS Z, GRECA V, VASSILAKO- POULOS TP, ANARGYROY K, CHRYSOCHOOY C, DIMOU M, PANA- GOULIAS G, KOKORIS SI, DIMITRIADOU EM, ANGELOPOULOU MK , VINIOU N, PANAYIOTIDIS P, PANGALIS GA. Bortezomib therapy multiple myeloma. Experience outside the context of a clinical trial.

113

Eleventh Congress of the European Haematology Association, June 15- 18, 2006, Amsterdam, the Netherlands. Haematologica/The Hematology Journal, 91 (Suppl 1): 283, 2006.

124. ANGELOPOULOU MK , KOKORIS SI, TSAFTARIDIS P, PLATA E, KO- NTOPIDOU FN, DIMITRIADOU EM, VASSILAKOPOULOS TP, SIAKA- NTARIS MP, GALANIS Z, KALPADAKIS C, SACHANAS S, KYRTSONIS MC, KORKOLOPOULOU P, PANAYIOTIDIS P, PANGALIS GA, DIMO- POULOU MN. Efficacy of rituximab in hairy cell leukemia. Eleventh Congress of the European Haematology Association, June 15- 18, 2006, Amsterdam, the Netherlands. Haematologica/The Hematology Journal, 91 (Suppl 1): 293, 2006.

125. VASSILAKOPOULOS TP, ANGELOPOULOU MK , GALANI Z, SACHA- NAS S, KATSIGIANNIS A, VRAKIDOU E, POZIOPOULOS C, CONSTA- NTINOU N, REPOUSSIS P, DIMOPOULOU MN, KOKORIS SI, MICHALI E, DIMITRIADOU EM, SIAKANTARIS MP, KONTOPIDOU FN, KALPA- DAKI C, KORKOLOPOULOU P, PANAYIOTIDIS P, ROUSSOU P, PAN- GALIS GA. Rituximab-CHOP (R-CHOP) and radiotherapy (RT) for primary mediastinal large B-cell lymphoma (PMLBCL). Mabthera Expert Forum, Valencia, 6-8 October 2006 (Προφορική παρου - σίαση , Βραβείο καλύτερης εργασίας ).

126. VASSILAKOPOULOS TP, ANGELOPOULOU MK , GALANI Z, SACHA- NAS S, KATSIGIANNIS A, VRAKIDOU E, POZIOPOULOS C, CONSTA- NTINOU N, REPOUSSIS P, DIMOPOULOU MN, KOKORIS SI, MICHALI E, DIMITRIADOU EM, SIAKANTARIS MP, KONTOPIDOU FN, KALPA- DAKI C, VINIOU NA, KYRIAKOU E, KORKOLOPOULOU P, PANAYIO- TIDIS P, ROUSSOU P, PANGALIS GA. Rituximab-CHOP (R-CHOP) and radiotherapy (RT) for primary mediastinal large B-cell lymphoma (PMLBCL).

114

Forty-eitghth Annual Meeting of the American Society of Hematology, Orlando, Florida, USA, December 9-12, 2006. Blood 108: Abstr 2745, 2006, αρ . Αναφορών : 1.

127. KYRTSONIS MC, VASSILAKOPOULOS TP, KAFASI N, SACHANAS S, TZENOU T, PAPADOGIANNIS A, GALANIS Z, KALPADAKIS C, DIMOU M, KYRIAKOU E, ANGELOPOULOU MK , DIMOPOULOU MN, SIAKA- NTARIS MP, KOKORIS SI, DIMITRIADOU EM, PANAYIOTIDIS P, PAN- GALIS GA. Serum free light chain ratio (FLCR) at diagnosis constitute a powerful prognostic factor of survival in multiple myeloma (MM). Forty-eitghth Annual Meeting of the American Society of Hematology, Orlando, Florida, USA, December 9-12, 2006. Blood 108: Abstr 3522, 2006.

128. SIAKANTARIS MP, ANGELOPOULOU MK , LILAKOS K, METAXAS Y, MOSCHOYIANNI M, GAMALETSOU M, VASSILAKOPOULOS TP, KYR- TSONIS MC, KORKOLOPOULOU P, PANAYIOTIDIS P, PANGALIS GA. Evaluation of microsatellite instability in gastric MALT lymphomas. Forty-eitghth Annual Meeting of the American Society of Hematology, Orlando, Florida, USA, December 9-12, 2006. Blood 108: Abstr 4625, 2006.

129. ANGELOPOULOU MK , PAPAKONSTANTINOU M, KONTOPIDOU FN, DIMOPOULOU MN, SIAKANTARIS MP, VASSILAKOPOULOS TP, KAL- PADAKIS C, KOKORIS SI, DIMITRIADOU EM, GALANI Z, SACHANAS S, TSIRKINIDIS P, KYRTSONIS MC, KORKOLOPOULOU P, PANAYIO- TIDIS P, PANGALIS GA. B-chronic lymphoproliferative disorders (BCLD) presenting with spleno- megaly: Differential diagnosis and outcome. Forty-eitghth Annual Meeting of the American Society of Hematology, Orlando, Florida, USA, December 9-12, 2006. Blood 108: Abstr 4655, 2006.

115

130. SACHANAS S, ANGELOPOULOU MK , ANARGYROU K, KOKORIS SI, VASSILAKOPOULOS TP, GALANI Z, DIMITRIADOU EM, SIAKANTARIS MP, DIMOPOULOU MN, KONTOPIDOU FN, KYRTSONIS MC, PLATA E, TSAFTARIDIS P, PANAYIOTIDIS P, PANGALIS GA. Long term follow up of hairy cell leukemia (HCL) patients (pts) treated with interferon-alpha (IFN-α). The importance of maintenance. Forty-eitghth Annual Meeting of the American Society of Hematology, Orlando, Florida, USA, December 9-12, 2006. Blood 108: Abstr 4718, 2006.

131. KOKORIS SI, ANGELOPOULOU MK , GALANI Z, ANARGYROU K, SA- CHANAS S, VASSILAKOPOULOS TP, SIAKANTARIS MP, KONTOPI- DOU FN, DIMITRIADOU EM, DIMOPOULOU MN, TSAFTARIDIS P, PLATA E, KALPADAKIS C, KYRTSONIS MC, PANAYIOTIDIS P, PAN- GALIS GA. Efficacy of rituximab in hairy cell leukemia. Forty-eitghth Annual Meeting of the American Society of Hematology, Orlando, Florida, USA, December 9-12, 2006. Blood 108: Abstr 4719, 2006.

132. ANGELOPOULOU MK , LILAKOS K, SALPEAS V, SACHANAS S, KOR- KOLOPOULOU P, SIAKANTARIS MP, VASSILAKOPOULOS TP, PA- NAYIOTIDIS P, PANGALIS GA. Z-Guggulsterone downregulates survivin and induces cell death in large B cell lymphoma cells in vitro. Forty-eitghth Annual Meeting of the American Society of Hematology, Orlando, Florida, USA, December 9-12, 2006. Blood 108: Abstr 4752, 2006.

133. ANGELOPOULOU MK, ANARGYROU K, SACHANAS S, KOKORIS S, VASSILAKOPOULOS TP, GALANI Z, DIMOPOULOU MN, KONTOPI- DOU FN, PLATA E, TSAFTARIDIS P, DIMITRIADOU E, SIAKANTARIS MP, PANGALIS GA.

116

Long term follow up of hairy cell leukemia patients (pts) treated with interferon-α. The importance of maintenance. Twelveth Congress of the European Haematology Association, June 7-10, 2007, Vienna, Austria. Haematologica/The Hematology Journal, 92 (Suppl 1): 42, 2007.

134. TSIRKINIDIS P, VASSILAKOPOULOS TP, MOSCHOGIANNIS M, GALA- NI Z, ANARGYROU K, MASOURIDIS S, KONTOPIDOU F, SACHANAS S, DIMITRIADOU E, KALOTYCHOU V, KALPADAKIS C, ANTONIADIS A, PRASSAS E, CHASIOTIS D, VARIAMI E, VINIOU NA, KOKORIS S, SIAKANTARIS M, ROMBOS Y, PANGALIS GA, ANGELOPOULOU M . ESHAP vs GIN as salvage and mobilizing regimens in relapsed or refractory HL. Twelveth Congress of the European Haematology Association, June 7-10, 2007, Vienna, Austria. Haematologica/The Hematology Journal, 92 (Suppl 1): 65, 2007, αρ . Αναφορών : 1.

135. ANGELOPOULOU M , LILAKOS K, SALPEAS V, SACHANAS S, VASSI- LAKOPOULOS TP, SIAKANTARIS MP, DIMOPOULOU MN, KORKOLO- POULOU P, PANAYIOTIDIS P, PANGALIS GA. Z-Guggulsterone downregulates survivin and induces cell death in large B cell lymphoma cells in vitro. Twelveth Congress of the European Haematology Association, June 7-10, 2007, Vienna, Austria. Haematologica/The Hematology Journal, 92 (Suppl 1): 104, 2007.

136. GALANI H, VASSILAKOPOULOS TP, TSIRKINIDIS P, MOSCHOGIAN- NIS M, BOUTSIS D, ANARGYROU K, MASOURIDIS S, SACHANAS S, KALPADAKIS C, SARANTOPOULOS A, DIMITRIADOU E, DIMOPOU- LOU M, STAVROGIANNIS N, KALOTYCHOU V, VARIAMIS E, VINIOU NA, KOKORIS SI, SIAKANTARIS MP, KYRTSONIS MC, ROMBOS I, VAIOPOULOS G, PANGALIS GA, ANGELOPOULOU M . High dose therapy and autologous stem cell transplantation in 58 patients with Hodgkin’s lymphoma. Outcome and prognostic factors. 117

Twelveth Congress of the European Haematology Association, June 7-10, 2007, Vienna, Austria. Haematologica/The Hematology Journal, 92 (Suppl 1): 144, 2007 (oral presentation, αρ . Αναφορών : 1).

137. ZAROULIS C, KYRTSONIS MC, KOUTRA E, SACHANAS S, ANARGY- ROU K, MASOURIDIS S, GALANIS Z, DIMOU M, VASSILAKOPOULOS TP, DIMITRIADOU EM, DIMOPOULOU MN, KOKORIS SI, SIAKA- NTARIS MP, ANGELOPOULOU MK , PANAYIOTIDIS P, MATIKAS N, PANGALIS GA. Nerve conduction study in multiple myeloma patients presenting bortezomib induced peripheral neuropathy. Twelveth Congress of the European Haematology Association, June 7-10, 2007, Vienna, Austria. Haematologica/The Hematology Journal, 92 (Suppl 1): 256, 2007.

138. TZENOU T, KYRTSONIS MC, KALPADAKIS C, VASSILAKOPOULOS TP, SACHANAS S, GALANIS Z, MASOURIDIS S, DIMOPOULOU MN, KOKORIS SI, DIMITRIADOU EM, KOKOLOPOULOU P, SIAKANTARIS MP, ANGELOPOULOU MK , PANAYIOTIDIS P, PANGALIS GA. The follicular lymphoma International Prognostic Index is applicable in lymphoplasmacytic lymphoma / Waldenstrom’s Macroglobulinemia. Twelveth Congress of the European Haematology Association, June 7-10, 2007, Vienna, Austria. Haematologica/The Hematology Journal, 92 (Suppl 1): 266, 2007.

139. ANARGYROU K, TERPOS E, SACHANAS S, TZENOU T, MASOURIDIS S, CHRISTOULAS T, ANGELOPOULOU MK , KOKORIS SI, VASSILA- KOPOULOS TP, SIAKANTARIS MP, KALPADAKIS C, PANAYIOTIDIS P, TSIONOS K, PANGALIS GA, KYRTSONIS MC. Angiopietin 1 / angiopoietin 2 ratio is reduced and correlates with disease severity in relapsed / refractory myeloma patients. Normalization of the ratio post Bortezomib therapy.

118

Twelveth Congress of the European Haematology Association, June 7-10, 2007, Vienna, Austria. Haematologica/The Hematology Journal, 92 (Suppl 1): 330, 2007 (oral presentation).

140. THANOPOULOU I, ANGELOPOULOU M , ANARGYROU K, TSIRKINI- DIS P, MOSCHOGIANNIS M, CHATZILEONIDA E, VASSILAKOPOU- LOS TP, YAKOUMIS X, KONSTADOUDAKIS K, ROMBOS Y, VAIOPO- ULOS G, POLYZOS N, PANGALIS GA. Cost analysis of high dose chemotherapy and autologous stem cell transplantation (HDT / ASCT) in Greece. Twelveth Congress of the European Haematology Association, June 7-10, 2007, Vienna, Austria. Haematologica/The Hematology Journal, 92 (Suppl 1): 434, 2007.

141. SIAKANTARIS MP, ANGELOPOULOU MK , METAXAS Y, LILAKOS K, MOSCHOGIANNI M, MAVROGIANNI D, VASSILAKOPOULOS TP, EVANGELATOS NG, BOUROS S, KORKOLOPOULOU P, KYRTSONIS MC, PANAYIOTIDIS P, PANGALIS GA. Mononucleotide markers are continuously stable in gastric MALT lymphomas after H. pylori eradication therapy and chemotherapy. Twelveth Congress of the European Haematology Association, June 7-10, 2007, Vienna, Austria. Haematologica/The Hematology Journal, 92 (Suppl 1): 456, 2007.

142. KYRTSONIS MC, VASSILAKOPOULOS TP, KAFASI N, ANAGNOSTO- POULOS A, DELIMPASI S, TERPOS E, REPOUSSIS P, SACHANAS S, TZENOU T, GALANIS Z, MASOURIDIS S, KALPADAKIS C, DIMOU M, ANGELOPOULOU MK , DIMOPOULOU MN, SIAKANTARIS MP, DIMI- TRIADOU EM, KOKORIS SI, PANAYIOTIDIS P, ZERVAS K, DIMO- POULOS MA, PANGALIS GA. Prognostic implication of the combination sFLCR + ISS in MM. XIth International Myeloma Workshop and IVth International Workshop on Waldenstrom’s Macroglobulinemia, June 25-30, 2007, Kos Island,

119

Greece. Haematologica/The Hematology Journal, 92 (6, Suppl 2): 207, 2007, αρ . Αναφορών : 1.

143. KYRTSONIS MC, TZENOU T, VASSILAKOPOULOS TP, KALPADAKIS C, SACHANAS S, VOGIATZAKIS F, ANGELOPOULOU MK , SIAKANTA- RIS MP, DIMOPOULOU MN, KOKORIS SI, DIMITRIADOU EM, PA- NAYIOTIDIS P, PANGALIS GA. Serum soluble syndecan-1 is increased in WM/LPL and SMZL. XIth International Myeloma Workshop and IVth International Workshop on Waldenstrom’s Macroglobulinemia, June 25-30, 2007, Kos Island, Greece. Haematologica/The Hematology Journal, 92 (6, Suppl 2): 223, 2007, αρ . Αναφορών : 1.

144. TZENOU T, KYRTSONIS MC, KALPADAKIS C, VASSILAKOPOULOS TP, SACHANAS S, VOGIATZAKIS F, ANGELOPOULOU MK , SIAKA- NTARIS MP, DIMOPOULOU MN, KOKORIS SI, DIMITRIADOU EM, PANAYIOTIDIS P, PANGALIS GA. Differing serum cytokine levels in LPL and WM. XIth International Myeloma Workshop and IVth International Workshop on Waldenstrom’s Macroglobulinemia, June 25-30, 2007, Kos Island, Greece. Haematologica/The Hematology Journal, 92 (6, Suppl 2): 223, 2007, αρ . Αναφορών : 1.

145. VASSILAKOPOULOS TP, ANGELOPOULOU MK , SACHANAS S, ZOR- BALA A, SIAKANTARIS MP, KOKORIS SI, DIMITRIADOU EM, DIMO- POULOU MN, MASOURIDIS S, KALPADAKIS C, KYRTSONIS M-C, TSIRKINIDIS P, GALANIS Z, TSAFTARIDIS P, VARIAMIS E, MICHAIL P, PANAYIOTIDIS P, PANGALIS GA. Conventional prognostic factors in clinical stage (CS) IA/IIA Hodgkin's lymphoma (HL) after ABVD-based combined modality therapy (CMT). Seventh International Symposium on Hodgkin’s Lymphoma, November 3- 7, 2007, Cologne, Germany. Haematologica/The Hematology Journal, 92 (Suppl 5): 54, 2007.

120

146. ANGELOPOULOS MPK, ANGELOPOULOU MK , PANGALIS GA, GOU- LIAMOS AD, SIAKANTARIS MP, KOKORIS S, DIMITRIADOU E, KYR- TSONIS M-C, TSAFTARIDIS P, VARIAMIS E, KALPADAKIS C, SACHA- NAS S, MASOURIDIS S, VASSILAKOPOULOS TP. Chest X-ray (CXR) and thoracic CT scan evaluation of mediastinal lymphadenopathy in patients with Hodgkin’s lymphoma revisited. Seventh International Symposium on Hodgkin’s Lymphoma, November 3- 7, 2007, Cologne, Germany. Haematologica/The Hematology Journal, 92 (Suppl 5): 57, 2007.

147. VASSILAKOPOULOS TP, DOUSSIS-ANAGNOSTOPOULOU IA, KOR- KOLOPOULOU P, RASSIDAKIS GZ, ANGELOPOULOU MK , THYMARA I, KOKORIS SI, DIMITRIADOU EM, SIAKANTARIS MP, KALPADAKIS C, DIMOPOULOU MN, KYRTSONIS M-C, KAVANTZAS N, PANAYIOTIDIS P, PATSOURIS E, KITTAS C, SARRIS AH, PANGALIS GA. Topoisomerase II α (topoII α) expression in Hodgkin's lymphoma (HL): Prognostic significance and correlations with conventional prognostic factors and biological markers related to angiogenesis and apoptosis. Seventh International Symposium on Hodgkin’s Lymphoma, November 3- 7, 2007, Cologne, Germany. Haematologica/The Hematology Journal, 92 (Suppl 5): 62, 2007.

148. VASSILAKOPOULOS TP, PANGALIS GA, MASOURIDIS S, KOKORIS SI, SACHANAS S, KALPADAKIS C, DIMITRIADOU EM, TSAFTARIDIS P, GALANIS Z, GOULIAMOS A, PRASSOPOULOS V, GOGOU L, EFTHI- MIADOU R, ANDREOU I, PAPAVASSILIOU C, ANGELOPOULOU MK . Clinical significance of post-ABVD PET/CT findings in Hodgkin's lymphoma (HL). Seventh International Symposium on Hodgkin’s Lymphoma, November 3- 7, 2007, Cologne, Germany. Haematologica/The Hematology Journal, 92 (Suppl 5): 73, 2007.

149. TSIRKINIDIS P, VASSILAKOPOULOS TP, MOSCHOGIANNIS M, GA- LANIS Z, ANARGYROU K, DIMITRIADOU E, MASOURIDIS S, PAPPIS 121

V, GRATSIAS N, CHATZILEONIDAS E, SACHANAS S, KALOTYCHOU V, KONSTANTOUDAKIS K, KOKORIS S, SIAKANTARIS M, ROMBOS I, PANGALIS GA, ANGELOPOULOU MK . ESHAP vs GIN as salvage and mobilizing regimens in relapsed or refractory Hodgkin Lymphoma (HL). Seventh International Symposium on Hodgkin’s Lymphoma, November 3- 7, 2007, Cologne, Germany. Haematologica/The Hematology Journal, 92 (Suppl 5): 79, 2007.

150. ANGELOPOULOU MK , GALANIS Z, VASSILAKOPOULOS TP, TSIRKI- NIDIS P, MOSCHOGIANNIS M, DIMITRIADOU E, PAPPIS V, MASOU- RIDIS S, CHATZILEONIDA E, CHASIOTIS D, KATSANDRIS K, KALO- TYCHOU V, BOUTSIS D, ANARGYROU K, SACHANAS S, DIMOPOU- LOU MN, KOKORIS S, KYRTSONIS MC, SIAKANTARIS MP, ROMBOS I, PANGALIS GA. High dose therapy and autologous stem cell transplantation (HDT/ASCT) in Hodgkin’s lymphoma (HL). Outcome and prognostic factors. Seventh International Symposium on Hodgkin’s Lymphoma, November 3- 7, 2007, Cologne, Germany. Haematologica/The Hematology Journal, 92 (Suppl 5): 79, 2007.

151. VASSILAKOPOULOS TP, PANGALIS GA, MASOURIDIS S, SACHANAS S, SIAKANTARIS MP, KOKORIS SI, DIMITRIADOU EM, DIMOPOULOU MN, KYRTSONIS M-C, KALPADAKIS C, TSAFTARIDIS P, PLATA E, GALANIS Z, TSIRKINIDIS P, MICHAIL P, VARIAMIS E, VINIOU NA, PANAYIOTIDIS P, ANGELOPOULOU MK . Very late relapses in patients with Hodgkin's lymphoma (HL). Seventh International Symposium on Hodgkin’s Lymphoma, November 3- 7, 2007, Cologne, Germany. Haematologica/The Hematology Journal, 92 (Suppl 5): 80, 2007.

152. KYRTSONIS MC, VASSILAKOPOULOS TP, KAFASI N, MALTEZAS D, ANAGNOSTOPOULOS A, TERPOS E, ELEFTERAKIS-PAPAIAKOVOU E, POULI A, REPOUSSIS P, DELIMPASSI S, ANARGYROU K, STAFA- 122

NOUDAKI C, MICHALIS E, SACHANAS S, TZENOU T, MASOURIDIS S, DIMOU M, ANGELOPOULOU MK , DIMOPOULOU MN, SIAKANTARIS MP, DIMITRIADOU EM, KOKORIS SI, KALPADAKIS C, PANAYIOTIDIS P, DIMOPOULOS MA, PANGALIS GA. The addition of sFLCR improves ISS prognostication in multiple myeloma (MM). Forty-nineth Annual Meeting of the American Society of Hematology, Orlando, Florida, USA, December 9-12, 2007. Blood 110: Abstr 1490, 2007, αρ . αναφορών 2:

153. VASSILAKOPOULOS TP, PANGALIS G, GALANI Z, SACHANAS S, KA- TSIGIANNIS A, VRAKIDOU E, POZIOPOULOS C, CONSTANTINOU N, REPOUSSIS P, DIMOPOULOU M, KOKORIS S, MICHALI E, DIMI- TRIADOU E, MASOURIDIS S, SIAKANTARIS M, KALPADAKIS C, KYR- TSONIS M, PANAYIOTIDIS P, ROUSSOU P, ANGELOPOULOU M. Addition of Rituximab to CHOP greatly improves the outcome of patients with primary mediastinal large B-cell lymphoma (PMLBCL). Tenth International Conference on Malignant Lymphoma, June 4-7, 2008, Lugano, Switzerland. Ann Oncol, 19 (Suppl.4): 188, 2008.

154. KALPADAKIS C, PANGALIS GA, VASSILAKOPOULOS TP, DIMOPOU- LOU MN, KYRTSONIS M, KORKOLOPOULOU P, KONTOPIDOU F, SIAKANTARIS M, DIMITRIADOU E, PANAYIOTIDIS P, PAPADAKI H, ANGELOPOULOU M . Rituximab monotherapy is the treatment of choice of splenic marginal zone lymphoma (SMZL). Tenth International Conference on Malignant Lymphoma, June 4-7, 2008, Lugano, Switzerland. Ann Oncol, 19 (Suppl.4): 191, 2008, αρ . Αναφορών : 1.

155. KALPADAKIS C, PANGALIS G, VASSILAKOPOULOS TP, KYRTSONIS M, SIAKANTARIS M, KONTOPIDOU F, KORKOLOPOULOU P, ANA- GNOSTOU D, BOBOTSIS P, YIAKOUMIS X, PANAYIOTIDIS P, PAPA- DAKIS H, ANGELOPOULOU M . 123

Non-gastrointestinal extranodal marginal zone B-cell lymphomas (EMZL) : A single center experience. Tenth International Conference on Malignant Lymphoma, June 4-7, 2008, Lugano, Switzerland. Ann Oncol, 19 (Suppl.4): 226, 2008.

156. KALPADAKIS C, DIMITRIADOU E, VASSILAKOPOULOS T, ANGELO- POULOU M , SIAKANTARIS M, KONTOPIDOU F, PAPADAKI H, PANA- YIOTIDIS P, PANGALIS G. Mutation analysis of IgVH genes in 18 splenic marginal zone lymphoma (SMZL) cases and correlation with clinical and immunophenotypic characteristics. Thirtienteth Congress of the European Haematology Association, June 12-15, 2008, Copenhagen, Denmark. Haematologica/The Hematology Journal, 93 (Suppl 1): 102, 2008.

157. ANGELOPOULOU MK , TERPOS E, TSIRKINIDIS P, ANARGYROU K, PAPPIS V, MOSCHOYIANNIS M, CHATZILEONIDA E, TSOPRA O, PA- PAKOSTAS E, KYRTSONIS MC, DIMITRIADOU E, KONTOPIDOU FN, VASSILAKOPOULOS TP, PANGALIS GA. Bone as a regulator of hematopoietic stem cell trafficking: Biochemical markers of bone remodeling and angiogenic cytokines in stem cell mobilization. Thirtienteth Congress of the European Haematology Association, June 12-15, 2008, Copenhagen, Denmark. Haematologica/The Hematology Journal, 93 (Suppl 1): 344, 2008.

158. VASSILAKOPOULOS TP, MASOURIDIS S, ANGELOPOULOU MK , KO- KORIS SI, SAHANAS S, KALPADAKIS C, DIMITRIADOU EM, TIRKINI- DIS P, MOSCHOYIANNIS M, TSAFTARIDIS P, GALANIS Z, VARIAMIS E, GOULIAMOS A, PRASSOPOULOS V, GOGOU L, EFTHIMIADOU R, ANDREOU I, DATSERIS K, PAPAVASSILIOU C, PANGALIS GA. PET/CT findings in patients with Hodgkin's lymphoma (HL) after ABVD combination chemotherapy: Clinical and prognostic significance.

124

Thirtienteth Congress of the European Haematology Association, June 12-15, 2008, Copenhagen, Denmark. Haematologica/The Hematology Journal, 93 (Suppl 1): 247, 2008, αρ . Αναφορών : 1.

159. ANGELOPOULOS MPK, ANGELOPOULOU M , PANGALIS G, GOULIA- MOS A, SIAKANTARIS M, KOKORIS S, DIMITRIADOU E, KYRTSONIS M-C, TSAFTARIDIS P, VARIAMIS E, KALPADAKIS C, SAHANAS S, MASOURIDIS S, VASSILAKOPOULOS T. Chest X-ray (CXR) and thoracic CT scan evaluation of mediastinal lymphadenopathy in patients with Hodgkin’s lymphoma revisited. Thirtienteth Congress of the European Haematology Association, June 12-15, 2008, Copenhagen, Denmark. Haematologica/The Hematology Journal, 93 (Suppl 1): 247, 2008.

160. KYRTSONIS MC, VASSILAKOPOULOS TP, SACHANAS S, PANAGOU- LIAS G, BARTZIS V, ANARGYROY K, DIMOU M, TZENOU T, MASOU- RIDIS S, KALPADAKIS C, DIMITRAKOPOULOU E, KOKORIS SI, DIMI- TRIADOU E, SIAKANTARIS MP, ANGELOPOULOU MK, PANAYIOTIDIS P, PANGALIS GA. Prognostication of response to Bortezomib, progression free and overall survival in relapsed/refractory myeloma patients. Thirtienteth Congress of the European Haematology Association, June 12-15, 2008, Copenhagen, Denmark. Haematologica/The Hematology Journal, 93 (Suppl 1): 263, 2008.

161. ANGELOPOULOU MK , VASSILAKOPOULOS TP, TSIRKINIDIS P, MA- SOURIDIS S, MOSCHOYIANNIS M, KORKOLOPOULOU P, KOKORIS S, SIAKANTARIS M, SACHANAS S, GALANI Z, DIMITRIADOU E, KALPADAKIS C, ANARGYROU K, DIMOPOULOU MN, KYRTSONIS MC, PATSOURIS E, VAIOPOULOS G, PANGALIS GA. Nodal peripheral T-cell lymphomas: Treatment outcome and prognostic factors.

125

Thirtienteth Congress of the European Haematology Association, June 12-15, 2008, Copenhagen, Denmark. Haematologica/The Hematology Journal, 93 (Suppl 1): 310, 2008.

162. VASSILAKOPOULOS TP, PANGALIS G, GALANI Z, SACHANAS S, KATSIGIANNIS A, VRAKIDOU E, POZIOPOULOS C, KONSTANTINOU N, REPOUSSIS P, DIMOPOULOU M, KOKORIS S, MICHALI E, DIMI- TRIADOU E, MASOURIDIS S, SIAKANTARIS M, KONTOPIDOU F, KAL- PADAKIS C, VINIOU NA, YIAKOUMIS X, KORKLOPOULOU P, KYR- TSONIS MC, PANAYIOTIDIS P, ROUSSOU P, ANGELOPOULOU M . The addition of Rituximab to CHOP greatly improves the outcome of patients with primary mediastinal large B-cell lymphoma (PMLBCL): Mature results of a retrospective muticenter study. Thirtienteth Congress of the European Haematology Association, June 12-15, 2008, Copenhagen, Denmark. Haematologica/The Hematology Journal, 93 (Suppl 1): 310, 2008.

163. KYRTSONIS MC, VASSILAKOPOULOS TP, TZENOU T, KAFASI N, SA- CHANAS S, KOULIERIS E, MALTEZAS D, DIMOPOULOU M, KOKORIS SI, DIMITRIADOU E, SIAKANTARIS MP, ANGELOPOULOU MK , PA- NAYIOTIDIS P, PANGALIS GA. Serum free light chains in Waldenstrom’s Macroglobulinemia (WM) patients at diagnosis. Thirtienteth Congress of the European Haematology Association, June 12-15, 2008, Copenhagen, Denmark. Haematologica/The Hematology Journal, 93 (Suppl 1): 263, 2008.

164. TZENOU T, LEVIDOU G, KORKOLOPOULOU P, VASSILAKOPOULOS TP, STAVROPOULOS N, SALPEAS V, BARTZIS V, GASSIAMIS A, PA- PANIKOLAOU X, MOSCHOYIANNIS M, KOULIERIS E, KALPADAKIS C, ANGELOPOULOU MK , PANAYIOTIDIS P, PANGALIS GA, KYRTSONIS MC.

126

Bone marrow immunohistochemical findings including morphology, mast cell presence, syndecan-1 and cyclin D1 expression in Waldenstrom’s Macroglobulinemia (WM). Thirtienteth Congress of the European Haematology Association, June 12-15, 2008, Copenhagen, Denmark. Haematologica/The Hematology Journal, 93 (Suppl 1): 418, 2008.

165. YIAKOUMIS X, PANGALIS GA, ANGELOPOULOU MK , PAPPIS V, KYRTSONIS MC, SAHANAS S, SIAKANTARIS M, DIMITRIADOU E, KOKORIS S, KALPADAKIS C, PLATA E, MASOURIDIS S, TSIRKINIDIS P, MOSCHOYIANNIS M, CHATZILEONIDA E, VARIAMIS E, PANAYIO- TIDIS P, VAIOPOULOS G, VASSILAKOPOULOS TP. C-Reactive Protein (CRP) serum levels at the time of diagnosis in patients with Hodgkin’s lymphoma (HL): Clinical and laboratory correlations and prognostic significance. Thirtienteth Congress of the European Haematology Association, June 12-15, 2008, Copenhagen, Denmark. Haematologica/The Hematology Journal, 93 (Suppl 1): 470, 2008.

166. KALPADAKIS C, PANGALIS GA, VASSILAKOPOULOS TP, DIMOPOU- LOU MN, KYRTSONIS MC, KORKOLOPOULOU P, KONTOPIDOU FN, SIAKANTARIS MP, DIMITRIADOU EM, KOKORIS SI, SAHANAS S, DI- MITRAKOPOULOS S, PAPADAKI HA, PANAYIOTIDIS P, ANGELO- POULOU MK . Treatment of splenic marginal zone lymphoma (SMZL) in a series of 78 patients: From watch and wait to rituximab monotherapy. Thirtienteth Congress of the European Haematology Association, June 12-15, 2008, Copenhagen, Denmark. Haematologica/The Hematology Journal, 93 (Suppl 1): 558, 2008.

167. MALTEZAS D, TZENOU T, PAPANIKOLAOU X, KOULIERIS E, BARTZIS V, GASIAMIS A, ILIAKIS T, VASSILAKOPOULOS TP, REPOUSIS P, DIMOU M, GEORGIOU G, ANGELOPOULOU MK ,

127

KOTSOPOULOU M, MITSOULI-MENTZIKOF C, PANAYIOTIDIS P, PANGALIS GA, KYRTSONIS MC. Elevated serum B-Lymphocyte Stimulator levels in diagnosis are related to disease aggressiveness and adverse survival in multiple myeloma. Thirtienteth Congress of the European Haematology Association, June 12-15, 2008, Copenhagen, Denmark. Haematologica/The Hematology Journal, 93 (Suppl 1): 388, 2008.

168. MOSCHOGIANNIS M, VASSILAKOPOULOS TP, PANGALIS GA, TSIRKINIDIS P, PAPPI V, TSOPRA O, SACHANAS S, GALANIS Z, ANGELOPOULOS M, YIAKOUMIS X, KALPADAKIS C, SIAKANTARIS MP, KONSTANTOPOULOS K, KYRTSONIS MC, PANAYIOTIDIS P, ANGELOPOULOU MK . The prognostic significance of PET scan in patients with relapsed/refractory Hodgkin Lymphoma treated with high dose therapy and autologus stem cell transplantation. Fourteenth Congress of the European Haematology Association, June 4- 7, 2009, Berlin, Germany. Haematologica/The Hematology Journal, 94 (Suppl 2): 37, 2009.

169. VASSILAKOPOULOS TP, PANGALIS GA, ANASTASOPOULOU A, ANGELOPOULOU MK , DIMOU M, STAVROULAKI E, KARAKATSANIS S, KALPADAKIS C, SACHANAS S, KYRTSONIS MC, KOKORIS SI, SIAKANTARIS MP, YIAKOUMIS X, ROUSSOU P, PANAYIOTIDIS P, PAPADAKI H, CONSTANTINOU N. Rituximab-CHOP (R-CHOP) in the treatment of 441 diffuse large B-cell lymphoma patients: Outcome and prognostic factors focusing to the Revised International Prognostic Index (R-IPI). Fourteenth Congress of the European Haematology Association, June 4- 7, 2009, Berlin, Germany. Haematologica/The Hematology Journal, 94 (Suppl 2): 163, 2009.

170. KALPADAKIS C, PANGALIS GA, VASSILAKOPOULOS TP, SACHANAS S, KYRTSONIS MC, DIMOPOULOU M, KORKOLOPOULOU P, 128

KONTOPIDOU F, YIAKOUMIS X, SIAKANTARIS MP, DIMITRIADOU EM, PANAYIOTIDIS P, PAPADAKI HA, ANGELOPOULOU MK . Splenectomy versus rituximab in the treatment of splenic marginal zone lymphoma. Fourteenth Congress of the European Haematology Association, June 4- 7, 2009, Berlin, Germany. Haematologica/The Hematology Journal, 94 (Suppl 2): 168, 2009.

171. KALPADAKIS C, PANGALIS GA, KORKOLOPOULOU P, VASSILAKO- POULOS TP, LEVIDOU G, KYRTSONIS MC, SACHANAS S, YIAKOUMIS X, DIMITRIADOU EM, KONTOPIDOU FN, SIAKANTARIS MP, PATSOURIS E, PANAYIOTIDIS P, PAPADAKI H, ANGELOPOULOU MK . Detection of plasmacytoid (plasmacytic) differentiation in marginal zone B cell lymphomas (MZL) by CD138 expression. Fourteenth Congress of the European Haematology Association, June 4- 7, 2009, Berlin, Germany. Haematologica/The Hematology Journal, 94 (Suppl 2): 277, 2009.

172. ANGELOPOULOU MK , KORKOLOPOULOU P, SALPEAS V, GALANI Z, VASSILAKOPOULOS TP, LEVIDOU G, ANASTASOPOULOU A, LILAKOS K, SACHANAS S, SIAKANTARIS MP, KYRTSONIS MC, PANAYIOTIDIS P, ANDROULAKI A, PAPADAKI T, PATSOURIS E, PANGALIS GA. Survivin expression in aggressive B-cell lymphoma. Fourteenth Congress of the European Haematology Association, June 4- 7, 2009, Berlin, Germany. Haematologica/The Hematology Journal, 94 (Suppl 2): 278, 2009.

173. ANGELOPOULOU MK , VASSILAKOPOULOS TP, MASOURIDIS S, MOSCHOGIANNIS M, TSIRKINIDIS P, PAPPI V, GALANI Z, KALOTYCHOU V, KONSTANTOUDAKIS K, DIMITRIADOU E, KALPADAKI C, DIMOPOULOU M, KOKORIS S, VINIOU NA, VARIAMIS

129

E, SIAKANTARIS MP, ROMBOS Y, KYRTSONIS MC, PANAYIOTIDIS P, PANGALIS GA. Prognostic factors for successful mobilization and collection of peripheral blood stem cells (PBSC) in patients with hematologic malignancies. A study of 209 patients. Fourteenth Congress of the European Haematology Association, June 4- 7, 2009, Berlin, Germany. Haematologica/The Hematology Journal, 94 (Suppl 2): 300, 2009.

174. GEORGIOU G, ROUMELIOTI M, PALAIOLOGOU D, MPARTZI V, MAR- KOPOULOS A, STRAVODIMOS G, DIMOU M, EFTHYMIOU A< PETRIKOS L, ANGELOPOULOU MK , VASSILAKOPOULOS T, AGGELOPOULOU M, KYRTSONIS C, PANAYIOTIDIS P. CLLU1 gene expression levels predicts VH mutational status in 90% of CLL patients. Fourteenth Congress of the European Haematology Association, June 4- 7, 2009, Berlin, Germany. Haematologica/The Hematology Journal, 94 (Suppl 2): 368, 2009.

175. VASSILAKOPOULOS TP, ANASTASOPOULOU A, CONSTANTINOU N, ANGELOPOULOU MK , STAVROULAKI E, KALPADAKIS C, SACHANAS S, PAPPIS V, TSIRKINIDIS P, MOSCHOYIANNIS M, TSOPRA O, TZENOU T, GASSIAMIS A, YIAKOUMIS X, KYRTSONIS MC, KOKORIS SI, SIAKANTARIS MP, DIMOU M, GEORGIOU G, PLATA E, VINIOU NA, VARIAMIS E, KONSTANTOPOULOS K, PANAYIOTIDIS P, PAPADAKI H, PANGALIS GA. Serum β2-microglobulin levels in patients with diffuse large B-cell lymphoma (DLBCL): Prognostic significance under treatment with Rituximab-CHOP. Fourteenth Congress of the European Haematology Association, June 4- 7, 2009, Berlin, Germany. Haematologica/The Hematology Journal, 94 (Suppl 2): 393, 2009.

130

176. KALPADAKIS C, PANGALIS GA, VASSILAKOPOULOS TP, KYRTSONIS MC, SACHANAS S, SIAKANTARIS MP, KONTOPIDOU FN, DIMITRIADOU EM, YIAKOUMIS X, KORKOLOPOULOU P, PANAYIOTIDIS P, PAPADAKI H, ANGELOPOULOU MK . Chlorambucil with or without rituximab is an effective therapy in non- gastric MALT lymphomas. Fourteenth Congress of the European Haematology Association, June 4- 7, 2009, Berlin, Germany. Haematologica/The Hematology Journal, 94 (Suppl 2): 398, 2009.

177. KALPADAKIS C, PANGALIS GA, KORKOLOPOULOU P, VASSILAKO- POULOS TP, LEVIDOU G, KYRTSONIS MC, SACHANAS S, YIAKOUMIS X, DIMITRIADOU EM, KONTOPIDOU FN, SIAKANTARIS MP, PATSOURIS E, PANAYIOTIDIS P, PAPADAKI H, ANGELOPOULOU MK . Immunohistochemical detection of ZAP-70 in a series of marginal zone lymphoma (MZL) patients. Fourteenth Congress of the European Haematology Association, June 4- 7, 2009, Berlin, Germany. Haematologica/The Hematology Journal, 94 (Suppl 2): 404, 2009.

178. PAPANIKOLAOU X, MALTEZAS D, REPOUSIS P, TZENOU T, MEGALAKAKI K, SAHANAS S, ANGELOPOULOU MK , VASILAKOPOULOS T, MITSOULI-MENTZIKOF C, PANGALIS G, PANAGIOTIDIS P, KYRTSONI MC. Extrameddulary relapses in patients with multiple myeloma. Thirtienteth Congress of the European Haematology Association, June 12-15, 2008, Copenhagen, Denmark. Haematologica/The Hematology Journal, 93 (Suppl 1): 617, 2008.

179. ANGELOPOULOU MK , TERPOS E, TSIRKINIDIS P, ANARGYROU K, TSOPRA O, PAPPIS V, MOSCHOYIANNIS M, KYRTSONIS MC, DIMITRIADOU E, KONTOPIDOU FN, PANAYIOTIDIS P, VASSILAKOPOULOS TP, PANGALIS GA. 131

Bone as a regulator of hematopoietic stem cell trafficking: Biochemical markers of bone remodeling and angiogenic cytokines in stem cell mobilization. 38th Annual Scientific Meeting of the ISEH – Society for Hematology and Stem Cells, Athens, September 9-12, 2009. Experimental Hematology, 37(Suppl 1): 20 (P002).

180. SIAKANTARIS M, PAPADAVID E, MARINOS L, VASSILAKOPOULOS T, ANGELOPOULOU M , EVANGELATOS N, KORKOLOPOULOU P, ANTONIOU C, NIKOLAOU V, PANGALIS G, PAPADAKI T. Clinical, histological and immunohistochemical analysis of tumor-stage mycosis fungoides. EORTC CTLF 2009: Cutaneous Lymphoma Clinical Meeting. Cutaneous Lymphomas: New insights in diagnosis and treatment. From bench to bedside, October 23-25, 2009, Athens, Greece. Final Program & Book of Abstracts, pp 31-32.

181. SIAKANTARIS M, RASSIDAKIS G, KONTOPIDOU F, VASSILAKOPOULOS T, ANGELOPOULOU MK , PAPADAVID E, EVANGELATOS N, KORKOLOPOULOU P, ANTONIOU C, PANGALIS GA. CD4 (+)/ CD56 (+) hematodermic (plasmacytoid dendritic cell) tumor: a highly proliferating neoplasm with aberrant expression of immunohistochemical markers and poor outcome. EORTC CTLF 2009: Cutaneous Lymphoma Clinical Meeting. Cutaneous Lymphomas: New insights in diagnosis and treatment. From bench to bedside, October 23-25, 2009, Athens, Greece. Final Program & Book of Abstracts, pp 63-64.

182. SIAKANTARIS M, PAPADAVID E, MARINOS L, VASSILAKOPOULOS T, ANGELOPOULOU M , EVANGELATOS N, KORKOLOPOULOU P, ANTONIOU C, NIKOLAOU V, PANGALIS G, PAPADAKI T. Clinical, histological and immunohistochemical analysis of tumor-stage mycosis fungoides. 132

EORTC CTLF 2009: Cutaneous Lymphoma Clinical Meeting. Cutaneous Lymphomas: New insights in diagnosis and treatment. From bench to bedside, October 23-25, 2009, Athens, Greece. Final Program & Book of Abstracts, pp 31-32.

183. SIAKANTARIS M, RASSIDAKIS G, KONTOPIDOU F, VASSILAKOPOULOS T, ANGELOPOULOU MK , PAPADAVID E, EVANGELATOS N, KORKOLOPOULOU P, ANTONIOU C, PANGALIS GA. CD4 (+)/ CD56 (+) hematodermic (plasmacytoid dendritic cell) tumor: a highly proliferating neoplasm with aberrant expression of immunohistochemical markers and poor outcome. EORTC CTLF 2009: Cutaneous Lymphoma Clinical Meeting. Cutaneous Lymphomas: New insights in diagnosis and treatment. From bench to bedside, October 23-25, 2009, Athens, Greece. Final Program & Book of Abstracts, pp 63-64.

184. VASSILAKOPOULOS T, PANGALIS G, MASOURIDIS S, DIMITRIADOU E, GOULIAMOS A, PRASSOPOULOS V, GOGOU L, EFTHIMIADOU R, ANDREOU I, ANGELOPOULOU M . Clinical significance of post-ABVD PET/CT findings in Hodgkin's lymphoma (HL). Journal of Nuclear Medicine, 50 (Suppl 2): 53, 2009.

185. ANARGYROU K, VASSILAKOPOULOS TP, TSIONOS K, KOKKORIS P, BOUTSIKAS G, ANGELOPOULOU MK , CHRISTOULAS D, MASOURIDOU S, DIMOU M, PAPATHEODOROU A, PANAYIOTIDIS P, TERPOS E. First-line chemotherapy leads to high bone turnover and reduced bone mass in patients with non-Hodgkin's lymphoma (NHL). Fifty-first Annual Meeting of the American Society of Hematology, New Orleans, USA, December 9-12, 2009. Blood 114: Abstr 1951, 2009.

133

186. SIAKANTARIS M, RASSIDAKIS G, KONTOPIDOU F, DIMITRAKOPOULOU A, VASSILAKOPOULOS T, ANGELOPOULOU MK , KOKKORIS S, EVANGELATOS N, ANARGYROU K, MICHAIL O, KORKOLOPOULOU P, PANGALIS GA. CD4 (+)/ CD56 (+) hematodermic (plasmacytoid dendritic cell) tumor: a highly proliferating neoplasm with aberrant expression of immunohistochemical markers and poor outcome. Fifty-first Annual Meeting of the American Society of Hematology, New Orleans, USA, December 9-12, 2009. Blood 114: Abstr 2930, 2009.

187. TZENOU TK, PANGALIS GA, LEVIDOU G, KALPADAKIS C, SIAKAVELLAS S, MALTEZAS D, KOULIERIS E, DIMOU M, BARTZI V, GEORGIOU G, VASSILAKOPOULOS TP, ANGELOPOULOU MK , KOKKORIS SI, KORKOLOPOULOU P, ANDROULAKI A, PATSOURIS E, PANAYIOTIDIS P, KYRTSONIS MC. Increased immunohistochemical CD138 expression in Waldenström's Macroglobulinemia (WM) in comparison with splenic marginal zone lymphoma (SMZL). Fifty-first Annual Meeting of the American Society of Hematology, New Orleans, USA, December 9-12, 2009. Blood 114: Abstr 5008, 2009.

188. TZENOU TK, ANDROULAKI A, SALPEAS V, PATSOURIS E, ANGELO- POULOU M , LEVIDOU G, KORKOLOPOULOU P, VASSILAKOPOULOS TP, BARTZIS V, KAVANTZAS N, PANAYIOTIDIS P, PANGALIS GA, KYRTSONIS MC. CD138, VEGF and CD34 immunohistochemical expression in LPL: Correlations with clinical data. Fifty-first Annual Meeting of the American Society of Hematology, New Orleans, USA, December 9-12, 2009. Clin Lymphoma Myeloma 9: S67, 2009.

189. TZENOU T, VASSILAKOPOULOS TP, KAFASI N, SACHANAS S, KOULIERIS E, MALTEZAS D, ANGELOPOULOU M , PANAYIOTIDIS P, PANGALIS GA, KYRTSONIS MC. 134

sFLCR in LPL/MW patients at diagnosis. Fifty-first Annual Meeting of the American Society of Hematology, New Orleans, USA, December 9-12, 2009. Clin Lymphoma Myeloma 9: S67, 2009.

190. VASSILAKOPOULOS TP, PANGALIS GA, ANGELOPOULOU MK , PAPPAS P, KOKORIS SI, PAZAITI A, KONSTANTOPOULOS K, KARLES D, PAPALAMPROS E, KONTOS M. Breast cancer in patients with Hodgkin’s lymphoma predominantly treated with anthracycline-based chemotherapy with or without radiotherapy: A preliminary analysis. CTRC-AACR San Antonio Breast Cancer Symposium, San Antonio, USA, December 9-13, 2009. Cancer Research 69 (Suppl.3): S846, 2009.

191. M.K. ANGELOPOULOU , T.P. VASSILAKOPOULOS, O. TSOPRA, V. PAPPI,S. MASOURIDIS, P. TSIRKINIDIS, M. MOSCHOGIANNIS, Z. GALANI,V. KALOTYCHOU, E. DIMITRIADOU, S. SACHANAS, X. YIAKOUMIS,C. KALPADAKIS, K. KONSTANTOUDAKIS, M.P. SIAKANTARIS, M.-C.KYRTSONIS, Y. ROMBOS, P. PANAYIOTIDIS, G.A. PANGALIS, P. BERIS Parameters predicting for successful mobilization and collection of peripheral blood stem cells in patients with haematologic malignacies. A study of 209 patients 36 th Annual Meeting of the European Group for Blood and Marrow Transplantation, Vienna, Austria, March 21-24 2010.Bone Marrow Transplant. 2010;45(Suppl 2s): P598

192. M.K. ANGELOPOULOU, T.P. VASSILAKOPOULOS, M. MOSCHOGIANNIS,V. PAPPI, P. TSIRKINIDIS, O. TSOPRA, C. KALPADAKIS, M. DIMOU,D. EXARCHOS, K. DATSERIS, A. GOULIAMOS, M.-C. KYRTSONIS,P. PANAYIOTIDIS, G.A. PANGALIS, P. BERIS

135

The prognostic signifi cance of PET scan before and after high-dose therapy and autologous stem cell transplantation in relapsed/refractory Hodgkin’s lymphoma patients 36 th Annual Meeting of the European Group for Blood and Marrow Transplantation, Vienna, Austria, March 21-24 2010.Bone Marrow Transplant. 2010;45(Suppl 2s): P836

193. M.K. ANGELOPOULOU , T.P. VASSILAKOPOULOS, P. TSIRKINIDIS,O. TSOPRA, Z. GALANI, V. PAPPI, M. MOSCHOGIANNIS, E. DIMITRIADOU,K. ANARGYROY, C. KALPADAKIS, S. MASOURIDIS, D. BOUTSIS,S. SACHANAS, M. DIMOPOULOU, E. VARIAMIS, N.-A. VYNIOU,S. KOKORIS, M.P. SIAKANTARIS, M.-C. KYRTSONIS, P. PANAYIOTIDIS, Y. ROMBOS, G.A. PAMGALIS, P. BERIS High-dose therapy and autologous stem cell transplantation (HDT/ ASCT) in relapsed/refractory Hodgkin’s lymphoma. Outcome and prognostic factors 36 th Annual Meeting of the European Group for Blood and Marrow Transplantation, Vienna, Austria, March 21-24 2010.Bone Marrow Transplant. 2010;45(Suppl 2s): P837

194. KALPADAKIS C, PANGALIS GA, SACHANAS S, KORKOLOPOULOU P, KONTOPIDOU F, LEVIDOU G, DIMITRAKOPOULOU A, ANGELOPOULOU M, KYRTSONIS MC, DIMITRIADOU E, KOKORIS S, YIAKOUMIS X, TSIRKINIDIS P, MOSCHOYIANNIS M, RONTOYIANNI D, PANAYIOTIDIS P, PAPADAKI H, VASSILAKOPOULOS T. Primary bone marrow marginal zone lymphoma (PBMZL): A new disease entity? 15 th Congress of the European Haematology Association, June 10-13, 2010, Barcelona, Spain. Haematologica/The Hematology Journal, 95 (Suppl 2): 109-110, 2010.

195. SACHANAS S, PANGALIS G, VASSILAKOPOULOS T, KORKOLOPOULOU P, ATHANASOULIA C, YIAKOUMIS X, 136

MASOURIDIS S, KALPADAKIS C, MOSCHOYIANNIS M, SIAKANTARIS M, TSIRKINIDIS P, KOKORIS S, PAPPIS V, ANGELOPOULOU M . Combination of rituximab with chlorambucil as first line treatment in patients with mantle cell lymphoma: a highly effective regimen. 15 th Congress of the European Haematology Association, June 10-13, 2010, Barcelona, Spain. Haematologica/The Hematology Journal, 95 (Suppl 2): 113-114, 2010.

196. VASSILAKOPOULOS T, ANGELOPOULOU M , PANGALIS G, KATSIGIANNIS A, PAPAGEORGIOU S, VRAKIDOU E, POZIOPOULOS C, CONSTANTINOU N, REPOUSSIS P, DIMOPOULOU M, KOKORIS S, DIMOU M, KYRTSONIS M, PANAYIOTIDIS P, DERVENOULAS J, ROUSSOU P, BERIS P. Prognostic factors for the outcome of patients with primary mediastinal large B-cell lymphoma (PMLBCL) under chemotherapy with Rituximab- CHOP (R-CHOP) with or without radiotherapy. 15 th Congress of the European Haematology Association, June 10-13, 2010, Barcelona, Spain. Haematologica/The Hematology Journal, 95 (Suppl 2): 116, 2010.

197. VASSILAKOPOULOS T, ANASTASOPOULOU A, PANGALIS G, CONSTANTINOU N, STAVROULAKI E, KARAKATSANIS S, PAPAGEORGIOU S, SACHANAS S, PAPPI V, TSIRKINIDIS P, MOSCHOYIANNI M, KYRTSONIS M, KOKORIS S, KALPADAKIS C, SIAKANTARIS M, DIMOU M, GEORGIOU G, KONSTANTINIDOU P, DERVENOULAS J, ROUSSOU P, PAPADAKI H, PANAYIOTIDIS P, BERIS P, ANGELOPOULOU M . Lymphocytopenia may add to the prediction achieved by the Revised International Prognostic Index (R-IPI) in patients with diffuse large B-cell lymphoma (DLBCL) treated with Rituximab-CHOP (R-CHOP). 15 th Congress of the European Haematology Association, June 10-13, 2010, Barcelona, Spain. Haematologica/The Hematology Journal, 95 (Suppl 2): 280, 2010. 137

198. YIAKOUMIS X,PANGALIS G, KALPADAKIS C, KYRITSI E, PAPAGEORGIOU E, KONTOPIDOU F, SACHANAS S, VASSILAKOPOULOS T, ANGELOPOULOU M , KORKOLOPOULOU P, PAPADAKI H. T-large granular lymphocytosis (T-LGL) in patients with chronic neutropenia: Epidemiological characteristics, clinical course and relation with clonal disease. 15 th Congress of the European Haematology Association, June 10-13, 2010, Barcelona, Spain. Haematologica/The Hematology Journal, 95 (Suppl 2): 327, 2010.

199.TSIRKINIDIS P, VASSILAKOPOULOS T, TSOPRA O, PAPPIS V, MOSCHOGIANNI M, GALANI Z, ANARGYROU K, VARDOUNIOTI I, DIMITRAKOPOULOU A, MASOURIDIS S, KYRTSONIS MC, PANAYIOTIDIS P, PANGALIS G, BERIS P, ANGELOPOULOU M. ESHAP vs IGEV as salvage and mobilizing regimens in relapsed or refractory Hodgkin Lymphoma (HL). 15 th Congress of the European Haematology Association, June 10-13, 2010, Barcelona, Spain. Haematologica/The Hematology Journal, 95 (Suppl 2): 885, 2010.

200. PAPPI V, ANGELOPOULOU M , TSOPRA O, DIMOU M, KYRTSONIS M, SIAKANTARIS M, YIAKOUMIS X, GASIAMIS A, PANAYIOTIDIS P, PANGALIS G, BERIS P, VASSILAKOPOULOS T. Baseline serum C-Reactive Protein levels (CRP) in Hodgkin Lymphoma (HL) and alterations during ABVD chemotherapy: Correlation with clinical, laboratory features and prognostic significance. 15 th Congress of the European Haematology Association, June 10-13, 2010, Barcelona, Spain. Haematologica/The Hematology Journal, 95 (Suppl 2): 887, 2010.

201.ANARGYROU K, VASSILAKOPOULOS T, TSIONOS K, KOKKORIS P, BOUTSIKAS G, ANGELOPOULOU M , CHRISTOULAS D, 138

MASOURIDOU S, DIMOU M, PAPATHEODOROU A, CHATZIFOTIADIS D, PANAYIOTIDIS P, PANGALIS G, Beris P, TERPOS E. First-line chemotherapy leads to high bone turnover and reduced bone mass in patients with non-Hodgkin's lymphoma: Results from a prospective study. 15 th Congress of the European Haematology Association, June 10-13, 2010, Barcelona, Spain. Haematologica/The Hematology Journal, 95 (Suppl 2): 891, 2010.

202.KYRTSONIS MC, TZENOU T, KOULIERIS E, PAPANIKOLAOU X, MALTEZAS D, STAVROPOULOS N, BARTZIS V, DIMOU M, GEORGIOU G, VASSILAKOPOULOS T, ANGELOPOULOU M, BERIS P, PANAYIOTIDIS P. Impact of the magnitude of fall of serum soluble syndecan-1 (s-Synd-1) levels at plateau phase, after treatment with bortezomib or lenalidomide in relapsed/refractory multiple myeloma (MM). 15 th Congress of the European Haematology Association, June 10-13, 2010, Barcelona, Spain. Haematologica/The Hematology Journal, 95 (Suppl 2): 932, 2010.

203.PALAIOLOGOU D, GEORGIOU G, VASSILAKOPOULOS T, PAPANIKOLAOU G, VINIOU N, VARIAMI E, ROMBOS Y, VERVESSOU E, MPOULA A, PANGALIS G, PANAYIOTIDIS P, SAKELLAROPOULOS N, BERIS P, ANGELOPOULOU M . Correlation of ATP-binding cassette (ABC) transporters PGP, BCRP and ABCB6 expression to response to induction chemotherapy in acute myeloid leukemia patients. 15 th Congress of the European Haematology Association, June 10-13, 2010, Barcelona, Spain. Haematologica/The Hematology Journal, 95 (Suppl 2): 1215, 2010.

204. ANGELOPOULOU M, PANGALIS G, TSIRKINIDIS P, KOKORIS S, SIAKANTARIS M, DIMITRIADOU E, DIMOU M, SACHANAS S,

139

KORKOLOPOULOU P, KYRTSONIS MC, PANAYIOTIDIS P, BERIS P, VASSILAKOPOULOS T. Outcome and prognostic factors in follicular lymphoma. Results with chlorambucil with or without rituximab. 15 th Congress of the European Haematology Association, June 10-13, 2010, Barcelona, Spain. Haematologica/The Hematology Journal, 95 (Suppl 2): 1561, 2010.

205. PAPPI V, ANGELOPOULOU MK , PANGALIS GA, TSOPRA O, DIMOU M, BARTZI V, YIAKOUMIS X, KYRTSONIS MC, SIAKANTARIS MP, TSIRKINIDIS P, GASSIAMIS A, PESSACH I, PANAYIOTIDIS P, BERIS P, VASSILAKOPOULOS TP. Baseline serum C-Reactive Protein levels (CRP) in patients with Hodgkin’s lymphoma (HL) and alterations during ABVD chemotherapy: Correlations with clinical and laboratory features and prognostic significance. Eighth International Symposium on Hodgkin Lymphoma, October 23-26, 2010, Cologne, Germany. Haematologica/The Hematology Journal, 95 (Suppl 4): 16, 2010.

206. ANGELOPOULOU M , PANGALIS GA, MOSCHOGIANNIS M, PAPPI V, TSIRKINIDIS P, TSOPRA O, MASOURIDIS S, VARDOUNIOTI I, RONDOGIANNI PH, DATSERIS IE, DIMOU M, KALPADAKIS C, PAPADAKIS E, GOULIAMOS A, KYRTSONIS MC, PANAYIOTIDIS P, BERIS P, VASSILAKOPOULOS TP. The prognostic significance of PET Scan before and after high-dose therapy and autologous stem cell transplantation (HDT / ASCT) in relapsed/refractory Hodgkin’s lymphoma (HL)s. Eighth International Symposium on Hodgkin Lymphoma, October 23-26, 2010, Cologne, Germany. Haematologica/The Hematology Journal, 95 (Suppl 4): 31, 2010.

207. ANGELOPOULOU MK , TSIRKINIDIS P, PANGALIS GA, TSOPRA O, LALOU E, GALANI Z, PAPPI V, MASOURIDIS S, DIMITRIADOU E, 140

VARDOUNIOTI I, DIMITROULIS D, DIMITRAKOPOULOU A, PANAYIOTIDIS P, BERIS PH, VASSILAKOPOULOS TP. IGEV is a superior mobilizing and equally effective salvage regimen compared to ESHAP in relapsed or refractory Hodgkin Lymphoma (HL) patients. Eighth International Symposium on Hodgkin Lymphoma, October 23-26, 2010, Cologne, Germany. Haematologica/The Hematology Journal, 95 (Suppl 4): 31, 2010.

208. MARNERIDES A, VASSILAKOPOULOS TP, BOLTETSOU E, LEVIDOU G, ANGELOPOULOU MK, THYMARA I, KYRTSONIS MC, TSOPRA O, PANAYIOTIDIS P, PANGALIS GA, BERIS P, PATSOURIS E, KORKOLOPOULOU P. Immunohistochemical expression and prognostic significance of the proliferation markers MCM2, MCM7 and cyclin D3 (CCND3) in Hodgkin Lymphoma. Eighth International Symposium on Hodgkin Lymphoma, October 23-26, 2010, Cologne, Germany. Haematologica/The Hematology Journal, 95 (Suppl 4): 48, 2010.

209.VASSILAKOPOULOS TP, PANGALIS GA, RONDOGIANNI PH, MASOURIDIS S, EXARHOS D, KOKORIS SI, DIMOU M, SAHANAS S, DIMITRIADOU E, VARIAMIS E, KYRTSONIS MC, SIAKANTARIS MP, GOULIAMOS A, ANDREOU I, PRASSOPOULOS V, PANAYIOTIDIS P, DATSERIS I, BERIS P, ANGELOPOULOU MK . PET/CT findings in patients with Hodgkin's lymphoma (HL) after ABVD combination chemotherapy: Prognosic significance and implications for further radiotherapy and follow-up strategies. Eighth International Symposium on Hodgkin Lymphoma, October 23-26, 2010, Cologne, Germany. Haematologica/The Hematology Journal, 95 (Suppl 4): 49, 2010.

210.ANARGYROU K, VASSILAKOPOULOS TP, TSIONOS K, KOKKORIS P, BOUTSIKAS G, ANGELOPOULOU M , CHRISTOULAS D, 141

MASOURIDOU S, DIMOU M, PAPATHEODOROU A, CHATZIFOTIADIS D, PANAYIOTIDIS P, PANGALIS GA, BERIS P, TERPOS E. Low bone mineral density and high bone turnover in patients with non- Hodgkin's lymphoma (NHL) who receive frontline therapy: Results of a multicenter prospective study. Fifty-second Annual Meeting of the American Society of Hematology, Orlando, Florida, USA, December 2-7, 2010. Blood 116: 5071, 2010.

211.ANGELOPOULOU M , TSIRIGOTIS P, VASSILAKOPOULOS TP, PANGALIS GA, TSOPRA O, DIMITRIADOU E, TSIRKINIDIS P, GALANI Z, LALOU E, BOUTSIKAS G, PAPPI V, MASOURIDIS S, MOSCHOYIANNIS M, PAPPA V, KALPADAKIS C, ANARGYROU K, SIAKANTARIS M, GEORGIOU G, PAPADAKI H, PANAYIOTIDIS P, DERVENOULAS J, MELETIS I. High dose therapy and autologous hematopoietic stem cell transplantation in relapsed/primary refractory Hodgkin Lymphoma patients: Outcome and prognostic factors. Experience from two Greek centers . 16 th Congress of the European Haematology Association, June 9-12, 2011, London, UK. Haematologica/The Hematology Journal, 96 (Suppl 2): 184, 2011.

212. SACHANAS S, RONTOYIANNI D, MOSCHOYIANNIS M, VASSILAKOPOULOS TP, KALPADAKIS C, YIAKOUMIS X, DIMITRAKOPOULOU A, ANGELOPOULOU M , PANGALIS G. Immunohistochemical expression of TCL1 and ZAP70 in chronic lymphocytic leukemia and splenic marginal zone lymphoma patients: Correlations with clinical and laboratory characteristics. 16 th Congress of the European Haematology Association, June 9-12, 2011, London, UK. Haematologica/The Hematology Journal, 96 (Suppl 2): 279, 2011. .

142

213. VASSILAKOPOULOS TP, PAPPI V, CONSTANTINOU N, YIAKOUMIS X, TSOPRA O, DIMOU M, KONSTANTINIDOU P, PESSACH I, MOSCHOYIANNIS M, BARTZI V, VARDOUNIOTI I, DALAGEORGOS T, PETEVI K, KANELOPOULOS A, TSIRKINIDIS P, KYRTSONIS MC, SIAKANTARIS MP, SACHANAS S, GASIAMIS A, GEORGIOU G, PANAYIOTIDIS P, PANGALIS G, MELETIS J, ANGELOPOULOU M . Baseline serum C-Reactive Protein levels (CRP) in Hodgkin Lymphoma (HL): Correlations with clinical and laboratory parameters and prognostic significance under anthracycline-based chemotherapy. 16 th Congress of the European Haematology Association, June 9-12, 2011, London, UK. Haematologica/The Hematology Journal, 96 (Suppl 2): 318, 2011.

214. VASSILAKOPOULOS TP, PANGALIS GA, BOUTSIKAS G, KOKORIS S, GALANI Z, SIAKANTARIS M, DIMITRIADOU E, DIMOPOULOU M, GEORGIOU G, DIMOU M, KALPADAKI C, KONTOPIDOU F, KYRTSONIS MC, PAPPIS V, TSOPRA O, TSIRKINIDIS P, KOUTSOUKOS K, ZOGRAFOS E, VARIAMIS E, VINIOU NA, PANAYIOTIDIS P, MELETIS J, ANGELOPOULOU M . Hodgkin Lymphoma (HL) in patients ≥60 years old: Clinical and laboratory features, outcome after anthracycline-based treatment and comparison with younger patients: A single center experience. 16 th Congress of the European Haematology Association, June 9-12, 2011, London, UK. Haematologica/The Hematology Journal, 96 (Suppl 2): 320, 2011.

215. VASSILAKOPOULOS TP, ANGELOPOULOU MK , RONDOGIANNI P, GALANI Z, DADAKARIDOU M, DIMOU M, PRASSOPOULOS V, CHATZIIOANNOU S, PAPPIS V, TSOPRA O, SACHANAS S, TSIRKINIDIS P, KONTOPIDOU F, VARIAMI E, KOUTSOUKOS K, ZOGRAFOS E, REPOUSSIS P, PANGALIS GA, PANAYIOTIDIS P, DATSERIS I, MELETIS J.

143

Interim PET-Scan for early response assessment and potential modification of treatment plan after 2 ABVD cycles in advanced stage Hodgkin Lymphoma (HL). 16th Congress of the European Haematology Association, June 9-12, 2011, London, UK. Haematologica/The Hematology Journal, 96 (Suppl 2): 322, 2011.

216.ANGELOPOULOU M , MASOURIDIS S, PANGALIS GA, TSOPRA O, MOSCHOYIANNIS M, PAPPI V, TSIRKINIDIS P, GALANI Z, PETEVI K, DIMOU M, KOUTSOUKOS K, GEORGIOU G, SACHANAS S, PANAYIOTIDIS P, MELETIS I, VASSILAKOPOULOS TP. Outcome and prognostic factors in Hodgkin Lymphoma (HL) patients who relapse after high dose therapy and autologous stem cell transplantation (HDT / ASCT). 16 th Congress of the European Haematology Association, June 9-12, 2011, London, UK. Haematologica/The Hematology Journal, 96 (Suppl 2): 323, 2011.

217.YIAKOUMIS X, KALPADAKIS C, SACHANAS S, KYRITSI H, PAPAGEORGIOU E, MOSCHOGIANNIS M, VASSILAKOPOULOS TP, ANGELOPOULOU MK , PANGALIS GA. Chronic neutropenia: Causes, clinical-laboratory characteristics and follow-up of 229 patients. 16 th Congress of the European Haematology Association, June 9-12, 2011, London, UK. Haematologica/The Hematology Journal, 96 (Suppl 2): 340, 2011.

218.VASSILAKOPOULOS TP, PANGALIS G, MASOURIDIS S, PRASSOPOULOS V, KATSIGIANNIS A, TERPOS E, KALPADAKIS C, RONDOGIANNI P, GALANI Z, PAPAGEORGIOU S, POZIOPOULOS C, CHATZIIOANNOU S, BOUTSIS D, CONSTANTINOU N, VRAKIDOU E, SACHANAS S, GEORGIOU G, KOKORIS S, SIAKANTARIS M, DIMOU M, YIAKOUMIS X, VINIOU N, CHRISTOULAS D, KYRTSONIS MC,

144

DATSERIS I, PAPADAKI H, DIMOPOULOS MA, PANAYIOTIDIS P, ROUSSOU P, ANGELOPOULOU M, MELETIS I. PET-Scan for response assessement after Rituximab-CHOP (R-CHOP) in primary mediastinal large B-cell lymphoma (PMLBCL): Prognostic significance and implications for subsequent radiotherapy (RT). 16 th Congress of the European Haematology Association, June 9-12, 2011, London, UK. Haematologica/The Hematology Journal, 96 (Suppl 2): 391, 2011.

219. KALPADAKIS C, PANGALIS GA, SACHANAS S, KORKOLOPOULOU P, RONTOYIANNI D, YIAKOUMIS X, MOSCHOGIANNIS M, KONTOPIDOU F, LEVIDOU G, DIMITRAKOPOULOU A, ANGELOPOULOU M , TSIRKINIDIS P, DIMITRIADOU E, PAPADAKI H, VASSILAKOPOULOS TP. Comparative study of splenic marginal zone lymphoma (SMZL) and primary bone marrow MZL (PBMZL). 16 th Congress of the European Haematology Association, June 9-12, 2011, London, UK. Haematologica/The Hematology Journal, 96 (Suppl 2): 392, 2011.

220.ANGELOPOULOU M , MOSCHOGIANNIS M, PANGALIS GA, TSIRKINIDIS P, TSOPRA O, PAPPI V, VARDOUNIOTIS I, RONDOGIANNI P, DATSERIS I, LALOU E, GALANI Z, MASOURIDIS S, DIMOU M, SACHANAS S, KOUTSOUKOS K, GEORGIOU G, PANAYIOTIDIS P, KYRTSONIS MC, MELETIS I, VASSILAKOPOULOS TP. The prognostic significance of PET Scan pre- and post- high dose therapy and hematopoietic stem cell transplantation (HDT / ASCT) in relapsed/refractory Hodgkin Lymphoma (HL) patients. 16 th Congress of the European Haematology Association, June 9-12, 2011, London, UK. Haematologica/The Hematology Journal, 96 (Suppl 2): 414, 2011.

145

221. VASSILAKOPOULOS TP, PAPAGEORGIOU S, ANGELOPOULOU M , PETEVI K, ANASTASOPOULOU A, STAVROULAKI A, KONSTANTINIDOU P, KOTSIANIDIS J, KYRTSONIS MC, SIAKANTARIS MP, KOKORIS S, KALPADAKIS C, SIAKANTARIS M, DIMOU M, GEORGIOU G, MOSCHOGIANNIS M, YIAKOUMIS X, PAPPIS V, TSOPRA O, TSATALAS K, PAPADAKI H, DERVENOULAS J, PANAYIOTIDIS P, MELETIS J, PANGALIS G, CONSTANTINOU N. Diffuse large B-cell lymphoma (DLBCL) in very elderly patients (older than 80 years): Promising results in the era of chemoimmunotherapy despite lower dose intensity. 16 th Congress of the European Haematology Association, June 9-12, 2011, London, UK. Haematologica/The Hematology Journal, 96 (Suppl 2): 438, 2011.

222. KALPADAKIS C, PANGALIS GA, VASSILAKOPOULOS TP, SACHANAS S, KONTOPIDOU F, YIAKOUMIS X, KOKORIS S, DIMITRIADOU E, MOSCHOGIANNIS M, KORKOLOPOULOU P, KYRTSONIS MC, TSIRKINIDIS P, SIAKANTARIS M, PAPADAKI H, ANGELOPOULOU M . Treatment of splenic marginal zone lymphoma with rituximab monotherapy vs splenectomy. 16 th Congress of the European Haematology Association, June 9-12, 2011, London, UK. Haematologica/The Hematology Journal, 96 (Suppl 2): 438, 2011.

223. YIAKOUMIS X, MOSCHOGIANNIS M, VASSILAKOPOULOS TP, SACHANAS S, ANGELOPOULOU M , PRASSOPOULOS V, RONTOYIANNI P, KALPADAKIS C, PANGALIS G. FDG PET CT Scan role on diagnosis and initial staging of lymphoproliferative diseases. 16 th Congress of the European Haematology Association, June 9-12, 2011, London, UK. Haematologica/The Hematology Journal, 96 (Suppl 2): 574, 2011.

146

224. GEORGE GEORGIOU, MARIA ROUMELIOTI, MARIA DIMOU, DANAI PALAIOLOGOU, ANGELIKI STEFANOU, EFSTATHIA STAIKOU, MARIE-CHRISTINE KYRTSONIS, MARIA K. ANGELOPOULOU, THEODOROS P. VASSILAKOPOULOS, ZACHAROULA I GALANI, ELENI PLATA, ELENI VARIAMI, IOANNIS KORANTZIS, KONSTANTINOS TSATALAS, MARIA PROTOPAPA, MARIA PAPAIOANNOU, GERASIMOS PANGALIS, THEODORE MARINAKIS, GEORGIOS XANTHOPOULIDIS, VASSILIKI PAPPI, ELISSAVET VERVESOU, ARGIRIS SYMEONIDIS, CHARIS MATSOUKA, KONSTANTINOS ANARGYROU, KONSTANTINOS TSIONOS, NORA VYNIOU, DIMITRA GOUGOPOULOU, DIMITRA LIAPI, DIONYSIS KOLOKYTHOPOULOS, PARASKEVI ROUSSOU, KONSTANTINA REPPA, ELENI POUMBOURIDOU, EIRINI KATODRITOU, IOANNIS KLONIZAKIS AND PANAYIOTIS PANAYIOTIDIS.

Determination of the Percentage of CML Patients that Achieve Continuous Complete Molecular Response Under Treatment with TKIs and Are Eligible for Participation in a TKI Discontinuation Study.

The 53 rd American Society of Hematology (ASH) Annual Meeting, December 10-13, 2011, San Diego, CA, USA. Blood 2011; 118: Abstract 4446.

225. SOTIRIOS P. SACHANAS, GEORGIA LEVIDOU, MARIA K. ANGELOPOULOU , MARIA MOSCHOGIANNIS, XANTHI YIAKOUMIS, THEODOROS P. VASSILAKOPOULOS, FLORA KONTOPIDOU, CHRISTINA H. KALPADAKIS, PANTELIS TSIRKINIDIS, AGLAIA DIMITRAKOPOULOU, STYLIANI KOKORIS, PANAYIOTIS PANAYIOTIDIS, HELEN A. PAPADAKI, EUSTRATIOS PATSOURIS, PENELOPE KORKOLOPOULOU AND GERASSIMOS PANGALIS.

Chronic Lymphocytic Leukemia: Proliferative and Apoptotic Profile on Lymph Node, Studied by Immunohistochemistry Including the Proliferation Centers.

147

The 53 rd American Society of Hematology (ASH) Annual Meeting, December 10-13, 2011, San Diego, CA, USA. Blood 2011; 118: Abstract 2538.

226. Panagiotis Theodorou Diamantopoulos, Vassiliki Kalotychou, Athanassios Galanopoulos, Nikolaos Spanakis, Katerina Polonyfi, Georgia Diamantopoulou, Efthymia Bazanis, Marina Siakantaris, Theodoros Vassilakopoulos, Maria K. Angelopoulou , Eleni Variami, Nikolaos Anagnostopoulos, Ioannis Rombos, Konstantinos Konstantopoulos, Panagoula Kollia, Gerasimos Pangalis, John Meletis and Nora-Athina Viniou.

Correlation of Fc Gamma RIIA Polymorphisms with EBV-Positivity and LMP1 Expression in Patients with Low Grade B-Cell Lymphomas

The 53 rd American Society of Hematology (ASH) Annual Meeting, December 10-13, 2011, San Diego, CA, USA. Blood 2011; 118: Abstract 1600

227. CHRISTINA H. KALPADAKIS, MD, GERASSIMOS PANGALIS, THEODOROS P. VASSILAKOPOULOS, SOTIRIOS P. SACHANAS, MD, FLORA KONTOPIDOU, XANTHI YIAKOUMIS, MD, STYLIANI KOKORIS, EVANGELIA DIMITRIADOU, MARIA DIMOPOULOU, MARIA MOSCHOGIANNIS, MD, PENELOPE KORKOLOPOULOU, MARIE-CHRISTINE KYRTSONIS, MARINA SIAKANTARIS, HELEN A. PAPADAKI AND MARIA K. ANGELOPOULOU.

Treatment of Splenic Marginal Zone Lymphoma with Rituximab Monotherapy in 59 Patients

The 53 rd American Society of Hematology (ASH) Annual Meeting, December 10-13, 2011, San Diego, CA, USA. Blood 2011; 118: Abstract 2712

148

228. PANAGIOTIS THEODOROU DIAMANTOPOULOS, KATERINA POLONYFI, NIKOLAOS SPANAKIS, ATHANASSIOS GALANOPOULOS, GEORGIA DIAMANTOPOULOU, EFTHYMIA BAZANIS, ANGELIKI-MARIA SARIDAKI, MARIA K. ANGELOPOULOU , CHRISTOS POZIOPOULOS, ELENI VARIAMI, MARINA MANTZOURANI, THEODOROS P. VASSILAKOPOULOS, MARINA SIAKANTARIS, NIKOLAOS ANAGNOSTOPOULOS, DESPOINA PERREA, PANAGOULA KOLLIA, JOHN MELETIS AND NORA-ATHINA VINIOU.

Regulation of Apoptosis and Oxidative Stress by LMP1 Oncoprotein of Epstein-Barr Virus in Patients with Low Grade B-Cell Leukemic Lymphomas.

The 53 rd American Society of Hematology (ASH) Annual Meeting, December 10-13, 2011, San Diego, CA, USA. Blood 2011; 118: Abstract 5212

229. KALPADAKIS C, PANGALIS G, ANGELOPOULOU M , SACHANAS S, KORKOLOPOULOU P, MAVROUDI E, KONTOPIDOU F, LEVIDOU G, DIMITRAKOPOULOU A, KYRTSONIS M, DIMITRIADOU E, KOKORIS S, YIAKOUMIS X, TSIRKINIDIS P, MOSCHOYIANNIS M, RONTOGIANNI D, PANAYIOTIDIS P, PAPADAKI H, VASSILAKOPOULOS T. CD5- MONOCLONAL B-CELL LYMPHOPROLIFERATION (MBL): CLINICAL CHARACTERISTICS AND OUTCOME. 17 th Congress of the European Haematology Association, June 14-17, 2012, Amsterdam The Netherlands. Haematologica/The Hematology Journal, 97 (Suppl 1): 215, 2012.

230. T VASSILAKOPOULOS, A KANELLOPOULOS, G PANGALIS, N CONSTANTINOU, G BOUTSIKAS, S KOKORIS, Z GALANI, M DIMOU, M SIAKANTARIS, K PETEVI, E DIMITRIADOU, M DIMOPOULOU, G GEORGIOU, C KALPADAKIS, F KONTOPIDOU,

149

MC KYRTSONIS, T TZENOU, V PAPPI, O TSOPRA, M MOSCHOGIANNIS, X YIAKOUMIS, I VARDOUNIOTI, V KARALI, G GAINARU, T NTALAGIORGOS, P FLEVARI, K KOUTSI, E BITSANI, NA VINIOU, P PANAYIOTIDIS, M ANGELOPOULOU , I MELETIS. VALIDATION OF THE INTERNATIONAL PROGNOSTIC SCORE IN PATIENTS WITH ADVANCED HODGKIN LYMPHOMA TREATED WITH ANTHRACYCLINE-BASED CHEMOTHERAPY. 17 th Congress of the European Haematology Association, June 14-17, 2012, Amsterdam The Netherlands. Haematologica/The Hematology Journal, 97 (Suppl 1): 216, 2012.

231. T VASSILAKOPOULOS, G PANGALIS, G BOUTSIKAS, P RONTOGIANNI, S MASOURIDIS, V PRASSOPOULOS, M DIMOU, Z GALANI, S SACHANAS, M MOSCHOGIANNIS, P TSIRKINIDIS, S CHATZIIOANNOU, O TSOPRA, G GEORGIOU, C KALPADAKIS, E DIMITRIADOU, E SINNI, A BILALIS, K PETEVI, A KANELLOPOULOS, G GAINARU, P FLEVARI, L PAPAGEORGIOU, E PESSACH, V BARTZI, A EFTHIMIOU, NA VINIOU, E VARIAMIS, MC KYRTSONIS, P BERIS, I DATSERIS , P PANAYIOTIDIS , I MELETIS , M ANGELOPOULOU . PROGNOSTIC FACTORS IN PATIENTS WITH HODGKIN LYMPHOMA (HL) AND A NEGATIVE PET/CT AFTER ABVD CHEMOTHERAPY: POTENTIAL APPLICATIONS FOR THE DESIGN OF FOLLOW-UP STRATEGIES. 17 th Congress of the European Haematology Association, June 14-17, 2012, Amsterdam The Netherlands. Haematologica/The Hematology Journal, 97 (Suppl 1): 218, 2012.

232. M ANGELOPOULOU , E MOSA, M MOSCHOGIANNIS, O TSOPRA, Z GALANI, P RONDOGIANNI, S SACHANAS, X YIAKOUMIS, M DIMOU, G BOUTSIKAS, P TSIRKINIDIS, V PAPPIS, G GEORGIOU, P TSAFTARIDIS, K PETEVI, I VARDOUNIOTIS, A KANELLOPOULOS, L PAPAGEORGIOU, M SIAKANTARIS, D EXARCHOS, I DATSERIS, V

150

PRASSOPOULOS, MC KYRTSONIS, P PANAYIOTIDIS, G PANGALIS, I MELETIS, T VASSILAKOPOULOS. IS THERE A ROLE FOR POSITRON EMISSION TOMOGRAPHY (PET/CT) IN THE INITIAL STAGING OF HODGKIN LYMPHOMA(HL) ? 17 th Congress of the European Haematology Association, June 14-17, 2012, Amsterdam The Netherlands. Haematologica/The Hematology Journal, 97 (Suppl 1): 220, 2012.

233. M ANGELOPOULOU , M MOSCHOGIANNIS, P RONDOGIANNI, V PAPPIS, P TSIRKINIDIS, O TSOPRA, Z GALANI, S SACHANAS, X YIAKOUMIS, S MASOURIDI, G BOUTSIKAS, C KALPADAKIS, E DIMITRIADOU, M DIMOPOULOU, V TELONIS, P FLEVARI, G GAINAROU, T NTALAGIORGOS, D EXARCHOS, I DATSERIS, A GOULIAMOS, MC KYRTSONIS, P PANAYIOTIDIS, G PANGALIS, I MELETIS, T VASSILAKOPOULOS. THE PROGNOSTIC SIGNIFICANCE OF PET SCAN BEFORE AND AFTER HIGH-DOSE THERAPY AND AUTOLOGOUS STEM CELL TRANSPLANTATION (ASCT) IN RELAPSED/REFRACTORY HODGKIN LYMPHOMA (HL) PATIENTS. 17 th Congress of the European Haematology Association, June 14-17, 2012, Amsterdam The Netherlands. Haematologica/The Hematology Journal, 97 (Suppl 1): 443, 2012.

234. S SACHANAS, G LEVIDOU, M ANGELOPOULOU , M MOSCHOGIANNIS, X YIAKOUMIS, T VASSILAKOPOULOS, MC KYRTSONIS, F KONTOPIDOU, C KALPADAKIS, P TSIRKINIDIS, E DIMITRIADOU, A DIMITRAKOPOULOU, S KOKORIS, P PANAYIOTIDIS, H PAPADAKI, E PATSOURIS, P KORKOLOPOULOU, G PANGALIS. PROLIFERATIVE AND APOPTOTIC STATUS ON LYMPH NODE SECTIONS, INCLUDING THE PROLIFERATION CENTERS (PC), OF CHRONIC LYMPHOCYTIC LEUKEMIA (CLL) PATIENTS.

151

17 th Congress of the European Haematology Association, June 14-17, 2012, Amsterdam The Netherlands. Haematologica/The Hematology Journal, 97 (Suppl 1): 731, 2012.

235. MC KYRTSONIS, K SARRIS, G PANGALIS, T TZENOU, S SACHANAS, E KOULIERIS, V BARTZIS, A EFTHYMIOU, M DIMOU, M SIAKANTARIS, T VASSILAKOPOULOS, M ANGELOPOULOU , P PANAYIOTIDIS. CONTRADICTORY IMPACT OF SERUM BLYS LEVELS IN CHRONIC LYMPHOCYTIC LEUKEMIA (CLL), WALDESTR ΦM’S MACROGLOBULINEMIA (WM) AND MULTIPLE MYELOMA (MM). 17 th Congress of the European Haematology Association, June 14-17, 2012, Amsterdam The Netherlands. Haematologica/The Hematology Journal, 97 (Suppl 1): 741, 2012.

236. S SACHANAS, D RONDOGIANNI, M MOSCHOYIANNIS, T VASSILAKOPOULOS, C KALPADAKIS, X YIAKOUMIS, F KONTOPIDOU, A DIMITRAKOPOULOU, P KORKOLOPOULOU, P TSIRKINIDIS, MC KYRTSONIS, S KOKKORIS, E DIMITRIADOU, H PAPADAKI, P PANAYIOTIDIS, M ANGELOPOULOU , G PANGALIS. TCL1 AND PAKT EXPRESSION IN CHRONIC LYMPHOCYTIC LEUKEMIA PATIENTS: CORRELATION WITH CLINICAL, LABORATORY FEATURES AND OUTCOME 17 th Congress of the European Haematology Association, June 14-17, 2012, Amsterdam The Netherlands. Haematologica/The Hematology Journal, 97 (Suppl 1): 1269, 2012.

237. T VASSILAKOPOULOS, P RONTOGIANNI, G PANGALIS, G BOUTSIKAS, V PRASSOPOULOS, S MASOURIDIS, S KOKORIS, M DIMOU, Z GALANI, S CHATZIIOANNOU, M MOSCHOGIANNIS, S SACHANAS, X YIAKOUMIS, V PAPPI, E SINNI, T TZENOU, K PETEVI, A KANELLOPOULOS, T NTALAGIORGOS, I VARDOUNIOTI, K KOUTSI, L PAPAGEORGIOU, E PESSACH, V TELONIS, E VARIAMIS, MC KYRTSONIS, M DIMOPOULOU, M SIAKANTARIS, P 152

BERIS, I DATSERIS, P PANAYIOTIDIS, I MELETIS, M ANGELOPOULOU . OUTCOME AND PROGNOSTIC FACTORS IN PATIENTS WITH HODGKIN LYMPHOMA (HL) WHO REMAIN PET/CT-POSITIVE AFTER ABVD COMBINATION CHEMOTHERAPY: POTENTIAL APPLICATIONS FOR THE DESIGN OF SUBSEQUENT TREATMENT. 17 th Congress of the European Haematology Association, June 14-17, 2012, Amsterdam The Netherlands. Haematologica/The Hematology Journal, 97 (Suppl 1): 1404, 2012.

238. E KOULIERIS, D MALTEZAS, T TZENOU, N KAFASSI, V BARTZIS, K BITSANIS, A EFTHYMIOU, I VARDOUNIOTI, V KARALI, E NIKOLAOU, M DIMOU, P TSAFTARIDIS, M ANGELOPOULOU , P PANAYIOTIDIS, G PANGALIS, M KYRTSONIS. PROGNOSTIC CONTRIBUTION OF UNINVOLVED SERUM FREE LIGHT CHAINS (USFLC) IN MULTIPLE MYELOMA (MM). 17 th Congress of the European Haematology Association, June 14-17, 2012, Amsterdam The Netherlands. Haematologica/The Hematology Journal, 97 (Suppl 1): 1514, 2012.

239. T TZENOU, E KOULIERIS, D MALTEZAS, K BITSANIS, I VARDOUNIOTI, V BARTZIS, M DIMOU, C KALPADAKIS, T VASSILAKOPOULOS, M ANGELOPOULOU , G PANGALIS, P PANAYOTIDIS, MC KYRTSONIS. INCREASED SERUM TRANSFORMING GROWTH FACTOR-BETA (TGF-BETA) IS RELATED TO LONGER TIME TO FIRST TREATMENT (TFT) AND OVERALL SURVIVAL (OS) IN WALDENSTROM’S MACROGLOBULINEMIA (WM). 17 th Congress of the European Haematology Association, June 14-17, 2012, Amsterdam The Netherlands. Haematologica/The Hematology Journal, 97 (Suppl 1): 1527, 2012.

240. T TZENOU, G LEVIDOU, N KAVANTZAS, K XIROKOSTA, D MALTEZAS, P KORKOLOPOULOU, E KOULIERIS, K DIMOU, C 153

KALPADAKIS, T VASSILAKOPOULOS, M ANGELOPOULOU , P PANAYIOTIDIS, G PANGALIS, E PATSOURIS, MC KYRTSONIS. INCREASED BONE MARROW TOTAL VASCULAR AREA (TVA) CORRELATES WITH A MORE AGGRESSIVE DISEASE IN WALDENSTROM’S MACROGLOBULINEMIA (WM) PATIENTS. 17 th Congress of the European Haematology Association, June 14-17, 2012, Amsterdam The Netherlands. Haematologica/The Hematology Journal, 97 (Suppl 1): 1534, 2012.

241. TSOPRA, T VASSILAKOPOULOS, P TSIRKINIDIS, M DIMOU, I VARDOUNIOTI, S KOKORIS, G BOUTSIKAS, Z GALANI, E PLATA, P TSAFTARIDIS, K PETEVI, A KANELLOPOULOS, V BARTZI, T TZENOU, A BILALIS, G GEORGIOU, N VYNIOU, G PANGALIS, J MELETIS, M KYRTSONIS, P PANAYIOTIDIS, M ANGELOPOULOU . ESSENTIAL THROMBOCYTHAEMIA (ET): DISEASE SUBGROUPS AND PROGNOSTIC FACTORS IN 181 PATIENTS FROM A SINGLE CENTER. 17 th Congress of the European Haematology Association, June 14-17, 2012, Amsterdam The Netherlands. Haematologica/The Hematology Journal, 97 (Suppl 1): 1610, 2012.

242. P TSIRKINIDIS, T VASSILAKOPOULOS, O TSOPRA, M DIMOU, I VARDOUNIOTI, G GEORGIOU, S KOKORIS, E PLATA, Z GALANI, G BOUTSIKAS, K PETEVI, A KANELLOPOULOS, A EUTHYMIOU, V KARALI, A BITSANI, T TZENOU, G PANGALIS, N VYNIOU, J MELETIS, M KYRTSONIS, P PANAYIOTIDIS, M ANGELOPOULOU . EVALUATION OF THE DIAGNOSTIC CRITERIA OF POLYCYTAHEMIA VERA IN EVERYDAY CLINICAL PRACTICE: THE RELEVANCE OF JAK2V617F MUTATION. 17 th Congress of the European Haematology Association, June 14-17, 2012, Amsterdam The Netherlands. Haematologica/The Hematology Journal, 97 (Suppl 1): 1626, 2012.

154

243. P DIAMANTOPOULOS, K POLONYFI, M SOFOTASIOU, A GALANOPOULOS, G DIAMANTOPOULOU, V PAPADOPOULOU, F KALALA, M ANGELOPOULOU , VARIAMI, T VASSILAKOPOULOS, M SIAKANTARIS, A ANAGNOSTOPOULOS, N SPANAKIS, J MELETIS, NA VINIOU. EVIDENCE FOR REGULATION OF APOPTOSIS BY LMP1 ONCOPROTEIN OF EPSTEIN-BARR VIRUS IN PATIENTS WITH LOW GRADE B-CELL LEUKEMIC LYMPHOMAS. 17 th Congress of the European Haematology Association, June 14-17, 2012, Amsterdam The Netherlands. Haematologica/The Hematology Journal, 97 (Suppl 1): 1651, 2012.

244. P DIAMANTOPOULOS, K POLONYFI, M SOFOTASIOU, N SPANAKIS, A GALANOPOULOS, G DIAMANTOPOULOU, T ILIAKIS, T VASSILAKOPOULOS, M ANGELOPOULOU, E VARIAMI, NA VINIOU. LACK OF ASSOCIATION OF HHV-6 WITH LEUKEMIC LOW GRADE B-CELL LYMPHOMAS. 17 th Congress of the European Haematology Association, June 14-17, 2012, Amsterdam The Netherlands. Haematologica/The Hematology Journal, 97 (Suppl 1): 1659, 2012.

245. M ANGELOPOULOU , P TSIRIGOTIS, Z GALANI, M MOSCHOGIANNIS, M DIMOU, P TSIRKINIDIS, S MASOURIDI, G GAINAROU, E DIMITRIADOU, S SACHANAS, X YIAKOUMIS, V PAPPA, L PAPAGEORGIOU, G BOUTSIKAS, C KALPADAKIS, P FLEVARI, K KOUTSI, E SINNI, MC KYRTSONIS, P PANAYIOTIDIS, M SIAKANTARIS, I DERVENOULAS, I MELETIS, G PANGALIS, T VASSILAKOPOULOS. NODAL PERIPHERAL T-CELL LYMPHOMA (PTCL): CHARACTERISTICS, PROGNOSIS AND OUTCOME OF 120 PATIENTS. 17 th Congress of the European Haematology Association, June 14-17, 2012, Amsterdam The Netherlands. Haematologica/The Hematology Journal, 97 (Suppl 1): 1677, 2012. 155

246. M SIAKANTARIS, X YIAKOUMIS, S SACHANAS, M MOSCHOYIANNIS, P TSIRKINIDIS, P KORKOLOPOULOU, MC KYRTSONIS, X SPILIADI, P BOBOTSI, M ANGELOPOULOU , C KALPADAKIS, T TZENOU, H PAPADAKI, T VASSILAKOPOULOS, G A PANGALIS. COMBINATION OF RITUXIMAB-CHLORAMBUCIL AS 1ST LINE TREATMENT FOR GASTRIC MALT LYMPHOMA 17 th Congress of the European Haematology Association, June 14-17, 2012, Amsterdam The Netherlands. Haematologica/The Hematology Journal, 97 (Suppl 1): 1686, 2012.

247. X YIAKOUMIS, G PANGALIS, S SACHANAS, M MOSCHOYIANNIS, P TSIRKINIDIS, M ANGELOPOULOU , V PRASSOPOULOS, F RONTOGIANNI, C KALPADAKIS, T VASSILAKOPOULOS. FDG-PET CT SCAN CONTRIBUTION IN DIAGNOSIS AND INITIAL STAGING OF INDOLENT LYMPHOMAS. 17 th Congress of the European Haematology Association, June 14-17, 2012, Amsterdam The Netherlands. Haematologica/The Hematology Journal, 97 (Suppl 1): 1730, 2012.

248. S SACHANAS, I KOTSIANIDIS, T VASSILAKOPOULOS, N KONSTANTINOU, P REPOUSIS, K GIRKAS, E MICHALI, P TSIRIGOTIS, I DERVENOULAS, N ANAGNOSTOPOULOS, M MOSHOYIANNIS, X YIAKOUMIS, H PAPADAKI, C KALPADAKIS, P PANAYIOTIDIS, M KYRTSONIS, K PAPANASTASIOU, P MATSOUKA, M ANGELOPOULOU , G PANGALIS. COMPARISON OF RITUXIMAB-CHLORAMBUCIL(R-CHL) COMBINATION WITH OTHER FIRST LINE TREATMENTS IN MANTLE CELL LYMPHOMA (MCL) PATIENTS: EXPERIENCE FROM 6 CENTERS IN GREECE 17 th Congress of the European Haematology Association, June 14-17, 2012, Amsterdam The Netherlands. Haematologica/The Hematology Journal, 97 (Suppl 1): 1731, 2012.

156

249. M MOSCHOYIANNIS, G PANGALIS, S SACHANAS, C KALAPADAKIS, X YIAKOUMIS, T VASILAKOPOULOS, M ANGELOPOULOU. THE EFFICACY OF INTERFERON-a IN NON CUTANEOUS PERIPHERAL T CELL LYMPHOMAS. 17 th Congress of the European Haematology Association, June 14-17, 2012, Amsterdam The Netherlands. Haematologica/The Hematology Journal, 97 (Suppl 1): 1743, 2012.

250. DIMITRIOS MALTEZAS, KATERINA SARRIS, EFSTATHIOS KOULIERIS, TATIANA TZENOU, VASSILIKI BARTZIS, EFTYCHIA NIKOLAOU, MARIA GAVRIATOPOULOU, MARIA DIMOU, EVANGELOS TERPOS, MARIA K. ANGELOPOULOU, THEODOROS P. VASSILAKOPOULOS, PANAYIOTIS PANAYIOTIDIS, GERASIMOS PANGALIS, MELETIOS A DIMOPOULOS, MD AND MARIE- CHRISTINE KYRTSONIS. Increased Serum Transforming Growth Factor-beta1 (Tgf-beta1) Is Related to a Better Outcome in MM, WM and CLL Patients. The 54th American Society of Hematology (ASH) Annual Meeting, December 8-11, 2012, Atlanta, GA, USA. Blood 2012; 120: Abstract 4976.

251. PANAGIOTIS THEODOROU DIAMANTOPOULOS, KATERINA POLONYPHI, MARIA SOFOTASIOIU, ATHANASSIOS GALANOPOULOS, NIKOLAOS SPANAKIS, GEORGE RASSIDAKIS, PANAGIOTIS KOUZIS, VASSILIKI PAPADOPOULOU, FANI KALALA, THEODOROS ILIAKIS, THEODOROS VASSILAKOPOULOS, MARIA K. ANGELOPOULOU , MARINA SIAKANTARIS, EVANGELOS TERPOS, ELENI VARIAMI, PANAGOULA KOLLIA, GERASSIMOS A PANGALIS AND NORA-ATHINA VINIOU.

Lower Levels of Survivin in Patients with Leukemic Low Grade B-Cell Lymphomas Expressing LMP1 Oncoprotein of Epstein-Barr Virus.

157

The 54th American Society of Hematology (ASH) Annual Meeting, December 8-11, 2012, Atlanta, GA, USA. Blood 2012; 120: Abstract 1560

252. EFSTATHIOS KOULIERIS, DIMITRIOS MALTEZAS, NIKOLAOU EYTYCHIA, VASSILIKI BARTZIS, TATIANNA TZENOU, VASSILIKI KARALI, PESSACH ILIAS, KATERINA SARRIS, STEPHEN HARDING, ARTHUR BRADWELL, FRCP, FRCPATH, THEODOROS P. VASSILAKOPOULOS, MARIA K. ANGELOPOULOU, NIKOLITSA KAFASI, PANAYIOTIS PANAYIOTIDIS AND MARIE-CHRISTINE KYRTSONIS.

Impact of Novel M-Component Based Biomarkers On to Progression Free Survival After Treatment in Intact Immunoglobulin Multiple Myeloma.

The 54th American Society of Hematology (ASH) Annual Meeting, December 8-11, 2012, Atlanta, GA, USA. Blood 2012; 120: Abstract 2927.

253. EFSTATHIOS KOULIERIS, KATERINA SARRIS, NIKOLITSA KAFASI, VASSILIKI BARTZIS, TATIANA TZENOU, DIMITRIOS MALTEZAS, SOTIRIOS P. SACHANAS, ANNA EFTHYMIOU, KATERINA MPITSANIS, IOANNA VARDOUNIOTI, MARIA DIMOU, THEODOROS P. VASSILAKOPOULOS, MARINA SIAKANTARIS, MARIA K. ANGELOPOULOU , PANAGIOTIS TSAFTARIDIS, DESPOINA MPARMPAROUSIS, CHARIS MATSOUKA, GERASIMOS PANGALIS, PANAYIOTIS PANAYIOTIDIS AND MARIE-CHRISTINE KYRTSONIS.

A Shorter Time to First Treatment and Worst Overall survival Is Observed in Cll Patients with Reduced Serum IgM As Evaluated with Novel Serum Immunoassays.

158

The 54th American Society of Hematology (ASH) Annual Meeting, December 8-11, 2012, Atlanta, GA, USA. Blood 2012; 120: Abstract 4585.

254. KATERINA SARRIS, VASSILIKI BARTZIS, DIMITRIS MALTEZAS, EFSTATHIOS KOULIERIS, TATIANA TZENOU, SOTIRIOS P. SACHANAS, EFTYCHIA NIKOLAOU, ANNA EFTHYMIOU, KATERINA BITSANI, MARIA DIMOU, THEODOROS VASSILAKOPOULOS, MARINA SIAKANTARIS, MARIA K. ANGELOPOULOU , FLORA KONTOPIDOU, PANAGIOTIS TSAFTARIDIS, NIKOLITSA KAFASI, GERASSIMOS A PANGALIS, PANAYIOTIS PANAYIOTIDIS, STEPHEN HARDING AND MARIE-CHRISTINE KYRTSONIS.

Significance of Serum Free Light Chains in Chronic Lymphocytic Leukemia (cll) Prognosis.

The 54th American Society of Hematology (ASH) Annual Meeting, December 8-11, 2012, Atlanta, GA, USA. Blood 2012; 120: Abstract 4568

255. MARINA SIAKANTARIS, GEORGIA LEVIDOU, THEODORA PAPADAKI, EVANGELIA PAPADAVID, THEODOROS P. VASSILAKOPOULOS, MARIA K. ANGELOPOULOU, LEONIDAS MARINOS, VASSILIKI NIKOLAOU, APHRODITE ECONOMIDI, CHRISTINA ANTONIOU, EFSTRATIOS PATSOURIS, G.A. PANGALIS AND PENELOPE KORKOLOPOULOU

A Comprehensive Immunohistochemical Approach of AKT/mTOR Pathway and p-STAT3 in Mycosis Fungoides.

The 54th American Society of Hematology (ASH) Annual Meeting, December 8-11, 2012, Atlanta, GA, USA. Blood 2012; 120: Abstract 2663.

256. G. BOUTSIKAS, E. TERPOS, A. PAPATHEODOROU, A. MELETIOU, V. TELONIS, K. PETEVI, A. KANELLOPOULOS, P. FLEVARI,

159

G. GAINARU, A. KOUTSI, L. PAPAGEORGIOU, A. ZANNOU, P. TSIRKINIDIS, Z. GALANI, M. DIMOU, E. LALOU, M. NIKOLOPOULOU, P. PANAYIOTIDIS, M.-C. KYRTSONIS, G. PANGALIS, J. MELETIS, T. VASSILAKOPOULOS, M. ANGELOPOULOU. Study of bone metabolism and angiogenesis markers following high dose chemotherapy/autologous stem cell transplantation 39th Annual Meeting of the European Group for Blood and Marrow Transplantation, 7–10 April 2013, London, UK. Bone Marrow Transplant.2013;48(S2), abstract O287, oral presentation.

257. V. TELONIS, T. VASSILAKOPOULOS, E. LALOU, G. BOUTSIKAS, Z. GALANI, M. MOSCHOGIANNIS, A. DIMITRAKOPOULOU, C. KALPADAKI, A. MELETIOU, K. ANARGYROU, S. SACHANAS, P. FLEVARI, G. GAINARU, A. KOUTSI, L. PAPAGEORGIOU, A. ZANNOU, M. DIMOU, N. VYNIOU, P. PANAYIOTIDIS, M.- C. KYRTSONIS, P. TSAFTARIDIS, J. MELETIS, M. ANGELOPOULOU. Preemptive use of plerixafor in patients with lymphoproliferative diseases undergoing haematopoietic stem cell mobilization. 39th Annual Meeting of the European Group for Blood and Marrow Transplantation, 7–10 April 2013, London, UK. Bone Marrow Transplant.2013;48(S2), abstract P527

258. A KANELLOPOULOS, M ANGELOPOULOU , G BOUTSIKAS, K PETEVI, G GAINARU, Z GALANI, E SINNI, M SIAKANTARIS, M MOSCHOGIANNIS, P TSAFTARIDIS, V KOMNINAKA, M DIMOPOULOU, E PLATA, X YIAKOUMIS, P TSIRKINIDIS, P FLEVARI, L PAPAGEORGIOU, K KOUTSI, A ZANNOU, V TELONIS, A BILALIS, E PAPAKOSTAS, J MELETIS, G PANGALIS, T VASSILAKOPOULOS. THE LYMPHOCYTIC HISTOPATHOLOGIC SUBTYPES OF HODGKIN LYMPHOMA (HL): CLINICAL PRESENTATION AND LONG-TERM OUTCOME IN A CASE SERIES OF 61 PATIENTS

160

18 th Congress of the European Hematology Association, Stockholm, Sweden, June 13-16, 2013. Haematologica (The hematology journal) 2013; 98(Suppl 1): Abstract P160

259. T VASSILAKOPOULOS, M ANGELOPOULOU , P RONTOGIANNI, S MASOURIDIS, V PRASSOPOULOS, A KATSIGIANNIS, J APOSTOLIDIS, E TERPOS, C KALPADAKIS, Z GALANI, S PAPAGEORGIOU, C POZIOPOULOS, S CHATZIIOANNOU, D BOUTSIS, N KONSTANTINOU, E VRAKIDOU, S SACHANAS, M SIAKANTARIS, M DIMOU, X YIAKOUMIS, E VARIAMIS, N VINIOU, D CHRISTOULAS, M KYRTSONIS, I DATSERIS, E PAPADAKI, N HARHALAKIS, M DIMOPOULOS, P PANAYIOTIDIS, P ROUSSOU, J MELETIS, G PANGALIS. THE ROLE OF PET/CT AFTER RITUXIMAB-CHOP (R-CHOP) IN PRIMARY MEDIASTINAL LARGE B-CELL LYMPHOMA (PMLBCL): RESPONSE ASSESSMENT, PROGNOSTIC SIGNIFICANCE AND IMPLICATIONS FOR SUBSEQUENT RADIOTHERAPY (RT). 18 th Congress of the European Hematology Association, Stockholm, Sweden, June 13-16, 2013. Haematologica (The hematology journal) 2013; 98(Suppl 1): Abstract P137

260. T VASSILAKOPOULOS, G PANGALIS, S PAPAGEORGIOU, A ANASTASOPOULOU, E VERROU, M DIMOU, K PETEVI, G BOUTSIKAS, A KANELLOPOULOS, L PAPAGEORGIOU, M KYRTSONI, M SIAKANTARIS, M KAPAROU, V PAPPA, E IOANNIDOU, K ZERVAS, E PAPADAKI, P TSAFTARIDIS, P PANAYIOTIDIS, N KONSTANTINOU, J MELETIS, M ANGELOPOULOU. EVALUATION OF THE PROGNOSTIC SIGNIFICANCE OF THE BODY MASS INDEX (BMI) IN PATIENTS WITH DIFFUSE LARGE B- CELL LYMPHOMA (DLBCL) RECEIVING RITUXIMAB-CHOP (R- CHOP) OR SIMILAR IMMUNOCHEMOTHERAPY.

161

18 th Congress of the European Hematology Association, Stockholm, Sweden, June 13-16, 2013. Haematologica (The hematology journal) 2013; 98(Suppl 1): Abstract P327

261. E KYRITSI, X YIAKOUMIS, G PANGALIS, C PONTIKOGLOU, K PYROVOLAKI, CHRISTINA KALPADAKIS, I MAVROUDI, H KOUTALA, S MASTRODEMOU, T VASSILAKOPOULOS, G VAIOPOULOS, E DIAMANTI-KANDARAKIS, H PAPADAKI, M KONSTANTINOS ANGELOPOULOU. THYROID DISEASE-ASSOCIATED NEUTROPENIA: FREQUENCY, CLINICAL, LABORATORY AND IMMUNOPHENOTYPICAL FINDINGS. 18 th Congress of the European Hematology Association, Stockholm, Sweden, June 13-16, 2013. Haematologica (The hematology journal) 2013; 98(Suppl 1): Abstract S564, oral presentation.

262. S SACHANAS, G LEVIDOU, M ANGELOPOULOU , M MOSCHOGIANNIS, X YIAKOUMIS, T VASSILAKOPOULOS, C CALPADAKIS, M KYRTSONIS, F KONTOPIDOU, A DIMITRAKOPOULOU, P TSIRKINIDIS, S KOKORIS, H PAPADAKI, P PANAYIOTIDIS, K NIKOLAOS, E PATSOURIS, K PINELOPI, G PANGALIS. STUDY OF ANGIOGENESIS ON LYMPH NODES OF CHRONIC LYMPHOCYTIC LEUKEMIA PATIENTS. 18 th Congress of the European Hematology Association, Stockholm, Sweden, June 13-16, 2013. Haematologica (The hematology journal) 2013; 98(Suppl 1): Abstract B1308

263. S SACHANAS, D RONTOGIANNI, T VASSILAKOPOULOS, M MOSCHOGIANNIS, C CALPADAKIS, X YIAKOUMIS, M KYRTSONIS, F KONTOPIDOU, A DIMITRAKOPOULOU, G LEVIDOU, K PINELOPI, PTSIRKINIDIS, H PAPADAKI, P PANAYIOTIDIS, M ANGELOPOULOU , G PANGALIS

162

INCIDENCE AND PROGNOSTIC SIGNIFICANCE OF TCL-1 ONCOGENE IN CHRONIC LYMPHOCYTIC LEUKEMIA. 18 th Congress of the European Hematology Association, Stockholm, Sweden, June 13-16, 2013. Haematologica (The hematology journal) 2013; 98(Suppl 1): Abstract B1318

264. C KALPADAKIS, G PANGALIS, T VASSILAKOPOULOS, S SACHANAS, P TSIRKINIDIS, M MOSCHOGIANNIS, P KORKOLOPOULOU,A DIMITRAKOPOULOU, S KOKKORIS, X YIAKOUMIS, E DIMITRIADOU, P TSAFTARIDIS, M KYRTSONIS, D RONTOGIANNIS, E PLATA, P PANAYIOTIDIS, H PAPADAKI, M ANGELOPOULOU DESCRIPTION OF A FAVORABLE GROUP OF PATIENTS WITH CD5(+) MONOCLONAL B-CELL LYMPHOCYTOSIS AND CHRONIC LYMPHOCYTIC LEUKEMIA RAI-0. 18 th Congress of the European Hematology Association, Stockholm, Sweden, June 13-16, 2013. Haematologica (The hematology journal) 2013; 98(Suppl 1): Abstract B1329.

265. V PAPADOPOULOU, T ILIAKIS, P DIAMANTOPOULOS, K ZERVAKIS, G TSILIMIDOS, F KALALA, M SIAKANTARIS, N GIANNAKOPOULOU, G PANGALIS, M ANGELOPOULOU , K PESTE, P PANAYIOTIDIS, E VARIAMI, N VINIOU. IDENTIFICATION AND CHARACTERISTICS OF CANDIDATES FOR CESSATION OF TYROSINE KINASE INHIBITORS AMONG PATIENTS WITH CHRONIC PHASE CHRONIC MYELOGENOUS LEUKEMIA SHOWING DURABLE COMPLETE MOLECULAR RESPONSE 18 th Congress of the European Hematology Association, Stockholm, Sweden, June 13-16, 2013. Haematologica (The hematology journal) 2013; 98(Suppl 1): Abstract B1376

163

266. T VASSILAKOPOULOS, E ZOGRAFOS, K PETEVI, G BOUTSIKAS, A KANELLOPOULOS, G CHILAS, M DIMOU, G GAINARU, E SINNI, M KYRTSONIS, V PAPPI, T TZENOU, A BILALIS, A EUTHYMIOU, I VARDOUNIOTI, E PESSACH, P FLEVARI, L PAPAGEORGIOU, V TELONIS, K KOUTSI,A ZANNOU, P TSAFTARIDIS, P PANAYIOTIDIS, P BERIS, M ANGELOPOULOU , J MELETIS PROCALCITONIN (PCT) LEVELS IN NEWLY DIAGNOSED PATIENTS WITH HODGKIN LYMPHOMA (HL) PRESENTING WITH FEVER AND/OR ELEVATED C-REACTIVE PROTEIN (CRP) 18 th Congress of the European Hematology Association, Stockholm, Sweden, June 13-16, 2013. Haematologica (The hematology journal) 2013; 98(Suppl 1): Abstract B1414

267. A ANASTASOPOULOU, G GEORGIOU, M ANGELOPOULOU , K LILAKOS, P DIAMANTOPOULOS, N VINIOU, M KYRTSONIS, D PALAIOLOGOUU, J MELETIS, G PANGALIS, P PANAYIOTIDIS, T VASSILAKOPOULOS THE IMPACT OF FC Γ RECEPTOR POLYMORPHISMS AND GLUTATHIONES- TRANSFERASES POLYMORPHISMS IN PATIENTS WITH DIFFUSE LARGE B-CELL LYMPHOMA TREATED WITH R-CHOP 18 th Congress of the European Hematology Association, Stockholm, Sweden, June 13-16, 2013. Haematologica (The hematology journal) 2013; 98(Suppl 1): Abstract B1603

268. E GEORGAKOPOULOU, M MOSCHOGIANNIS, P TSIRKINIDIS, M ACHTARI, X YIAKOUMIS, C KALPADAKIS, S SACHANAS, M ANGELOPOULOU , T VASSILAKOPOULOS, M SIAKANTARIS, M KYRTSONIS, C KITTAS, G LASKARIS, G PANGALIS. ORAL MUCOSA NON-HODGKIN’S LYMPHOMAS: A CLINICOPATHOLOGIC STUDY OF 22 CASES.

164

18 th Congress of the European Hematology Association, Stockholm, Sweden, June 13-16, 2013. Haematologica (The hematology journal) 2013; 98(Suppl 1): Abstract B1618

269. VASSILAKOPOULOS TP, ZOGRAFOS E, PETEVI K, BOUTSIKAS G, KANELLOPOULOS A, HILLAS G, DIMOU M, GAINARU G, PAPAGEORGIOU L, SINNI E, KYRTSONIS MC, PAPPI V, TSOPRA O, TZENOU T, EFTHYMIOU A, VARDOUNIOTI I, PESSACH E, FLEVARI P, TELONIS V, KOUTSI K, ZANNOU A, PAPAKOSTAS V, TSAFTARIDIS P, PLATA E, PANAYIOTIDIS P, BERIS PH, ANGELOPOULOU MK , MELETIS J. PROCALCITONIN (PCT) LEVELS IN NEWLY DIAGNOSED PATIENTS WITH HODGKIN LYMPHOMA (HL) PRESENTING WITH FEVER AND/OR ELEVATED C-REACTIVE PROTEIN (CRP). 9th International Symposium on Hodgkin Lymphoma, Cologne, Germany, October 12-15, 2013. Haematologica (The Haematology Journal) 2013; 98(s2): Abstract P098

270. VASSILAKOPOULOS TP, ANGELOPOULOU MK , PRASSOPOULOS V, CHATZIIOANNOU S, MOSCHOGIANNIS M, TSIRKINIDIS P, POZIOPOULOS C, SYMEONIDIS A, REPOUSSIS P, MATSOUKA CH, KONTOPIDOU FN, SOTIROPOULOS V, VARIAMI E, VINIOU NA, ZIKOS P, PETEVI K, BOUTSIKAS G, KANELLOPOULOS A, PAPAGEORGIOU L, PANAYIOTIDIS P, PANGALIS GA, DATSERIS I, MELETIS J, RONDOGIANNI PH. COMPARATIVE ASSESSMENT OF BONE MARROW INVOLVEMENT (BMI) BY BM BIOPSY (BMB) OR POSITRON EMISSION TOMOGRAPHY / COMPUTED TOMOGRAPHY (PET/CT) IN HODGKIN LYMPHOMA (HL). 9th International Symposium on Hodgkin Lymphoma, Cologne, Germany, October 12-15, 2013. Haematologica (The Haematology Journal) 2013; 98(s2): Abstract P114.

165

271. ANGELOPOULOU MK , MOSCHOGIANNIS M, RONDOGIANNI P, TSIRKINIDIS P, NIKAKI A, CHATZIIOANNOU S, GALANI Z, TSAFTARIDIS P, SACHANAS S, TELONIS V, FLEVARI P, PETEVI K, ZANNOU A, DATSERIS K, PRASSOPOULOS V, KYRTSONIS M, PANAYIOTIDIS P, MELETIS J, PANGALIS G, VASSILAKOPOULOS TP. PET/CT IN THE SETTING OF AUTOLOGOUS STEM CELL TRANSPLANTATION (ASCT) FOR RELAPSED/REFRACTORY HODGKIN LYMPHOMA PET/CT IN THE SETTING OF AUTOLOGOUS STEM CELL TRANSPLANTATION (ASCT) FOR RELAPSED/REFRACTORY HODGKIN LYMPHOMA (HL): PERFORMANCE OF VARIOUS INTERPRETATION SYSTEMS. 9th International Symposium on Hodgkin Lymphoma, Cologne, Germany, October 12-15, 2013. Haematologica (The Haematology Journal) 2013; 98(s2): Abstract P119.

272. JOHN ASIMAKOPOULOS, EVANGELOS TERPOS, LOULA PAPAGEORGIOU, OLGA KAMPOUROPOULOU, DIMITRIOS CHRISTOULAS, ANASTASIOS GIAKOUMIS, GEORGE VAIOPOULOS, KOSTAS KONSTANTOPOULOS, MARIA K. ANGELOPOULOU, THEODOROS P. VASSILAKOPOULOS, AND JOHN MELETIS Presence Of CD55- and/Or CD59-Deficient Erythrocytes In Patients With Rheumatic Diseases: An Immune-Mediated Phenomenon? Blood 2013 122:3429 . The 55th American Society of Hematology (ASH) Annual Meeting, December 6-10, New Orleans, LA, USA. Blood 2013; 122: Abstract 342.

273. EFTYCHIA NIKOLAOU, PANAYIOTIS PANAYIOTIDIS, KATERINA SARRIS, DIMITRIOS MALTEZAS, EFSTATHIOS KOULIERIS, THEODOROS ILIAKIS, NORA VYNIOU, IOANNA VARDOUNIOTI, VASSILIKI KARALI, ILIAS PESSACH, ANNA EFTHYMIOU, VASSILIKI BARTZIS, TATIANA TZENOU, MARIA DIMOU, THEODOROS P.

166

VASSILAKOPOULOS, MARIA K. ANGELOPOULOU, PANAGIOTIS TSAFTARIDIS, NIKOLITSA KAFASI, AND MARIE-CHRISTINE KYRTSONIS.

Evaluation Of Immunoglobulin Variations (Clonal Changes) In Symptomatic Multiple Myeloma (MM) Patients’ Course. The 55th American Society of Hematology (ASH) Annual Meeting, December 6-10, New Orleans, LA, USA. Blood 2013; 122: 3173 .

274. VASSILAKOPOULOS T, ANGELOPOULOU MK , PRASSOPOULOS V, CHATZIIOANNOU S, MOSCHOGIANNIS M, TSIRKINIDIS P, POZIOPOULOS C, REPOUSSIS P, MATSOUKA C, KONTOPIDOU F, VARIAMI E, VINIOU N, PETEVI K, BOUTSIKAS G, KANELLOPOULOS A, PANAYIOTIDIS P, PANGALIS G, DATSERIS I, MELETIS J, RONDOGIANNI P. Comparative assessment of bone marrow involvement by bone marrow biopsy or positron emission tomography in Hodgkin lymphoma. 12th International Conference on Malignant Lymphoma, Lugano, Switzerland, June 19-22, 2013. Hematological Oncology 2013; 31(s1): Abstract 276.

275. PAPAGEORGIOU S, ANGELOPOULOU M , ANASTASOPOULOU A, VEROU E, KALPADAKIS C, DIMOU M, GALANI C, SINNI H, KYRTSONIS MC, SIAKANTARIS MP, PAPPA V, IOANNIDOU ED, KAPAROU M, ZERVAS K, PAPADAKI H, PANAYIOTIDIS P, CONSTANTINOU N, MELETIS J, PANGALIS G, VASSILAKOPOULOS TP. Additive prognostic role of the degree of lactate dehydrogenase (LDH) elevation in patients with diffuse large B cell lymphomas (DLBCL) treated with rituximab-CHOP (R-CHOP) or R-CHOP-like chemotherapy. 12th International Conference on Malignant Lymphoma, Lugano, Switzerland, June 19-22, 2013. Hematological Oncology 2013; 31(s1): Abstract 387.

167

276. PETEVI K, ANGELOPOULOU M , MOSCHOGIANNIS M,BOUTSIKAS G, KANELLOPOULOS A, SIAKANTARIS M, DIMOPOULOU M, DIMOU M, KYRTSONIS M, TZENOU T, GAINAROU G, FLEVARI P, PAPAGEORGIOU L, KOUTSI K, TELONIS V, ZANNOU A, PANAYIOTIDIS P, PANGALIS G, MELETIS J, VASSILAKOPOULOS T. The prognostic significance of the absolute lymphocyte to absolute monocyte count ratio (ALC/AMC) in Hodgkin lymphoma (HL) under treatment with ABVD or equivalent regimens. 12th International Conference on Malignant Lymphoma, Lugano, Switzerland, June 19-22, 2013. Hematological Oncology 2013; 31(s1): Abstract 454bis.

277. ANGELOPOULOU MK , MOSCHOGIANNIS M, RONDOGIANNI P, TSIRKINIDIS P, NIKAKI A, CHATZIIOANNOU S, GALANI Z, TSAFTARIDIS P, SACHANAS S, TELONIS V, FLEVARI P, PETEVI K, ZANNOU A, DATSERIS K, PRASSOPOULOS V, KYRTSONIS M, PANAYIOTIDIS P, MELETIS J, PANGALIS G, VASSILAKOPOULOS TP. PET/CT in the setting of autologous stem cell transplantation (ASCT) for relapsed/refractory Hodgkin lymphoma (HL): Performance of various interpretation systems. 12th International Conference on Malignant Lymphoma, Lugano, Switzerland, June 19-22, 2013. Hematological Oncology 2013; 31(s1): Abstract 503.

, 278. Levidou G, Sachanas S, Pangalis G, Kalpadakis C, Yiakoumis X, Moschogiannis M, Kyrtsonis MC, Vassilakopoulos T, Tsirkinidis P, Kontopidou F, Kokoris S, Angelopoulou M , Siakantaris M, Papadakis H, Kavantzas N, Panayiotidis P, Patsouris E, Korkolopoulou P IMMUNOHISTOCHEMICAL ANALYSIS OF IL-6, IL-8/CXCR2 AXIS, TYROSINE P-STAT–3 AND SOCS-3 IN CLL LYMPH NODES: CORRELATION WITH MICROVASCULAR CHARACTERISTICS, CLINICAL FEATURES AND PROGNOSIS

168

19 th Congress of the European Hematology Association, June 12-15, 2014, Milan, Italy, Haematologica/The Hematology Journal; 99: suppl.1, Abstract No. P206

279. Dimopoulou M, Petevi K, Angelopoulou M , Boutsikas G, Kanellopoulos A, Siakantaris M, Dimou M, Kyrtsonis MC, Tzenou T, Gainarou G, Flevaris P, Panagiotidis P, Koutsi K, Telonis V, Papageorgiou L, Plata E, Tsafatridis P, Sachanas S, Pangalis G, Meletis J, Konstantopoulos K, Vassilakopoulos T THE PROGNOSTIC SIGNIFICANCE OF THE ABSOLUTE LYMPHOCYTE TO ABSOLUTE MONOCYTE COUNT RATIO (ALC/AMC) IN HODGKIN LYMPHOMA (HL) UNDER TREATMENT WITH ABVD OR EQUIVALENT REGIMENS WITH OR WITHOUT RADIOTHERAPY 19 th Congress of the European Hematology Association, June 12-15, 2014, Milan, Italy, Haematologica/The Hematology Journal; 99: suppl.1, Abstract No. P1048

280. Vassilakopoulos T, Rondogiannis P, Prasopoulos V, Chatziioanou S, Moschogiannis M, Poziopoulos C, Symeonidis A, Repoussis P, Matsouka C, Kontopidou FN, Sotiropoulos V, Variamis E, Viniou NA, Zikos P, Petevis K, Boutsikas G, Kanellopoulos A, Papageorgiou L, Meletis J, Panayiotidis P, Pangalis GA, Datseris I, Konstantopoulos K, Angelopoulou MK COMPARATIVE ASSESSMENT OF BONE MARROW INVOLVEMENT (BMI) BY BM BIOPSY (BMB) OR POSITRON EMISSION TOMOGRAPHY / COMPUTED TOMOGRAPHY (PET/CT) IN HODGKIN LYMPHOMA (HL) 19 th Congress of the European Hematology Association, June 12-15, 2014, Milan, Italy, Haematologica/The Hematology Journal; 99: suppl.1, Abstract No. P1050 169

281. Vassilakopoulos TP, Gainaru G, Angelopoulou MK, Petevis K, Boutsikas G, Kanellopoulos A, Siakantaris M, Variamis E, Dimou M, Kyrtsonis MC, Dimopoulou MN, Tzenou T, Bartzis V, Flevaris P, Papageorgiou L, Koutsis A, Telonis V, Zervakis K, Pessach I, Zannou A, Viniou N, Komninaka V, Tsaftaridis P, Plata E, Panayiotidis P, Meletis J, Pangalis GA, Konstantopoulos K SERUM IMMUNOGLOBULINS IN PATIENTS WITH HODGKIN LYMPHOMA (HL): A NEGLECTED POTENTIAL PROGNOSTIC MARKER? 19 th Congress of the European Hematology Association, June 12-15, 2014, Milan, Italy, Haematologica/The Hematology Journal; 99: suppl.1, Abstract No. P1053

282. Angelopoulou MK , Lakiotakis E, Levidou G, Pangalis G, Vassilakopoulos T, Anargyrou K, Gainaru G, Flevaris P, Sachanas S, Saetta A, Tsirkinidis P, Sepsa A, Moschogiannis M, Kalpadakis C, Milionis V, Chatziandreou I, Kokoris S, Kyrtsonis MC, Siakantaris M, Panayiotidis P, Viniou NA, Tsaftaridis P, Dimopoulou M, Plata E, Konstantopoulos K, Patsouris E, Korkolopoulou P INTRACELLULAR SIGNALING PATHWAYS IN HAIRY CELL LEUKEMIA (HCL) AND THEIR PROGNOSTIC RELEVANCE 19 th Congress of the European Hematology Association, June 12-15, 2014, Milan, Italy, Haematologica/The Hematology Journal; 99: suppl.1, Abstract No. P1062

283. Kyrtsonis MC, Sarris K, Koulieris E, Maltezas D, Nikolaou E, Angelopoulou MK , Bartzis V, Tzenou T, Dimou M, Siakandaris MP, Vyniou E, Sachanas S, Kalpadakis C, Pangalis GA, Panayiotidis P SOLUBLE TACI SERUM CONCENTRATIONS AT DIAGNOSIS IS A POWERFULL PROGNOSTIC MARKER IN CLL

170

19 th Congress of the European Hematology Association, June 12-15, 2014, Milan, Italy, Haematologica/The Hematology Journal; 99: suppl.1, Abstract No. PB1522

284. Kalpadakis C, Pangalis GA, Kyriakakis S, Angelopoulou MK , Sachanas S, Tsirkinidis P, Korkolopoulou P, Kontopidou F, Dimitrakopoulou A, Dimitriadou E, Yiakoumis X, Kokoris S, Moschogiannis M, Devetzoglou M, Kyrtsonis MC, Rontogiannis D, Panayiotidis P, Tsaftaridis P, Papadakis H, Vassilakopoulos T BONE MARROW FINDINGS IN CLL-LIKE MBL AND CLL RAI STAGE 0: CORRELATION WITH MAIN DISEASE FEATURES AND OUTCOME 19 th Congress of the European Hematology Association, June 12-15, 2014, Milan, Italy, Haematologica/The Hematology Journal; 99: suppl.1, Abstract No. PB1530

285. Nikolaou E, Koulieris E, Maltezas D, Sarris K, Iliakis T, Vyniou E, Vardouniotis I, Karalis V, Bartzis V, Tzenou T, Dimou M, Vassilakopoulos T, Angelopoulou M , Tsaftaridis P, Kafasi N, Panayiotidis P, Kyrtsonis MC FREE LIGHT CHAIN ESCAPE REFLECT A RESISTANT RELAPSE IN MULTIPLE MYELOMA (MM), ACCOMPANIED BY DECREASED SERUM TGF-BETA1 (TGFB1); CLINICAL CORRELATIONS 19 th Congress of the European Hematology Association, June 12-15, 2014, Milan, Italy, Haematologica/The Hematology Journal; 99: suppl.1, Abstract No. PB1669

286. Kyrtsonis MC, Nikolaou E, Maltezas D, Koulieris E, Iliakis T, Sarris K, Vyniou E, Vardouniotis I, Efthymiou A, Bitsanis K, Karalis V, Pessach I, Bartzis V, Tzenou T, Dimou M, Vassilakopoulos T, Angelopoulou M , Tsaftaridis P, Panayiotidis P COMPARISON OF RESPONSE DURATION (RPD) AFTER THALIDOMIDE, BORTEZOMIB AND LENALIDOMIDE

171

ADMINISTRATION TO MULTIPLE MYELOMA (MM) PATIENTS; A SINGLE CENTER EXPERIENCE 19 th Congress of the European Hematology Association, June 12-15, 2014, Milan, Italy, Haematologica/The Hematology Journal; 99: suppl.1, Abstract No. PB1674

287. Vassilakopoulos TP, Kanellopoulos A, Papageorgiou S, Pangalis GA, Anastasopoulou A, Moschogiannis M, Galanis Z, Petevis K, Boutsikas G, Kokkoris SI, Dimou M, Papageorgiou L, Tzenou T, Gainaru G, Koutsis A, Pessach E, Telonis V, Sachanas S, Viniou N, Variamis E, Kyrtsonis MC, Dimopoulou MN, Tsirigotis P, Plata E, Tsaftaridis P, Siakantaris M, Panayiotidis P, Meletis J, Ioannidou H, Pappa V, Angelopoulou MK , Konstantopoulos K CLINICAL IMPLICATIONS AND PROGNOSTIC SIGNIFICANCE OF POSITRON EMISSION TOMOGRAPHY (PET/CT) IN PATIENTS WITH DIFFUSE LARGE B-CELL LYMPHOMA (DLBCL) AFTER R- CHOP CHEMOIMMUNOTHERAPY 19 th Congress of the European Hematology Association, June 12-15, 2014, Milan, Italy, Haematologica/The Hematology Journal; 99: suppl.1, Abstract No. PB1831

288. Kalpadakis C, Pangalis GA, Vassilakopoulos T, Sachanas S, Kontopidou F, Moschogiannis M, Ximeris M, Tsirkinidis P, Yiakoumis X, Papadakis H, Angelopoulou MK , Thieblemont C RISK STRATIFICATION IN SMZL PATIENTS: VALIDATION OF THE SIMPLIFIED PROGNOSTIC SCORE FOR SPLENIC MARGINAL ZONE LYMPHOMA OF THE SPLENIC MARGINAL ZONE LYMPHOMA WORKING GROUP 19 th Congress of the European Hematology Association, June 12-15, 2014, Milan, Italy, Haematologica/The Hematology Journal; 99: suppl.1, Abstract No. S653 289. Vassilakopoulos TP, Rondogiannis Ph, Pangalis G, Prassopoulos V, Chatziioannou S, Sotiropoulos V, Mosch οgiannis M, Matsouka H,

172

Symeonidis A, Panayiotidis P, Datseris I, Konstantopoulos K, Angelopoulou M COMPARATIVE ASSESSMENT OF BONE MARROW INVOLVEMENT (BMI) BY BM BIOPSY (BMB) OR PET/CT IN PATIENTS (PTS) WITH HODGKIN LYMPHOMA (HL) 5th International Workshop on PET in Lymphoma, September 19-20, 2014, Menton, France, Abstract No. A8

290. Vassilakopoulos TP, Pangalis GA, Angelopoulou MK , Prassopoulos V, Chatziioannou S, Papageorgiou S, Sotiropoulos V, Panayiotidis P, Roussou P, Konstantopoulos K, Rondogiannis Ph PROGNOSTIC SIGNIFICANCE OF POST-RITUXIMAB-CHOP (R- CHOP) PET/CT IN PRIMARY MEDIASTINAL LARGE B-CELL LYMPHOMA (PMLBCL) 5th International Workshop on PET in Lymphoma, September 19-20, 2014, Menton, France, Abstract No. B1

291. Vassilakopoulos TP, Kanellopoulos A, Papageorgiou S, Pangalis GA, Anastasopoulou A, Moschogiannis M, Petevis K, Boutsikas G, Papageorgiou L, Viniou N, Pappa V, Angelopoulou MK , Konstantopoulos K CLINICAL IMPLICATIONS AND PROGNOSTIC SIGNIFICANCE OF PET/CT IN PATIENTS WITH DIFFUSE LARGE B-CELL LYMPHOMA (DLBCL) AFTER IMMUNOCHEMOTHERAPY 5th International Workshop on PET in Lymphoma, September 19-20, 2014, Menton, France, Abstract No. B3

292. TSIRKINIDIS P, TERPOS E, BOUTSIKAS G, PAPATHEODOROU A, ANARGYROU K, TELONIS V, ZANNOU A, LALOU E, MELETIOU A, GALANIS Z, PETEVIS K, DIMITRAKOPOULOU A, MOSCHOGIANNIS M, KONSTANTOPOULOS K, KALPADAKIS C, SIAKANTARIS M, PANAYIOTIDIS P, PANGALIS G, KYRTSONIS MC, VASSILAKOPOULOS T, ANGELOPOULOU M 173

Bone as a regulator of human hematopoietic stem cell (HSC) trafficking: Study of biochemical markers of bone remodeling and angiogenic cytokines during HSC mobilization, in patients with lymphoma and myeloma 41 st EBMT ANNUAL MEETING, 22 nd -25 th March 2015, Istanbul, Turkey, Bone Marrow Transplantation; 50: suppl1, Abstract No. O082

293. Kyrtsonis MC, Nikolaou E, Tzenou T, Bartzis V, Bitsanis A, Kotsantis S, Dimou M, Iliakis T, Angelopoulou M , Vassilakopoulos T, Panayiotidis P RETROSPECTIVE REFINING OF DIAGNOSIS IN 286 MGUS AND SMM PATIENTS ACCORDING TO THE UPDATED IMWG CRITERIA. CLINICAL IMPLICATIONS 20 th Congress of the European Hematology Association, June 11-14, 2015, Vienna, Austria, Haematologica/Journal of the European Hematology Association; 100: suppl1: Abstract No. P290

294. Kalpadakis C, Pangalis G, Angelopoulou M , Sachanas S, Kontopidou F, Moschogiannis M, Ximeris M, Dimitrakopoulou A, Tsirkinidis P, Kyrtsonis MC, Tzenou T, Yiakoumis X, Koulieris E, Panayiotidis P, Papadakis H, Vassilakopoulos T VALIDATION OF THE SIMPLIFIED PROGNOSTIC SCORE FOR SMZL OF THE SMZLSG (SMZL STUDY GROUP) IN A SERIES OF PATIENTS TREATED WITH RITUXIMAB MONOTHERAPY, AND LONG TERM OUTCOME OF RITUXIMAB RESPONDERS 20 th Congress of the European Hematology Association, June 11-14, 2015, Vienna, Austria, Haematologica/Journal of the European Hematology Association; 100: suppl1: Abstract No. P681

295. Kalpadakis C, Pangalis G, Angelopoulou M , Roumeliotis M, Sachanas S, Korkolopoulou P, Kontopidou F, Dimitrakopoulou A, Koulieris E, Moschogiannis M, Kyrtsonis MC, Tzenou T, Kokoris S, Yiakoumis X, Tsirkinidis P, Pontikoglou C, Rontoyiannis D, H. Papadakis, P. Panayiotidis P, Vassilakopoulos T 174

MYD-88 L265P IN A SERIES OF CD5(-) CLONAL B-CELL LYMPHOCYTOSIS OF MARGINAL ZONE ORIGIN (CD5- CBL) 20 th Congress of the European Hematology Association, June 11-14, 2015, Vienna, Austria, Haematologica/Journal of the European Hematology Association; 100: suppl1: Abstract No. P684

296. Tsirigotis P, Vassilakopoulos T, Bousiou Z, Mpatsis I, Gkirkas K, Sakellaris I, Papageorgiou S, Roussou P, Pangalis G, Galanis Z, Moschoyiannis M, Vassilopoulos G, Repoussis P, Megalakakis E, Michalis E, Anagnostopoulos N, Calpadakis C, Papadakis H, Margaritis D, Chatzimichail E, Briassoulis E, Spyridonidis A, Grentzelias D, Anargyrou K, Tsionos K, Mpantis A, Poulakidas E, Palaska C, Gribabis D, Apostolidis J, Pappa V, Harhalakis N, Panayiotidis P, Konstantopoulos K, Anagnostopoulos A, Angelopoulou M SALVAGE TREATMENT OF PATIENTS WITH RELAPSED/REFRACTORY HODGKIN LYMPHOMA WITH BRENTUXIMAB VEDOTIN: THE GREEK EXPERIENCE 20 th Congress of the European Hematology Association, June 11-14, 2015, Vienna, Austria, Haematologica/Journal of the European Hematology Association; 100: suppl1: Abstract No. E1139

297. Kalpadakis C, Pangalis G, Konstantinidou P, Vassilakopoulos T, Siakantaris M, Nikolaou V, Roussou P, Yiakoumis X, Katodritou E, Apostolopoulos C, Sachanas S, Tsirkinidis P, Papadakis S, Moschogiannis M, Stavroulakis A, Kyrtsonis MC, Kontopidou F, Korkolopoulou P, Levidou G, Rontoyiannis D, Kokoris S, Koulieris E, Panayiotidis P, Antoniou C, Papadakis H, Angelopoulou M NON-GASTRIC MALT LYMPHOMAS (NG-MALT). CLINICAL CHARACTERISTICS AND OUTCOME IN A SERIES OF 185 PATIENTS: ASSESSING PARAMETERS OF PROGNOSTIC SIGNIFICANCE 20 th Congress of the European Hematology Association, June 11-14, 2015, Vienna, Austria, Haematologica/Journal of the European Hematology Association; 100: suppl1: Abstract No. E1150 175

8. GREEK PUBLICATIONS Α. PUBLICATIONS IN GREEK JOURNALS Total Number: 8 Rank between the authors: • 1st in : 4 • 2nd in: 1 • Last in : 3 B. CHAPTERS IN GREEK BOOKS AND MEETING PROCEEDINGS Total Number: 32 Rank between the authors: • 1st in : 18 • 2nd in: 7 • Last in : 3 • Other rank in: 4 C. ABSTRACTS PRESENTED IN GREEK MEETINGS Total Number: 260 Rank between the authors: • 1st in : 33 • 2nd in: 62 • Last in : 47 • Other rank in: 170 Citations: 16 Self-Citations: 10

176

9.SUMMARY OF PUBLICATIONS Total Number: 130 (104 in SCI Journals and 26 in non-SCI Journals 1st Author: 12 2nd Author: 22 Last Author: 19 Other Rank: 77 Total Impact Factor: 389.959 Mean Impact Factor: 3.846 Total Number of Citations: 2498

Number Impact Factor Citations Α. ENGLISH PUBLICATIONS Papers in SCI Journals 104 388.459 2474 Papers in non -SCI Journals 26 1.5 24 Chapters in Books or Meeting Proceedings 19 - 23 Abstracts Presented in Internatio nal Meetings 297 - 14 4 Β. GREEK PUBLICATIONS Papers in Greek Journals 8 - - Chapters in Books or Meeting Proceedings 32 - Abstracts Presented in Greek Meetings 260 - 16 Total 389.959 2681

177

296

APPENDIX I

CITATIONS

297

Ι. CITATIONS OF ENGLISH PUBLICATIONS

• ANGELOPOULOU MK , LAFIONATIS SN, PANGALIS GA. Low Grade Non-Hodgkin’s Lymphomas. Disease Control With Mitoxanthrone Monotherapy In Patients Refractory To Conventional Chemotherapy. Leukemia and Lymphoma 12:253-258, 1994 Α. Citations from Books, Medical sites and other Literature 1. Biotechnology Annual Review, Volume 10, by El-Gewely MR, pp209, Elsevier 2004, Amsterdam, The Netherlands.

2. European School of Oncolofy: ESO Monographs. Malignant Lymphomas: Biology and Treatment. Chapter: Fludarabine Monophosphate, an Effective New Agent in Leukaemias and Lymphomas by Pangalis GA, Angelopoulou MK, Poziopoulos C, Polliack A, Gillis S, pp: 151-161, publisher: Springer, Berlin, Heidelberg, 1995.

3. European School of Oncolofy: ESO Monographs. Malignant Lymphomas: Biology and Treatment. Chapter: Treatment of Low-Grade Non-Hodgkin’s Lymphomas by Angelopoulou MK , Pangalis GA, publisher: Springer, Berlin, Heidelberg, 1995.

B. Citations from Journals Α/Α Όνοµα Συγγραφέως Περιοδικό Τόµος Σελίδα Έτος 1 Theuer, C.P. Biotechnology Annual 10 265 2004 2 Pangalis, G.A. Leukemia and Lymphoma 44 635 2003 3 Wiseman, G.A. Blood 99 4336 2002

• PANGALIS GA, POZIOPOULOS CH, ANGELOPOULOU MK , SIAKANTARIS M, PANAYIOTIDIS P. Εffective Treatment Of Disease Related Anemia In Β-Chronic Lymphocytic Leukemia Patients With Recombinant Human Erythropoietin. British Journal of Hematology 89:627-629, 1995 298

Α. Citations from Books, Medical sites and other Literature 1. Erythropoietin by Emmanuel Dessypris. Education Session 4: Hematopoietic Growth Factors, IX Congress of ISH, Asian Pacific Division, Bangkok, Thailand October 24–28, 1999 (ishpad.org). 2. Transplantation in Hematology and Oncology . Chapter: Erythropoietin Use in Therapy of Anemia Associated with Bone Marrow Transplantation in Children by A. Chybicka , E. Gorczynska , J. Boguslawska- Jaworska , D. Kurpas , pp: 50-56, publisher: Springer Berlin Heidelberg, 2000. 3. AHRQ Evidence Report SummariesChapter: Chapter: Uses of Epoetin for Anemia in Oncology by Sedenfeld J, 2001.

4. Recombinant Human Erythropoietin (rhEPO) in Clinical Oncology by Nourousian MR. Chapter XII by Osterborg A, pp 234, Springer Verlag, Wien, Austria, 2002.

5. Chronic Lymphocytic Leukemia: Molecular Genetics, Diagnosis and Management (Contemporary Hematology) by Faguet GB, p52, Humana Press Inc, Totowa, NJ, USA, 2004.

6. Heatopoietic Growth Factors in Oncology. Chapter: Role of Cytokines in the Management of Chronic Lymphocytic Leukemia by Long CA, pp:311-322, publisher: Humana Press, 2004.

7. Chronic Lymphocytic Leukemia. Contemporary Hematology. Chapter: The Natural history of CLL by Marti GE, Zeneger V, pp: 3-54, publisher: Humana Press, 2004.

8. www.SupportiveOncology.net , Erythropoietic Agents in the Management of Cancer Patients. Part 1: Anemia, Quality of Life, and Possible Effects on Survival by Robert E. Smith, Jr., MD, volume 1, number 4, November/December 2003.

9. Women’s Health: Principles and Clinical Practice by Pregler JP, Decherney AH (ed), PP738.

10. rhErythropoetin in Cancer Supportive Treatment by Smyth JF (ed). Chapter: rhErythropoietin Treatment for the Anemia of Multiple Myeloma and non- Hodgkin Lymphoma by Birgegard G, p97, Marcel Dekker Inc, New York, NY, USA, 1996.

11. http://sunnybrook.ca/uploads/chronic_lymphocytic_leukemia.pdf . Chronic Lymphocytic Leukemia by Spaner D & Cheung M, updated 2007. 299

12. Fludarabine combined with cyclophosphamide for the treatment of elderly B- CLL patients: lessons from LRF CLL4 trial by van Neste E, Dartigeas C, LeBlond V. Correspondances en Onco-hématologie - Vol. III - n° 1 - janvier- février-mars 2008

13. ∆ιερεύνηση του µηχανισµού αναιµίας στη χρόνια λεµφογενή λευχαιµία σε µοριακό και κυτταρικό επίπεδο . ∆ιδακτορική ∆ιατριβή της Τσοπρά Όλγας , Πανεπιστήµιο Πατρών , 2009, : http://nemertes.lis.upatras.gr/jspui/handle/10889/1765#sthash.AXSBbY 3D.dpuf

B. Citations from Journals Α/Α Όνοµα Συγγραφέως Περιοδικό Τόµος Σελίδα Έτος 1 Hedenus M Leuk. Lymphoma 53 2151 2012 2 Glaspy J Br J Cancer 102 301 2010 3 Bohlius, J., Cochrane Database of 3 2009 4 Tsopra, O.A. Acta Haematologica 121 187 2009 5 Shehata, N. Annals of Hematology 87 . 961 2008 6 Wierda, W.G. American Journal of Cancer 3 163 2004 7 Steurer, M., Wiener Klinische 116 367 2004 8 Ceglarek B Wspó³czesna Onkologia 7 317 2003 9 Littlewood, T.J. Hematological Oncology 21 169 2003 10 Ghevaert, C.J. CME Journal Geriatric 5 62 2003 11 Olsson, A. -M. Acta Oncologica 41 517 2002 12 Capalbo, S. Acta Haematologica 108 84 2002 13 Pangalis, G.A. Hematological Oncology 20 103 2002 14 Mauro, F.R Reviews in C linical and 6 21 2002 15 Ludwig, H. Seminars in Oncology 29 45 2002 16 Ludwig, H. Hematology Journal 3 121 2002 17 Pangalis, G.A. Haematologica 87 500 2002 18 Coccia, M.A. Experimental Hematology 29 1201 2001 19 Kasper, C Annals of Hematology 80 . 319 2001 20 Siakantaris, M.P. Leukemia and Lymphoma 40 141 2001 21 Osterborg, A Medical Oncology 17 S 17 2000 22 Erslev, A.J European Journal of 64 . 353 2000 23 Kalil, N. Drugs and Aging 16 9 2000 24 Russo, F. Europe an Journal of 63 325 1999 25 Davidson, T.G. Journal of Oncology 4 S12 1998 26 Montserrat, E., Annals of Oncology 8 S93 1997 27 Tsatalas, C. Journal of Experimental and 16 163 1997 28 Spyridonidis, A. Current Opinion in 3 321 1996 Hematology 29 Henry, D.H Cancer Practice 4 180 1996 30 Rozman C New Engl J Med 333 1052 1995

• ANGELOPOULOU MK , POZIOPOULOS CH, BOUSSIOTIS VA, PANGALIS GA. 300

Fludarabine Monophosphate In Refractory To Conventional Chemotherapy B-Chronic Lymphocytic Leukemia: Maintenance May Be Significant To Sustain Response. Leukemia and Lymphoma 21:321-324, 1996

A. Citations from Books, Medical sites and other Literature 1. Drugs. Chapter: Fludarabine by Adkins JC, pp:1005-1037, publisher: Springer International Publishing, 1997. 2. Hematology and Cell Therapy. Chapter: Chronic Lymphocytic Leukemia by Dighero G, pp: 531-540, publisher: Springer-Verlag, 1997. 3. Kompendium Internidche Onkoologie. Chapter: Chronische lymphatische Leukemie/lymphoplamocytoides Lymphom by Hallek M, Emmerich B, pp: 2845-3886, publisher: Springer Berlin Heidelberg, 2006.

B. Citations from Journals Α/Α Όνοµα Συγγραφέως Περιοδικό Τόµος Σελίδα Έτος 1 Rosen AC Anti -Cancer Drugs 25 225 2014 2 Zhao, X. Journal of Pharmaceutical 97 1508 2008 3 Callea, V. Leukemia and Lymphoma 47 2314 2006 4 Elter, T. Journal of Clinical Oncology 23 7024 2005 5 Salih BA Saudi Medical Journal 25 2004 6 Ayyildiz, O. Saudi Medical Journal 25 2054 2004 7 Wierda, W.G. American Journal of Cancer 3 163 2004 8 Leporrier, M Hematology Journal 5 S10 2004 9 Hallek, M. Onkologie 27 97 2004 10 Hallek, M. Internist 43 1245 2002 11 Trojan, A. Annals of Hematology 81 535 2002 12 Pangalis, G.A. Hematological Oncology 20 103 2002 13 Kulkarni, R. Oncology Spectrums 2 610 2001 14 Robak, T. Leukemia and Lymphoma 41 545 2001 15 Pangalis, G.A. Medical Oncol ogy 17 70 2000 16 Kipps, T.J. Current Opinion in 5 244 1998 Hematology

17 Anaissie, E.J. Annals of Internal Medicine 129 559 1998 18 Dighiero, G. Hematology and Cell 39 S31 1997 19 Kipps, T.J. Current Opinion in 4 268 1997

• KORKOLOPOULOU P, ANGELOPOULOU MK , KONTOPIDOU F, TSENGA A, PATSOURIS E, THOMAS-TSAGLI E, KITTAS CH, PANGALIS GA. Prognostic Relevance Of Apoptotic Cell Death In Non-Hodgkin’s Lymphomas. A Multivariate Survival Analysis Including Ki-67 And P53 Oncoprotein Expression. 301

Α. Citations from Books, Medical sites and other Literature 1. Book: Prognostic Markers in Hematologic Oncology, Gorczyca W (ed), publisher: Taylot & Francis, 2006.

B. Citations from Journals Α/Α Όνοµα Συγγραφέως Περιοδικό Τόµος Σελίδα Έτος 1 Edinger, J.T. American Journal of Surgical 33 1860 2009 Pathology 2 Iguchi, T. Oncology 76 293 2009 3 Ben -Izhak, O. British Journal of Cancer 96 1101 2007 4 Dey, P Cytopathology 17 275 2006 5 Jung, J.T. Annals of Hematology 85 575 2006 6 Belgaumi, A.F. Pediatric Blood and Cancer 46 367 2006 7 Arias -Mendoza, F. Academic Radiology 11 368 2004 8 Chiu, K.C. Human Pathology 34 1259 2003 9 Provencio, M. Clinical Cancer Research 9 1406 2003 10 Klumb, C.E. Revista Brasileira de 24 111 2002 Hematologia e Hemoterapia 11 Gała ̧ zka , K. Polish Journal of Pathology 53 239 2002 12 Konstantinidou, A. -E. Apoptosis 7 461 2002 13 Rassidakis, G.Z. American Journal of Clinical 118 328 2002 14 Chaidos, A.I. European Journal of 69 90 2002 15 Şen, F. Modern Pat hology 15 625 2002 16 MacNamara, B. Haematologica 86 386 2001 17 Nieder, C. Annals of Hematology 80 2 2001 18 Korkolopoulou, P. Histopathology 38 45 2001 19 Gala ̧ zka, K. Polish Journal of Pathology 51 115 2000 20 Kiviniemi, M. British Journal of Cance r 83 1161 2000 21 Symmans, W.F. Acta Cytologica 44 194 2000 22 Yuki, H. Japanese Journal of Cancer 91 127 2000 23 Zhao Y J Clin Intern Med 23 115 2006 24 Pizzolo G Haematologica 84 (s) 18 1999

• KORKOLOPOULOU P, ANGELOPOULOU MK , KONTOPIDOU F, TSENGAS A, PATSOURIS E, KITTAS CH, PANGALIS GA. Prognostic Implication Of Proliferating Cell Nuclear Antigen (PCNA) AgNORs and p53 In Non-Hodgkin’s Lymphomas.

Leukemia and Lymphoma; 30:625-636, 1998 Α. Citations from Books, Medical sites and other Literature 1. Clinical Oncology: A multi-Disciplinary Approach for Physicians and Students by Rubin P, Williams J, Rubin W, Rubin P (eds). Chapter: Hodgkin’s Disease and the Lymphomas by Hoppe R, Constine III LS, Qazi R, pp333, WB Saunders Company, Philadelphia, PA, USA., 2001. 302

2. Cytometry , Third edition, Volume 63 by Z Darzynkiewicz (ed). Chapter 19: Detection of Proliferating Cell Nuclear Antigen by Larsen JK, Landberg G, Roos G, pp 419, Academic Press

3. http://www.researchgate.net/publication/244987997 Prognostic role of proliferating cell nuclear antigen (PCNA) in cancer and other diseases , by Lindstrom MS, Wallin K-L.

. B. Citations from Journals Α/Α Όνοµα Συγγραφέως Περιοδικό Τόµος Σελίδα Έτος 1 Meyer A Veterinary and 8 127 2010 2 Edinger, J.T. American Journal of Surgical 33 1860 2009 3 Lorand -Metze , I. Cellular Oncology 26 63 2004 4 Zakian, K.L. Academic Radiology 11 365 2004 5 Arias -Mendoza, F. Academic Radiology 11 368 2004 6 Pich, A. Leukemia 18 172 2004 7 Arias -Mendoza, F. Disease Markers 19 49 2003 8 Larsen, J.K. Methods in Cell Biology 63 419 2001 9 Gruszka -Westwood, Hematology 6 241 2001 10 Gruszka -Westwood, Blood 97 3552 2001 11 Biesterfeld, S. Virchows Archiv 438 478 2001 12 Nieder, C. Annals of Hematology 80 2 2001 13 Korkolopoulou, P. Histopathology 38 45 2001 14 Tsuya, H. Japanese Journal of 33 1691 2000 15 Papadhimitriou, S.I. Journal of Clinical Pathology 53 462 2000 16 Kim D The Korean Journal of 37 407 2003 Pathology

• PANGALIS GA, ANGELOPOULOU MK , VASSILAKOPOULOS THP, SIAKANTARIS MP, KITTAS CH. B-Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, And Lymphoplasmacytic Lymphoma, Including Waldenstrom’s Macroglobulinemia: A Clinical, Morphologic And Biologic Spectrum Of Similar Disorders. Seminars in Hematology, 36: 104-114, 1999

Α. Citations from Books, Medical sites and other Literature 1. Μονογραφή Της ∆ιηµερίδας Με Θέµα : Λεµφώµατα Χαµηλής Κακοηθείας , Χρόνιες Λεµφοκυτταρικές Λευχαιµίες , Του Τµήµατος Λεµφοϋπερπλαστικών Νόσων Της Ελληνικής Αιµατολογικής Εταιρίας , Αθήνα , 30 Σεπτεµβρίου -1 Οκτωβρίου 2000. ( Κεφάλαιο : Ανοσοφαινοτυπική Μελέτη Χρονίων Λεµφοϋπερπλαστικών Νόσων Με Κυτταροµετρία Ροής . Αγγελοπούλου ΜΚ , ∆ηµοπούλου ΜΝ , Κοντοπίδου ΦΝ , Σιακαντάρη ΜΠ , Βασιλακόπουλος ΘΠ , Πάγκαλης ΓΑ , σελ .15-18). 2. Μονογραφή Της ∆ιηµερίδας Με Θέµα : Λεµφώµατα Χαµηλής Κακοηθείας , Χρόνιες Λεµφοκυτταρικές Λευχαιµίες , Του Τµήµατος Λεµφοϋπερπλαστικών 303

Νόσων Της Ελληνικής Αιµατολογικής Εταιρίας , Αθήνα , 30 Σεπτεµβρίου -1 Οκτωβρίου 2000. ( Κεφάλαιο : Β-Χρόνια Λεµφογενής Λευχαιµία . Αγγελοπούλου ΜΚ , Βασιλακόπουλος ΘΠ , ∆ηµοπούλου ΜΝ , Σιακαντάρη ΜΠ , Κοντοπίδου ΦΝ , Γιαννακάκη ΑΛ , Κίττας Χ, Πάγκαλης ΓΑ , σελ .28-35). 3. Μονογραφή Της ∆ιηµερίδας Με Θέµα : Λεµφώµατα Χαµηλής Κακοηθείας , Χρόνιες Λεµφοκυτταρικές Λευχαιµίες , Του Τµήµατος Λεµφοϋπερπλαστικών Νόσων Της Ελληνικής Αιµατολογικής Εταιρίας , Αθήνα , 30 Σεπτεµβρίου -1 Οκτωβρίου 2000. ( Κεφάλαιο : Λέµφωµα από µικρά λεµφοκύτταρα , λεµφοπλασµατοκυτταρικό λέµφωµα και µακροσφαιριναιµία του Waldenstrom. Ζέρβας Κ, σελ .36-45). 4. WILLIAMS HEMATOLOGY, 6 th ed., Beutler E, Lichtman MA, Coller BS, Kipps TJ, Seligsohn U eds., McGraw Hill, 2001, ISBN 0-07-116293-3, International (Chapter: Lymphomas, by Foon KA, Fisher RI, pp1253). 5. WILLIAMS HEMATOLOGY, 6 th ed., Beutler E, Lichtman MA, Coller BS, Kipps TJ, Seligsohn U eds., McGraw Hill, 2001, ISBN 0-07-116293-3, International (Chapter: Macroglobulinemia, by Kipps TJ, pp1317-1325). 6. CHRONIC LYMPHOCYTIC LEUKEMIAS, 2 nd Edition Revised and Expanded, Cheson BD ed., Marcel-Dekker, 2001, ISBN 0-8247-0543-2, New York, Basil (Chapter: Developing risk-adapted treatment strategies for chronic lymphocytic leukemia, by Montserrat E, pp 377-391). 7. CAMPATH-1H: Emerging frontline therapy in chronic lymphocytic leukemia, Rai KR, Stephenson J (eds.), Parthenon Publishing Group, 2001, ISBN 1- 84214-060-4 (Chapter 1: B-cell chronic lymphocytic leukemia: Molecular basis and prognostic markers, pp 11-32). 8. ATLAS OF BONE MARROW AND BLOOD PATHOLOGY, Naeim ed., 2001, ISBN 0-7216-8735-0 (Chapter: Lymphomas, pp 118-137). 9. ANNUAL OF LYMPHOID MALIGNANCIES, Cavalli F, Armitage JO, Longo DL, eds., Martin Dunitz, 2001, ISBN 1-84184-000-9, London (Chapter: Chronic Lymphocytic Leukemia, by Montserrat E, pp 117-127). 10. Medical Immunology, Parslow TJ, Stites DP, Terr AI, Imboden JB, 10 th Edition, McGraw-Hill, 2001, ISBN 0-8385-6300-7, (Chapter: Neoplasms of the immune system, by Atwater SK, pp 578-606). 11. Morphology Methods: Cell & molecular biology techniques. Lloyd RV, Kurtin PJ: Application of immunohistochemistry in the diagnosis of lymphoid lesions. HUMANA PRESS, 2001, ISBN 0-89603-955-2, p.317 12. ΠΑΘΟΛΟΓΙΑ , Χατζηγιάννης Σ, Μαυρικάκης Μ, Μουντοκαλάκης Θ, Νανά - Αναστασίου Μ, Πάγκαλης ΓΑ , Παπαδογιάννης ∆, Χαλεβελάκης Γ, από το ∆ιδακτικό και Επιστηµονικό Προσωπικό του Τοµέως Παθολογίας , Εκδόσεις ΠΑΣΧΑΛΙ∆Η , 2002, ISBN 960-399-053-1, Αθήνα ( Κεφάλαιο : Πάγκαλης ΓΑ , Βασιλακόπουλος ΘΠ , ∆ηµοπούλου ΜΝ , Σιακαντάρη ΜΠ , Aγγελοπούλου ΜΚ : Κακοήθη λεµφώµατα και χρονία λεµφογενής λευχαιµία . σελ . 1289-1301). 13. BONE MARROW PATHOLOGY, 2 nd Edition, Foucar K ed., ASCP Press, American Society of Clinical Pathology, 2001, ISBN 0-89189-440-3, Chicago (Chapter: Chronic lymphoproloferative diseases, pp 366-405). 14. CANCER, Principles and Practice of Oncology, 6 th ed., De Vita VT, Hellman S, Rosenberg SA eds., Lippincott, 2001, ISBN 0-7817-2387-6, Philadelphia (Chapter Non-Hodgkin’s lymphomas, by Armitage JO, Mauch PM, Harris NL, Bierman P, pp2256-2316). 15. Successfully managing the triad in hematologic malignancies: The cancer, the Anemia, the Patient. Symposium Proccedings at the 6th Meeting of the European Hematology Association, Frankfurt 2001 (Chapter Hematologic Cancer, anemia and patient outcomes: here are we now? What is the future? By Diehl V, pp 4-13). 304

16. MALIGNANT LYMPHOMAS, ATLAS OF CLINICAL ONCOLOGY, Grossbard ML ed., American Cancer Society, BC Decker Inc, 2002, ISBN 1-55009-152- 2, Hamilton-London (Chapter: Indolent B-cell lymphomas, by Petryk A, Peterson BA), pp94-111). 17. The Diagnosis of Lymphoproliferative Diseases: An Atlas, Gatter K, Delsol G eds., Oxford University Press, 2002, ISBN 0-19-850891-3 [Chapter: Lymphoplasmacytic lymphoma (also known as immunocytoma), pp 74]. 18. Flow cytometric analysis of hematologic neoplasms: A color atlas and text, Tsieh Sun ed., Lippincot Williams & Wilkins, 2002, ISBN 7817-2964-5 (Chapter: Case 27: Waldenstrom’s Macroglobulinemia, pp 199-204). 19. UpToDate ( www.uptodate.com ) 2003 (11.2). ( Κεφάλαιο : Kyle RA: Clinical manifestations and diagnosis of Waldenstrom’s macroglobulinemia, last updated 10 Jan 2007, by Kyle RA, Rajkumar SV). 20. UpToDate ( www.uptodate.com ) 2003 (11.2). ( Κεφάλαιο : Freedman AS, Harris NL: Clinical and pathologic features of small lymphocytic, prolymphocytic, and lymphoplasmacytic lymphoma, last updated 18 Oct 2006). 21. Από το Αιµατολογικό Εύρηµα στη ∆ιάγνωση , 6 η έκδοση , Γιάννης Χρ . Μελέτης , Εκδόσεις Νηρέας , Αθήνα , 2003, ISBN 960-7597-09-05. 22. www.cancer.org/downloads/PUB/DOCS/SECTION36/127.pdf , 2003. Rai KR, Keating MJ. Chronic Lymphocytic Leukemia, chapter 127, pp 1989- 2001. 23. www.cancer.org/downloads/PUB/DOCS/SECTION36/130.pdf , 2003. Freedman AS, Nadler LM. Non-Hodgkin’s lymphomas, chapter 130. 24. www.waldenstromsprogram.org/Diagnosis/Waldenstrom’s (D&G)- MerliniTreonDef.pdf, 2003. Merlini G, Treon B. Biotechnology Research Labs. 25. www.cmelink.com/lymphoma/case3/l.html , 2003. Cases in Lymphoma: Marginal zone lymphoma. 26. Neoplastic diseases of the blood, Wiernik PH, Goldman JM, Dutcher JP, Kyle RA eds., Cambridge University Press, 2003, ISBN 0-521-79136-7 (Chapter: Diagnosis and treatment of chronic lymphocytic leukemia, by Tannir N, Keating M, O’ Brien S, pp 91). 27. Neoplastic diseases of the blood, Wiernik PH, Goldman JM, Dutcher JP, Kyle RA eds., Cambridge University Press, 2003, ISBN 0-521-79136-7 (Chapter: Immunology of the lymphomas, by Parikh R, Ozer H, pp 735). 28. Multiple Myeloma and Related Disorders, Gahrton G, Durie BGM, Samson DM, ARNOLD, ISBN 0-340-81010-6 (Chapter: Waldenstrom’s disease, by Merlini G & Treon SP, pp 429-451). 29. Multiple myeloma & related disorders (Hematologic Malignancies), Gertz MA, Greipp PR, Springer-Verlang, Berlin, 2004, ISBN 3-540-00811-X (Chapter: Winkler JM, Fonseca R: Waldenstrom Macroglobulinemia, pp.205-226). 30. Histopathology of Nodal and Extranodal non-Hodgkin’s Lymphoma, Based on the WHO Classification, Feller AC, Diebold J, ISBN 3-540-63801-6 (Chapter: Nodal B-cell Lymphoma, pp 19-120). 31. Pathology of bone marrow and blood cells, Farhi DC, Chiling CC, Edelman AS, Parveen T, Thi Vo TL eds., Lippincot Williams & Wilkins, 2004, ISBN 0- 397-51611-8 (Chapter: B-cell neoplasms, pp 305). 32. Hematopoietic Growth Factors in Oncology: Basic Science and Clinical Therapeutics, Morstyn G, Foote MA eds., Humana Press Inc, 2004, ISBN 1- 58829-302-5, pp 330. 33. WINTROBE’S Clinical Hematology (Vol 2), Greer JP, Foerster J, Lukens JN, Rodgers GM, Paraskevas F, Glader B, IIth Edition, Lippincott Williams & Wilkins, ISBN 0-7817-3650-1, (Chapter 100: Waldenstrom’s Macroglobulinemia, by Fonseca R, Witzig TE, pp 2667-2681). 305

34. www.conganat.org/info.tortosa/8curso/CD3/S8CL.htm , Domingo- Claros A, Alonso E, Romagosa V: Correlations entre el-aspirado medular, la biopsia osea y el immunofenotipo en linfomas de cellulu pequena. Caso 1, 2001. 35. www.tdx.cesca.es/TESIS_UAB/AVAILABLE/TDX-1026101- 111202/bes4de4.pdf 36. www.orlforum.com/documents/Lymfom_vp.pdf , MALIGNA LYMFOM 2000, Onkologiskt Centrum, Vastrasjukvardsregionen 37. WILLIAMS HEMATOLOGY, 7 th ed., Lichtman MA, Beutler E, Kipps TJ, Seligsohn U, Kaushansky K, Prchal JT eds., McGraw Hill, 2006, ISBN 0-07- 143591-3 (Chapter 102: Macroglobulinemia, by Kipps TJ, pp 1549-1560). 38. Μελέτη κλωνικότητος σε ασθενείς µε χρόνια λεµφογενή λευχαιµία και συσχέτιση µε κλινικά και βιολογικά δεδοµένα . Ευαγγελία Μ. ∆ηµητριάδου , ∆ιδακτορική ∆ιατριβή , Ιατρική Σχολή Εθνικού και Καποδιστριακού Πανεπιστηµίου Αθηνών , Αθήνα , Μάιος 2007. 39. LYMPH NODES (Cambridge Illustrated Surgical Pathology), Weiss L (ed.), Cambridge University Press, New York, ISBN 978-0-521-87161-7, 2008 (Reference List, pp 257-284). 40. Flow cytometry and immunohistochemistry for hematologic neoplasms. Tsieh Sun (ed.), Wolters Kluwer Health; Lippincott Williams & Wilkins, Philadelphia, 2007, ISBN-13: 978-0-7817-8400-9; ISBN-10: 0-7817-8400-X, pp 91. 41. HEMATOPATHOLOGY, second edition, Hsi ED ed. (Foundation in Diagnostic Pathology), Churchill Livingstone - ELSEVIER, Philadelphia 2012, ISBN: 978- 1-4377-2606-0; (Chapter 7: Small B-cell lymphomas, by Kurtin PJ and Aboudola S, pp 203-257). 42. ΑΙΜΑΤΟΛΟΓΙΑ ΣΤΗΝ ΚΛΙΝΙΚΗ ΠΡΑΞΗ , Πάγκαλης ΓΑ , Εκδόσεις Π.Χ. Πασχαλίδης , Αθήνα 2008, ISBN 978-960-399-776-4 ( Κεφ . 32: Χρονία Λεµφογενής Λευχαιµία , σελ . 583-602). 43. ΑΙΜΑΤΟΛΟΓΙΑ ΣΤΗΝ ΚΛΙΝΙΚΗ ΠΡΑΞΗ , Πάγκαλης ΓΑ , Εκδόσεις Π.Χ. Πασχαλίδης , Αθήνα 2008, ISBN 978-960-399-776-4 ( Κεφ . 37: Μη οζώδη λεµφώµατα « χαµηλής κακοηθείας » καθ ’ υπεροχήν λεµφαδενικά , σελ . 659- 665). 44. ΑΙΜΑΤΟΛΟΓΙΑ ΣΤΗΝ ΚΛΙΝΙΚΗ ΠΡΑΞΗ , Πάγκαλης ΓΑ , Εκδόσεις Π.Χ. Πασχαλίδης , Αθήνα 2008, ISBN 978-960-399-776-4 ( Κεφ . 54: Μακροσφαιριναιµία του Waldenstrom, σελ . 815-821). 45. ATLAS OF DIFFERENTIAL DIAGNOSIS IN NEOPLASTIC HEMATOPATHOLOGY, 2 nd Edition, by Gorczyca W and Emmons FN, Informa UK Ltd., 2008, ISBN-10: 0 415 46185 5, ISBN-13: 978-0-415-46185- 6 (backmatter). 46. Λεµφώµατα Οριακής Ζώνης . Κλινική και Εργαστηριακή Μελέτη . Χριστίνα Καλπαδάκη , ∆ιδακτορική ∆ιατριβή , Ιατρική Σχολή Εθνικού και Καποδιστριακού Πανεπιστηµίου Αθηνών , Αθήνα , 2008. 47. ΕΣΩΤΕΡΙΚΗ ΠΑΘΟΛΟΓΙΑ , από το ∆ιδακτικό και Επιστηµονικό Προσωπικό του Τοµέως Παθολογίας , Εκδόσεις ΠΑΣΧΑΛΙ∆Η , 2 η Έκδοση , 2010, ISBN 978-960-399-951-5, Αθήνα ( Κεφάλαιο : Θ. Βασιλακόπουλος , Μ. Αγγελοπούλου , Μ. Σιακαντάρη , Γ. Πάγκαλης , Χ. Κυρτσώνη , Σ. Κοκόρη , Χ. Καλπαδάκη , Φ. Κοντοπίδου , Ε. ∆ηµητριάδου , Μ. ∆ηµοπούλου : Κακοήθη λεµφώµατα και χρόνια λεµφογενής λευχαιµία . σελ . 1386-1403). 48. Diagnostica Citometrica Delle Neoplasie Ematologiche, Ortolani C, 2002. 49. Sirac C. Thesis: Regulation concertee de l’ expressions des chaines d’ immunoglobulines et consequences de ses anomalies en pathologie. Universite de Limoges, 2003. 50. NEOPLASTIC DISEASES OF THE BLOOD, by Wiernik PH et al. (eds.), Springer Science+Business Media, New York, 2013, DOI 10.1007/978-1- 306

4614-3764-2_35 (Chapter 35: Waldenstrom’s Macroglobulinemia, by Kastriris E & Dimopoulos MA). 51. Weidner N, Cote RJ, Suster S, Weiss LM: Modern Surgical Pathology. 2009, Elsevier Inc. ISBN: 978-141603966-2 (Chapter: Arber DA. Bone marrow, pp 1536-1593, DOI: 10.1016/B978-1-4160-3966-2.00043-6). 52. Gherardi G. Fine-needle biopsy of superficial and deep masses: Interventional approach and interpretation methodology by pattern recognition. ISBN: 978-884701432-9, DOI: 10.1007/978-88-470-1433-6, pp 1- 2009. 53. Hematology: clinical principles and applications by BF Rodak, GA Fritsma, E Keohane (eds). Chapter 37: Mature lymphoid Neoplasms by Czader M, pp: 558, 2013, Saunders, Elsevier, St Louis, Missouri, USA, ISBN: 978-1-4377- 0692-5. 54. Flow Cytometry in Neoplastic Hematology: Morphologic- Immunophenotypic Correlation by W Gorczyca (ed) 2010, pp: 316. Informa Healthcare, Essex UK, ISBN-13: 978 1 841 84702 3 55. Encyclopedia of Medical Immunology by Mackay IR, Rose NR, Diamond B, Davidson A (eds), 2014. Chapter: CD5 by Sigal LH, pp: 263, Springer New York, DOI 10.1007/978-0-387-84828-0_20, ISBN: 978-0-387-84827-3 56. Vispute K. Thesis: CD180/RP105 Toll-like Receptor (TLR) mediated signalling in Chronic Lymphocytic Leukaemia, 2014. University of Westminster, westminsterresearch.wmin.ac.uk 57. Bund D. Thesis: hTERT, CD23 und CD229 als Tumorantigene bei der B-CLL, 2012. Dissertation, LMU München: Fakultät für Chemie und Pharmazie, edoc.ub.uni-muenchen.de

B. Citations from Journals Α/Α Όνοµα Συγγραφέως Περιοδικό Τόµος Σελίδα Έτος 1 Merlini G Hematology 1999 358 1999 2 Pangalis GA Anemia in Oncology 2 2 1999 3 Angelopoulou MK ISH Educational 1999 182 1999 4 Kamper EF Clin Biochem 32 639 1999 5 Dimopoulos MA J Clin Oncol 18 214 2000 6 Angelopoulou MK Panarab Congress 45 2000 7 Angelopoulou MK Panarab Congress 50 2000 8 Angelopoulou MK Panarab Congress 59 2000 9 Siakantaris MP Leuk Lymphoma 40 141 2000 10 Hippen KL J Exp Med 191 883 2000 11 Pangalis GA Med Oncol 17 70 2000 12 Αγγελοπούλου ΜΚ Haema 3(Sup) 30 2000 13 Campana D J Immunol Meth 243 59 2000 14 Lance Evans H Leuk Lymph 39 625 2000 15 Weisburger J Int J Oncol 17 1165 2000 16 Wu ML Arch Pathol Lab Med 124 1710 2000 17 Lorand -Metze I Rev Bras Hematol Hemoter 22 41 2000 18 Kyrtsonis MC Acta Haematol 105 92 2001 19 Woodlock TJ Blood Cells Mol Dis 27 27 2001 20 Miller -Hermelink HK Histopathology 38 285 2001 21 Rosales CM Am J Clin Pathol 116 34 2001 22 Genevieve F Ann Biol Clin -Paris 59 403 2001 23 Pangalis GA Me d Oncol 18 99 2001 24 Jelic TM Ped Develop Pathol 4 505 2001 25 Kyrtsonis MC Ann Hematol 80 722 2001 26 Nakajima A Haematologica 86 109 2001 307

27 Seymour JF Ann Oncol 12 1455 2001 28 Heyman MR Am J Med Sci 322 365 2001 29 Clavio M J Exp Clin Canc Res 20 351 2001 30 Angelopoulou MK Eur J Haematol 68 12 2002 31 Pangalis GA Haematologica 87 500 2002 32 Pangalis GA Hematol Oncol 20 103 2002 33 Hernandez AM Clin Lab Med 22 215 2002 34 Siakantaris MP Anaemia in Cancer 3 12 2002 35 Angelopoulou MK Kairo Congress 28 2002 36 Ludwig H Semin Oncol 29(S8) 45 2002 37 Ludwig H Hematol J 3 121 2002 38 Witkowski JM Blood 100 1802 2002 39 Maeda Y Am J Hematol 71 238 2002 40 Feng CB J Rare Uncom Dis 9 2002 41 Rudiger T Radiologe 42 936 2002 42 Gar cia -Conde J Rev Cancer 16 220 2002 43 Nakamura N Pathol Int 53 195 2003 44 Pangalis GA Semin Oncol 30 201 2003 45 San Miguel JF Semin Oncol 30 187 2003 46 Baldini L J Clin Oncol 21 1459 2003 47 Hiddemann W Semin Oncol 30(S2) 16 2003 48 Rusynyk RA Gas trointest Endosc 57 800 2003 49 Nagy B Haematologica 88 654 2003 50 Solomou EE Leuk Lymphoma 44 1579 2003 51 Segel GB Blood Cell Mol Dis 30 277 2003 52 Ghobrial IM Lancet Oncol 4 679 2003 53 Vorobyev IA Terapevt Arkh 75 5 2003 54 Cochran DAE Mol Cell Proteomics 2 1331 2003 55 Wasik -Szczepanek E Pol Arch Med Wewnet 110 1431 2003 56 Aoun P Leuk Lymphoma 45 1595 2004 57 Caporaso N Semin Hematol 41 201 2004 58 Steurer M Wien Klin Wochenschr 116 367 2004 59 Lynn J J Allergy Clin Immunol 114 409 2004 60 Morra E Leukemia 18 1512 2004 61 Babusikova O Neoplasma 51 422 2004 62 Ghobrial IM Curr Treat Opt Oncol 5 239 2004 63 Bernatsky S Arthr Rheum 52 1481 2005 64 Weiler CR Mayo Clin Proc 80 1187 2005 65 Pangalis GA Hematology 10(S1) 6 2005 66 Pangalis GA Clin Lymphoma 5 235 2005 67 Morra E Clin Lymphoma 5 265 2005 68 Ganguly S Am J Clin Oncol -Canc 29 104 2006 69 Pangalis GA Cur Top Med Chem 6 1657 2006 70 Πάγκαλης ΓΑ MED Review Oncology 1 23 2006 71 Rayzman VM Hum Antibodies 15 71 2006 72 Pangalis GA Turkish J Hematol 23 (S2) 54 2006 73 Katodritou E Ann Hematol 86 369 2007 74 Centkowski P J Clin Immunol 27 339 2007 75 Fonseca R Br J Haematol 138 700 20 07 76 Καρακάσης ∆ Αρχεία Ελλην Ιατρ 24 13 2007 77 Dillman RO J Clin Oncol 26 1193 2008 78 Peinert S Hem/Onc Clin North Am 22 903 2008 79 AbdelSalam M Hematology 13 147 2008 80 Ferrario A Ann Hematol 90 323 2011 81 Gertz MA Am J Hematol 86 412 2011 82 Zare H Am J Clin Pathol 137 75 2012 83 Dimou M Leuk Lymphoma 53 1481 2012 84 Sigal LH J Clin Rheumatol 18 83 2012 308

85 Gertz MA Am J Hematol 87 504 2012 86 Ferrario A Cancer 118 3954 2012 87 Bluth MH CancerImmunolImmunothe 61 1585 2012 88 Nichele I PLoS One 7 e52811 2012 89 Nayak HK J Pancreas 14 92 2013 90 Gertz MA Am J Hematol 20 Jun 2013 91 Chen YH Cytopathol Oncol 160 211 2014 92 Salma M Int J Biomed Res 5 56 2014 93 Dragovic Ivancevic T Srp Arh Celok Lek 142 197 2014 94 Maule WJ Med Tec hnol SA 28 13 2014 95 Gertz MA Am J Hematol 90 347 2015 96 Bluth M Cancer Immunol 61 1585 2012 Immunother

• ANGELOPOULOU MK , KONTOPIDOU FN, PANGALIS GA.

Adhesion Molecules In B-Chronic Lymphoproliferative Disorders.

Seminars in Hematology, 36: 178-197, 1999

Α. Citations from Books, Medical sites and other Literature 1. Flow Cytometry & Immunohistochemistry for Hematologic Neoplasmas by Sun T (ed), pp66. Lippincott Williams & Wilkins, Philadelphia, PA, USA, 2008.

2. Annual of lymphoid Malignancies by Cavalli F, Armitage JO, Longo D (eds). Chapter: Mantle Cell Lymphoma by Dreyling M, Meyer T, Hiddemann W, p67. Martin Dunitz, London, UK, 2001.

3. Bone Marrow pathology 2 nd Edition, by Foucar K and Foucar A (eds). Chapter 18: Chronic Lymphoproliferative Disorders, pp400, American Society of Clinical pathology (ASCP), 2001.

4. Analisis de la expresión de moléculas de adhesión celular en leucemia linfática cronica y otros syndromes linfoproliferativos cronicoscon expression leukemica ( ∆ιδακτορική ∆ιατριβή ), Universitat de València - BIOQUÍMICA I BIOLOGIA MOLECULAR , 2002.

5. Flow Cytometric Analysis of Hematologic Neoplasms: A Color Atlas and Text by Sun T (ed). Chapter: Case 19: Chronic Lymphocytic Leukemia of B-cell Lineage, pp154, Lippincott Williams & Wilkins, Philadelphia, PA, USA, 2002.

6. Der Einfluss von cAMP-erhöhenden Substanzen und Antidepressiva auf Apoptoseinduktion bei chronischer lymphatischer B-Zell Leukämie. ∆ιδακτορική διατριβή της Patz M, Ludwig-Maximilians-Universität zu München, 2006, http://edoc.ub.uni- muenchen.de/6507/1/Patz_Monika.pdf , 309

7. Rivas H. Estudio de los factores pronósticos genéticos de la leucemia linfática crónica e identificación de nuevos marcadores moleculares con relevancia clínica. Repositorio Documental de la Universidad de Salamanca , 2008, www.gredos.usal.es/jspui/handle/10366/22492 .

8. Neoplastic Hematopathology. Chapter 5: The Bone Marrow in Normal and Disease States by Jones D, Mirranda R, pp:99-121, publisher:Humana Press, 2010.

9. Flow Cytometry of Hematological Malignancies. (Book), Ortolani C (ed), Blackwell Publishing Ltd, June 2011. Г.

10. hTERT, CD23 und CD229 als Tumorantigene bei der B-CLL. ∆ιδακτορική ∆ιατριβή του Bund Dagmar, Ludwig-Maximilians-Universität zu München, 2012.

11. Textbook of Uncommon Cancer. Chapter: Uncommon Hepatobiliary Tumors, pp 423, by Siegel, A.B , Sheynzon, V , Samstein, B. John Wiley & Sons, Inc,. 2012

B. Citations from Journals Α/Α Όνοµα Συγγραφέως Περιοδικό Τόµος Σελίδα Έτος 1 Xoxhelli A Blood 123 1199 2014

2 Di Franco KM Comparative Medicine 63 331 2013 3 Jenny L Acta Cient ifica 2012 4 Тумян ΓC РОНЦ им . Н. Н. Блохина 2010 5 Kachlany SC Leukemia Research 34 777 2010 6 Kraus TS American Journal of 134 271 2010 7 Ovchinina NG Bulletin of Experimental 149 223 2010 8 Mani H American Journal of 34 1277 2010 Surgical Pathology 9 Ferrer A European journal of Clinical 2 2010 and Medical Oncology 10 Nikitin EN Vestnik Rossiiskoi 7 19 2010 Akademii Meditsinskikh 11 Ko HJ NaukKorean J Hematol 44 268 2009 12 Hartmann, T.N. Cancer Research 69 3121 2009 13 Siak antaris, M.P Oncologist 14 148 2009 14 Ferrer A Annals of Oncology 19 135 2008 15 Quijano, S Blood 111 5130 2008 16 Miyakura, T Journal of Dermatology 35 29 2008 17 Bund, D. Experimental Hematology 35 920 2007 18 Huang, W. -T. New Zealand Medical 120 1251 2007 19 Joshi, A.D Cancer Genetics and 172 120 2007 20 Matos, D.M Brazilian Journal of 39 1349 2006 Medical and Biological Research 21 Kornacker, M. International Journal of ncer 119 1377 2006 22 Bund, D. Experi mental Hematology 34 860 2006 23 Dickinson, J.D. Leukemia and Lymphoma 47 231 2006 24 Florena, A.M. Leukemia and Lymphoma 47 49 2006 310

25 Silla LMR Rev. Bras. Hematol. 27 † 2005 Hemoter. 26 Pangalis, G.A. Clinical Lymphoma 5 235 2005 27 López-Giral, S. Journal of Leukocyte 76 462 2004 Biology 28 Bairey, O. Israel Medical Association 6 147 2004 29 Basso, K. Journal of Experimental 199 59 2004 Medicine 30 Hall, B.M. Leukemia and Lymphoma 45 35 2004 31 Bairey O IMAJ 6 147 2004 32 Stacchini, A. Journal of Biological 17 308 2003 Regulators and Homeostatic Agents 33 Tzankov, A. Journal of Clinical Pathology 56 747 2003 34 Atanackovic, D. American Journal of 73 184 2003 Hematology 35 Wang, Y. Chinese Journal of 23 455 2003 Microbiology and Immunology 36 Lima, M. Cytometry Part B - Clinical 51 41 2003 37 Pangalis, G.A. Hematological Oncology 20 103 2002 38 Hjalmar, V. European Journal of 68 127 2002 Haematology 39 Angelopoulou, M.K. European Journal of 68 12 2002 Haematology 40 Jaksic, O. Haematologica 86 827 2001 41 Molica, S. Cancer 92 713 2001 42 Gu, B. Leukemia and Lymphoma 42 5 2001 43 Kyrtsonis, M. -C. Acta Haematologica 105 92 2001 44 Oviedo -Orta FASEB Journal 15 768 2001 45 Finn, W.G. Human Pathology 32 66 2001 46 Mit ropoulos, F.A. Leukemia and Lymphoma 40 123 2001 47 Franco, V. Cancer 91 294 2001 48 Chung, J. Endocrinology 141 2090 2000 49 Martin, S. Radiologe 40 675 2000 50 Kamper, E.F. Clinical Biochemistry 32 639 1999 51 Angelopoulou M Biomed Research 835138 2014 International

†dx.doi.org/10.1590/S1516-84842005000400009

• GUENOVA M, RASSIDAKIS GZ, GORGOULIS VG, ANGELOPOULOU MK , SIAKANTARIS MP, KANAVAROS P, PANGALIS GA, KITTAS CH. p16 INKA Is Regularly Expressed And Tightly Related To Retinoblastoma Protein In Hodgkin’s Disease: Comparison With P53, And Mdm2 Protein Status And The Presence Of Epstein-Barr Virus . Modern Pathology 12: 1062-1071, 1999 Α. Citations from Books, Medical sites and other Literature 311

1. Cell Cycle Inhibitors in Cancer Therapy (Cancer Drug Development) by Giordano A, Soprano KJ (eds). Chapter: Cell Cycle Regulators: Interactions and their Role in Diagnosis, Prognosis and Treatment of Cancer by van Diest PJ, Michailides RJAM, pp248, Humana press Inc, Totowa, NJ, USA, 2003.

2. Lejeune M, de la Cruz-Merino L, Alvaro T. Hodgkin’s Lymphoma: From Tumor Microenvironment to Immunotherapeutic Approach – Body’s Own Power Protection Challenges. www.intechopen.com

B. Citations from Journals Α/Α Όνοµα Συγγραφέως Περιοδικό Τόµος Σελίδα Έτος 1 Drakos, E. Clinical Cancer Research 13 3380 2007 2 Scambia, G. Oncogene 25 5302 2006 3 Kim, L. -H. Human Pathology 37 92 2006 4 O'Neill, C.J. Advances in Anatomic 13 8 2006 5 Bai, M. In Vivo 19 439 2005 6 Bai, M. Modern Pathology 17 1338 2004 7 Vassilakopoulos, HAEMA 7 147 2004 8 Chui, D.T.Y. Genes Chromosomes and 38 126 2003 Cancer 9 Jones, D. American Journal of Clinical 114 438 2000 10 Ramagosa C Oncogene 30 2087 2011 11 Chew I International Journal of 29 513 2010 Gynecological Pathology 12 Romagosa C Oncogene 30 2087 2011 13 Lee S Korean Journal of Pathology 46 253 2012 14 Al-Salam S International Journal of 6 2765 2013 Clinical and Experimental

• KAMPER EF, PAPAPHYLLIS AD, ANGELOPOULOU MK , KOPEIKINA LT, SIAKANTARIS MP, PANGALIS GA, STAVRIDIS JC. Serum Levels Of Tetranectin, Adhesion Molecule-1 And Interleukin-10 In B- Chronic Lymphocytic Leukemia. Clinical Biochemistry 32: 639-645, 1999 Α. Citations from Books, Medical sites and other Literature 1. Chronic lymphoid Leukemias, Second Edition (Basic and Clinical) Oncology by Cheson B (ed). Chapter: Cytokines and Regulatory Molecules in the Pathogenesis and Clinical Course of B-Cell Chronic Lymphocytic Leukemia, pp152, Marcel Dekker Inc, New York, NY, USA, 2001.

2. Análisis De La Expresión De Moléculas De Adhesión Celular En Leucemia Linfática Crónica Y Otros Síndromes Linfoproliferativos Crónicos Con Expresión Leucémica. ∆ιδακτορική ∆ιατριβή της Rosell Mas AI, UNIVERSITAT DE VALENCIA, 2004, http://roderic.uv.es/handle/10550/15065 312

3. Chronic Lymphocytic Leukemia. Contemporary hematology, Faguet GB (ed). Chapter 6: Cytokines and Soluble Molecules in CLL by Orsini E, Foa R, pp: 123-142, publisher: Humana Press, 2004.

4. MHC class II antigen presentation by B cells in health and disease. ∆ιδακτορική ∆ιατριβή του Souwer Y, Leiden University, 2009, http://hdl.handle.net/1887/14474.

5. Animal Lectins: Form, Function and Clinical Applications.Chapter 40: Emerging Groups of C-type Lectins by Gupta GS, pp: 881-900, publisher: Springer Vienna, 2012.

B. Citations from Journals Α/Α Όνοµα Συγγραφέως Περιοδικό Τόµος Σελίδα Έτος 1 Ye H Molecular and Cellular 343 91 2010 Biochemistry 2 Wang L Clinica Chimica Acta 411 581 2010 3 Ernoult E Journal of Biomeidine and 2010 Article 2010 Biotechnology number 4 Djurdjevic, P. Archives of Medical 40 927917357 2009 5 Souwer, Y. British Journal of 145 334 2009 6 Kara, I.O. Advances in Therapy 24 29 2007 7 Martin K Mediators in inflammation 2006 † 20 06 8 Klabusay, M. Mediators of Inflammation 2006 2006 9 Pamuk, G.E. Journal of Experimental and 25 537 2006 10 Kohútová, V. Transfuze a Hematologie 12 167 2006 11 McCarthy, B.A. Cancer Genomics and 1 407 2004 Proteomics 12 McCarthy, B.A. Cancer Immunity 4 2004 13 Orsini, E. Cancer Research 63 4497 2003 14 Hittel, D.S. Journal of Physiology 548 401 2003 15 Pangalis, G.A. Hematological Oncology 20 103 2002 16 Chong Y Genes and Immunity 2 239 2001 17 Krueger, G.R.F. An ticancer Research 21 3653 2001 18 Sohn, B.H. Biochemical Journal 360 31 2001 19 Yen Chong, S. Genes and Immunity 2 239 2001 20 Orsini, E. Reviews in Clinical and 4 73 2000 21 Ρέγκλη Αρετή Ιατρικά Χρονικά ΚΑ ’ 79 2008 †Article ID 65237

• TERPOS E, ANGELOPOULOU MK , VARIAMI E, MELETIS JC, VAIOPOULOS G. Sjogren’s Syndrome Associated With Multiple Myeloma. Annals of Hematology 79: 449-451, 2000 Α. Citations from Books, Medical sites and other Literature 1. Manifestations buccales du myélome multiple. ∆ιδακτορική ∆ιατριβή του Stucki TD, Univ. Genève, 2004, no. Méd. dent. 633, http://archive- ouverte.unige.ch 313

2. Impacto de la enfermedad cardiovascular en el síndrome de Sjögren primario. ∆ιδακτορική διατριβή της Pérez de Lis Novo M, Universitat de Barcelona, 31-May-2010, http://hdl.handle.net/2445/42320 3. Significado clínico de los autoanticuerpos en pacientes con síndrome de Sjögren primario. ∆ιδακτορική διατριβή της Nardi NN, Universitat de Barcelona, 7-Jun-2011, http://hdl.handle.net/2445/42335.

B. Citations from Journals Α/Α Όνοµα Συγγραφέως Περιοδικό Τόµος Σελίδα Έτος 1 Sanap RR Case Reports in Genetics 2013 † 2013 2 Weng M-Y Annals of the Rheumatic 71 524 2012 Diseases 3 Kulkarni UP Journal of Postgraduate 57 129 2011 Medicine 4 Ravindran, V Clinical Rheumatology 30 1143 2011 5 Sakurai, C. International Journal of 90 532 2009 6 Plastiras, S.C. Clinical and Experimental 27 700 2009 7 Fietta, P. Clinical and Experimental 27 140 2009 8 ЛОГВИНЕНКО ОА Научно -практическая 3 67 2006 ревматология 9 Kaneko, H. Asian Pacific Journal of 24 245 2006 10 Manganelli, P. Clin ical and Experimental 24 438 2006 11 Koide, H. World Journal of 12 1645 2006 12 Kurokawa, M. International Journal of 44 873 2005 13 Gentilini F Veterinary and Comparative 3 87 2005 Oncology 14 Brito -Zerón , P. Medicine 84 90 2005 15 Asherson, R.A. Journal of Rheumatology 31 196 2004 16 Rai, T. Hepatology Research 26 249 2003 17 Ben Ghorbel, I. Revue de Medecine Interne 24 138 2003 18 Chakravarty, E. Current Opinion in 15 35 2003 19 Wu, M. -J. Journal of the Formosan 101 421 2002 20 Harada Y Rinsho Ketsueki 42 1176 2001 †Article ID 279801

• PANGALIS GA, DIMOPOULOU MN, ANGELOPOULOU MK , TSEKOURAS CH, SIAKANTARIS MP. Campath-1H In B-Chronic Lymphocytic Leukemia. Report Of A Case Treated Thrice In A 3-Year Period. Medical Oncology 17: 70-73, 2000 A. Citations from Books, Medical sites and other Literature 1. Biologic Therapy of Leukemia (Contemporary Hematology) by Kalaycio M (ed). Chapter: Unconjugated Monoclonal Antibodies by Kalaycio M, pp29, Humana Press Inc, Totowa NJ, USA, 2003 . 314

2. Biodrugs. Chapter: Alemtuzumab in the Treatment of Chronic Lymphocytic Leukemia by Robak T, pp: 9-22, publisher: Springer International Publishing, 2005.

B. Citations from Journals Α/Α Όνοµα Συγγραφέως Περιοδικό Τόµος Σελίδα Έτος

1 Rao SP PLos One 7 Article 2012 number e 39416 2 Pangalis, G.A. Current Topics in Medicinal 6 1657 2006 3 Robak, T. BioDrugs 19 9 2005 4 Robak, T. Acta Haematologica 35 299 2004 5 Ke ating, M. Clinical Lymphoma 4 220 2004 6 Robak, T. Leukemia and Lymphoma 45 205 2004 7 Rieger, K. Leukemia and Lymphoma 45 345 2004 8 Frampton, J.E. Drugs 63 1229 2003 9 Rai, K.R. Journal of Clinical Oncology 20 3891 2002 10 Pangalis, G.A. Hematologi cal Oncology 20 103 2002 11 Aivado, M. Seminars in Oncology 29 19 2002 12 Lundin, J. Blood 100 768 2002 13 Osterborg, A. Medical Oncology 19 S21 2002 14 Rai, K. Medical Oncology 19 S57 2002 15 Pangalis, G.A. Medical Oncology 18 99 2001 16 Dumont, F.J . Current Opinion in 2 139 2001 17 Flynn, J.M. Current Opinion in Oncology 12 574 2000 18 Cheze, S. Hematologie 6 31 2000

• ANGELOPOULOU MK , VASSILAKOPOULOS THP, SIAKANTARIS MP, KONTOPIDOU FN, BOUSSIOTIS VA, PAPAVASSILIOU C, KITTAS CH, PANGALIS GA. EBVD Combination Chemotherapy Plus Low Dose Involved Field Radiation Is A Highly Effective Treatment Modality For Early Stage Hodgkin’s Disease. Leukemia and Lymphoma 37: 131-143, 2000. Α. Citations from Books, Medical sites and other Literature 1. ΠΑΘΟΛΟΓΙΑ , Χατζηγιάννης Σ, Μαυρικάκης Μ, Μουντοκαλάκης Θ, Νανά - Αναστασίου Μ, Πάγκαλης ΓΑ , Παπαδογιάννης ∆, Χαλεβελάκης Γ, από το ∆ιδακτικό και Επιστηµονικό Προσωπικό του Τοµέως Παθολογίας , Εκδόσεις ΠΑΣΧΑΛΙ∆Η , 2002, ISBN 960-399-053-1, Αθήνα ( Κεφάλαιο : Πάγκαλης ΓΑ , Βασιλακόπουλος ΘΠ , ∆ηµοπούλου ΜΝ , Σιακαντάρη ΜΠ , Aγγελοπούλου ΜΚ : Κακοήθη λεµφώµατα και χρονία λεµφογενής λευχαιµία . σελ . 1289-1301). 2. Βιολογικοί Παράγοντες και Κλινικά Χαρακτηριστικά κατά τη ∆ιάγνωση και Υποτροπή του Λεµφώµατος Hodgkin: Συσχετίσεις και Προγνωστική Σηµασία . Θεόδωρος Π. Βασιλακόπουλος , ∆ιδακτορική ∆ιατριβή , Ιατρική Σχολή Εθνικού και Καποδιστριακού Πανεπιστηµίου Αθηνών , Αθήνα , Μάρτιος 2004. 3. www.iqb.es/cbasicas/farma/farma04/v008.htm VADEMECUM, Vinblastina 29/04/2005 (Monografia). 4. ΑΙΜΑΤΟΛΟΓΙΑ ΣΤΗΝ ΚΛΙΝΙΚΗ ΠΡΑΞΗ , Πάγκαλης ΓΑ , Εκδόσεις Π.Χ. Πασχαλίδης , Αθήνα 2008, ISBN 978-960-399-776-4 ( Κεφ . 35: Λέµφωµα Hodgkin, σελ . 615-639). 315

5. ΕΣΩΤΕΡΙΚΗ ΠΑΘΟΛΟΓΙΑ , από το ∆ιδακτικό και Επιστηµονικό Προσωπικό του Τοµέως Παθολογίας , Εκδόσεις ΠΑΣΧΑΛΙ∆Η , 2 η Έκδοση , 2010, ISBN 978-960-399-951-5, Αθήνα ( Κεφάλαιο : Θ. Βασιλακόπουλος , Μ. Αγγελοπούλου , Μ. Σιακαντάρη , Γ. Πάγκαλης ,Χ. Κυρτσώνη , Σ. Κοκόρη , Χ. Καλπαδάκη , Φ. Κοντοπίδου , Ε. ∆ηµητριάδου , Μ. ∆ηµοπούλου : Κακοήθη λεµφώµατα και χρόνια λεµφογενής λευχαιµία . σελ . 1386-1403) 6. Chabrier J-E. Thesis: MOLECULES CYTOSTATIQUES D'ORIGINE NATURELLE, SITUATION ACTUELLE, PERSPECTIVES D'AVENIR, 2000. UNIVERSITE HENRI POINCARE - NANCY I, [email protected]

B. Citations from Journals Α/Α Όνοµα Συγγραφέως Περιοδικό Τόµος Σελίδα Έτος 1 Vassilakopoulos TP Haematologica 86 274 2001 2 Ng AK Int J Radiat Oncol 50 979 2001 3 Συµεωνίδ ης ΑΣ Haema 4(Supl) 95 2001 4 Vassilakopoulos TP Haema 4 230 2001 5 Vassilakopoulos TP Eur J Haematol 67 279 2001 6 Rassidakis GZ J Clin Oncol 20 1278 2002 7 Rassidakis GZ Clin Cancer Res 8 488 2002 8 Spector N Oncol Rep 9 439 2002 9 Vassilakopoulos TP Haematologica 87 701 2002 10 Vassilakopoulos TP Eur J Haematol 68 289 2002 11 Rassidakis GZ Blood 100 3935 2002 12 Provencio M Leuk Lymphoma 44 263 2003 13 Chronowski GM Int J Radiat Oncol Biol Phys 55 36 2003 14 Karmiris TD Leuk Lymphoma 44 1523 2003 15 Vassilakopoulos TP Clin Cancer Res 9 5430 2003 16 Vassilakopoulos TP Int J Radiat Oncol Biol Phys 59 765 2004 17 Vassilakopoulos TP Haema 7 147 2004 18 Visco C Leuk Lymphoma 45 2085 2004 19 Vassilakopoulos TP J BUON 10 59 2005 20 Vassilakopou los TP Haematologica 91 32 2006 21 Lee CK Hem Onc Clin N Am 20 471 2006 22 Doussis -Anagnostopoulou IA Clin Cancer Res 14 1759 2008 23 Γεωργακόπουλος Ι ΑΙΜΑ 3 231 2012

• MITROPOULOS FA, ANGELOPOULOU MK , SIAKANTARIS MP, RASSIDAKIS G, PAPALAMPROS E, KALOVIDOURIS A, VAIOPOULOS G, PANGALIS GA. Primary Non-Hodgkin’s Lymphoma Of The Gallbladder. Report Of A Case And Review Of The Literature. Leukemia and Lymphoma 40: 123-131, 2000 Α. Citations from Books, Medical sites and other Literature 1. Klinische Sonographie ind Sonographische Differezdiagnose (Schuler A, Seitz K, Rettenmaier (eds). Chapter 5: Gallenblase and Gallenwege. Verdacht auf Gallenerkrankung by Weiss H, Seitz K, pp:169, publisher: Thieme Verlag, 2007. 316

2. Klinische Sonographie ind Sonographische Differezdiagnose (Schuler A, Seitz K, Rettenmaier (eds). Chapter 6: Gallenblase and Gallenwege. Ikterus by Seitz K, Schuler A, Will U, pp:223, publisher: Thieme Verlag, 2007. 3. Extranodal lymphomas: Pathology and Management by Cavalli F, Stein H, Zucca E (eds). Chapter 27: Rare primary extranodal sites (genitourinary, adrenal, cardiac, memingeal, esophageal, pancreatic, gallbladder and soft tissue lymphomas), pp318, Informa Ltd, London, UK, 2008. 4. CT and MRI of the Whole Body, 2-Volume Set by Haaga JR, Dogra VS, Forsting M, Gilkeson RC (eds). Chapter 31: Biliary Tract and Gallbladder by Lim JH, Kim KN, Chol D, pp1448, Mosby Elsevier, Philadelphia, PA, USA, 2009.

B. Citations from Journals Α/Α Όνοµα Συγγραφέως Περιοδικό Τόµος Σελίδα Έτος 1 Gundes E Dicle Medical Journal 40 492 2013 2 Lahoti TS Current Neurovascular 9 282 2012 Research 3 Tsutsumi Y OJIM 2 11 2012 4 Ezenekwe AM Acta Cytologica 48 239 2004 5 Mani H American Journal of 34 1277 2010 Surgical Pathology 6 Gonzalez Lopez GA Cirugia Espanola 88 204 2010 7 Ko HJ Korean J Hematol 44 268 2009 8 Biko, D.M. American Journal of 192 1304 2009 Roentgenology 9 Ono, A. British Journal of Radiology 82 http://d 2014 x.doi.o rg/10.1 10 Kato, H. Journal of Hepato-Biliary- 15 659 2008 Pancreatic Surgery 11 Koshy, M. Journal of Gastrointestinal 17 207 2008 and Liver Diseases 12 Li, J. -Y. BMC Cancer 7 125 2007 13 Huang, W. -T. New Zealand Medical 120 2007 14 Kim, M. -J. American Journal of 187 473 2006 15 Level L Centro Medico 50 23 2005 16 Yamamoto T AJR 184 (s) 01840s 2005 17 Repine, T.B. Journal of Clinical Oncology 22 5014 20 04 18 Ezenekwe, A.M. Acta Cytologica 48 239 2004 19 Jelic, T.M. Leukemia and Lymphoma 45 381 2004 20 Ferluga, D. Virchows Archiv 442 136 2003 21 Rana S Journal of Cancer Research 10 749 2014 and Therapeutics 22 Acharya V BMJ Reports DOI: 10.1136/bcr -2013 - 2014 202715 23 Lee SW Journal of Radiology Case 9 14 2015 Reports 317

24 Doussis- Haema 4 2001 Anagnostopoulou I

• SIAKANTARIS MP, ANGELOPOULOU MK , VASSILAKOPOULOS THP, DIMOPOULOU MN, KONTOPIDOU FN, PANGALIS GA. Correction Of Disease Related Anemia Of B-Chronic Lymphoproliferative Disorders By Recombinant Human Erythopoietin. Maintenance Is Necessary To Sustain Response. Leukemia and Lymphoma 40: 141-147, 2000, Α. Citations from Books, Medical sites and other Literature 1. Μονογραφή Της ∆ιηµερίδας Με Θέµα : Λεµφώµατα Χαµηλής Κακοηθείας , Χρόνιες Λεµφοκυτταρικές Λευχαιµίες , Του Τµήµατος Λεµφοϋπερπλαστικών Νόσων Της Ελληνικής Αιµατολογικής Εταιρίας , Αθήνα , 30 Σεπτεµβρίου -1 Οκτωβρίου 2000. ( Κεφάλαιο : Β-Χρόνια Λεµφογενής Λευχαιµία . Αγγελοπούλου ΜΚ , Βασιλακόπουλος ΘΠ , ∆ηµοπούλου ΜΝ , Σιακαντάρη ΜΠ , Κοντοπίδου ΦΝ , Γιαννακάκη ΑΛ , Κίττας Χ, Πάγκαλης ΓΑ , σελ .28-35). 2. ANAEMIA IN CANCER, Bokemeyer C & Ludwig H eds., ESO Scientific Updates Vol.6, Elsevier Science B.V., 2001, ISBN 0-444-509046, Amsterdam (Chapter: Overview of clinical trials on rHuEPO in cancer patients, by Ludwig H, Fritz E, pp115-143). 3. ANAEMIA MANAGEMENT: Select, Support, Succeed, Satelite Symposium at the 8 th International Conference on Malignant Lymphoma, Lugano, Switzerland, F. Hoffmann-La Roche Ltd Pharmaceuticals, 2002, CH-4070 Basel, (Chapter: Can anaemia management improve survival? by Glaspy J, pp6-8). 4. Hematopoietic Growth Factors in Oncology: Basic Science and Clinical Therapeutics, Morstyn G, Foote MA eds., Humana Press Inc, 2004, ISBN 1-58829-302-5, pp 331. 5. Chronic Lymphocytic Leukemia: Molecular Genetics, Biology, Diagnosis and Management, Faguet GB ed., Humana Press Inc, 2004, ISBN 1- 58829-099-9, (Chapter: The natural history of chronic lymphocytic leukemia: Historical perspective, by Marti GE, Zenger V, pp 53). 6. Anemia of chronic disease, Weiss G, Gordeuk VR, Hershko C (eds.), CRC Press Taylor & Francis Group, 2005, ISBN-10: 0-8247-5972-9, ISBN-13: 978-0-8247-5972-8, (Chapter 18: Positive effects of correction of anemia in malignant diseases, by Pohl G, Ludwig H, pp. 489-558). 318

7. WILLIAMS HEMATOLOGY, 7 th ed., Lichtman MA, Beutler E, Kipps TJ, Seligsohn U, Kaushansky K, Prchal JT eds., McGraw Hill, 2006, ISBN 0- 07-143591-3 (Chapter 92: Chronic Lymphocytic Leukemia and Related Disorders, by Kipps TJ, pp1343-1383). 8. The Chemotherapy Source Book, 4 th Edition. Perry MC (ed.), Wolters Kluwer Health; Lippincott Williams & Wilkins, Philadelphia, 2008, ISBN- 13: 978-0-7817-7328-7; ISBN-10: 0-7817-7328-8 (Chapter 44: Acute myeloid leukemia, acute lymphoblastic leukemia, and chronic lymphocytic leukemia, by Wooldridge JE, pp 534-551). 9. ΑΙΜΑΤΟΛΟΓΙΑ ΣΤΗΝ ΚΛΙΝΙΚΗ ΠΡΑΞΗ , Πάγκαλης ΓΑ , Εκδόσεις Π.Χ. Πασχαλίδης , Αθήνα 2008, ISBN 978-960-399-776-4 ( Κεφ . 32: Χρονία Λεµφογενής Λευχαιµία , σελ . 583-602).

B. Citations from Journals Α/Α Όνοµα Συγγραφέως Περιοδικό Τόµος Σελίδα Έτος 1 Angelopoulou MK Panarab Congress 50 2000 2 Kyrtsonis MC Ann Hematol 80 722 2001 3 Pangalis GA Haematologica 87 500 2002 4 Pangalis GA Hematol Oncol 20 103 2002 5 Samuelsson J Med On col 19 69 2002 6 Hallek M Deut Med Wahenschr 127 982 2002 7 Barthel Deut Med Wahenschr 127 982 2002 8 Ludwig H Semin Oncol 29(S8) 45 2002 9 Ludwig H Hematol J 3 121 2002 10 Capalbo S Acta Haematol 108 84 2002 11 Kyrtsonis MC Haema 5(S) 46 2002 12 Ma uro FR Rev Cln Ex Hematol 6(S1) 21 2002 13 Chin J Intern Med 19 412 2002 14 Niscola P Haema 6 187 2003 15 Ross SD Clin Ther 25 1786 2003 16 Henry DH Arch Intern Med 164 262 2004 17 Wendtner CM Semin Hematol 41 224 2004 18 Domnikova NP B Exp Biol Med 138 593 2004 19 Redaelli A Exp Rev Anticanc Ther 3 311 2003 20 Stephens JM Am J Therapeutics 12 460 2005 21 Levin TT Gen Hosp Psych 29 251 2007 22 Wilson J Health Technol Asses 11 1 2007 23 Levin TT Gen Hosp Psychiat 29 251 2007 24 De Gaona RE Rev Med Univ Navarra 51 3 2007 25 Birgegard G Ther Clin Risk Manag 4 527 2008 26 Tsopra O Acta Haematol 121 187 2009 27 Molica S Cancer Management 3 211 2011 and Research 28 Milano M Journal de Pharmacie 24 11 2005 Clinique 30 Ceglarek B Wspólczesna 2003 Onkologia 319

31 Oster HS IMAJ 8 703 2006

31 Lerner S Haematologica 89 1419 2004

32 Τζουρά Ε Archives of Hellenic 25 60 2008 Medicine

• KORKOROPOULOU PA, ANGELOPOULOU MK , KONTOPIDOU FN, TSENGA AG, PATSOURIS EV, CHRISTODOULOU PN, KITTAS CH, PANGALIS GA. Retinoblastoma Gene Product and p21 (WAF 1, C1P1) Protein Expression In Non-Hodgkin’s Lymphomas. A Multivariate Analysis. Leukemia and Lymphoma 40: 647-658, 2001 Α. Citations from Books, Medical sites and other Literature 1. Molecular Pathology of Gynecologic Cancer (Current Clinical Oncolgy) by Giordano A, Bovicelli A, Kuran RJ (eds). Chapter 1: The Cell Cycle and Molecular Biology of Cancer by D’Andrilli G, Bovicelli A, pp14, Humana Press Inc, Totowa, NJ, USA, 2007. 2. Eye Cancer Reasearch Progress, Bospene EB (ed). Chapter I: Occular Adnexal tumors: The role of infectious agents and cell cycle proteins by Haedrich CA, Goebel N, Illerhaus G, pp:17-47,Nova Science Publishers, Inc, 2008.

B. Citations from Journals Α/Α Όνοµα Συγγραφέως Περιοδικό Τόµος Σελίδα Έτος 1 Tonini, T. Journal of Cellular 214 295 2008 2 Chabay, P. Applied Immunohistochemistry 14 12 2006 and Molecular Morphology 3 Ito, Y. Oncology 68 87 2005 4 Jack, A. Current Diagnostic 10 360 2004 Ito, Y International Journal of 13 431 2004 Molecular Medicine 5 Ito, Y. Pathobiology 71 164 2004 6 Coupland, S.E. Graefe's Archive for Clinical 242 130 2004 7 Milde -Langosch, K. Journal of Cellular 196 224 2003 8 Milde-Langosch, K. International Journal of 22 168 2003 Gynecological Pathology 9 Konstantinidou, A.E. Gynecologic Oncology 88 369 2003

320

• KORKOLOPOULOU P, ANGELOPOULOU MK , SIAKANTARIS MP, MITROPOULOS F, VASSILAKOPOULOS THP, ZORZOS H, RASSIDAKIS G, ANDROULAKI A, PATSOURIS E, KITTAS CH, DAVARIS P, PANGALIS GA. Evaluation Of DNA Topoisomerase Iia Expression In Non-Hodgkin’s Lymphomas. Histopathology 38: 45-53, 2001 A. Citations from Journals

Α/Α Όνοµα Συγγραφέως Περιοδικό Τόµος Σελίδα Έτος 1 Ni CR World Chin J 9 897 2001 2 Provencio M Clin Cancer Res 9 1406 2003 3 Aytac U Br J Cancer 88 455 2003 4 Sato K Int J Oncol 22 481 2003 5 Zorzos HS Pathology 35 315 2003 6 Vassilakopoulos TP Clin Cancer Res 9 54 30 2003 7 Kenny LM Clin Oncol UK 16 176 2004 8 Schrader C Leukemia 18 1200 2004 9 Korkolopoulou P Leukemia 18 1347 2004 10 Schrader C Eur J Haematol 75 498 2005 11 Chako G Surg Neurol 65 11 2006 12 Doussis -Anagnostopoulou IA Clin Cancer Res 14 175 9 2008 13 Pentheroudakis G Leukemia and 51 1260 2010 Lymphoma 14 Chen Z Eur J Clin Invest 42 310 2012 15 Nobili s Leuk Lymphoma 55 2071 2014 16 Tsukinoki K Oral Medicine and 1 1 2003 Pathology

• KYRTSONIS MC, ANGELOPOULOU MK , KONTOPIDOU FN, SIAKANTARIS MP, DIMOPOULOU MN, MITROPOULOS F, KALOVIDOURIS A, VAIOPOULOS GA, PANGALIS GA. Primary Lung Involvement In Waldenstrom’s Macroglobulinemia. Report Of Two Cases And Review Of The Literature. Acta Haematologica 105: 92-96, 2001 Α. Citations from Books, Medical sites and other Literature 1. Rare Lymphomas. Hematologic Malignancies. Chapter 16: Waldenstrom’s Macroglobulinemia by Leblond V, Merlini G, Rodig S, Delabie J, pp: 303-329, publisher: Springer Berlin Heidelberg, 2014. 2. Neoplastic Diseases of the Blood. Chapter 35: Waldenstrom’s Macroglobulinemia by Kastritis E, Dimopoulos A, pp: 681-699, publisher: Springer New York , 2013. 321

3. Lymphoma. Current Clinical Oncology. Volume 43. Chapter 5: Waldenstrom’s Macroglobulinemia/Lymphoplasmacytic Lymphoma by Treon SP, Merlini G, pp: 83-109, publisher: Humana Press, 2013

4. Myeloma: Pathology, Diagnosis, and Treatment. Chapter: Waldenstrom’s macroglobulinemia/lymphoplasmacytic lymphoma by Treon SP, Merlini G, pp: 190, publisher: Cambridge University Press, 2011, ISBN: 978-051186246- 5;978-110701057-4 5. Rare Hematological Malignancies (Cancer Treatment and Research) by Ansell SM (ed). Chapter: Waldenstrom’s Macroglobulinemia / Lymphoplasmacytic Lymphoma by Treon SP, Hajiharissi E, Merlini G, pp233, Springer Science Media LLC, New York, NY, USA, 2008. 6. Treatment of Multiple Myeloma and Related Disorders by Rajkumar V, Kyle RA. Chapter II: Waldenstrom’s Macroglobulinemia / Lymphoplasmacytic Lymphoma by Treon SP, Merlini G, pp146, Cambridge University Press, New York, NY, USA, 2009. . B. Citations from Journals Α/Α Όνοµα Συγγραφέως Περιοδικό Τόµος Σελίδα Έτος 1 Chung Y -Y Renal Failure 34 1173 2012 2 Uzunhan Y Revue des Maladies 27 599 2010 Respiratoires 3 Christopoulos, C Annals of Hematology 87 159 2008 4 Adam, Z. Vnitrni Lekarstvi 53 1325 2007 5 Ling, S. Americ an Journal of 81 110 2006 6 Sharma, O.P. Current Opinion in 11 408 2005 7 Capalbo, S. Annals of Hematology 84 625 2005 8 Fukuda, R. Tokai Journal of 30 133 2005 9 Pangalis, G.A. Clinical Lymphoma 5 235 2005 10 Okuda, M. Respirology 9 414 2004 11 Alexandrakis, M.G. Chest 125 1546 2004 12 Reichenberger F Pneumonologie 58 33 2004 13 Johnson SA Reviews in Clinical and 6 421 2002 Experimental Hematology 14 Kyrtsonis M -C Annals of Hematolo gy 80 772 2001 15 Doussis- Haema 4 2001 Anagnostopoulou I

• VASSILAKOPOULOS TP, NADALI G, ANGELOPOULOU MK , SIAKANTARIS MP, DIMOPOULOU MN, KONTOPIDOU FN, RASSIDAKIS G, DOUSSIS- ANAGNOSTOPOULOU I, HATZIOANNOU M, VAIOPOULOS G, KITTAS CH, SARRIS AH, PIZZOLO G, PANGALIS GA. 322

Serum Interleukin10 Levels Are An Independent Prognostic Factor For Patients With Hodgkin’s Lymphoma. Haematologica 88: 274-281, 2001. Α. Citations from Books, Medical sites and other Literature 1. BLOOD, Principles and Practice of Hematology, 2 nd Ed., Handin RI, Lux SE, Stossel TP, Lippincott, Williams & Wilkins, 2002, ISBN 0-7817-1993-3 (Chapter: Hodgkin’s disease, by Friedberg JW, Asler JC, Canellos GP, pp 837-860). 2. Cancer Immune Therapy: Current and Future Strategies, Stahler G, Walden P eds., Wiley-VCH Verlag GmbH & Co, 2002, ISBN 3-527-30441-X (Chapter 8: IL-10 in cancer immunity, by Sabat R, Asadullah K, pp 173). 3. Βιολογικοί Παράγοντες και Κλινικά Χαρακτηριστικά κατά τη ∆ιάγνωση και Υποτροπή του Λεµφώµατος Hodgkin: Συσχετίσεις και Προγνωστική Σηµασία . Θεόδωρος Π. Βασιλακόπουλος , ∆ιδακτορική ∆ιατριβή , Ιατρική Σχολή Εθνικού και Καποδιστριακού Πανεπιστηµίου Αθηνών , Αθήνα , Μάρτιος 2004. 4. Βασιλακόπουλος Θ, Σαρρής Α: Λέµφωµα Hodgkin: Εξελίξεις στην βιολογία και θεραπεία . Στο : ΕΞΕΛΙΞΕΙΣ ΣΤΗΝ ΠΑΘΟΛΟΓΙΑ . Νεώτερες απόψεις στη διάγνωση και θεραπεία . Σεϊτανίδης Β, Γεωργιλής Κ, Αποστολάκης Ι. Έκδοση του ∆ιαγνωστικού και Θεραπευτικού Κέντρου Αθηνών ΥΓΕΙΑ , σελ . 17-31, 2006. 5. Βιολογικοί Παράγοντες και Κλινικά Χαρακτηριστικά κατά τη ∆ιάγνωση και Υποτροπή του Λεµφώµατος Hodgkin: Συσχετίσεις και Προγνωστική Σηµασία . Σερένα Βαλσάµη , ∆ιδακτορική ∆ιατριβή , Ιατρική Σχολή Εθνικού και Καποδιστριακού Πανεπιστηµίου Αθηνών , Αθήνα , Σεπτέµβριος 2007. 6. Cancer Immunotherapy at the crossroads: How tumors evade immunity and what can be done, Finke JH, Bukowski RM eds., Humana Press 2004, ISBN 1-59259-743-2 (Chapter: Interleukin-10 immune suppression, by Yang AS, Lattime EC, pp 157-172). 7. Integration/Interaction of Oncologic Growth (Cancer Growth and Progression). Meadows GG (ed.) Springer, Dordrecht, the Netherlands, 2005, ISBN-13: 978-1-4020-3413-8; ISBN-10: 1-4020-3413-X (chapter 17: Role of tumor microenvironment in chemoresistance, by Wei Y, Au JLS, pp 285-322). 8. Pharmakognosie-Phytopharmazie (Springer-Lehrbuch), Hansel R and Sticker O, Springer Medizin Verlag Heidelberg, 2007, ISBN-10: 3-540-34256-7, ISBN-13: 978-3-540-34265-4, pp 733. 323

9. Αγγειογένεση στο λέµφωµα Hodgkin: Μορφοµετρική µελέτη και προγνωστική σηµασία επί 286 ασθενών . Ειρήνη Α. Θυµαρά . ∆ιδακτορική ∆ιατριβή , Ιατρική Σχολή Εθνικού και Καποδιστριακού Πανεπιστηµίου Αθηνών , Αθήνα , 2008. 10. Hodgkin Lymphoma, Hoppe RT, Mauch PT, Armitage JO, Diehl V, Weiss LM (eds.), Wolters Kluwer Health; Lippincott Williams & Wilkins, Philadelphia, 2007, ISBN-13: 978-0-7817-6422-3; ISBN-10: 0-7817-6422-X (Chapter 6: Cytokines, cytokine receptors, and chemokines in Hodgkin Lymphoma, by Ma Y, van den Bergh A, Atayar G, Visser L, Poppema S, pp 87-98). 11. Hodgkin Lymphoma, Hoppe RT, Mauch PT, Armitage JO, Diehl V, Weiss LM (eds.), Wolters Kluwer Health; Lippincott Williams & Wilkins, Philadelphia, 2007, ISBN-13: 978-0-7817-6422-3; ISBN-10: 0-7817-6422-X (Chapter 12: Prognostic factors in Hodgkin Lymphoma, by Specht L, Hasenclever D, pp 157-174). 12. Genomics and Pharmacogenomics in Anticancer Drug Development and Clinical Response (Cancer Drug Development and Discovery), Innocenti F (ed.), HUMANA Press, 2008, ISBN: 978-1-58829-646-7; e-ISBN: 978-1- 60327-088-5 (Impact of polymorphisms on the clinical outcomes of monoclonal antibody therapy against hematologic malignancies, by Dong Hwan Kim, pp 226). 13. ΑΙΜΑΤΟΛΟΓΙΑ ΣΤΗΝ ΚΛΙΝΙΚΗ ΠΡΑΞΗ , Πάγκαλης ΓΑ , Εκδόσεις Π.Χ. Πασχαλίδης , Αθήνα 2008, ISBN 978-960-399-776-4 ( Κεφ . 35: Λέµφωµα Hodgkin, σελ . 615-639). 14. Rafael Dezen Gaiolla. Thesis: Avaliacao do nivel serico de IL-6,IL-10 e IL-13 antes e apos o tratamento do linfoma de hodgkin classico. Universidade Estadual Paulista “Julio de Mesquita Julio”, 2008. 15. Hodgkin Lymphoma Chapter 4: Hodgkin’s Lymphoma: From tumor microenvironment to immunotherapeutic approach – Body’s own power protection challenges, by Lejeune M et al, pp. 63-110), identified through googlescholar, 2012. 16. Canellos GP, Lister TA, Young BD: The Lymphomas. 2006, Elsevier Inc. ISBN: 978-072160081-9 (Chapter: No Author Name Available. Hodgkin’s Lymphoma: Diagnosis and Treatment, pp 526-535, DOI: 10.1016/B978-0- 7216-0081-9.50036-4).

B. Citations from Journals Α/Α Όνοµα Συγγραφέως Περιοδικό Τόµος Σελίδα Έτος 1 Vassilakopoulos TP Eur J Haematol 67 279 2001 324

2 Vassilakopoulos TP Haema 4 230 2001 3 Rassidakis GZ J Clin Oncol 20 1278 2002 4 Rassi dakis GZ Clin Cancer Res 8 488 2002 5 Vassilakopoulos TP Haematologica 87 701 2002 6 Vassilakopoulos TP Eur J Haematol 68 289 2002 7 Zander T Ann Oncol 13(S1) 67 2002 8 Hagemeister FB Oncology -NY 16 617 2002 9 Galizia G J Interf Cytok Res 22 473 2002 10 Rassidakis GZ Blood 100 3935 2002 11 Salgami EV Haematologia 32 377 2002 12 Smith RS J Clin Oncol 21 2026 2003 13 Herling M Clin Cancer Res 9 2114 2003 14 Asadullah K Pharmacol Rev 55 241 2003 15 Karmiris TD Leuk Lymphoma 44 1523 2003 16 Gonzale z Baron M Rev Cancer 17 143 2003 17 Vassilakopoulos TP Int J Radiat Oncol Biol 59 765 2004 18 Vassilakopoulos TP Haema 7 147 2004 19 Spaner DE J Leukocyte Biol 76 338 2004 20 Visco C Leuk Lymphoma 45 2085 2004 21 Vassilakopoulos TP Haema 7(S1) 53 2004 22 Βασιλακόπουλος Θ Haema Συµπλ 137 2004 23 Vassilakopoulos TP J BUON 10 59 2005 24 Wu SL J Clin Oncol 23 3038 2005 25 Korkolopoulou P Leukemia 19 894 2005 26 Vassilakopoulos TP Anticancer Res 25 4743 2005 27 Muti G Leuk Lymphoma 46 1397 2005 28 Lech -Maranda E Eur Cytokine Netw 17 60 2006 29 Inagaki A Int J Cancer 118 3054 2006 30 Pamuk GE J Exp Clin Cancer Res 25 537 2006 31 Casasnovas RO J Clin Oncol 25 1732 2007 32 Lee JJ Br J Haematol 137 329 2007 33 Domingo -Domenech E Haematologica/TH J 92 1475 2007 34 Vassilakopoulos TP Haema 10 (S2) 90 2007 35 Doussis -Anagnostopoulou IA Clin Cancer Res 14 1759 2008 36 Hsi ED Leuk Lymphoma 49 1668 2008 37 Rautert R Leuk Lymphoma 49 2091 2008 38 Hohaus S Leuk Res 33 1352 2009 39 Bien E Clin Biochem 42 1144 2009 40 Mitelman AK Rev Brasil Hematol 31 260 2009 41 Rathore B Exp Opin Pharmacother 11 2891 2010 42 Gaudio F Adv Hematol 707542 2011 43 Gaiolla RD Arch Pathol Lab Med 135 483 2011 44 Barros MHM J Ped Sci 2 e25 2010 45 Sasayama T NeuroOncology 14 368 2012 46 Yri WE Leuk Lymphoma 53 1934 2012 47 Attia FM Cancer Biomarkers 11 41 2011 48 Schoof N Oncologist 18 80 2013 49 Vassilakopoulos TP Semin Hematol 50 4 2013 50 Rudnicka K APMIS 121 806 2013 51 Ghesquieres H Cyt okine 64 523 2013 52 Βασιλακόπουλος ΘΠ ΑΙΜΑ 3 212 2012 53 Venkataraman G Br J Haematol 165 287 2014 54 Cuccaro A Med J Hematol Infect 6 E2014 2014 55 Al -Hashemi HS Iraqi J Hematol 3 23 2014 56 Johnson P Blood 125 1717 2015 57 Remer M Chin Clin Oncol 4 13 2015 58 Barros MHM PLOS One 10 01245 2015 325

• PANGALIS GA, DIMOPOULOU MN, ANGELOPOULOU MK , TSEKOURAS CH, VASSILAKOPOULOS THP, SIAKANTARIS MP. Campath-1H (Anti-CD52) Monoclonal Antibody Therapy In Lymphoproliferative Disorders. A Review. Medical Oncology 18: 99-107, 2001. Α. Citations from Books, Medical sites and other Literature 1. Chronic Leukemias and Lymphomas: Biology, Pathophysiology, and Clinical Management, Schiller GJ, Humana Press, 2003, ISBN 0-89603-907-2, (Chapter: Low-grade lymphoma, by Emmanouilides C, pp 275). 2. Κλινική , Ανοσολογική και Μοριακή Μελέτη του Επιθηλιοτροπισµού και της ∆ιασποράς Λεµφοκυττάρων σε Ασθενείς µε Χρονία Λεµφογενή Λευχαιµία και Χαµηλής Κακοηθείας Λεµφώµατα τύπου MALT. Μαρίνα Π. Σιακαντάρη , ∆ιδακτορική ∆ιατριβή , Ιατρική Σχολή Εθνικού και Καποδιστριακού Πανεπιστηµίου Αθηνών , Αθήνα , Ιούλιος 2003. 3. An illustrated guide to skin lymphoma, Cerroni L, Gatter K, Kerl H, 2 nd Edition, 2004, ISBN 1-4051-1376-6, (Part 1: Cutaneous T-cell lymphomas, pp 7-88). 4. THE BIOLOGY OF CANCER, Gabriel J ed., Whurr Publishers Ltd., 2004, ISBN 1-86156-434-1, (Chapter 9: Monoclonal Antibodies, by Modjtabedi H, pp 109-125). 5. Molecular Oncology of Breast Cancer. Ross JS, Hortobagyi GN (eds.), World Headquarters, Jones and Bartlett Publishers, Sudbury, Massachussets, 2005, ISBN: 0-7637-4810-2, (Chapter 14: Targeted Therapy for Cancer: Integrating Diagnostics and Therapeutics, by Ross JS, pp 205). 6. Cancer Nursing: Principles and Practice (Jones and Bartlett Series in Oncology), 6 th Edition. Yarbro CH, Hansen Froqqe M, Goodman M (eds.), Jones and Bartlett Publishers, Sudbury, Massachussets, 2005, (Chapter 58: Lymphomas, by Manson SD, Porter C, pp 1414-1459). 7. Living Donor Transplantation. Tan HP, Marcus A, Shapiro R (eds.), Informa HealthCare USA, Inc, New York, 2007, ISBN-13: 978-0-08493-3766-6; ISBN- 10: 0-8493-3766-6, (Chapter 9: Donor and recipient outcomes after laparoscopic live-donor nephrectomy, by Tan HP, Kaczorowski DJ, Basu A, Donaldson J, Shapiro R, pp 101-112). 8. ΑΙΜΑΤΟΛΟΓΙΑ ΣΤΗΝ ΚΛΙΝΙΚΗ ΠΡΑΞΗ , Πάγκαλης ΓΑ , Εκδόσεις Π.Χ. Πασχαλίδης , Αθήνα 2008, ISBN 978-960-399-776-4 ( Κεφ . 32: Χρονία Λεµφογενής Λευχαιµία , σελ . 583-602). 9. ΑΙΜΑΤΟΛΟΓΙΑ ΣΤΗΝ ΚΛΙΝΙΚΗ ΠΡΑΞΗ , Πάγκαλης ΓΑ , Εκδόσεις Π.Χ. Πασχαλίδης , Αθήνα 2008, ISBN 978-960-399-776-4 ( Κεφ . 83: Χρήση µονοκλωνικών αντισωµάτων στην Αιµατολογία , σελ . 1272-1279). 10. Gabriel J: The Biology of Cancer: Second edition. 2008, John Wiley and Sons, ISBN: 978-047005759-9, DOI: 10.1002/9780470988121. 11. ΕΣΩΤΕΡΙΚΗ ΠΑΘΟΛΟΓΙΑ , από το ∆ιδακτικό και Επιστηµονικό Προσωπικό του Τοµέως Παθολογίας , Εκδόσεις ΠΑΣΧΑΛΙ∆Η , 2 η Έκδοση , 2010, ISBN 978-960-399-951-5, Αθήνα ( Κεφάλαιο : Θ. Βασιλακόπουλος , Μ. Αγγελοπούλου , Μ. Σιακαντάρη , Γ. Πάγκαλης ,Χ. Κυρτσώνη , Σ. Κοκόρη , Χ. Καλπαδάκη , Φ. Κοντοπίδου , Ε. ∆ηµητριάδου , Μ. ∆ηµοπούλου : Κακοήθη λεµφώµατα και χρόνια λεµφογενής λευχαιµία . σελ . 1386-1403). 12. Norberg Maria. Thesis: In vitro drug sensitivity and apoptosis in chronic lymphocytic leukemia. Uppsala Universitet, 2010. 326

13. Ginsburg SG, Willard FH: Essentials of genomic and personalized medicine. 2010, Elsevier Inc. ISBN: 978-012374934-5 (Chapter: Ross JS. Targeted therapies for cancer, pp 532-547, DOI: 10.1016/B978-0-12-374934-5.00042- 8). 14. Ginsburg GS, Willard H: Genomic and personalized medicine. 2009, Elsevier Inc. ISBN: 978-012369420-1 (Chapter: Ross JS. Diagnostic-Therapeutic combinations in the treatment of cancer, pp 990-1007, DOI: 10.1016/B978-0- 12-369420-1.00082-2). 15. Cerroni L, Gatter K, Kerl H: Skin Lymphoma: The illustrated guide, third edition. 2010, Wiley Blackwell. ISBN: 978-140518554-7, DOI: 10.1002/9781444316742. 16. Kaplan B, Burckart GJ, Lakkis FG: Immunotherapy in transplantation. Principles and practice. 2012, Wiley-Blackwell, ISBN: 978-140518271-3 (Chapter: Agarwal A, Bruno D, Knechtle SJ. The role of alemtuzumab in solid organ transplantation, pp 346-361, DOI: 10.1002/9781444355628.ch23). 17. Ginsburg G, Willard H: Genomic and personalized medicine. 2013, Elsevier Inc. ISBN: 978-012382227-7 (Chapter: Ross JS. Diagnostic-Therapeutic combinations, pp 798-819, DOI: 10.1016/B978-0-12-382227-7.00069-0).

B. Citations from Journals Α/Α Όνοµα Περιοδικό Τόµος Σελίδα Έτος Συγγραφέως 1 Pangalis GA Hematol Oncol 20 103 2002 2 Montillo Haematologica 87 695 2002 3 Adler SH Curr Opin Immunol 14 660 2002 4 Rayzman VM Cancer Forum 26 104 2002 5 Saad SY Saudi Pharm J 10 143 2002 6 Herold KC J Clin Invest 111 409 2003 7 Mueller A PNAS 100 1292 2003 8 Winter WE Biodrugs 17 39 2003 9 Ross JS Am J Clin Pathol 119 472 2003 10 Frampton JE Drugs 63 1229 2003 11 Campb ell P Blood Rev 17 143 2003 12 Jager U Wien Klin Wochenschr 115 462 2003 13 O’Brien S Drugs Today 39 541 2003 14 Ross JS Exp Rev Anticancer Ther 3 107 2003 15 Robak T Leuk Lymphoma 45 205 2004 16 Bolli N Lancet Oncol 5 64 2004 17 Foss F Leuk Lymphoma 44 S55 2003 18 Bae J Cell Immunol 227 38 2004 19 Lundin J Semin Hematol 41 234 2004 20 Lenihan DJ Blood 104 655 2004 21 Nadeau L Eur J Haematol 73 300 2004 22 Laurenti Haematologica 89 1248 2004 23 Gibbs SDJ Eur J Haematol 73 447 2004 24 Ross JS Am J Clin Pathol 122 598 2004 25 Bettelheim P LaboratoriumMedizin 28 410 2004 26 Sasaki S Biotherapy 18 511 2004 27 Woo M Endocrinology Rounds 4 2004 28 Bae J Clin Cancer Res 11 1629 2005 29 Watson CJE Am J Transplant 5 1347 2005 30 Wierda WG J Clin O ncol 23 6325 2005 31 Zell JA Support Care Cancer 13 870 2005 32 O’ Brien S Curr Mol Med 5 663 2005 33 Tanner JE Cancer Metast Rev 24 585 2005 327

34 Kuriakose P Cancer Control 12 82 2005 35 Omoti CE Haema 8 678 2005 36 Chin J Leuk Lymphoma 14 248 2005 37 Mojtahedi H IJI 2 3 2005 38 Li Zi -Ming For Med Sci (Oncol) 32 905 2005 39 Pangalis GA Eur J Hosp Pharm Pract 12 59 2006 40 Wierda WG Semin Oncol 33 202 2006 41 Pangalis GA Cur Top Med Chem 6 1657 2006 42 Watanabe T Clin Immunol 120 247 2006 43 Boo y EP Arch Immunol Ther Exper 54 85 2006 44 Tan HP Am J Transplant 6 2409 2006 45 Kaleem Z Arch Pathol Lab Med 130 1850 2006 46 Wertheim MS Eye 20 1453 2006 47 Alfonso -Perez M J Leukocyte Biol 79 1157 2006 48 Zinzani PL Crit Rev Oncol/Hematol 65 172 20 08 49 Hollander S J Med 36 147 2005 50 Liebman HA Semin Hematol 46 33 2009 51 Rate R Ann Hematol 85(S1) 42 2006 52 Bugelski PJ Exp Rev Clin Immunol 5 499 2009 53 Ross JS Meth Pharmacol Toxicol 267 2008 54 Παπαδαυίδ Ε Αίµα ( Haema) 1 72 2010 55 Bae JE Trends Biopharm Industr 4 63 2008 56 Feng B J Modern Oncol (Chinese) 11 321 2003 57 Fallen RS Med Clin North Am 96 565 2012 58 Baughman RP Chest 142 1S 2012 59 Kuramochi T Methods Mol Biol 1060 123 2014 60 Liebman HA Thromb Res 133(S S63 2014 61 Aboutorabi R Adv Biomed Res 3 124 2014 62 Cheng H Tex Heart Inst J 41 626 2014 63 Brady JL Clin Transl Immunol 3 e29 2014

• KYRTSONIS M-C, VASSILAKOPOULOS TP, ANGELOPOULOU MK , SIAKANTARIS MP, KONTOPIDOU FN, DIMOPOULOU MN, BOUSSIOTIS V, GRIBABIS DA, KONSTANTOPOULOS K, VAIOPOULOS GA, FESSAS P, KITTAS CH, PANGALIS GA. Waldenstrom’s Macroglobulinemia: Clinical Course And Prognostic Factors In 60 Patients. Annals of Hematology 80: 722-727, 2001 A. Citations from Books, Medical sites and other Literature 1. www.waldenstromsprogram.org/Diagnosis/Waldenstrom’s(D&G)- MerliniTreonDef.pdf, 2003. Merlini G, Treon B. Biotechnology Research Labs. 2. Non-Hodgkin’s Lymphomas, Mauch PM, Armitage JO, Coiffier B, Dalla- Favera R, Harris NL, Lippincott Williams & Wilkins, 2004, ISBN 0-7817- 3526-2 (Chapter 15: Lymphoplasmacytic lymphoma and Waldenstrom’s macroglobulinemia, by Rohatiner AZS, Harris NL, Dalla-Favera R, Lister TA, pp 263-273). 3. Multiple Myeloma and Related Disorders, Gahrton G, Durie BGM, Samson DM, ARNOLD, ISBN 0-340-81010-6 (Chapter: Waldenstrom’s disease, by Merlini G & Treon SP, pp 429-451). 328

4. Pathology of bone marrow and blood cells, Farhi DC, Chiling CC, Edelman AS, Parveen T, Thi Vo TL eds., Lippincot Williams & Wilkins, 2004, ISBN 0-397-51611-8 (Chapter: B-cell neoplasms, pp 305). 5. Multiple myeloma & related disorders (Hematologic Malignancies), Gertz MA, Greipp PR, Springer-Verlang, Berlin, 2004, ISBN 3-540-00811-X (Chapter: Winkler JM, Fonseca R: Waldenstrom Macroglobulinemia, pp.205-226). 6. RADIOLOGICAL IMAGING IN HEMATOLOGIC MALIGNANCIES, Castellino RA and Guermazi A (eds.), Springer-Verlag, 2004, ISBN 3- 540-43999-4, (Chapter: Waldenstrom’s Macroglobulinemia, by Moulopoulos LA, Guermazi A, pp 289-296). 7. WINTROBE’S Clinical Hematology (Vol 2), Greer JP, Foerster J, Lukens JN, Rodgers GM, Paraskevas F, Glader B, IIth Edition, Lippincott Williams & Wilkins, ISBN 0-7817-3650-1, (Chapter 100: Waldenstrom’s Macroglobulinemia, by Fonseca R, Witzig TE, pp 2667-2681). 8. www.leukaemie- hilfe.de/Info/Literatur/Archiv/DLH_371_WaldenTherapie.pdf ,Gertz MA: Morbus Waldenstrom, Dec 2004. 9. IMMUNE HEMOLYTIC ANEMIAS, Petz LD, Garraty G eds., Churchil- Livingston, 2 nd ed., 2004, ISBN 0-443-08559-5, (Chapter 3: Classification and clinical characteristics of autoimmune haemolytic anemia, pp. 61- 131). 10. ΑΙΜΑΤΟΛΟΓΙΑ ΣΤΗΝ ΚΛΙΝΙΚΗ ΠΡΑΞΗ , Πάγκαλης ΓΑ , Εκδόσεις Π.Χ. Πασχαλίδης , Αθήνα 2008, ISBN 978-960-399-776-4 ( Κεφ . 54: Μακροσφαιριναιµία του Waldenstrom, σελ . 815-821). 11. Molecular Pathology of Haematolymphoid diseases, Molecular Pathology, Library 4. Dunphy CH (ed.). Springer Science + Business Media, LLC 2010 (Chapter 18: Lymphoplasmacytic lymphoma, by Lin P, DOI: 10.1007/978-1-4419-5698-9_18, pp 233-239). 12. Advances in Malignant Hematology. Saba HI and Mufti GJ (eds.), 2011 Wiley-Blackwell, Oxford, UK. ISBN: 978-140519626-0 (Chapter 21: Waldenström's Macroglobulinemia, by Kyle RA, Hayman S, pp 342-354, doi: 10.1002/9781444394016.ch21). 13. NEOPLASTIC DISEASES OF THE BLOOD, by Wiernik PH et al. (eds.), Springer Science+Business Media, New York, 2013, DOI 10.1007/978-1- 4614-3764-2_35 (Chapter 35: Waldenstrom’s Macroglobulinemia, by Kastriris E & Dimopoulos MA). 14. Cepika A, Zargar A, Mohamed B, Iwamoto I. P.F. In vivo MALDI-TOF markers for early detection of Aleutian disease (AD) among the AD virus infected mink. In: Larsen et al. (eds.), Proceedings of the X th International Scientific Congress in fur animal production, DOI 10.3920/978-90-8686-760-8_19, © Wageningen Academic Publishers 2012. 15. Kyrtsonis MC, Koulieris E, Bartzis V, Pessah I, Nikolaou E, Karali V, Maltezas D, Panayiotidis P, Harding SJ. Chapter 2: Monoclonal Immunoglobulin. http://dx.doi.org/10.5772/55855 . INTECH, pp. 13-37, 2013. 16. WINTROBE’S …………….. 2013a 17. WINTROBE’S …………….. 2013b

B. Citations from Journals 329

Α/Α Όνοµα Συγγραφέως Περιοδικό Τόµος Σελίδα Έτος 1 Pangalis GA He matol Oncol 20 103 2002 2 Blaha M Lek Zpr LF UK Hradec 47 151 2002 3 Johnson SA Rev Clin Exp Hematol 20 103 2002 4 Pangalis GA Semin Oncol 30 201 2003 5 Owen RG Semin Oncol 30 110 2003 6 Kyle RA Semin Oncol 30 116 2003 7 Morra E Semin Oncol 30 17 2 2003 8 Owen RG Semin Oncol 30 196 2003 9 Merlini G Semin Oncol 30 211 2003 10 Stalnikiewicz L Semin Oncol 30 216 2003 11 Cesana C Semin Oncol 30 2231 2003 12 Dimopoulos MA Ann Oncol 14 1299 2003 13 Lin P Am J Clin Pathol 120 246 2003 14 Mehta J Se minThromb Hemost 29 467 2003 15 Sung Hwa Bae Kor J Hematol 38 234 2003 16 Uchino K Intern Med 43 131 2004 17 Chen CI Ann Oncol 15 550 2004 18 Dimopoulos MA Leuk Lymphoma 45 1809 2004 19 Morra E Leukemia 18 1512 2004 20 Tojo K Intern Med 43 990 2004 21 Jurczyszyn A Adv Clin Exp Med 13 327 2004 22 Leblond V Clin Exp Med 3 187 2004 23 Tziomalos K Haema 8 125 2005 24 Pangalis GA Clin Lymphoma 5 235 2005 25 Gertz MA Am J Hematol 79 147 2005 26 Dimopoulos MA Best Pract Res Cl Ha 18 747 2005 27 Weiler CR Mayo Clin Proc 80 1187 2005 28 Morra E Clin Lymphoma 5 265 2005 29 Lin P Adv Anat Pathol 12 246 2005 30 Levine T J Neurol Neurosur PS 77 224 2006 31 Anagnostopoulos A Clin Lymphoma Myel 7 205 2006 32 Peregrinova M Endoskopie 16 15 2007 33 Hauswi rth AW Leuk Lymphoma 48 1139 2007 34 Pratz KW Medicine 86 210 2007 35 Fonseca R Br J Haematol 138 700 2007 36 Falagas ME Infection 35 370 2007 37 Adam Z Vnitrni Lekarstvi 53 1325 2007 38 Yamamoto R Bone Marrow Transpl 41 591 2008 39 Moreau AS Eur J H aematol 80 503 2008 40 Vijay A Clin Lymph Myeloma 8 219 2008 41 Peinert S Hem/Onc Clin North Am 22 903 2008 42 Baehring JM Nat Clin Pract Neurol 4 547 2008 43 Ustun C Amyl –J Prot Fold Dis 16 42 2009 45 Eby C Br J Haematol 145 151 2009 45 Morel P Bloo d 113 4163 2009 46 Yang JG Clin Nucl Med 34 441 2009 47 Zangari M Cancer Treat Res 148 295 2009 48 Kastritis E Leuk Res 34 1340 2010 49 Nakazaki K Int J Hematol 92 360 2010 50 Kyrtsonis MC Clin Lymph Myel Leuk 11 99 2011 51 Eby CS Hematology (ASH 200 7) 158 2007 52 Fabricant PD J Bone Joint Surg Ser A 93 e46 2011 53 Lechner K Leuk Lymphoma 52 1836 2011 54 Shiseki M Hematology Rep 3 e10 2011 55 Copolla A Semin Hemost Thromb 37 929 2011 56 Morel P Exp Rev Hematol 5 187 2012 330

57 Kyrtsonis MC Am J Me d Med Sci 2 136 2012 58 Ramon Rodriguez Rev Cub Hematol 29 259 2013 59 Levidou G Curr Angiogenesis 2 110 2013 60 Yamanuchi J Ann Hematol 93 711 2014 61 Lechner K Semin Thromb 40 359 2014 62 Wei Q Hum Pathol 45 2063 2014 63 Hamadeh F Mod Pathol 28 564 2015

• VASSILAKOPOULOS TP, ANGELOPOULOU MK , SIAKANTARIS MP, KONTOPIDOU FN, DIMOPOULOU MN, BARBOUNIS A, GRIGORAKIS V, KARKANTARIS C, ANARGYROU K, CHATZIIOANOOU M, ROMBOS J, BOUSSIOTIS VA, VAIOPOULOS GA, KITTAS CH, PANGALIS GA. Prognostic Factors In Advanced Stage Hodgkin’s Lymphoma: The Significance Of The Number Of Involved Anatomical Sites. European Journal of Hematology 67: 279-288, 2001 A. Citations from Books, Medical sites and other Literature 1. Βιολογικοί Παράγοντες και Κλινικά Χαρακτηριστικά κατά τη ∆ιάγνωση και Υποτροπή του Λεµφώµατος Hodgkin: Συσχετίσεις και Προγνωστική Σηµασία . Θεόδωρος Π. Βασιλακόπουλος , ∆ιδακτορική ∆ιατριβή , Ιατρική Σχολή Εθνικού και Καποδιστριακού Πανεπιστηµίου Αθηνών , Αθήνα , Μάρτιος 2004. 2. ∆ιερεύνηση της ιστογένεσης του Reed-Sternberg κυττάρου στην κλασική νόσο Hodgkin και συσχέτιση µε βιολογικούς δείκτες . Σερένα Βαλσάµη , ∆ιδακτορική ∆ιατριβή , Ιατρική Σχολή Εθνικού και Καποδιστριακού Πανεπιστηµίου Αθηνών , Αθήνα , Σεπτέµβριος 2007. 3. Linfoma de Hodgkin na infancia e adolescensia. Um estudo das caracteristicas histologicas, clinicas, epidemiologicas e de associacao com o virus Epsein-Barr, Mario Henrique Magalhaes Barros. Dissertacao de Mestrado apresentada ao Programa de pos-graduacao em Oncologia, Instituto Nacional do Cancer, Ministerio da Saude, como parte dos requisitos necassarios a obtencao do titulo de Mestre em Oncologia. Rio de Janeiro, 2007. 4. ΑΙΜΑΤΟΛΟΓΙΑ ΣΤΗΝ ΚΛΙΝΙΚΗ ΠΡΑΞΗ , Πάγκαλης ΓΑ , Εκδόσεις Π.Χ. Πασχαλίδης , Αθήνα 2008, ISBN 978-960-399-776-4 ( Κεφ . 35: Λέµφωµα Hodgkin, σελ . 615-639). 5. Μονογραφή Της Ηµερίδας Με Θέµα : ‘‘ Λέµφωµα Hodgkin: Πρόσφατες Εξελίξεις ’’ Του Τµήµατος Λεµφοϋπερπλαστικών Νόσων Της Ελληνικής Αιµατολογικής Εταιρίας , Αθήνα , 31 Ιανουαρίου 2009. ( Κεφάλαιο : Λέµφωµα Hodgkin: Θεραπεία περιορισµένων σταδίων . Βασιλακόπουλος ΘΠ , Αγγελοπούλου ΜΚ , Πάγκαλης ΓΑ , σελ . 29-39). 6. Hussong JW, Arber DA, Bradley KT, Brown MS, Chang CC, de Baca ME, Ellis DW, Foucar K, His ED, Jaffe ES, Lill M, McClure MP, Medeiros JL, Perkins SL. Protocol for the examination of specimens from patients with Hodgkin lymphoma. Based on AJCC/UICC TNM 7 th Edition. Protocol web posting date: October 2009.

B. Citations from Journals Α/Α Όνοµα Συγγραφέως Περιοδικό Τόµος Σελίδα Έτος 1 Vassilakopoulos TP Haema 4 230 2001 2 VassilakopoulosTP Haematologica 87 701 2002 331

3 VassilakopoulosTP Eur J Haematol 68 289 2002 4 Vassilakopoulos TP Int J Radiat Oncol Biol Phys 59 765 2004 5 Vassilakopoulos TP Haema 7 147 2004 6 Montalban C J Clin Oncol 22 1664 2004 7 Gobbi PG Cancer 101 1824 2004 8 Vassilakopoulos TP Haema 7(S1) 53 2004 9 Βασιλακόπουλος Θ Haema Συµπλ 137 2004 10 Lespinet V Int J Cancer 114 909 2005 11 Vassilakopoulos TP Blood 105 1875 2005 12 Vassilakopoulos TP J BUON 10 59 2005 13 Vassilakopoulos TP Haematologica/The Hematology J 91 32 2006 14 Visco C Eur J Haematol 77 387 2006 15 Jakovic LR Med Oncol 24 45 2007 16 Rueda A Clin Lymphoma Myeloma 7 400 2007 17 Valsami S Haematologica/The Hematology J 92 1343 2007 18 Vassilakopoulos TP Haema 10 (S2) 90 2007 19 Doussis -Anagnostopoulou IA Clin Cancer Res 14 1759 2008 20 Morais A J Pediatr 85 236 2009 21 Βασιλακόπουλος ΘΠ Haema 12 (S2) 169 2009 22 Belgaumi A Hematol Oncol Stem Cell Ther 2 178 2009 23 Itoh K Int J Hematol 91 446 2010 24 Barros MHM Leuk Lymphoma 51 1513 2010 25 Daw S Br J Haematol 152 249 2011 26 Marnerides A Anticancer Res 31 3585 2011 27 Hong X Chin J Cancer 25 1013 2006 28 Cojbasic I Facta Universitatis 14 117 2007 29 Jakovic LR Leuk Lymphoma 52 1913 2011 30 Koh YW Ann Hematol 91 1403 2012 31 Gobbi PG Oncology Rep 28 815 2012 32 Vassilakopoulos TP Semin Hematol 50 4 2013 33 Βασ ιλακόπουλος ΘΠ ΑΙΜΑ 3 212 20 12 34 Kanellopoulos A Arch Hellen Med 30 647 2013 35 Dimtsas GS Leuk Lymphoma 55 558 2014

• RASSIDAKIS GZ, MEDEIROS LJ, VIVIANI S, BONFANTE V, NADALI G-P, VASSILAKOPOULOS TP, MESINA O, HERLING M, ANGELOPOULOU MK , GIARDINI R, CHILOSI M, KITTAS CH, MCLAUGHLIN P, RODRIGUEZ MA, ROMAGUERA J, BONADONNA G, GIANNI AM, PIZZOLO G, PANGALIS GA, CABANILLAS F, SARRIS AH. CD20 Expression In Hodgkin And Reed-Sternberg Cells Of Classical Hodgkin’s Disease: Association With Presenting Features And Clinical Outcome. Journal of Clinical Oncology 20: 1278-1287, 2002 Α. Citations from Books, Medical sites and other Literature 1. Neoplastic diseases of the blood, Wiernik PH, Goldman JM, Dutcher JP, Kyle RA eds., Cambridge University Press, 2003, ISBN 0-521-79136-7 (Chapter: Immunology of the lymphomas, by Parikh R, Ozer H, pp 745). 2. Manual of Diagnostic Antibodies for Immunohistology, Leong ASY, Cooper K, Leong JFWM, 2 nd Edition, Greenwich Medical Media Ltd, 2003, ISBN 1- 84110-100-1, (Chapter: CD20, pp 3). 332

3. Βιολογικοί Παράγοντες και Κλινικά Χαρακτηριστικά κατά τη ∆ιάγνωση και Υποτροπή του Λεµφώµατος Hodgkin: Συσχετίσεις και Προγνωστική Σηµασία . Θεόδωρος Π. Βασιλακόπουλος , ∆ιδακτορική ∆ιατριβή , Ιατρική Σχολή Εθνικού και Καποδιστριακού Πανεπιστηµίου Αθηνών , Αθήνα , Μάρτιος 2004. 4. HOFFMAN’S Hematology: Basic Principles and Practice, Hoffman R, Benz E, Shattil SJ, Furie B, Cohen HJ, Silberstein LE, McGlave P, 4th Edition, ELSEVIER Churchill-Livingston, 2005, ISBN 0-443-06628-0, (Chapter 74: Pathobiology of Hodgkin’s lymphoma, by Pileri SA, Falini B, Stein H, pp 1325- 1346). 5. Βασιλακόπουλος Θ, Σαρρής Α: Λέµφωµα Hodgkin: Εξελίξεις στην βιολογία και θεραπεία . Στο : ΕΞΕΛΙΞΕΙΣ ΣΤΗΝ ΠΑΘΟΛΟΓΙΑ . Νεώτερες απόψεις στη διάγνωση και θεραπεία . Σεϊτανίδης Β, Γεωργιλής Κ, Αποστολάκης Ι. Έκδοση του ∆ιαγνωστικού και Θεραπευτικού Κέντρου Αθηνών ΥΓΕΙΑ , σελ. 17-31, 2006. 6. UpToDate (www.uptodate.com ) 2006, version 15.1 (Κεφάλαιο : Aster JC: The Reed-Sternberg cell and the pathogenesis of Hodgkin’s disease, Last update 23.09.2010, συνεχίζεται έως σήµερα ). 7. ∆ιερεύνηση της ιστογένεσης του Reed-Sternberg κυττάρου στην κλασική νόσο Hodgkin και συσχέτιση µε βιολογικούς δείκτες . Σερένα Βαλσάµη , ∆ιδακτορική ∆ιατριβή , Ιατρική Σχολή Εθνικού και Καποδιστριακού Πανεπιστηµίου Αθηνών , Αθήνα , Σεπτέµβριος 2007. 8. Linfoma de Hodgkin na infancia e adolescensia. Um estudo das caracteristicas histologicas, clinicas, epidemiologicas e de associacao com o virus Epsein-Barr, Mario Henrique Magalhaes Barros. Dissertacao de Mestrado apresentada ao Programa de pos-graduacao em Oncologia, Instituto Nacional do Cancer, Ministerio da Saude, como parte dos requisitos necassarios a obtencao do titulo de Mestre em Oncologia. Rio de Janeiro, 2007. 9. Viral and Immunological Malignancies (Clinical Oncology Series). Volberding PA, Joel M, Palefsky MD, Walsh CC (eds.), 2006, pp.204. 10. ΑΙΜΑΤΟΛΟΓΙΑ ΣΤΗΝ ΚΛΙΝΙΚΗ ΠΡΑΞΗ , Πάγκαλης ΓΑ , Εκδόσεις Π.Χ. Πασχαλίδης , Αθήνα 2008, ISBN 978-960-399-776-4 ( Κεφ . 35: Λέµφωµα Hodgkin, σελ . 615-639). 11. Zelenetz A, Czuczman M, Harris NL. NCCN – MedscapeCME Oncology non- Hodgkin’s lymphoma Tumor Board. Released 30.12.2009. 12. ΑΤΛΑΝΤΑΣ ΟΓΚΟΛΟΓΙΑΣ ΘΩΡΑΚΑ , Συρίγος Κ, Γκιόζος Γ, Χαρπίδου Α, Εκδόσεις ΠΑΡΙΣΙΑΝΟΥ , 2012, ISBN 978-960-394-838-4, Αθήνα ( Κεφάλαιο 43: Θ. Βασιλακόπουλος , Α. Ζορµπαλά : Λεµφώµατα µεσοθωρακίου . σελ . 541- 563). 13. Hodgkin Lymphoma. (Chapter 2: Advances in classical Hodgkin Lymphoma Biology, by Sanchez-Espiridion B et al, pp. 29-46), identified through googlescholar, 2012. 14. Neoplastic Diseases of the Blood, Wiernik PH et al (eds.), Springer Science+Business Media, New York, 2013, DOI 10.1007/978-1-4614-3764- 2_42 (Chapter 42: Pathology of non-Hodgkin’s and Hodgkin’s Lymphomas, by Medeiros LJ, pp 867-918). 15. Canellos GP, Lister TA, Young BD: The Lymphomas. 2006, Elsevier Inc. ISBN: 978-072160081-9 (Chapter: No Author Name Available. Hodgkin’s Lymphoma: Diagnosis and Treatment, pp 526-535, DOI: 10.1016/B978-0- 7216-0081-9.50036-4). 16. Textbook of Organ Transplantation, Kirk AD, Knechtle SJ, Larsen CP, Madsen JC, Pearson TC, Webber SA (eds.), John Wiley & Sons Ltd, 2014, Print ISBN 9781118870143, Online 9781118873434 (Chapter 17: Current pathways for immune manipulation, by Lees JR, Azimzadeh AM, Ding Y, Xu 333

J, Bromberg JS, pp. 219-238, published online 25 Jul 2014, DOI: 10.1002/9781118873434.ch17).

B. Citations from Journals Α/Α Όνοµα Συγγραφέως Περιοδικό Τόµος Σελίδα Έτος 1 Cavalli FG Ann Oncol 13(S4) 159 2002 2 Tzankov A Clin Cancer Res 9 1381 2003 3 Boye J Ann Oncol 14 520 2003 4 Herling M Clin Cancer Res 9 2114 2003 5 Younes A Cancer 98 310 2003 6 Tzankov A Mod Pathol 16 1141 2003 7 Alcindor T Blood 102(11) 4960 2003 8 Rossi JF Oncologie 5 43 2003 9 VassilakopoulosTP Haema 7 147 2004 10 Portlock CS Br J Haematol 125 701 2004 11 Herling M Hum Pathol 35 455 2004 12 Shiramizu B Clin Lymphoma 5 184 2004 13 Suzuki J Exp Anim Tokyo 54 101 2005 14 Lionakis MS Infect Immun 73 7747 2005 15 Kano R Vet Immunol Immunop 108 265 2005 16 Pangalis GA Curr Top Med Chem 6 1657 2006 17 Yazbeck V Future Oncol 2 533 2006 18 Tzankov A Pathobiology 73 107 2006 19 Ry got B Polskie Arch Med Wew 116 838 2006 20 Tedoldi S J Pathol 213 429 2007 21 Schnell R Onkologie 31 49 2008 22 Patkar N Ind J Cancer 45 59 2008 23 Aldred V Leuk Lymphoma 49 2198 2008 24 Youinou P Immunol Endocr Metab 8 222 2008 Agent Med Chem 25 Bo rakzai M Ind J Pathol Microbiol 52 1 2009 26 Das DK Diagn Cytopathol 37 564 2009 27 Younes A Ann Oncol 20 1147 2009 28 Morais A J Pediatr 85 236 2009 29 Schnitzer B Hem Onc Clin North Am 23 747 2009 30 Canioni D PLOS One 4 e6341 2009 31 Miles RR Hum Pathol 40 1731 2009 32 Canellos GP Haematol Meet Rep 3 115 2009 33 Giesta RP J Bras Patol Med Lab 45 247 2009 34 Drakos E Am J Surg Pathol 33 1725 2009 35 Oki Y Curr Hematol Malig Rep 5 135 2010 36 Takach S Bone Marrow Transplant 45 856 2010 37 Aldin ucci D J Pathol 221 248 2010 38 Blum KA Hematology 2010 93 2010 39 Carbone A Am J Hematol 86 170 2011 40 Steidl C J Clin Oncol 29 1812 2011 41 Saini KS Cancer Treat Rev 37 385 2011 42 Juszczynski P Hematologia 2 1 201 1 43 Jain S Int J Case Rep Imag 2 13 2011 44 Derenzini E Genome Med 3 26 2011 45 Chin J Cancer 7 1197 2008 46 Barros MHM J Ped Sci 2 e25 2010 47 Younes A Blood 119 4123 2012 48 Xiao CJ Chin J Cancer Prev Treat 19 351 2012 334

49 De la Cruz -Merino L Clin Develop Immunol 756353 2012 50 Khedmat H Exp Clin Transplant 10 325 2012 51 Currin ESR Kor J Haematol 47 8 2012 52 Steidl C Blood 120 3530 2012 53 Domingos PLB An Bras Dermatol 87 851 2012 54 Massod A Med Oncol 30 431 2013 55 Iilkhanizadeh B Urmia Med J 24 2013 56 Diefenbach C Clin Cancer Res 19 2797 2013 57 Tudor CS Human Pathol 44 2475 2013 58 Βασιλακόπουλος ΘΠ ΑΙΜΑ 3 212 2012 59 Κοτσιανίδης Ι ΑΙΜΑ 3 260 2012 60 Weiss LM Surg Pathol Clin 6 729 2013 61 Cacoub L Leukemia Lymphoma 2013 62 King RL Adv Anatom Pathol 21 12 2014 63 Gharbaran R Crit Rev Oncol Hematol 2014 64 Venkataraman G Br J Haematol 165 287 2014 65 Emara NM Egypt J Pathol 34 52 2014 66 Elsayed AA Pathol Int 64 336 2014 67 Hollman -Hewgley D Am J Surg Pathol 38 1193 2014 68 Gholipour -Shoiili A Saudi J Kidney Dis 25 29 2014 69 Khedmat H Saudi J Kidney Dis 25 1293 2014 70 Salama A Int J Sci Res 3 12 2014

• ANGELOPOULOU MK , SIAKANTARIS MP, VASSILAKOPOULOS TP, KONTOPIDOU FN, RASSIDAKIS G, DIMOPOULOU MN, KITTAS CH, PANGALIS GA. The Splenic Form Of Mantle Cell Lymphoma. European Journal of Hematology 68: 12-21, 2002. Α. Citations from Books, Medical sites and other Literature 1. STERNBERG’ S DIAGNOSTIC SURGICAL PATHOLOGY: Mills SE, Carter D, Greenson JK, Oberman HA, Renter V, Stoler MH, 4th Edition, Lippincot Williams & Wilkins, 2004, ISBN 0-7817-4051-7, (Chapter: The spleen, by Burke JS, pp 872). 2. Manual of Diagnostic Antibodies for Immunohistology, Leong ASY, Cooper K, Leong JFWM, 2 nd Edition, Greenwich Medical Media Ltd, 2003, ISBN 1- 84110-100-1, [Chapter: CD54 (ICAM-1), pp 125)]. 3. ΑΙΜΑΤΟΛΟΓΙΑ ΣΤΗΝ ΚΛΙΝΙΚΗ ΠΡΑΞΗ , Πάγκαλης ΓΑ , Εκδόσεις Π.Χ. Πασχαλίδης , Αθήνα 2008, ISBN 978-960-399-776-4 ( Κεφ . 39: Λέµφωµα από κύτταρα του µανδύα , σελ . 676-684). 4. ΕΣΩΤΕΡΙΚΗ ΠΑΘΟΛΟΓΙΑ , από το ∆ιδακτικό και Επιστηµονικό Προσωπικό του Τοµέως Παθολογίας , Εκδόσεις ΠΑΣΧΑΛΙ∆Η , 2 η Έκδοση , 2010, ISBN 978-960-399-951-5, Αθήνα ( Κεφάλαιο : Θ. Βασιλακόπουλος , Μ. Αγγελοπούλου , Μ. Σιακαντάρη , Γ. Πάγκαλης ,Χ. Κυρτσώνη , Σ. Κοκόρη , Χ. Καλπαδάκη , Φ. Κοντοπίδου , Ε. ∆ηµητριάδου , Μ. ∆ηµοπούλου : Κακοήθη λεµφώµατα και χρόνια λεµφογενής λευχαιµία . σελ . 1386-1403). 5. TEXTBOOK OF UNCOMMON CANCER, 3 rd ed., Raghavan D, Brecher ML, Johnson DH, Meropol NJ, Moots PL, Rose PG, Mayer IA (eds.), John Wiley and Sons Ltd. 2006, DOI: 10.1002/0470030542.ch48 (Chapter 48: Rare Leukemias, by Pawarode A, Baer MR). 335

6. FLOW CYTOMETRY OF HEMATOLOGICAL MALIGNANCIES, Ortolani C (ed.), Wiley-Blackwell, 2011, ISBN 978-1-4443-3588-0 (Ref 785, p.281). 7. Diagnostica Citometrica Delle Neoplasie Ematologiche, Ortolani C, 2002. 8. UpToDate (www.uptodate.com ) 2011, version 15.1 (Κεφάλαιο : Freedman AS, Friedberg JW: Initial treatment of mantle cell lymphoma, Last update 07.04.2011, συνεχίζεται έως σήµερα ). 9. Petroianu A: The spleen. 2011, Elsevier Inc. ISBN: 978-160805082-6 (Chapter: Vaiphei K. Histology and histopathology of the spleen, pp 37-74, DOI: 10.2174/97816080527381110101). 10. Gatusso P, Reddy VB, David O, Haber MH: Differential diagnosis in surgical pathology. 2010, Elsevier Inc. ISBN: 978-141604580-9 (Chapter: Orazi A, Czader M. Spleen, pp 791-835, DOI: 10.1016/B978-1-4160-4580-9.00015-0).

B. Citations from Journals Α/Α Όνοµα Συγγραφέως Περιοδικό Τόµος Σελίδα Έτος 1 Thieblemont C Lancet Oncol 4 95 2003 2 Antonucci F Electrophoresis 24 2376 2003 3 Korkolopoulou P Leukemia 18 1347 2004 4 Rajendran J Cancer Biother Radio 19 738 2004 5 Puerto IM Haema 7 104 2004 6 Pangalis GA Hematology 10(S1) 6 2005 7 Medeiros JL Leuk Res 30 497 2006 8 Pangalis GA Turkish J Hematol 23 54 2006 9 Altintas A Ulusl Hematol Onkol Derg 16 211 2006 10 Lefebvre C Hum Pathol 38 660 2007 11 Vijayakumar V Applied Radiol 36 38 2007 12 Ferrer A Ann Oncol 19 135 2008 13 Jares P Br J Haematol 142 149 2008 14 Doger FK Turk Klin Tip Bil Derg 29 1463 2009 15 Kraus TS Am J Clin Pathol 134 271 2010 16 Iannitto E Blood 117 2585 2011 17 Rule SAJ J Clin Oncol 29 437 2011 18 Na varro A Ann Oncol 22(S4) 32 2011 19 Navarro A Semin Hematol 48 155 2011 20 Kimura Y Cancer Sci 102 1734 2011 21 Sachanas S Leuk Lymphoma 52 387 2011 22 Tumyan GS OHKO ΓΕΜΑΤΟΛΟΓ HR 3 10 2010 23 Altindas A Int J Hematol Oncol 16 211 2006 24 Carulli G J M ed Case Rep 5 # 476 2011 25 Royo C Leukemia 26 1895 2012 26 Shah BD Cancer Control 19 227 2012 27 Iannitto E Hematology Educ EHA 17 6 429 2012 28 Jares P J Clin Invest 122 3416 2012 29 Caballero D Ann Hematol 92 1151 2013 30 Hsi E Leuk Lymphoma 2013 31 Kanellopoulos A Int J Hematol 99 777 2014 32 Chen Y Br J Haematol 167 3 2014 33 Chovancova J Cytometry Part B: Clin 28 Nov 2014 34 Bouabdallah K Libertas Acad 5 1 2015

• PANGALIS GA, SIAKANTARIS MP, ANGELOPOULOU MK , VASSILAKOPOULOS TP, DIMOPOULOU MN, KYRTSONIS MC, 336

KONSTANTOPOULOS K, TSAFTARIDIS P, VAIOPOULOS GA, KONTOPIDOU FN. Downstaging Rai Stage III B-Chronic Lymphocytic Leukemia Patients With The Administration Of Recombinant Human Erythropoietin. Haematologica. 87:500-6, 2002 Α. Citations from Books, Medical sites and other Literature 1. ANAEMIA IN CANCER, Bokemeyer C & Ludwig H eds., ESO Scientific Updates Vol.6, Elsevier Science B.V., 2001, ISBN 0-444-509046, Amsterdam (Chapter: Overview of clinical trials on rHuEPO in cancer patients, by Ludwig H, Fritz E, pp 115-143). 2. ANAEMIA MANAGEMENT: Select, Support, Succeed, Satelite Symposium at the 8 th International Conference on Malignant Lymphoma, Lugano, Switzerland, F. Hoffmann-La Roche Ltd Pharmaceuticals, 2002, CH-4070 Basel, (Chapter: Can anaemia management improve survival? by Glaspy J, pp 6-8). 3. Living Stronger, Living Longer? Optimizing the management of patients with hematologic malignancies and myelodysplasia. Symposium Abstracts at the 7th Meeting of the European Hematology Association, Florence 2002 (Chapter: Anemia: Impact on quality of life and survival, by Degos L, pp 4). 4. Living Stronger, Living Longer? Optimizing the management of patients with hematologic malignancies and myelodysplasia. Symposium Abstracts at the 7th Meeting of the European Hematology Association, Florence 2002 (Chapter: Effects of Epoetin alfa on progression of chronic lymphocytic leukemia, by Pangalis GA, pp 8). 5. Anemia of chronic disease, Weiss G, Gordeuk VR, Hershko C (eds.), CRC Press Taylor & Francis Group, 2005, ISBN-10: 0-8247-5972-9, ISBN-13: 978- 0-8247-5972-8, (Chapter 18: Positive effects of correction of anemia in malignant diseases, by Pohl G, Ludwig H, pp. 489-558). 6. WILLIAMS HEMATOLOGY, 7 th ed., Lichtman MA, Beutler E, Kipps TJ, Seligsohn U, Kaushansky K, Prchal JT eds., McGraw Hill, 2006, ISBN 0-07- 143591-3 (Chapter 92: Chronic Lymphocytic Leukemia and Related Disorders, by Kipps TJ, pp1343-1383). 7. Ανίχνευση και χαρακτηρισµός γονιδίων στην χρωµοσωµική περιοχή ελλείψεων 13q14 που παρατηρείται σε ασθενείς µε χρόνια λεµφογενή λευχαιµία . Ελισσάβετ Βερβεσσού , ∆ιδακτορική ∆ιατριβή , Ιατρική Σχολή Εθνικού και Καποδιστριακού Πανεπιστηµίου Αθηνών , Αθήνα , Μάιος 2007. 8. ΑΙΜΑΤΟΛΟΓΙΑ ΣΤΗΝ ΚΛΙΝΙΚΗ ΠΡΑΞΗ , Πάγκαλης ΓΑ , Εκδόσεις Π.Χ. Πασχαλίδης , Αθήνα 2008, ISBN 978-960-399-776-4 ( Κεφ . 32: Χρονία Λεµφογενής Λευχαιµία , σελ . 583-602). 9. ΕΣΩΤΕΡΙΚΗ ΠΑΘΟΛΟΓΙΑ , από το ∆ιδακτικό και Επιστηµονικό Προσωπικό του Τοµέως Παθολογίας , Εκδόσεις ΠΑΣΧΑΛΙ∆Η , 2 η Έκδοση , 2010, ISBN 978-960-399-951-5, Αθήνα ( Κεφάλαιο : Θ. Βασιλακόπουλος , Μ. Αγγελοπούλου , Μ. Σιακαντάρη , Γ. Πάγκαλης ,Χ. Κυρτσώνη , Σ. Κοκόρη , Χ. Καλπαδάκη , Φ. Κοντοπίδου , Ε. ∆ηµητριάδου , Μ. ∆ηµοπούλου : Κακοήθη λεµφώµατα και χρόνια λεµφογενής λευχαιµία . σελ . 1386-1403).

B. Citations from Journals Α/Α Όνοµα Συγγραφέως Περιοδικό Τόµος Σελίδα Έτος 1 Pangalis GA Hematol Oncol 20 103 2002 2 Samol J Br J Haematol 121 3 2003 337

3 Cazzola M Haematologica 88 601 2003 4 Johnson AJ Curr Opin Hematol 10 297 2003 5 Cazzola M Br J Haematol 122 386 2003 6 Hartley C Br J Haematol 122 623 2003 7 Remacha Sevilla AF Hem Citok Immun Ter 6 149 2003 8 Schneider M Cancer Futures 2 141 2003 9 Leporrier M Haematologica 88 1321 2003 10 Byrd JC Proc ASCO 94 2003 11 Mittelman M Eur J Haematol 72 155 2004 12 Van Belle SJP EJC 2 11 2004 13 Wendtner CM Semin Hematol 41 224 2004 14 Bokemeyer C Eur J Cancer 40 2201 2004 15 Hudis CA Oncologist 9 (S5) 55 2004 16 Anonymous Haematologica 89 1419 2004 17 Van den Neste E Ann Hematol 83 356 2004 18 Milano M J Pharm Clin 24 11 2005 19 Velenik V Radiol Oncol 39 133 2005 20 Molica S Leuk Lymphoma 46 1709 2005 21 Heuser M Ann Hematol 85 69 2006 22 Oster HS Isr Med Assoc J 8 703 2006 23 Milano M Crit Rev Oncol/Hematol 62 119 2007 24 Wilson J Health Technol Asses 11 1 2007 25 De Gaona ER Rev M ed Univ Navarra 51 3 2007 26 Birgegard G Ther Clin Risk Manag 4 527 2008 27 Tzoura E Arch Hellen Med 25 60 2008 28 Fonseca PJ Clin Transl Oncol 10 426 2008 29 Molica S Cancer Management 3 211 2011 and Research

• VASSILAKOPOULOS TP, NADALI G, ANGELOPOULOU MK , SIAKANTARIS MP, DIMOPOULOU MN, KONTOPIDOU FN, KOKORIS SI, GIANNAKAKIS A, KYRTSONIS M-C, TSAFTARIDIS P, KITTAS C, PIZZOLO G, PANGALIS GA.

The Prognostic Significance Of Β2-Microglobulin In Patients With Hodgkin’s Lymphoma. Haematologica 87:701-8; discussion 708, 2002 Α. Citations from Books, Medical sites and other Literature 1. Βιολογικοί Παράγοντες και Κλινικά Χαρακτηριστικά κατά τη ∆ιάγνωση και Υποτροπή του Λεµφώµατος Hodgkin: Συσχετίσεις και Προγνωστική Σηµασία . Θεόδωρος Π. Βασιλακόπουλος , ∆ιδακτορική ∆ιατριβή , Ιατρική Σχολή Εθνικού και Καποδιστριακού Πανεπιστηµίου Αθηνών , Αθήνα , Μάρτιος 2004. 2. Hodgkin Lymphoma, Hoppe RT, Mauch PT, Armitage JO, Diehl V, Weiss LM (eds.), Wolters Kluwer Health; Lippincott Williams & Wilkins, Philadelphia, 2007, ISBN-13: 978-0-7817-6422-3; ISBN-10: 0-7817-6422-X (Chapter 12: Prognostic factors in Hodgkin Lymphoma, by Specht L, Hasenclever D, pp 157-174). 3. Prognosis in advanced cancer, Glare P, Christakis NA (eds.), Oxford University Press, 2008, ISBN: 978-0-19-853022-0 (Chapter 19: Non- Hodgkin’s Lymphoma, by Dymontet C and Thieblemont C, pp 215-224). 338

4. Hodgkin Lymphoma, Engert A, Horning SJ (eds.), Springer-Verlag, Berlin- Heidelberg, 2011, ISBN: 978-3-642-12779-3; eISBN: 978-3-642-12780-9 (Chapter: Prognostic Factors, by Specht L, Hasenclever D, pp 97-115). 5. Susanne Muller. Thesis: Frühzeitige Beurteilung der Wirksamkeit einer Chemotherapie bei Patienten mit Lymphomen und akuter myeloischer Leukämie durch zirkulierende Nukleosomen. Universitat Munchen, 2008. 6. Hodgkin Lymphoma: A comprehensive overview, Engert A, Younes A (eds.), Springer International Publishing, 2015, ISBN: 978-3-319-12504-6; eISBN: 978-3-319-12505-3 (Chapter: Prognostic Factors, by Specht L, Hasenclever D, pp 131-155, DOI: 10.1007/978-3-319-12505-3_8).

B. Citations from Journals Α/Α Όνοµα Συγγραφέως Περιοδικό Τόµος Σελίδα Έτος 1 Vassilakopoulos TP Eur J Haem atol 68 289 2002 2 Herling M Clin Cancer Res 9 2114 2003 3 Vassilakopoulos TP Int J Radiat Oncol Biol Phys 59 765 2004 4 Vassilakopoulos TP Haema 7 147 2004 5 Visco C Leuk Lymphoma 45 2085 2004 6 Vassilakopoulos TP J BUON 10 59 2005 7 Qian Xuxiao Chi nese J Hematol 26 444 2005 8 Vassilakopoulos TP Anticancer Res 25 4743 2005 9 Vassilakopoulos TP Haematologica 91 32 2006 10 Gonzalez Cao M Anticancer Res 27 595 2007 11 Wood L Transf Apher Sci 37 93 2007 12 Doussis -Anagnostopoulou IA Clin Cancer Res 14 1759 2008 13 Matsushita K Blood 112 2272 2008 14 Itoh K Int J Hematol 91 446 2010 15 Chin J Hemorheology 20 2010* 16 Cen Haiyan Chin J Postgrad Med 30 2007 17 Qian X J Leuk Lymphoma 3 27 2006 18 Zheng Jia J Modern Oncol 15 700 2007 19 Clin Fo cus 2 883 2008 20 Marnerides A Anticancer Res 31 3585 2011 21 Rossi M Acta Radiologica 52 995 2011 22 Dimou M Leuk Lymphoma 53 1481 2012 23 Carlena NR Informa Medico 14 153 2012 24 Πάγκαλης ΓΑ ΑΙΜΑ 3 203 2012 25 Βασιλακόπουλος ΘΠ ΑΙΜΑ 3 212 2012 26 Cuccaro A Med J Hematol Infect Dis 6 E20140 2014 27 Nakajima Y Med Oncol 21 Aug 2014 28 Yoo C Blood Res 49 148 2014 29 Georgiadi EC Leuk Lymphoma 56 748 2015

30 Gatt ME Anticancer Res 35 3019 2015

• VASSILAKOPOULOS TP, ANGELOPOULOU MK , SIAKANTARIS MP, KONTOPIDOU FN, DIMOPOULOU MN, KARKANTARIS C, KOKORIS SI, GIANNAKAKIS A, KYRTSONIS M-C, PANGALIS GA. Hodgkin’s Lymphoma In First Relapse Following Chemotherapy Or Combined Modality Therapy: Analysis Of Outcome And Prognostic Factors After Conventional Salvage Therapy. European Journal of Hematology 68:289-98, 2002 339

Α. Citations from Books, Medical sites and other Literature 1. Βιολογικοί Παράγοντες και Κλινικά Χαρακτηριστικά κατά τη ∆ιάγνωση και Υποτροπή του Λεµφώµατος Hodgkin: Συσχετίσεις και Προγνωστική Σηµασία . Θεόδωρος Π. Βασιλακόπουλος , ∆ιδακτορική ∆ιατριβή , Ιατρική Σχολή Εθνικού και Καποδιστριακού Πανεπιστηµίου Αθηνών , Αθήνα , Μάρτιος 2004. 2. http://www.emedicine.com , Oct 3 2005: eMedicine: Instant Access to the Minds of Medicine (Chapter: Lymphomas of the Head and Neck, by Dunleavy KM). 3. www.acpmedicine.com/sam/pdf/medRII.pdf , ACP Medicine, ONCOLOGY: XI Lymphomas pp 1-17, May 2005 (update), 2005 WebMDInc, by Dunleavy K, Wilson WH. 4. Hodgkin Lymphoma, Hoppe RT, Mauch PT, Armitage JO, Diehl V, Weiss LM (eds.), Wolters Kluwer Health; Lippincott Williams & Wilkins, Philadelphia, 2007, ISBN-13: 978-0-7817-6422-3; ISBN-10: 0-7817-6422-X (Chapter 12: Prognostic factors in Hodgkin Lymphoma, by Specht L, Hasenclever D, pp 157-174). 5. ΑΙΜΑΤΟΛΟΓΙΑ ΣΤΗΝ ΚΛΙΝΙΚΗ ΠΡΑΞΗ , Πάγκαλης ΓΑ , Εκδόσεις Π.Χ. Πασχαλίδης , Αθήνα 2008, ISBN 978-960-399-776-4 ( Κεφ . 35: Λέµφωµα Hodgkin, σελ . 615-639). 6. Μονογραφή Της Ηµερίδας Με Θέµα : ‘‘ Λέµφωµα Hodgkin: Πρόσφατες Εξελίξεις ’’ Του Τµήµατος Λεµφοϋπερπλαστικών Νόσων Της Ελληνικής Αιµατολογικής Εταιρίας , Αθήνα , 31 Ιανουαρίου 2009. ( Κεφάλαιο : Λέµφωµα Hodgkin: Θεραπεία περιορισµένων σταδίων . Βασιλακόπουλος ΘΠ , Αγγελοπούλου ΜΚ , Πάγκαλης ΓΑ , σελ . 29-39). 7. Μονογραφή Της Ηµερίδας Με Θέµα : ‘‘ Λέµφωµα Hodgkin: Πρόσφατες Εξελίξεις ’’ Του Τµήµατος Λεµφοϋπερπλαστικών Νόσων Της Ελληνικής Αιµατολογικής Εταιρίας , Αθήνα , 31 Ιανουαρίου 2009. ( Κεφάλαιο : Θεραπεία διάσωσης στο λέµφωµα Hodgkin. Αγγελοπούλου ΜΚ , Βασιλακόπουλος ΘΠ , Πάγκαλης ΓΑ , σελ . 40-51).

B. Citations from Journals Α/Α Όνοµα Συγγραφέως Περιοδικό Τόµος Σελίδα Έτος 1 Vassilakopoulos TP Haematologica 87 701 2002 2 Balzarroti M Rev Cancer 17 164 2003 3 Vassilakopoulos TP Haema 7 147 2004 4 Vassilakopoulos TP Haema 7(S1) 53 2004 5 Βασιλακόπουλος Θ Haema Συµπλ 137 2004 6 Soni S Oncology -Basel 68 314 2005 7 Vassilakopoulos TP Haema 10 (S2) 90 2007 340

8 Βασιλακόπουλος ΘΠ Haema 12 (S2) 169 2009 9 Vassilakopoulos TP Semin Hematol 50 4 2013 10 Βασιλακόπουλος ΘΠ ΑΙΜΑ 3 212 2012 11 Αγγελοπούλου ΜΚ ΑΙΜΑ 3 239 2012 12 Kanellopoulos A Arch Hellen Med 30 647 2013 13 Dimtsas GS Leuk Lymphoma 55 558 2014

• PANGALIS GA, VASSILAKOPOULOS THP, SIAKANTARIS MP, DIMOPOULOU MN, KONTOPIDOU FN, ANGELOPOULOU MK . B-Chronic Lymphocytic Leukemia In The Year 2001. Practical Aspects. Hematological Oncology 20:103-46, 2002. Α. Citations from Books, Medical sites and other Literature 1. ΠΑΘΟΛΟΓΙΑ , Χατζηγιάννης Σ, Μαυρικάκης Μ, Μουντοκαλάκης Θ, Νανά - Αναστασίου Μ, Πάγκαλης ΓΑ , Παπαδογιάννης ∆, Χαλεβελάκης Γ, από το ∆ιδακτικό και Επιστηµονικό Προσωπικό του Τοµέως Παθολογίας , Εκδόσεις ΠΑΣΧΑΛΙ∆Η , 2002, ISBN 960-399-053-1, Αθήνα ( Κεφάλαιο : Πάγκαλης ΓΑ , Βασιλακόπουλος ΘΠ , ∆ηµοπούλου ΜΝ , Σιακαντάρη ΜΠ , Aγγελοπούλου ΜΚ : Κακοήθη λεµφώµατα και χρονία λεµφογενής λευχαιµία . σελ . 1289-1301). 2. Κλινική , Ανοσολογική και Μοριακή Μελέτη του Επιθηλιοτροπισµού και της ∆ιασποράς Λεµφοκυττάρων σε Ασθενείς µε Χρονία Λεµφογενή Λευχαιµία και Χαµηλής Κακοηθείας Λεµφώµατα τύπου MALT. Μαρίνα Π. Σιακαντάρη , ∆ιδακτορική ∆ιατριβή , Ιατρική Σχολή Εθνικού και Καποδιστριακού Πανεπιστηµίου Αθηνών , Αθήνα , Ιούλιος 2003. 3. www.biochem.emory.edu/classes/ibs522/Cunningham%20doc.pdf , Leslie Cunningham: Mechanism of Tcl1 induced Oncogenesis, 30/04/2003. 4. www.puo.pl/ksiazka/choroby_rozrostowe_ukl_krw.pdf , Konopka L, Bieniaszewska M, et al: Choroby rozrostowe ukladu krwiotworczg, pp. 413-468. 5. www.tdx.cesca.es/TESIS_UB/AVAILABLE/TDX-0919105- 115247/ BLOCK_3.pdf 6. www.bvs.sld.cu/revistas/hih/vol20_1_04/hih01104.htm , de la C. Sanchez Segura M, Marsan Suarez V, Socarras BB, Martinez Machado M : Leucemia linfoide cronica-B. Aspectos immunitarios y moleculares ; Rev Cubana Hematol Immunol Hemoter 2004 ; 20 (1), Approved 2 Feb 2004. 7. Internet: Cantero AM, Perez YLT, Naranjo YA, Naranjo YA. Las celulas NK como paradigma histologico. Principales, alterationes y perspectivas. Revision Bibliographica. ‘’Carlos J. Finlay’’. 8. Μελέτη κλωνικότητος σε ασθενείς µε χρόνια λεµφογενή λευχαιµία και συσχέτιση µε κλινικά και βιολογικά δεδοµένα . Ευαγγελία Μ. ∆ηµητριάδου , ∆ιδακτορική ∆ιατριβή , Ιατρική Σχολή Εθνικού και Καποδιστριακού Πανεπιστηµίου Αθηνών , Αθήνα , Μάιος 2007. 9. The Interface of Neurology and Internal Medicine. Biller J (eds.), Wolters Kluwer Health; Lippincott Williams & Wilkins, Philadelphia, 2008, ISBN-13: 978-0-7817- 7906-7 (Chapter 53: Lymphoproliferative Disorders, by Ko MY, Messmore HL, pp 341-346). 10. ΑΙΜΑΤΟΛΟΓΙΑ ΣΤΗΝ ΚΛΙΝΙΚΗ ΠΡΑΞΗ , Πάγκαλης ΓΑ , Εκδόσεις Π.Χ. Πασχαλίδης , Αθήνα 2008, ISBN 978-960-399-776-4 ( Κεφ . 32: Χρονία Λεµφογενής Λευχαιµία , σελ . 583-602). 11. REICHEL’S Care of the elderly: Clinical Aspects of Aging, 6 th edition. Aranson C, Busby-Whitehead J, Brummel-Smith K, O’Brien JG, Palmer MH, Reichel W (eds.), Cambridge University Press, 2009, ISBN 978-0-521-86929-4 (Chapter 35: 341

Anemia and other hematological problems of the elderly, by Sheyner I, Travis Stover K, pp 380-391). 12. ΕΣΩΤΕΡΙΚΗ ΠΑΘΟΛΟΓΙΑ , από το ∆ιδακτικό και Επιστηµονικό Προσωπικό του Τοµέως Παθολογίας , Εκδόσεις ΠΑΣΧΑΛΙ∆Η , 2 η Έκδοση , 2010, ISBN 978-960- 399-951-5, Αθήνα ( Κεφάλαιο : Θ. Βασιλακόπουλος , Μ. Αγγελοπούλου , Μ. Σιακαντάρη , Γ. Πάγκαλης ,Χ. Κυρτσώνη , Σ. Κοκόρη , Χ. Καλπαδάκη , Φ. Κοντοπίδου , Ε. ∆ηµητριάδου , Μ. ∆ηµοπούλου : Κακοήθη λεµφώµατα και χρόνια λεµφογενής λευχαιµία . σελ . 1386-1403). 13. Sheila Aparecida Coelho Siqueira. Thesis: Contribuicao da imuno-histoquimica para a classificacao dos linfomas de pequenas celulas B. Sao Paulo 2005. 14. Alessio Montresor. Thesis: Comparative analysis of normal versus CLL B- lymphocytes reveals patient-specific variability in signaling messages controlling LFA-1 activation by chemokines. Universita Degli Studi di Verona, 2004. 15. CANCER REHABILITATION: Principles and Practice. Stubblefield MD (ed.). 2009. (Chapter: Evaluation and treatment of leukemia and myelodysplasia, by Landau HJ, Nimmer SD, pp 253-266). 16. Hind Abdulrazak Yassin Abdulmajed. Thesis: Identification of tumor associated antigens as potential targets for the immunotherapy of B-cell chronic lymphocytic leukemia (B-CLL). University of Leicester, 2008. 17. Hempsch Birgit. Thesis: Experimentelle therapie der Chronischen lymphatischen leukamie vom B-zell-typ (B-CLL) mit den small molecule-inhibitoren CGP 049090 und PKF 115-584. Universitat zu Koln, 2009. 18. Cantero AM. Revision Bibliografica: Las celulas NK como paradigma histologico. Principales alteraciones y perpespectivas terapeuticas. Instituto Superior de Ciencias Medicas “Carlos Finlay”, 2005. 19. Fernandez Pasqual Veronica. Thesis: Analisi dels macanismes moleculars implicats en el desenvolupament I progression dels limfomes de cellula B petita. Universitat De Barcelona, 2008. 20. Daniel Iglesias i Serret. Thesis: Control de proteines reguladores de l’ apoptosis en cellules leukemiques. Universitat De Barcelona, 2005. 21. Monica Ulrike Patz. Thesis: Der einfluss von cAMP-erhohenden substanzen und antidepressiva auf apoptoseinduktion bei chronischer lymphatischer B-zell leukamie. Universitat Munchen, 2006. 22. Hettich Eva. Thesis: Etablierung einer optimierten helferzelllinie zum Genvektortransfer in humane B-zellen. Universitat Munchen, 2006.

B. Citations from Journals Α/Α Όνοµα Συγγραφέως Περιοδικό Τόµος Σελίδα Έτος 1 Pangalis GA Haematologica 87 500 2002 2 Kusenda J Neoplasma 51 97 2004 3 Aoun P Leuk Lymphoma 45 1595 2004 4 Ziakas Am J Hematol 76 271 2004 5 Tsatalas C Acta Haematologica 112 136 2004 6 Kometani K Trends Mol Med 10 401 2004 7 Hu XJ J Biol Chem 280 9498 2005 8 Alvi AJ Blood 105 4484 2005 9 Sindelarova L Canc er Genet Cytogen 160 27 2005 10 Secchiero P J Cell Physiol 205 246 2005 11 Secchiero P Am J Pathol 167 599 2005 12 Alzamora MG Onkologie 29 153 2006 13 Ishida D Immunity 24 417 2006 14 Ryan EP Clin Immunol 120 76 2006 15 Yee KWL Mayo Clin Proc 81 110 5 2006 16 Lorand -Metze I Rev Bras Hematol Hemoter 28 1 2006 342

17 Palma M Ann Oncol 17 144 2006 18 Redondo -Munoz J Blood 108 3143 2006 19 Farsangi MH Leuk Lymphoma 48 109 2007 20 Uckun FM Anti -Cancer Agent Med Chem 7 624 2007 21 Uckun FM Int Rev I mmunol 27 43 2008 22 Tomenendelova J Vet Med 53 564 2008 23 Tomenendelova J Acta Veterin Brno 77 595 2008 24 Tsopra O Acta Haematol 121 187 2009 25 Horvath E Rom J Morph Embryol 50 399 2009 26 Montresor A Cancer Res 69 9281 2009 27 Kokhaee P Koomesh 9 1 2007 28 Mohammed MS N Iraq J Med 6 6 2010 29 Gombelmann D Deutsche Med Wochen 136 2503 2011 30 Lakoumentas J Comp Meth Prog Biomed 108 158 2012 31 Charak S Int J Biol Macromol 51 406 2012 32 Wasik -Szczepanek E Acta Hematol Polon 43 146 2012 33 Te imori H Iran Red Cresc Med J 15 2013 34 O’ Cruz Onco Targets Ther 6 161 2013 35 Sachanas S Leuk Lymphoma 55 571 2013

• RASSIDAKIS GZ, MEDEIROS LJ, VIVIANI S, BONFANTE V, NADALI G-P, VASSILAKOPOULOS TP, HERLING M, ANGELOPOULOU MK , GIARDINI R, CHILOSI M, KITTAS C, MCDONNELL TJ, BONNADONA G, GIANNI M, PIZZOLO G, PANGALIS GA, CABANILLAS F, SARRIS AH. BCL-2 Expression In Hodgkin And Reed-Sternberg Cells Of Classical Hodgkin’s Disease Predicts A Poorer Prognosis In Patients Treated With ABVD Or Equivalent Regimens. Blood 100:3935-41, 2002 Α. Citations from Books, Medical sites and other Literature 1. UpToDate ( www.uptodate.com ) ( Κεφάλαιο : Canellos GP and Mauch PM: Clinical features of and prognostic factors for relapse of Hodgkin’s disease after initial chemotherapy, last updated 15.04.2010, συνεχίζεται έως σήµερα ). 2. Neoplastic diseases of the blood, Wiernik PH, Goldman JM, Dutcher JP, Kyle RA eds., Cambridge University Press, 2003, ISBN 0-521-79136-7 (Chapter: Immunology of the lymphomas, by Parikh R, Ozer H, pp 745). 3. Βιολογικοί Παράγοντες και Κλινικά Χαρακτηριστικά κατά τη ∆ιάγνωση και Υποτροπή του Λεµφώµατος Hodgkin: Συσχετίσεις και Προγνωστική Σηµασία . Θεόδωρος Π. Βασιλακόπουλος , ∆ιδακτορική ∆ιατριβή , Ιατρική Σχολή Εθνικού και Καποδιστριακού Πανεπιστηµίου Αθηνών , Αθήνα , Μάρτιος 2004. 4. WILLIAMS HEMATOLOGY, 7 th ed., Lichtman MA, Beutler E, Kipps TJ, Seligsohn U, Kaushansky K, Prchal JT eds., McGraw Hill, 2006, ISBN 0-07- 143591-3 (Chapter 97: Hodgkin Lymphoma, by Horning SJ, pp1461-1482). 5. Pracchia LF: Significado prognostico dos graus histologicos do linfoma de Hodgkin tipo esclerose nodular. Dissertacao (mestrado): Faculdade de Medicina da Universidade de Sao Paolo. Sao Paolo 2005. 6. Pracchia LF: Significado prognostico da epressao da proteina bcl-2 no linfoma de Hodgkin tipo predominancia linfocitaria nodular. Projeto: 343

Faculdade de Medicina da Universidade de Sao Paolo. Disciplina Ciclo Celular. Sao Paolo 2005. 7. Βασιλακόπουλος Θ, Σαρρής Α: Λέµφωµα Hodgkin: Εξελίξεις στην βιολογία και θεραπεία . Στο : ΕΞΕΛΙΞΕΙΣ ΣΤΗΝ ΠΑΘΟΛΟΓΙΑ . Νεώτερες απόψεις στη διάγνωση και θεραπεία . Σεϊτανίδης Β, Γεωργιλής Κ, Αποστολάκης Ι. Έκδοση του ∆ιαγνωστικού και Θεραπευτικού Κέντρου Αθηνών ΥΓΕΙΑ , σελ . 17-31, 2006. 8. The MD Anderson Manual of Medical Oncology. Kantarjian HM, Wolff RA, Koller CA (eds). McGraw-Hill Companies Inc. 2006, ISBN 0-07-141499-1 (Chapter 7: Hodgkin’s disease, by Shi GG, Medeiros LJ, Hagemeister FB), p.167. 9. ∆ιερεύνηση της ιστογένεσης του Reed-Sternberg κυττάρου στην κλασική νόσο Hodgkin και συσχέτιση µε βιολογικούς δείκτες . Σερένα Βαλσάµη , ∆ιδακτορική ∆ιατριβή , Ιατρική Σχολή Εθνικού και Καποδιστριακού Πανεπιστηµίου Αθηνών , Αθήνα , Σεπτέµβριος 2007. 10. Αγγειογένεση στο λέµφωµα Hodgkin: Μορφοµετική µελέτη και προγνωστική σηµασία επί 286 ασθενών . Ειρήνη Α. Θυµαρά . ∆ιδακτορική ∆ιατριβή , Ιατρική Σχολή Εθνικού και Καποδιστριακού Πανεπιστηµίου Αθηνών , Αθήνα , 2008. 11. The Chemotherapy Source Book, 4 th Edition. Perry MC (ed.), Wolters Kluwer Health; Lippincott Williams & Wilkins, Philadelphia, 2008, ISBN-13: 978-0- 7817-7328-7; ISBN-10: 0-7817-7328-8 (Chapter 42: Chemotherapy of Hodgkin’s Lymphoma, by Peterson BA, pp 499-517). 12. Έκφραση των Πρωτεϊνών bcl-2, bax, bcl-x και fas-ligand στη νόσο Hodgkin. Συσχέτιση µε την έκφραση της πρωτεϊνης p53, την παρουσία του ιού EBV και κλινικοεργαστηριακές παραµέτρους . Ηλίας ∆ράκος , ∆ιδακτορική ∆ιατριβή , Ιατρική Σχολή Εθνικού και Καποδιστριακού Πανεπιστηµίου Αθηνών , Αθήνα , Ιούνιος 2008. 13. ΑΙΜΑΤΟΛΟΓΙΑ ΣΤΗΝ ΚΛΙΝΙΚΗ ΠΡΑΞΗ , Πάγκαλης ΓΑ , Εκδόσεις Π.Χ. Πασχαλίδης , Αθήνα 2008, ISBN 978-960-399-776-4 ( Κεφ . 35: Λέµφωµα Hodgkin, σελ . 615-639). 14. ATLAS OF DIFFERENTIAL DIAGNOSIS IN NEOPLASTIC HEMATOPATHOLOGY, 2 nd Edition, by Gorczyca W and Emmons FN, Informa UK Ltd., 2008, ISBN-10: 0 415 46185 5, ISBN-13: 978-0-415-46185- 6 (backmatter). 15. ΕΣΩΤΕΡΙΚΗ ΠΑΘΟΛΟΓΙΑ , από το ∆ιδακτικό και Επιστηµονικό Προσωπικό του Τοµέως Παθολογίας , Εκδόσεις ΠΑΣΧΑΛΙ∆Η , 2 η Έκδοση , 2010, ISBN 978-960-399-951-5, Αθήνα ( Κεφάλαιο : Θ. Βασιλακόπουλος , Μ. Αγγελοπούλου , Μ. Σιακαντάρη , Γ. Πάγκαλης ,Χ. Κυρτσώνη , Σ. Κοκόρη , Χ. Καλπαδάκη , Φ. Κοντοπίδου , Ε. ∆ηµητριάδου , Μ. ∆ηµοπούλου : Κακοήθη λεµφώµατα και χρόνια λεµφογενής λευχαιµία . σελ . 1386-1403). 16. Hussong JW, Arber DA, Bradley KT, Brown MS, Chang CC, de Baca ME, Ellis DW, Foucar K, His ED, Jaffe ES, Lill M, McClure MP, Medeiros JL, Perkins SL. Protocol for the examination of specimens from patients with Hodgkin lymphoma. Based on AJCC/UICC TNM 7 th Edition. Protocol web posting date: October 2009. 17. Hodgkin Lymphoma (???). (Chapter 2: Advances in classical Hodgkin Lymphoma Biology, by Sanchez-Espiridion B et al, pp. 29-46), identified through googlescholar, 2012. 18. Hodgkin Lymphoma (???). (Chapter 4: Hodgkin’s Lymphoma: From tumor microenvironment to immunotherapeutic approach – Body’s own power protection challenges, by Lejeune M et al, pp. 63-110), identified through googlescholar, 2012. 19. Neoplastic Diseases of the Blood, Wiernik PH et al (eds.), Springer Science+Business Media, New York, 2013, DOI 10.1007/978-1-4614-3764- 344

2_42 (Chapter 42: Pathology of non-Hodgkin’s and Hodgkin’s Lymphomas, by Medeiros LJ, pp 867-918). 20. Miranda RN et al. Atlas of Lymph Node Pathology , Atlas of Anatomic Pathology, 363. DOI 10.1007/978-1-4614-7959-8_71, Springer Science +Business Media New York 2013 (Chapter 71: Nodular Sclerosis Hodgkin Lymphoma, pp 363-368). 21. Miranda RN et al. Atlas of Lymph Node Pathology , Atlas of Anatomic Pathology, DOI 10.1007/978-1-4614-7959-8_72, Springer Science +Business Media New York 2013 (Chapter 72: Lymphocyte-Rich Classical Hodgkin Lymphoma, pp 369-372). 22. Miranda RN et al. Atlas of Lymph Node Pathology , Atlas of Anatomic Pathology, DOI 10.1007/978-1-4614-7959-8_73, Springer Science +Business Media New York 2013 (Chapter 73: Mixed Cellularity Hodgkin Lymphoma, pp 373-376). 23. Miranda RN et al. Atlas of Lymph Node Pathology , Atlas of Anatomic Pathology, DOI 10.1007/978-1-4614-7959-8_74, Springer Science +Business Media New York 2013 (Chapter 74: Lymphocyte-Depleted Hodgkin Lymphoma, pp 377-380).

B. Citations from Journals Α/Α Όνοµα Συγγραφέως Περιοδικό Τόµος Σελίδα Έτος 1 Manion MK Cancer Biol Ther 2 105 2003 2 Gonzales-Baron M Rev Cancer 17 143 2003 3 Montalban C Hem Citok Immun Ter Cel 6 9 2003 4 Vassilakopoulos TP Int J Radiat Oncol Biol Phys 59 765 2004 5 Vassilakopoulos TP Haema 7 147 2004 6 Bueso -Ramos CE Hum Pathol 35 246 2004 7 Debatin KM Oncogene 23 16 2004 8 Montalban C J Clin Oncol 22 1664 2004 9 Lim MS Leuk Lymphoma 45 1329 2004 10 Kaplanov KD Gematol Transfuziol 49 3 2004 11 Visco C Leuk L ymphoma 45 2085 2004 12 Gaulard P Ann Pathol 24 330 2004 13 Vassilakopoulos TP Haema 7(S1) 53 2004 14 Βασιλακόπουλος Θ Haema Συµπλ 137 2004 15 Kim R Cancer 101 2177 2004 16 Garcia JF Hem Citok Immun Ter Cel 7 129 2004 17 Chinese Cancer Res Clin (Chinese) 3 153 2004 18 Chinese Chin J Cancer Prev Treat 11 282 2004 19 Vassilakopoulos TP J BUON 10 59 2005 20 Sup SJ J Clin Oncol 23 3773 2005 21 Korkolopoulou P Leukemia 19 894 2005 22 Claviez A J Clin Oncol 23 4048 2005 23 Nakamura N Virchows Arch 447 53 2005 24 Spector N Leuk Lymphoma 46 1301 2005 25 Hussein MR Cancer Biol Ther 4 324 2005 26 Vassilakopoulos TP Haematologica 91 32 2006 27 Chabay P Appl Immunohisto MM 14 12 2006 28 Sanchez -Aguilera A Blood 108 662 2006 29 Visco C Eur J Haematol 77 387 2006 30 Ohsawa M Leuk Lymphoma 47 1863 2006 31 Tzankov A Pathobiology 73 107 2006 32 Bai M Hum Pathol 38 103 2007 33 Aleman BMP Int J Radiat Oncol Biol Phys 67 19 2007 34 Skommer J Leuk Res 31 277 2007 345

35 Buglio D Exp Rev Anticanc 7 735 2007 36 Diepstra A J Clin Oncol 25 3101 2007 37 Jakovic LR Med Oncol 24 45 2007 38 Vassilakopoulos TP Haema 10 (S2) 90 2007 39 Kelley TW Am J Clin Pathol 128 958 2007 40 Alvaro T Clin Cancer Res 14 685 2008 41 Doussis -Anagnostopoulou IA Clin Cancer Res 14 1759 2008 42 Hsi ED Leuk Lymphoma 49 1668 2008 43 Flangea C Rom J Morphol Embryol 49 357 2008 44 Campos AHJFM Mol Cel Biochem 321 95 2009 45 Lynam -Lennon N Biol Rev 84 55 2009 46 Sanchez -Espiridion B Clin Cancer Res 15 1367 2009 47 Jayanthan A Leuk Lymphoma 50 1174 2009 48 Khaw SL Leuk Lymphoma 50 1069 2009 49 Canellos GP Haemato l Meet Rep 3 115 2009 50 Dinand V Ind J Med Res 130 526 2009 51 Persky DO Appl Immunohist Mol Morph 18 35 2010 52 Gerber HP Biochem Pharmacol 79 1544 2010 53 Barisik NO Diagn Pathol 5 Art 19 2010 54 Takach S Bone Marrow Transplant 45 856 2010 55 Sanc hez -Espiridion B Blood 116 E12 2010 56 Barros MHM Leuk Lymphoma 51 1513 2010 57 Rathore B Exp Opin Pharmacother 11 2891 2010 58 Blum KA Hematology 2010 93 2010 59 Chen Y Mol Carcinogen 50 16 2011 60 Babashah S Eur J Cancer 47 1127 2011 61 Maeda LS Leuk Lymphoma 52 962 2011 62 Marnerides A Anticancer Res 31 3585 2011 63 Derenzini E Genome Med 3 26 2011 64 Greaves WO Hum Pathol 42 1643 2011 65 Li HM J J Univ Med Ed 37 1111 2011 66 Aldinucci D Leuk Lymphoma 53 95 2012 67 Oki Y Blood 119 2171 2012 68 Zygogianni AG J BUON 17 116 2012 69 Montes -Moreno S Modern Pathol 25 968 2012 70 Benharroch D J Cancer 3 322 2012 71 Persengiev SP Disc Med 70 211 2012 72 Greaves W J Hematol Oncol 5 47 2012 73 De la Cruz -Merino L Clin Develop Immunol 756353 201 2 74 Jakovic LR Onkologie 35 733 2012 75 Horton TM Lymphoma ID 341629 2012 76 Vassilakopoulos TP Semin Hematol 50 4 2013 77 Venkataraman G Blood 121 1795 2013 78 Sanchez -Espiridion B Br J Haematol 162 336 2013 79 Campos AH PloS one 8 e74793 2013 80 Βασιλακόπουλος ΘΠ ΑΙΜΑ 3 212 2012 81 King RL Adv Anatom Pathol 21 12 2014 82 Koh YW Mod Pathol 27 1338 2014 83 Cepelova M Cesk Patol 50 40 2014 84 Cuccaro A Med J Hematol Infect Dis 6 E20140 2014 85 Badalica -Petrescu M Fiziologia -Physiology 24 4 20 14 86 Bachegowda LS Future Oncol 10 2509 2014 87 Filatova LV Vopr Onkol 60 625 2014

346

• ZINZANI PL, MARTELLI M, BERTINI M, GIANNI AM, DEVIZZI L, FEDERICO M, PANGALIS G, MICHELS J, ZUCCA E, CANTONETTI M, CORTELAZZO S, WOTHERSPOON A, FERRERI AJ, ZAJA F, LAURIA F, DE RENZO A, LIBERATI MA, FALINI B, BALZAROTTI M, CALDERONI A, ZACCARIA A, GENTILINI P, FATTORI PP, PAVONE E, ANGELOPOULOU MK , ALINARI L, BRUGIATELLI M, DI RENZO N, BONIFAZI F, PILERI SA, CAVALLI F; INTERNATIONAL EXTRANODAL LYMPHOMA STUDY GROUP (IELSG). Induction Chemotherapy Strategies For Primary Mediastinal Large B-Cell Lymphoma With Sclerosis: A Retrospective Multinational Study On 426 Previously Untreated Patients. Haematologica 87:1258-64, 2002. Α. Citations from Books, Medical sites and other Literature 1. Rare Lymphomas. Chapter: Primary Mediastinal Large B Cell Lymphoma by Johnson P, Delabie J, Martelli M, pp: 195-206, publisher: Springer Berlin Heidelberg, 2014. 2. Untersuchungen zur pathogenetischen Funktion des Oberflächenmarkers PDL2 für das PMBL unter Verwendung des retroviralen Gentransfers. ∆ιδακτορική ∆ιατριβή του Buchner G, Max-Delbrück-Centrum für Molekulare Medizin Berlin- Buch und der Medizinischen Klinik mit Schwerpunkt Hämatologie, Onkologie und Tumorimmunologie der Medizinischen Fakultät Charité – Universitätsmedizin Berlin, 2012. 3. Abreu DR. Linfomas No Hodgkin. http://files.sld.cu/oncologia/files/2010/03/linfomas-no-hodgkin.pdf 4. Neoplastic diseases of the Blood. Chapter: Non-Hodgkin Lymphoma of the Childhood by Truong TH, pp:1049-1072, publisher: Springer New York, 2013. 5. Oncologie Thoracique. Chapter: Tumeurs mediastinales by Peters S, pp: 263-281, publisher: Springer Paris , 2011 6. Extranodal Lymphomas. Chapter: Lymphomas of the Female Genital Tract by

Ferry JA, pp: 259-280, Publisher: Elsevier Inc., 2011 . 7. Extranodal Lymphomas. Chapter: Lymphomas of the Thorax by Ferry JA, pp: 81- 132, Publisher: Elsevier Inc., 2011 . 8. Blaustein’s Pathology of the Female Genital Tract by Robert J. Kurman, Lora Hedrick Ellenson, Brigitte M. Ronnett (eds). Chapter: Hematologic Neoplasms and Selected Tumor-Like Lesions Involving the Female Reproductive Organs by Ferry JA, pp:1137, Springer US, ISBN: 978-1-4419-0488-1 347

9. Medical Management of the Thoracic Surgery Patient. Chapter: Masses of the Anterior Mediastinum by Hakim A, pp: 365-384, Publisher: Elsevier Inc., 2010. 10. Rare Hematological Malignancies . Chapter: Rare b-cell lymphomas: Primary mediastinal, intravascular, and primary effusion lymphoma by Savage KJ, pp: 243-264, Publisher: Springer US, 2008. 11. The Lymphomas. Chapter: Principles, Indications, and Techniques of Radiation Therapy of Lymphomas by Yahalom J, pp: 203-224, Publisher: Elsevier Inc, 2006. 12. The Lymphomas. Chapter: Large-Cell Lymphoma, pp: 295-324, Publisher: Elsevier Inc, 2006. 13. Textbook of Uncommon Cancer, Third Edition . Chapter: Rare Lymphomas by Young GAR, pp: 555-568, Publisher: John Wiley & Sons, Ltd, 2006. 14. Cashen, A. F. (2015) Transplantation outcome in primary mediastinal large B- cell lymphoma, in Clinical Guide to Transplantation in Lymphoma (eds B. N. Savani and M. Mohty), John Wiley & Sons, Ltd, Chichester, UK. doi: 10.1002/9781118863282.ch25

B. Citations from Journals Α/Α Όνοµα Συγγραφέως Περιοδικό Τόµος Σελίδα Έτος 1 Soumerai JD Leukemia and Lymphoma 55 538 2014 2 Wilson WH ASCO Post 4 2013 3 Wilson WH ASH Education Book 2013 584 2013 4 Xu L-M International Journal of 85 1289 2013 Radiation Oncology Biology 5 Dunleavy K New England journal of Medicine 368 1408 2013 6 Foppoli M Recenti Progressi in 104 203 2013 Medicina 7 Xu L-M Leukemia and Lymphoma 54 1684 2013 8 Kuper-Hommel, M.J.J. Leukemia and Lymphoma 54 1698 2013 9 Filippi AR International Journal of 87 311 2013 Radiation Oncology Biology 10 Mo CM Int J Hematol Oncol 2 351 2013 11 Verhoef G Belg J Hematol 4 51 2013 12 Юрченк , OB ОНКОЛОГИЯ 15 55 2013 13 Vassilakopoulos Oncologist 17 239 2012 14 Aviles A International Journal of 83 1227 2012 Radiation Oncology Biology 15 Dunleavy K Current Hematologic 7 241 2012 Malignancy Reports 16 Rieger M Ann Oncol 22 664 2011 348

17 Tai WM Leuk Lymphoma 52 604 2011 18 Zelenetz AD JNCCN 9 484 2011 19 Mangasarova YK Gematologiya i 56 18 2011 Transfusiologiya 20 Wang Y-J Journal of Leukemia and 20 317 2011 Lymphoma 21 De Mello CAL Leukemia and Lymphoma 52 1495 2011 22 Kichigina MYu Terapevticheskii Arkhiv 83 38 2011 23 Steidl C Blood 118 2659 2011 24 Zinzani PL Current Oncology Reports 13 407 2011 25 Giza A Hematologia 1 180 2010

26 Tenroller S Arquivos Catarinenses de 39 77 2010 Medicina 27 Kaplanov KD ОНКОГЕМАТОЛОГИЯ 3 144 2010 28 Mangasarova Ya. K ТЕРАПЕВТИЧЕСКИЙ АРХИВ 82 61 2010 29 Coso D Revue de Pneumologie 66 32 2010 Clinique 30 Benéitez V European Journal of Clinical & 2 1 2010 Medical Oncology 31 Ahn HK Int J Hematol 91 456 2010 32 Giza A Hematologia 1 180 2010 33 Setty BA Current Hematologic 5 163 2010 Malignancy Reports 34 Mangasarova YK Terapevticheskii Arkhiv 82 61 2010 35 Poire X Exp Rev Hematol 2 31 2009 36 Zinzani, P.L. Clinical Lymphoma and Myeloma 9 381 2009 37 Walewski, J. Acta Haematologica Polonica 40 125 2009 38 Schnitzer, B. Hematology/Oncology Clinics 23 747 2009 39 Faris, J. Clinical Advances in 7 125 2009 40 Attias, D. Pediatr ic Blood and Cancer 52 566 2009 41 Fietz, T. Annals of Hematology 88 433 2009 42 Hochberg, J. British Journal of Haematology 144 24 2009 43 Johnson PWM ASH Eduction Book 2008 349 2008 44 Rodríguez, J. Hematological Oncology 26 171 2008 45 Martelli, M. Critical Reviews in 68 256 2008 Oncology/Hematology 46 De Sanctis, V. International Journal of 72 1154 2008 47 Van Besien, K. Leukemia and Lymphoma 49 52 2008 48 Mori, A. Clinical and Applied 14 468 2008 Thrombosis/Hemostasis 49 Massoud, M. Leukemia and Lymphoma 49 1510 2008 50 Gleissner, B. Deutsche Medizinische 133 1785 2008 51 Zinzani, P.L. Haematologica 93 1364 2008 52 Reiter, A. British Journal of Haematology 142 329 2008 53 Kuruvilla, J. Leuke mia and Lymphoma 49 1329 2008 54 Rodríguez, J. Leukemia and Lymphoma 49 1050 2008 55 Romagnoli, M. Rassegna di Patologia 23 75 2008 56 Shulman, L.N. New England Journal of 358 513 2008 57 Poletti, V. Progress in Resp iratory 36 307 2007 58 Novoselac, A.V. Community Oncology 4 673 2007 59 Wirth, A. Leukemia and Lymphoma 48 2121 2007 60 Mazzarotto, R. International Journal of 68 823 2007 349

61 Fedorova AS Детская онкология (Pediatric 1 39 2006 Oncology) 62 Mazurok, L.A. Gematologiya i 51 15 2006 63 Hsi, E.D. American Journal of Clinical 125 776 2006 64 Savage, K.J. Oncologist, 11 11 488 2006 65 Poletti, V. Minerva Pneumologic a 45 53 2006 66 Savage, K.J. Annals of Oncology 17 123 2006 67 Dzhumabaeva, B.T. Terapevticheskii Arkhiv 77 78 2005 68 Chilosi, M. Seminars in Respiratory and 26 490 2005 69 Hamlin, P.A. British Journal of Haematolog y 130 691 2005 70 Siracusano, L. American Journal of 78 312 2005 71 Perrotin, C. EMC - Pneumologie 2 33 2005 72 Sekiguchi, N. International Journal of 79 465 2004 73 Todeschini, G. British Journal of Cancer 90 372 2004 74 Pileri, S.A. Leukemia and Lymphoma 44 S21 2003 75 Arcaini L. Haematologica 87 1238 2002 76 Pileri, S.A. Histopathology 41 482 2002 77 Roschewski, M. Leuk Lympho ma 55 2428 2014 78 Wolach O Acta Haematologica 132 279 2014 79 Shi M Am J Surg Path 38 1715 2014 80 Ahn HJ Blood Research 49 36 2014 81 Avigdor A Ann Hematol 93 1297 2014 82 Maeshima, A.M. Pathology International 64 382 2014 83 Aoki T Haematologica 99 1817 2014 84 Dabrowska-Iwanicka, A. , Current Hematologic 9 273 2014 85 Mangasarova, Ya.K. TerapevticheskiiMalignancy Reports Arkhiv 86 53 2014 86 Papageorgiou SG Anticancer Research 34 6717 2014 87 Ferry JA Journal of Hematopathology 7 57 2014 88 Barnes JA Acta Haematologica 131 153 2014 89 Dunleavy K ONCOLOGY (United States) 28 2014 90 Hamlin PA Journal of Clinical Oncology 32 1751 2014 91 Dunleavy K Clinical Cancer Research 20 5182 2014 92 Martelli M Expert Review of 8 173 2015 93 Dunleavy K Blood 125 33 2015 94 Dunleavy K Seminars in Hematology 52 119 2015 95 Pytlik R Leukemia and Lymphoma 56 57 2015 96 Johnson PWM Hematological Oncology 33 (S1) 29 2015 97 Armatys A Acta Haematologica 46 55 2015 98 Nardi V AmJPolonica Hematol 90 529 2015 99 Ćojbaši ć Acta Medica Medianae 53 46 2014 100 R Orlando JOURNAL OF SOUTHERN 7 5 2013 CALIFORNIA CLINICIANS • PANGALIS GA, KYRTSONIS MC, KONTOPIDOU FN, VASSILAKOPOULOS TP, SIAKANTARIS MP, DIMOPOULOU MN, KITTAS C, ANGELOPOULOU MK . Differential Diagnosis Of Waldenstrom's Macroglobulinemia From Other Low- Grade B-Cell Lymphoproliferative Disorders. Seminars in Oncology 30:201-5, 2003 Α. Citations from Books, Medical sites and other Literature 350

1. Flow cytometry and immunohistochemistry for hematologic neoplasms. Tsieh Sun (ed.), Wolters Kluwer Health; Lippincott Williams & Wilkins, Philadelphia, 2007, ISBN-13: 978-0-7817-8400-9; ISBN-10: 0-7817-8400-X, pp 91. 2. ΑΙΜΑΤΟΛΟΓΙΑ ΣΤΗΝ ΚΛΙΝΙΚΗ ΠΡΑΞΗ , Πάγκαλης ΓΑ , Εκδόσεις Π.Χ. Πασχαλίδης , Αθήνα 2008, ISBN 978-960-399-776-4 ( Κεφ . 37: Μη οζώδη λεµφώµατα « χαµηλής κακοηθείας » καθ ’ υπεροχήν λεµφαδενικά , σελ . 659- 665). 3. ΑΙΜΑΤΟΛΟΓΙΑ ΣΤΗΝ ΚΛΙΝΙΚΗ ΠΡΑΞΗ , Πάγκαλης ΓΑ , Εκδόσεις Π.Χ. Πασχαλίδης , Αθήνα 2008, ISBN 978-960-399-776-4 ( Κεφ . 54: Μακροσφαιριναιµία του Waldenstrom, σελ . 815-821). 4. Λεµφώµατα Οριακής Ζώνης . Κλινική και Εργαστηριακή Μελέτη . Χριστίνα Καλπαδάκη , ∆ιδακτορική ∆ιατριβή , Ιατρική Σχολή Εθνικού και Καποδιστριακού Πανεπιστηµίου Αθηνών , Αθήνα , 2008. 5. TEXTBOOK OF UNCOMMON CANCER, 3 rd ed., Raghavan D, Brecher ML, Johnson DH, Meropol NJ, Moots PL, Rose PG, Mayer IA (eds.), John Wiley and Sons Ltd. 2006, DOI: 10.1002/0470030542.ch49 (Chapter 49: Rare Lymphomas, by Young GAR). 6. NEOPLASTIC DISEASES OF THE BLOOD, by Wiernik PH et al. (eds.), Springer Science+Business Media, New York, 2013, DOI 10.1007/978-1- 4614-3764-2_35 (Chapter 35: Waldenstrom’s Macroglobulinemia, by Kastriris E & Dimopoulos MA).

B. Citations from Journals Α/Α Όνοµα Συγγραφέως Περιοδικό Τόµος Σελίδα Έτος 1 Gono T Amyloid 11 130 2004 2 Singhal N J Assoc Phys India 52 981 2004 3 Chun-Xia L Chin J Clin Intern Med 21 550 2004 4 Dimopoulos MA Best Pract Res CL HA 18 747 2005 5 Pangalis GA Clin Lymphom a 5 235 2005 6 Berger F Clin Lymphoma 5 220 2005 7 Hunter ZR Clin Lymphoma 5 246 2005 8 Fen T Haema 8 651 2005 9 Alzamora MG Onkologie 29 153 2006 10 Pangalis GA Haematologica /The HJ 92(6S2) 74 2007 11 Jimenez Vibora E Nefrologia 1 117 2008 12 John son MR Mod Pathol 22 50 2009 13 Ocio EM Clin Lymph Myel Leuk 11 93 2011 14 Vibora EJ Nefrologia 28 116 2008 15 D’Angelo G Blood Res 48 301 2013 16 Levidou G Curr Angiogenesis 2 110 2013 17 Landgren O Leukemia 28 1799 2014 18 Petrikkos L BioMed Res Int 2014 80910 2014

• VASSILAKOPOULOS TP, DOUSSIS-ANAGNOSTOPOULOU I, ANGELOPOULOU MK , SIAKANTARIS MP, KITTAS C, PANGALIS GA. Topoisomerase II α expression in Hodgkin’s lymphoma. Clinical Cancer Research 9:5430-5431, 2003; author reply 5431. 351

Correspondence re: M. Provencio, et al. The topoisomerase IIa expression correlates with survival in patients with advanced Hodgkin's lymphoma. Clin. Cancer Res., 9: 1406-1411, 2003. A. Citations from Books, Medical sites and other Literature 1. Βιολογικοί Παράγοντες και Κλινικά Χαρακτηριστικά κατά τη ∆ιάγνωση και Υποτροπή του Λεµφώµατος Hodgkin: Συσχετίσεις και Προγνωστική Σηµασία . Θεόδωρος Π. Βασιλακόπουλος , ∆ιδακτορική ∆ιατριβή , Ιατρική Σχολή Εθνικού και Καποδιστριακού Πανεπιστηµίου Αθηνών , Αθήνα , Μάρτιος 2004.

B. Citations from Journals Α/Α Όνοµα Συγγραφέως Περιοδικό Τόµος Σελίδα Έτος 1 Vassilakopoulos TP Haema 7 147 2004 2 Korkolopoulou P Leukemia 18 1347 2004 3 Doussis -Anagnostopoulou IA Clin Cancer Res 14 1759 2008

• ANGELOPOULOU MK , NOVELLI E, GROVE JE, RINDER HM, CIVIN C, CHENG L, KRAUSE DS. Cotransplantation Of Human Mesenchymal Stem Cells Enhances Human Myelopoiesis And Megakaryocytopoiesis In NOD/SCID Mice. Experimental Hematology 31:413-20, 2003 Α. Citations from Books, Medical sites and other Literature

1. Radke TF. ∆ιδακτορική ∆ιατριβή µε τίτλο Hämatopoiese-unterstützende Eigenschaften neonataler Stromazellen aus Nabelschnurblut in vitro und in vivo, Heinrich-Heine-Universität Düsseldorf, 2012, http://docserv.uni- duesseldorf.de/servlets

2. Clinical and Experimental Medicine. Chapter: Role of mesenchymal stem cells in leukaemia: Dr. Jekyll or Mr. Hyde? By Wong RSY, published online June 2013, publisher: Springer Milan, 2013, doi: 10.1007/s10238- 013-0247-4, Online ISSN: 1591-9528, Print ISSN1591-8890 352

3. Kuçi, Z. ∆ιδακτορική ∆ιατριβή µε τίτλο Phenotypic and functional characterization of mesenchymal stromal cells generated from human bone marrow CD271+ mononuclear cells. Sveu čilište u Zagrebu, 2011,

http://medlib.mef.hr/id/eprint/1873

4. Stem Cells & Regenerative Medicine. Chapter: Therapeutic applications of mesenchymal stem/multipotent stromal cells by Zhao W, pp:195-218, publisher: Humana Press, 2011. 5. Platelet Proteomics: Principles, Analysis, and Applications . Chapter: Platelet Functional Genomics by Salles, I.I. , O'Connor, M.N , Thijssen- Timmer, D.C , Broos, K , Deckmyn, H , pp: 253-284, Publisher: John Wiley and Sons, 2011. 6. Allogeneic Stem Cell Transplantation. Chapter: The importance of non-human primate models for preclinical studies in hematopoiesis, by Szilagyi E, pp: 767-787, publisher: Humana Press, 2010. 7. Thomas' Hematopoietic Cell Transplantation: Stem Cell Transplantation, Fourth Edition . Chapter: Mesenchymal Stromal Cells and Hematopoietic Cell Transplantation by Horwitz EM, pp : 102-115, Publisher: John Wiley and Sons, 2009. 8. Samuelsson, Håkan. ∆ιαδακτορική διατριβή µε τίτλο : Mesenchymal/stromal stem cells: expansion, engraftment and immune modulation. Karolinska University, 2009, http://openarchive.ki.se/xmlui/handle/10616/39758?locale- attribute=en

9. Lai Wen-Tzu. ∆ιδακτορική ∆ιατριβή µε τίτλο : Interplay between FGF and Wnt signaling regulates self -renewal and commitment of murine mesenchymal stem cells. Tulane University, 2009, http://gradworks.umi.com/3366978.pdf

10. Humanized Mice (Current Topics in Microbiology and Immunology) by Nomura T, Watanabe T., Habu S. (eds). Chapter: Humanized SCID Mouse Models for Biochemical Research by Pearson T, Greiner DL, Schultz LD, pp45. Springer Verlag, Berlin Heidelberg, 2008.

11. Dumas A, ∆ιδακτορική ∆ιατριβή µε τίτλο : Cellules médullaires et biomatériaux implantables en site osseux (Bone marrow cells and biomaterials for the 353

repair of bone tissue), Université d'Angers. 2008, http://tel.archives- ouvertes.fr/tel-00433829 12. Stem Cells and Their Potential for Clinical Application (NATO Science for Peace and Security Series A: Chemistry and Biology), by Nadja M. Bilko Boris Fehse, Wolfram Ostertag, and Carol Stocking (eds), 2007, pp 61. 13. Cellular Transplantation . Chapter: Stem Cell Transplantation for Autoimmune Diseases by Tyndall, A , Le Blanc, K , pp:241-257, Publisher: Elsevier Inc., 2007. 14. Cellular Transplantation . Chapter: Concepts in Cell Therapy: From Cord Blood to Sertoli Cells by Sanberg, P.R , English, D.K , Hakki, A. , Cameron, D.F , Garbuzova-Davis, S. , Willing, A.E , Borlongan, C.V , Henning, R , Klasko, S.K , El-Badri, N, pp: 547-566, Publisher: Elsevier Inc., 2007. 15. Francois Sabine. ∆ιδακτορική ∆ιατριβή µε τίτλο : Etude de la capacite des Cellules Souches Mesenchymateuses humaines (CSM) après irradiation du tissue receveur: approche therapeutique de l’ atteinte multi-organe radio- induite, UNIVERSITE DE VERSAILLES SAINT-QUENTIN-EN-YVELI, 2006, http://irsnorg.customers.artful.net/FR/Larecherche/Formation_recherche/Thes es/Theses-soutenues/DRPH/Documents/2006-these-Francois.pdf

16. Stem Cell Transplantation, Biology, Processes, Therapy. Chapter: Immune escape and suppression by human mesencymal stem cells by LeBlanc K, pp:233-243, publisher: Wiley VCH Verlag, 2006.

17. Genetic Engineering of Mesenchymal Stem Cells . Chapter: Clinical trials of human mesenchymal stem cells to support hematopoietic stem cell transplantation by Koc ON, pp: 151-162, publisher: Springer, Netherlands, 2006.

18. Genetic Engineering of Mesenchymal Stem Cells, by Nolta JA (ed). Chapter 2: Esrablishment and Transduction of Primary Human Stromal Mesenchymal Stem Cell Monolayers by Meyerrose T, Rosova I, Doso M, Herrbrich P, Bauer G, Nolta J, pp57. Springer ,Dordrecht, The Netherlands, 2006.

19. Stem Cell Repair and Regeneration (the Hammersmith Series) by Habib NA (ed). Chapter 2: Fetal Mesenchymal Stem Cells are More Primitive than Adult 354

Mesenchymal Stem Cells by Gotherstrom C, Guillot PV, Fisk NM, pp29, Imperial College Press, London 2007.

20. Handbook of Stem Cells by Lanza R (ed). Chapter 12, Volume 2. Stem and progenitor cells isolated from cord blood by Broxmeyer H, pp181, Elsevier Academic Press, Burlington USA, 2004.

21. US patents Westenfelder, patent No: US8603462B2, dat of patent:dec 10, 2013. : http://www.google.com/patents/US8603462

22. Wells PS. Technology Development. Proceedings Tailings and Mine Waste 2011 Vancouver, BC, November 6 to 9, 2011, http://hdl.handle.net/2429/37806

23. Innovative Strategies in Tissue Engineering by Mayuri S. Prasad , Paolo Di Nardo (eds). Chapter: Immune properties of mesenchymal stem cells in the translation of neural disorders by Sinha G, River Publishers, 2015, ISBN: 879323709X, 9788793237094 24. Thesis of Raphaëlle Bessout:Traitement des lésions colorectales radio- induites par injection de Cellules Stromales Mésenchymateuses (CSM) : implication du processus inflammatoire Immunology. Université Pierre et Marie Curie - Paris VI, 2012. French.

B. Citations from Journals Α/Α Όνοµα Συγγραφέως Περιοδικό Τόµος Σελίδα Έτος 1 Hwang SJ Chonnam Med Journal 49 101 2013 2 Falavigna A World Neurosurgery †† 2013 3 Wu Y Annals of Hematology 92 1675 2013 4 Chen F Stem Cells and Development 22 1955 2013 5 Holtan SG J Stem Cell Res Ther E109† 2012

6 Silva FDS Journal of Biomedicine Article number 758102 2012 and Biotechnolog y 7 Chieregato K Blood Cells, Molecules and 49 159 2012 Diseases 8 Han L Chinese Medical Journal 125 3246 2012 9 Li J Xenotransplantation 19 273 2012 10 Lee YS Cellular Immunology 279 1 2012 11 Raynaud CM Stem Cells International Article number 658356 2012 12 Di G-H Cytotherapy 14 412 2012 13 Shabrani NC Cytotherapy 14 366 2012 14 Li T Bone Marrow Research Article ID 353878 2011 15 Hao L International Journal of 95 34 2011 Hematology 355

16 Maqbool M Cell Biology International 35 1247 2011 17 De Toni F Stem Cells and Development 20 2127 2011 18 [Chinese] Chinese J Hematol 2011 19 [Chinese] Chinese J of Clin Labor Sci 29 2011 20 Horwitz EM Biol Blood Marrow Transpl 17 S21 2011 21 Mielcarek M Biol Blood Marrow Transpl 17 214 2011 22 Feng Y Hematology 16 67 2011 23 De Bruyn C Stem Cells and Development 20 547 2011 24 Pineault N Cytotherapy 13 467 2011 25 Cai S Clin Cancer Res 17 2195 2011 26 Kastrinaki M-C Curr Stem Cell Res Ther 6 122 2011 27 Zeng R Spine 36 997 2011 28 Lazar-Karsten P Vox Sanguinis 101 65 2011 29 Kemp K Ann Hematol 90 777 2011 30 Pontikoglou C Stem Cell Reviews and 7 569 2011 31 Shou Z Journal of Clinical Rehabilitative 14 9235 2010 Tissue Engineering Research 32 Briquet A Haematologica 95 47 2010 33 Kuci S Haematologica 95 651 2010 34 Gao L Cell Cycle 9 1342 2010 35 Zhang X Int J Laboratory Hematol 32 256 2010 36 Liu M Platelets 21 199 2010 37 Herrero C Brazilian Journal of Medical 43 425 2010 38 Bertoncello I Exp Rev Resp Med 4 349 2010 39 Aueletta JJ Biol Blood Marrow Transpl 16 891 2010 40 Kemp K Ann Hematol 89 701 2010 41 Peters A Int J Devel Biol 54 965 2010 42 Tolar J Stem Cells 28 1446 2010 43 Meyerrose T Adv Drug Del Rev 62 1167 2010 44 Flores-Torales E Folia Histochemica et 48 682 2010 45 Briquet, A. Haematologica 95 47 2010 46 Park JH Journal of Korean Medical 24 (s2) S288 2009 Science 47 Salles I Blood 114 5044 2009 48 Falet H Blood 114 4729 2009 49 Luan X-Y Cell Biology International 33 1127 2009 50 Tian, X. Stem Cells 27 2675 2009 51 Chen, T.-W. Experimental Hematology 37 1330 2009 52 Popp, F.C. Liver Transplantation 15 1192 2009 53 Lazzarotto -Silva, C. Cytotherapy 11 268 2009 54 Hwang, J.H. Journal of Korean Med ical 24 547 2009 55 Yoo, K.H. Cellular Immunology 259 150 2009 56 Veyssade M Frontiers in Bioscience 14 2010 2009 57 Wang, M. Immunology 126 220 2009 58 Delalat, B. Hematology 14 125 2009 59 Zhou, L. Journal of Clinical 13 1849 2009 60 Casteilla, L. Medecine Therapeutique 11 46 2009 61 Kruglyakov PV, [Russian] Цитология 50 557 2008 62 [Chinese] J of SOOCHOW University 2008 63 Jarocha, D. Folia Histochemica et 46 307 2008 64 Nifontova, I.N. NATO Security through 55 2008 65 Pearson, T. Current Topics in 324 25 2008 66 Li, X.-Q. Gao Xiao Hua Xue Gong 22 985 2008 67 Chan, W.K. Experimental Hematology 36 1551 2008 68 Li, M., Wang Journal of Clinica l 12 7573 2008 356

69 Kruglyakov, P Tsitologiya 50 557 2008 70 Kennedy, J.A. Leukemia 22 2029 2008 71 Kucic, T. American Journal of Physiology - 295 F488 2008 Renal Physiology 72 Yuan, X. -L. Journal of Clinical 12 5723 2008 73 Bifari, F. Transfusion Medicine and 35 194 2008 74 Wagner, W. Transfusion Medicine and 35 185 2008 75 Han, L. -Y. Chinese Medical Journal 121 800 2008 76 Lee, S. -T. Intern ational Journal of 87 327 2008 77 Pelagiadis, I. Journal of Pediatric 30 301 2008 78 Ning, H. Leukemia 22 593 2008 79 Mattia, G. Experimental Hematology 36 244 2008 80 Tomiyama, K. Stem Cells 26 330 2008 81 Nasef A Libya n J. Med 2 190 2007 82 [Chinese] Immunological J 2007 83 [Chinese] Chinese J of 5 2007 84 Friedman, R Biology of Blood and Marrow 13 1477 2007 Transplantation 85 Brooke, G. Seminars in Cell and 18 846 2007 86 Le Blanc, K. Journal of Internal Medicine 262 509 2007 87 Le Blanc, K. Leukemia 21 1733 2007 88 Park, S. -K. Journal of Korean Medical 22 412 2007 89 Gootherstroom, C Transplantation 84 S35 2007 90 Trzaska, K.A. Current Neurovascular 4 99 2007 91 Han, J. -Y. Journal of Korean Medical 22 242 2007 92 Rasmusson, I. Scandinavian Journal of 65 336 2007 93 De Becker, A. Haematologica 92 440 2007 94 Rasmusson, I. Exper. Cell Research 312 2169 2006 95 Nifontova, I.N NATO Security through 55 2006 Science Series B: Physics 96 [Chinese] Chinese J. Practical Internal 26 2006 97 [Chinese] Basic and Clinical Medicine 4 319 2006 98 Jootar, S. Leukemia Research 30 1493 2006 99 Suzuki, T. Stem Cells 24 2456 2006 100 Chen, X. Stem Cells 24 2052 2006 101 Le Blanc, K. Current Opinion in 18 586 2006 Immunology 102 Lu, L. -L. Haematologica 91 1017 2006 103 El -Badri, N.S. Stem Cells and Development 15 497 2006 104 Moadsiri, A. Surgery 140 315 2006 105 Wang, Y. -C. Chinese Journal of Clinical 10 17 2006 106 van Hensbergen, Y. Experimental Hematology 34 943 2006 107 Sundin, M. Bone Marrow Transplantation 37 1051 2006 108 Ringdén , O. Transplantation 81 1390 2006 109 Robinson, S.N. Bone Marrow Transplantation 37 359 2006 110 Chi, Z. -H. Chinese Jour nal of Clinical 10 20 2006 111 [Chinese] Medical J of National 32 2005 112 [Chinese] Medical J of National 4 256 2005 113 Kim DH Cytokine 31 119 2005 114 Aguila, H. L. Immunological Reviews 208 7 2005 115 Kemp, K.C. Leukemia and Lymphoma 46 1531 2005 116 Krause, D.S. Transfusion 45 67S 2005 117 Zhao, Z. Bone Marrow Transplantation 36 355 2005 118 Sanberg, P.R. Annals of the New York 1049 67 2005 Academy of Sciences 119 Dong, H.K. Cytokine 31 119 2005 120 Mourcin, F. Radiation Research 164 1 2005 357

121 Drouet, M. Bone Marrow Transplantation 35 1201 2005 122 Heng, B.C. Wound Repair and 13 353 2005 123 Le Blanc, K. Biology of Blood and Marrow 11 321 2005 Transplantation 124 Rasmusson, I. Experimental Cell Research 305 33 2005 125 Soenen -Cornu, V. Oncogene 24 2441 2005 126 Kim, S.J. Biochemical and Biophysical 329 25 2005 127 Cronwright, G. Cancer Research 65 2207 2005 128 Cho, K.J. Stem Cells 23 383 2005 129 Sarugaser, R. Stem Cells 23 220 2005 130 Chunmeng, S. Journal of Surgical Research 121 13 2004 131 Wulf, G.G. Tissue Engineering 10 1136 2004 132 Shi, C. Radiation Research 162 56 2004 133 Chunmeng, S. Transplantati on Proceedings 36 1578 2004 134 Gluckman, E. Experimental Hematology 32 410 2004 135 Javazon, E.H. Experimental Hematology 32 414 2004 136 Kluger, Y. Proceedings of the National 101 6508 2004 Academy of Sciences of the United States of America 137 Mait ra, B. Bone Marrow Transplantation 33 597 2004 138 Shi, C. -M. Journal of Radiation 45 19 2004 139 Kassem, M Ugeskrift for Laeger 165 4852 2003 140 Bunting, K.D. Biology of the Cell 95 563 2003 141 Le Blanc, K. Cytotherapy 5 485 2003 142 Bonn et, D. Clinical and Experimental 3 140 2003 143 Berger, M.G. Bulletin du Cancer 90 771 2003 144 Wong RSY Clinical and Experimental 14 235 2014 145 Busser H StemMedicine Cells and Development 23 2390 2014 146 Ye Z-L Experimental and 7 1738 2014 Therapeutic Medicine 147 Van de Garde M Stem Cells and Development 24 1448 2015 148 Malara A Cellular and Molecular Life 72 1517 2015 Sciences 149 Hwang JS Immune Netw. 12 129 2012 2015 ٭ Eaton EB Eaton and Varney Military 2 150 Medical Research 151 Batorov EV Áþëëåòåíü ÂÑÍÖ ÑÎ ÐÀÌÍ 3 33 2012 152 Jun FS Journal of Life Science 17 678 2007

†: doi:10.4172/2157-7633.1000e109 †† http://dx.doi.org/10.1016/j.wneu.2013.02.026 DOI 10.1186/s40779-014-0027-9 ٭

• PANGALIS GA, VASSILAKOPOULOS TP, MICHALIS E, ROUSSOU P, VRAKIDOU E, REPOUSIS P, ANGELOPOULOU MK , SIAKANTARIS MP, KORANTZIS J, SYMEONIDIS A, GRIGORAKIS V, STEFANOUDAKIS E, STAMATELLOU M, BOURANTAS KL, KALMANTIS TH 1, CHRISTOPOULOS G, KOKKINIS G , MICHALAKEAS I, PAPAYIANNIS A FOR THE HELLENIC COOPERATIVE LYMPHOMA GROUP. 358

A Randomized Trial Comparing Intensified CNOP Versus CHOP In Patients With Aggressive Non-Hodgkin’s Lymphoma. Leukemia and Lymphoma 44:635-44, 2003 A. Citations from Books, Medical sites and other Literature 1. Kragler M. Akute myeloische leukamie nach mitoxantronbehandlung von patienten mit multipler sclerose – Hinweise auf eine hohere inzidence. Googlescholar 2005. 2. UpToDate (www.uptodate.com ) 2006, version 15.1 (Κεφάλαιο : Freedman AS, Friedberg JW: Treatment of aggressive non-Hodgkin’s lymphomas, 04 Jan 2007). 3. Treatment and management of cancer in the elderly, Muss HB, Hunter CP, Johnson KA eds., Taylor & Francis Group, LLC, New York, 2006, ISBN-13 978-0- 8493-4035-2 (Chapter: Lymphoma, by Shah NS, Ershler WB, Longo DL, pp 183). 4. WILLIAMS HEMATOLOGY, 7 th ed., Lichtman MA, Beutler E, Kipps TJ, Seligsohn U, Kaushansky K, Prchal JT eds., McGraw Hill, 2006, ISBN 0-07-143591-3 (Chapter 96: The non-Hodgkin’s lymphomas, by Foon KA, Ghobrial I, Geskin LJ, Jacobs SA, pp1407-1459). 5. ΑΙΜΑΤΟΛΟΓΙΑ ΣΤΗΝ ΚΛΙΝΙΚΗ ΠΡΑΞΗ , Πάγκαλης ΓΑ , Εκδόσεις Π.Χ. Πασχαλίδης , Αθήνα 2008, ISBN 978-960-399-776-4 ( Κεφ . 41: ∆ιάχυτο λέµφωµα από µεγάλα Β- κύτταρα και συναφείς οντότητες , σελ . 689-701). 6. NCCN Clinical Practice Guidelines in Oncology. Non-Hodgkin’s lymphomas, v. 2.2013 (plus 1.2013 and 3.2012).

B. Citations from Journals Α/Α Όνοµα Συγγραφέως Περιοδικό Τόµος Σελίδα Έτος 1 Bjorkholm M Eur J Haematol 80 477 2008 2 Mc Carthy J Clin Lymph Myeloma 9 167 2009 3 Zelenetz AD J Nat Compr Cancer Network 9 484 2011 4 Vassilakopoulos TP Oncologist 17 239 2012 5 Papageorgiou S Hematol Oncol 31 10 2013 6 Herbrecht R Ann Oncol 24 2618 2013

• KORKOLOPOULOU P, GRIBABIS D, KAVANTZAS N, ANGELOPOULOU MK , SIAKANTARIS MP, PATSOURIS E, ANDROULAKI A, THYMARA I, KOKORIS SI, KYRTSONIS M-C, KITTAS C, PANGALIS GA. A Morphometric Study Of Bone Marrow Angiogenesis In Hairy Cell Leukemia With Clinicopathological Correlations British journal of Hematology 2003, 122: 900-910. A. Citations from Books, Medical sites and other Literature

1. Molecular Histopathology and Tissue Biomarkers in Drug and Diagnostic Development by Potts SJ, Eberhard DA, Wharton KA (eds). Chapter: Practical Approaches to Microvessel Analysis: Hotspots, Microvessel Density, and Vessel Proximity by Potts SJ, Eberhard DA, Salama ME, pp: 87, 2015, doi: 10.1007/7653_2014_31, Springer New York, ISBN: 978-1-4939- 2680-0

B. Citations from Journals

359

Α/Α Όνοµα Συγγραφέως Περιοδικό Τόµος Σελίδα Έτος

1 Mikalsen LTG PLoSONE 8 e75954 2013 2 Kopic E Med Arch 65 9 2011 3 Safali M Pathology Research and 206 93 2010 4 Smolej, L. APMISPractice 116 1058 2008 5 Pangalis, G.A. Current Topics in Medicinal 6 1657 2006 Chemistry 6 Mainou-Fowler, T. Leukemia and Lymphoma 47 223 2006 6 Lapidot, T. Blood 106 1901 2005 7 Strupp, C. Leukemia Research 29 967 2005 8 Korkolopoulou, P. Leukemia 19 894 2005 9 Sharma, S. Histopathology 46 481 2005 10 Kvasnicka, H.M. Histology and Histopathology 19 1245 2004 11 Kvasnicka, H.M. Pathologe 25 127 2004 12 Kašparová P Čes.-slov. Patol. 43 50 2007

• KYRTSONIS M-C, VASSILAKOPOULOS TP, KOKORIS SI, GRIBABIS DA, DIMOPOULOU MN, ANGELOPOULOU MK , PANGALIS GA. Serum Syndecan-1, Basic Fibroblast Growth Factor and Osteoprotegerin in Myeloma Patients at Diagnosis and During the Course of the Disease. European Journal of Hematology, 72: 252-258, 2004. Α. Citations from Books, Medical sites and other Literature 1. Βιολογικοί Παράγοντες και Κλινικά Χαρακτηριστικά κατά τη ∆ιάγνωση και Υποτροπή του Λεµφώµατος Hodgkin: Συσχετίσεις και Προγνωστική Σηµασία . Θεόδωρος Π. Βασιλακόπουλος , ∆ιδακτορική ∆ιατριβή , Ιατρική Σχολή Εθνικού και Καποδιστριακού Πανεπιστηµίου Αθηνών , Αθήνα , Μάρτιος 2004. 2. www.biovendor.com/pdf/RD194003200.pdf Biovendor IVD, Human Osteoprotegerin, ELISA, Cat. No. RD 194003200 3. Αλληλεπιδράσεις µυελωµατικών κυττάρων και κυττάρων στρώµατος µυελού των οστών : Συσχέτιση των ευρηµάτων µε την παθογένεια , την κλινική ετερογένεια και την πρόγνωση του πολλαπλού µυελώµατος . Αργυρούλα Ι. Παπαδόγιαννη , ∆ιδακτορική ∆ιατριβή , Ιατρική Σχολή Εθνικού και Καποδιστριακού Πανεπιστηµίου Αθηνών , Αθήνα , 2007. 4. ΑΙΜΑΤΟΛΟΓΙΑ ΣΤΗΝ ΚΛΙΝΙΚΗ ΠΡΑΞΗ , Πάγκαλης ΓΑ , Εκδόσεις Π.Χ. Πασχαλίδης , Αθήνα 2008, ISBN 978-960-399-776-4 ( Κεφ . 53: Πολλαπλούν Μυέλωµα , σελ . 795-814). 5. Μελέτη της προγνωστικής αξίας της αγγειογένεσης του µυελού των οστών σε ασθενείς µε πολλαπλούν µυέλωµα . Κωνσταντίνος Αθ . Αναργύρου , ∆ιδακτορική ∆ιατριβή , Ιατρική Σχολή Εθνικού και Καποδιστριακού Πανεπιστηµίου Αθηνών , Αθήνα , 2008. 6. Anu Anttonen. Thesis: Syndecan-1 expression ans soluble syndecan-1 in head and neck and lung carcinomas. University of Helsinki, 2006. 7. Multiple Myeloma: An overview. Gupta A (ed.). InTech – Open Access Publisher 2012, ISBN 978-953-307-768-0. (Chapter 8: The contribution of prognostic factors to the better management of multiple myeloma 360

patients, by Kyrtsonis MC, Maltezas D, Koulieris E, Bitsani K, Pessach I, Efthymiou A, Bartzis V, Tzenou T, Panayiotidis P. pp. 145-174).

B. Citations from Journals Α/ Όνοµα Συγγραφέως Περιοδικό Τόµος Σελίδα Έτος Α 1 Vassilakopoulos TP Haema 7 147 2004 2 Lovell R Br J Haematol 130 542 2005 3 Vassilakopoulos TP Anticancer Res 25 4743 2005 4 Kirkbride KC Trends Biochem Sci 30 611 2005 5 Fjeldtad K Arch I mmunol Ther Exper 53 454 2005 6 Krai M Curr Drug Targets 6 665 2005 7 Blair JM Nat Clin Pract Oncol 3 41 2006 8 Maisnar V Neoplasma 53 26 2006 9 Heider U Eur J Cancer 42 1544 2006 10 Jacob C Eur J Cancer 42 1581 2006 11 Hjertner O Med Oncol 23 431 20 06 12 Galani Z Anticancer Res 27 571 2007 13 Coranova -Marinova M Haematologica 92 1000 2007 14 Muramatsu T Proteomics 8 3350 2008 15 Pika T Biomed Papers Olom 152 61 2008 16 Kyrtsonis MC Semin Hematol 46 110 2009 17 Scudla V Cas Lek Cesk 148 315 2009 18 Scudla V Biomed Papers Olom 153 275 2009 19 ElBaky AA Arch Med Sci 5 589 2009 20 Scudla V Neoplasma 57 102 2010 21 El -Aziz AA Pak J Biotechnol 5 63 2008 22 Scudla V Klinicka Onkologie 23 171 2010 23 Kyrtsonis MC Clin Lymph Myel Leuk 11 99 2011 24 Basile U Biochim Clin 35 56 2011 25 Casado -Vela J Exp Rev Proteomics 8 347 2011 26 Polanski M Biomarker Insights 1 1 2006 27 Clancy P Arterioscler Thromb Vasc Biol 26 2574 2006* 28 Kim JM Kor J Hematol 45 115 2010 29 Xi WX Chin J Oncol 29 2007 30 Zdzisinska B Postepy Hig Med Dosw 60 471 2006 31 Ismail NA Int J Acad Res 2 72 2010 32 Abdallah N J Appl Sci Res 6 937 2010 33 Hasegawa Y Oral Surg Oral Med 114 318 2012 34 Gharbaran R J Hematol Oncol 6 62 2013 35 Alexandrakis MG Curr Angiogenesis 2 76 2013 36 Stavropoulos NA J Cancer Ther 5 387 2014 37 Clavijo Jordan MV Conrast Med Mol Imag 9 323 2014 * In supplemental Material

• VASSILAKOPOULOS TP, ANGELOPOULOU MK , SIAKANTARIS MP, KONTOPIDOU FN, DIMOPOULOU MN, KOKORIS SI, KYRTSONIS M-C, TSAFTARIDIS P, KARKANTARIS C, ANARGYROU K, BOUTSIS DE, VARIAMIS E, MICHALOPOULOS T, BOUSSIOTIS VA, PANAYIOTIDIS P, PAPAVASSILIOU C, PANGALIS GA. 361

Eighteen-Year Experience of Combination Chemotherapy Plus Low Dose Involved Field Radiation Therapy for Early Clinical Stage Hodgkin’s Lymphoma. International Journal of Radiation, Oncology, Biology, Physics, 59 (3): 765- 781, 2004. Α. Citations from Books, Medical sites and other Literature 1. Βιολογικοί Παράγοντες και Κλινικά Χαρακτηριστικά κατά τη ∆ιάγνωση και Υποτροπή του Λεµφώµατος Hodgkin: Συσχετίσεις και Προγνωστική Σηµασία . Θεόδωρος Π. Βασιλακόπουλος , ∆ιδακτορική ∆ιατριβή , Ιατρική Σχολή Εθνικού και Καποδιστριακού Πανεπιστηµίου Αθηνών , Αθήνα , Μάρτιος 2004. 2. Βελτιστοποίηση θεραπείας λεµφωµάτων ( Ο ρόλος της PET). Παπαβασιλείου Κ, Ευθυµιάδου Ρ, Σάνδηλος Π. Έκδοση του ∆ιαγνωστικού και Θεραπευτικού Κέντρου Αθηνών ΥΓΕΙΑ , Κ.Α.Ο. ‘‘ Υγεία ’’ Αα .8, 2005. 3. Βασιλακόπουλος Θ, Σαρρής Α: Λέµφωµα Hodgkin: Εξελίξεις στην βιολογία και θεραπεία . Στο : ΕΞΕΛΙΞΕΙΣ ΣΤΗΝ ΠΑΘΟΛΟΓΙΑ . Νεώτερες απόψεις στη διάγνωση και θεραπεία . Σεϊτανίδης Β, Γεωργιλής Κ, Αποστολάκης Ι. Έκδοση του ∆ιαγνωστικού και Θεραπευτικού Κέντρου Αθηνών ΥΓΕΙΑ , σελ . 17-31, 2006. 4. Αγγειογένεση στο λέµφωµα Hodgkin: Μορφοµετική µελέτη και προγνωστική σηµασία επί 286 ασθενών . Ειρήνη Α. Θυµαρά . ∆ιδακτορική ∆ιατριβή , Ιατρική Σχολή Εθνικού και Καποδιστριακού Πανεπιστηµίου Αθηνών , Αθήνα , 2008. 5. www.ghsg.org/de/studien/literatur 6. ΑΙΜΑΤΟΛΟΓΙΑ ΣΤΗΝ ΚΛΙΝΙΚΗ ΠΡΑΞΗ , Πάγκαλης ΓΑ , Εκδόσεις Π.Χ. Πασχαλίδης , Αθήνα 2008, ISBN 978-960-399-776-4 ( Κεφ . 35: Λέµφωµα Hodgkin, σελ . 615-639). 7. ΑΙΜΑΤΟΛΟΓΙΑ ΣΤΗΝ ΚΛΙΝΙΚΗ ΠΡΑΞΗ , Πάγκαλης ΓΑ , Εκδόσεις Π.Χ. Πασχαλίδης , Αθήνα 2008, ISBN 978-960-399-776-4 ( Κεφ . 93: Η θέση της ακτινοβολίας στην αντιµετώπιση του Αιµατολογικού ασθενούς , σελ . 1314- 1322). 8. Μονογραφή Της Ηµερίδας Με Θέµα : ‘‘ Λέµφωµα Hodgkin: Πρόσφατες Εξελίξεις ’’ Του Τµήµατος Λεµφοϋπερπλαστικών Νόσων Της Ελληνικής Αιµατολογικής Εταιρίας , Αθήνα , 31 Ιανουαρίου 2009. ( Κεφάλαιο : Λέµφωµα Hodgkin: Θεραπεία περιορισµένων σταδίων . Βασιλακόπουλος ΘΠ , Αγγελοπούλου ΜΚ , Πάγκαλης ΓΑ , σελ . 29-39). 9. ΕΣΩΤΕΡΙΚΗ ΠΑΘΟΛΟΓΙΑ , από το ∆ιδακτικό και Επιστηµονικό Προσωπικό του Τοµέως Παθολογίας , Εκδόσεις ΠΑΣΧΑΛΙ∆Η , 2 η Έκδοση , 2010, ISBN 978-960-399-951-5, Αθήνα ( Κεφάλαιο : Θ. Βασιλακόπουλος , Μ. Αγγελοπούλου , Μ. Σιακαντάρη , Γ. Πάγκαλης ,Χ. Κυρτσώνη , Σ. Κοκόρη , Χ. Καλπαδάκη , Φ. Κοντοπίδου , Ε. ∆ηµητριάδου , Μ. ∆ηµοπούλου : Κακοήθη λεµφώµατα και χρόνια λεµφογενής λευχαιµία . σελ . 1386-1403). 10. Powrie RO, Greene MF, Camann W: de Swiet’s medical disorders in obstetric practice: 5 th Edition. 2010, Wiley-Blackwell, ISBN: 978-140514847-4 (Chapter: Sadanandan S, Hurley T, Muller C, et al. Cancer in pregnancy, pp 553-582, DOI: 10.1002/9781444323016.ch22). 11. ΑΤΛΑΝΤΑΣ ΟΓΚΟΛΟΓΙΑΣ ΘΩΡΑΚΑ , Συρίγος Κ, Γκιόζος Γ, Χαρπίδου Α, Εκδόσεις ΠΑΡΙΣΙΑΝΟΥ , 2012, ISBN 978-960-394-838-4, Αθήνα ( Κεφάλαιο 43: Θ. Βασιλακόπουλος , Α. Ζορµπαλά : Λεµφώµατα µεσοθωρακίο

B. Citations from Journals 362

Α/Α Όνοµα Συγγραφέως Περιοδικό Τόµος Σελίδα Έτος 1 Vassilakopoulos TP Haema 7 147 2004 2 Visco C Leuk Lymphoma 45 2085 2004 3 Vassilakopoulos TP Haem a 7(S1) 53 2004 4 Βασιλακόπουλος Θ Haema Συµπλ 137 2004 5 Vassilakopoulos TP J BUON 10 59 2005 6 Baxendale IR J Comb Chem 7 483 2005 7 Korkolopoulou P Leukemia 19 894 2005 8 Vassilakopoulos TP Anticancer Res 25 4743 2005 9 Klimm B Haematologica 90 1680 2005 10 Hurley TJ Obstet Gyn Clin N Am 32 595 2005 11 Vassilakopoulos TP Haematologica 91 32 2006 12 Koontz BF J Clin Oncol 24 605 2006 13 Pangalis GA Eur J Hosp Pharm Pract 12 62 2006 14 Vassilakopoulos TP Leuk Lymphoma 47 1450 2006 15 Santoro A Update on Cancer Ther 1 467 2006 16 Liaw TYE Cur Drug Targets 8 739 2007 17 Doussis -Anagnostopoulou IA Clin Cancer Res 14 1759 2008 18 Pavone V Ann Oncol 19 763 2008 19 Klimm B Cancer J 15 143 2009 20 Βασιλακόπουλος ΘΠ Haema 12 (S2) 169 2009 21 Lu NN J Leukemia Lymphoma 19 460 2010 22 Genovesi D Strahlen Onkologie 187 357 2011 23 Marnerides A Anticancer Res 31 3585 2011 24 Janjic T Medicinski Podmladak 59 37 2008 25 Datsenko PV Voprosy Onkologii 58 527 2012 26 Βασιλακόπουλος ΘΠ ΑΙΜΑ 3 212 2012 27 Γεωργακόπουλος Ι ΑΙΜΑ 3 231 2012 28 Dimtsas GS Leuk Lymphoma 55 558 2014 29 Georgiadi EC Leuk Lympho ma 56 748 2015

• ANGELOPOULOU MK , RINDER H, WANG C, BURTNESS B, COOPER DL AND KRAUSE DS. A preclinical xenotransplantation animal model to assess human hematopoietic stem cell engraftment. Transfusion. 2004;44:555-66 . A. Citations from Books, Medical sites and other Literature 1. Platelet Proteomics: Principles, Analysis, and Applications . Chapter: Platelet Functional Genomics by Salles, I.I. , O'Connor, M.N , Thijssen- Timmer, D.C , Broos, K , Deckmyn, H , pp: 253-284, Publisher: John Wiley and Sons, 2011. 2. Tijssen MR. ∆ιδακτορική ∆ιατριβή µε τίτλο : From stem cell to platelet, University of Amsterdam, 2008, http://dare.uva.nl/document/97924 , http://dare.uva.nl/record/261783

B. Citations from Journals 363

Α/Α Όνοµα Συγγραφέως Περιοδικό Τόµος Σελίδα Έτος 1 Hofer U J Infect Dis 208 S160 2013 (s2) 2 Salles II Blood 114 5044 2009 3 Tijssen, M.R. Leukemia 22 203 2008 4 Nervi, B. Experimental Hematology 35 1823 2007 5 Hawley, R.G. Methods in Enzymology 419 149 2006 6 Nakamura, T. Blood 107 4300 2006 7 Lapidot, T. Blood 106 1901 2005 8 Krause, D.S. Transfusion 45 67S 2005 SUPP L2 9 Hoffmann, S. Transfusion 45 885 20 05

• RODRIGUEZ R, PARKER P, NADEMANEE A, SMITH D, O'DONNELL MR, STEIN A, SNYDER DS, FUNG HC, KRISHNAN AY, POPPLEWELL L, COHEN S, SOMLO G, ANGELOPOULOU M , AL-KADHIMI Z, FALK PM, SPIELBERGER R, KOGUT N, SAHEBI F, SENITZER D, SLOVAK M, SCHRIBER J, FORMAN SJ. Cyclosporine and mycophenolate mofetil prophylaxis with fludarabine and melphalan conditioning for unrelated donor transplantation: a prospective study of 22 patients with hematologic malignancies. Bone Marrow Transplant, 2004;33:1123-9. Α. Citations from Books, Medical sites and other Literature 1. Blood and Marrow Transplant Handbook: Comprehensive Guide for Patient Care . Chapter: Graft-versus-host disease prophylaxis by Corella A, pp: 83-99, publisher: Springer New York, 2011. 2. Thesis of Pidala J: Achievement of Transplantation Tolerance: Novel Approaches and Mechanistic Insights. May 2014, University of South Florida, [email protected]

B. Citations from Journals Α/Α Όνοµα Συγγραφέως Περιοδικό Τόµος Σελίδα Έτος 1 Qian L Journal of Cellular and 17 966 2013 Molecular Medicine 2 Perez-Simon JA Haematologica 98 526 2013 3 Al-Kadimi Z Biol Blood Marrow Transplant 18 1734 2012

4 Minagawa K Int J Hematol 96 10 2012 364

5 Pidala J Cancer Control 18 268 2011 6 Nakane T Int J Hematol 93 509 2011 7 Rodriguez R Bone Marrow Transplant 45 205 2010 8 Kim, S.-W. International Journal of 88 324 2008 Hematology 9 Pérez-Simón, J.A. Biology of Blood and Marrow 14 664 2008 Transplantation 10 Potter, V. Reviews on Recent Clinical 3 130 2008 Trials 11 Li, N. Proceedings of the National 105 4796 2008 Academy of Sciences of the United States of America 12 Nakamura, R. Bone Marrow Transplantation 40 843 2007

13 Onishi, Y. International Journal of 85 256 2007 Hematology 14 Storb, R. Best Practice and Research in 20 2007 Clinical Haematology 15 Rodriguez, R. Biology of Blood and Marrow 12 1326 2006 Transplantation 16 Inamoto, Y. International Journal of 83 356 2006 Hematology 17 Maris, M.B. Biology of Blood and Marrow 12 454 2006 Transplantation 18 Molina, A. Journal of Clinical Oncology 23 6163 2005

19 Butcher, B.W. Bone Marrow Transplantation 36 1 2005

20 Sarkodee-Adoo, C. Current Opinion in Organ 10 44 2005 Transplantation 21 Burroughs, L. Current Opinion in Hematology 12 45 2005 22 Al-Kadimi Z Biology of Blood and Marrow 20 979 2014 Transplantation

• VASSILAKOPOULOS TP, ANGELOPOULOU MK , CONSTANTINOU N, KARMIRIS T, REPOUSSIS P, ROUSSOU P, SIAKANTARIS MP, KORKOLOPOULOU P, KYRTSONIS M-C, KOKORIS SI, DIMOPOULOU MN, VARIAMIS E, VINIOU NA, KONSTANTOPOULOS K, DIMITRIADOU EM, ANDROULAKI A, PATSOURIS E, DOUSSIS-ANAGNOSTOPOULOU IA, PANAYIOTIDIS P, BOUSSIOTIS VA, KITTAS CH, PANGALIS GA. 365

Development and validation of a clinical prediction rule for bone marrow involvement in patients with Hodgkin’s lymphoma. Blood, 105 (5): 1875-1880, 2005. A. Citations from Books, Medical sites and other Literature 1. UpToDate (www.uptodate.com ) ( Κεφάλαιο : Mauch PM: Initial evaluation and diagnosis of Hodgkin’s disease in adults, Last update 01.11.2010, συνεχίζεται έως σήµερα ). 2. Franco V, Tripodo C, Florena AM. Manifestation of Hodgkin lymphoma in the bone marrow. 8 th International Course on bone marrow biopsy pathology. European Association of Haematopathology, Graz, Austria, May 2007, pp. 65-68. 3. Linfoma de Hodgkin na infancia e adolescensia. Um estudo das caracteristicas histologicas, clinicas, epidemiologicas e de associacao com o virus Epsein-Barr, Mario Henrique Magalhaes Barros. Dissertacao de Mestrado apresentada ao Programa de pos-graduacao em Oncologia, Instituto Nacional do Cancer, Ministerio da Saude, como parte dos requisitos necassarios a obtencao do titulo de Mestre em Oncologia. Rio de Janeiro, 2007. 4. The Chemotherapy Source Book, 4 th Edition. Perry MC (ed.), Wolters Kluwer Health; Lippincott Williams & Wilkins, Philadelphia, 2008, ISBN-13: 978-0- 7817-7328-7; ISBN-10: 0-7817-7328-8 (Chapter 42: Chemotherapy of Hodgkin’s Lymphoma, by Peterson BA, pp 499-517). 5. ΑΙΜΑΤΟΛΟΓΙΑ ΣΤΗΝ ΚΛΙΝΙΚΗ ΠΡΑΞΗ , Πάγκαλης ΓΑ , Εκδόσεις Π.Χ. Πασχαλίδης , Αθήνα 2008, ISBN 978-960-399-776-4 ( Κεφ . 35: Λέµφωµα Hodgkin, σελ . 615-639). 6. ΕΣΩΤΕΡΙΚΗ ΠΑΘΟΛΟΓΙΑ , από το ∆ιδακτικό και Επιστηµονικό Προσωπικό του Τοµέως Παθολογίας , Εκδόσεις ΠΑΣΧΑΛΙ∆Η , 2η Έκδοση , 2010, ISBN 978-960-399-951-5, Αθήνα ( Κεφάλαιο : Θ. Βασιλακόπουλος , Μ. Αγγελοπούλου , Μ. Σιακαντάρη , Γ. Πάγκαλης ,Χ. Κυρτσώνη , Σ. Κοκόρη , Χ. Καλπαδάκη , Φ. Κοντοπίδου , Ε. ∆ηµητριάδου , Μ. ∆ηµοπούλου : Κακοήθη λεµφώµατα και χρόνια λεµφογενής λευχαιµία . σελ . 1386-1403). 7. Bone Marrow Pathology, 4 th Edition. Bain BJ, Clark DM, Wilkins BS (eds.), Wiley-Balckwell, 2010, ISBN 978-1-4051-6825-0 (Chapter 6: Lymphoproliferative disorders, pp. 300-420). 8. Hicks L, Mac Kenzie R, Buckstein R, Imrie K. Hodgkin’s lymphoma (updated May 2008). Odette Cancer Center Policy (Ontario, Canada) (identified through Googlescholar). 9. Ferry JA: Extranodal Lymphomas. 2011, Elsevier Inc. ISBN: 978-141604579- 3 (Chapter: Hasserjian RP. Lymphomas of the bone marrow, pp 341-393, DOI: 10.1016/B978-1-4160-4579-3.10013-0). 10. Gouliamos AD, Andreou J, Kosmidis P: Imaging in Clinical Oncology. 2014, Springer-Verlag Italia. ISBN print 978-88-470-5384-7, ISBN online 978-88- 470-5385-4 (Chapter 33: Vassilakopoulos TP, Prassopoulos V. The role of 18FDG-PET/CT in malignant lymphomas: Clinical implications, pp 249-265, DOI: 10.1007/978-88-470-5385-4_35). 11. Moulopoulos LA, Koutoulidis V: Bone Marrow MRI: A pattern-based approach. 2015, Springer-Verlag Italia. ISBN print 978-88-470-5315-1, ISBN online 978-88-470-5316-8 (Chapter 33: Moulopoulos LA, Koutoulidis V. MRI of the abnormal bone marrow: focal pattern, pp 57-99, DOI: 10.1007/978-88- 470-5316-8).

B. Citations from Journals 366

Α/Α Όνοµα Περιοδικό Τόµος Σελίδα Έτος Συγγραφέως 1 Schaefer NG Eur J Nucl Med Mol Imag 34 60 2006 2 Dabbagh Kakhki Haema 9 626 2006 3 Takasaki Y Leuk Res 31 751 2007 4 Subramanian R Ind J Pathol Microbiol 50 640 2007 5 Barros MH Pediatr Blood Cancer 50 765 2008 6 Kwee TC Br J Haematol 141 60 2008 7 Simpson DC Br J Haematol 141 820 2008 8 Zhang QY Hem Onc Clin North Am 23 873 2009 9 Hines -Thomas M Haematologica/THJ 95 1691 2010 10 Mulin -Romsee G Eur J Nucl Med Mol Imag 37 1095 2010 11 Montanari F Hum Pathol 41 1150 2010 12 Kwee TC Scient World J 11 391 2011 13 Purz S J Clin Oncol 29 3523 2011 14 Mittal BR Leuk Lymphoma 52 2111 2011 15 Muzahir S Br J Radiol 85 e490 2012 16 Dimou M Leuk Lymphoma 53 1481 2012 17 Pingali SR Hosp Ph ys Board Rev Man 7(3) 1 18 Gobbi PG Crit Rev Oncol Hematol 85 216 2013 19 Kini JR J Cancer Res Therap 8 457 2012 20 El -Galaly TC J Clin Oncol 30 4508 2012 21 Πάγκαλης ΓΑ ΑΙΜΑ 3 203 2012 22 Adams AJH Ann Oncol 18 Dec 2013 23 Alsuliman T J Blood Lymph 4 120 2014 24 Petkovic I Acta Facult Med Naissens 31 261 2014 25 Adams HJA Ann Nucl Med 29 132 2014 26 Sheng ZK Med Princ Pract 23 437 2014 27 Panjwani PK Leuk Lymphoma 56 236 2015 28 Cho SK Kaohsiung J Med Sci 31 130 2015 29 Vassilakopoulos TP MEMO 2015

• MOLINA Α, ZAIN J, ARBER DA, ANGELOPOLOU MK , O’DONNELL M, MURATA-COLLINSJ, FORMAN SJ, AND NADEMANEE A Durable Clinical, Cytogenetic, and Molecular Remissions After Allogeneic Hematopoietic Cell Transplantation for Refractory Sezary Syndrome and Mycosis Fungoides J Clin Oncol 2005 23:6163-6171. Α. Citations from Books, Medical sites and other Literature 1. The Cutaneous Lymphoid Proliferations: A Comprehensive Textbook of Lymphocytic Infiltrates of the Skin. Chapter 2: The therapy of cutaneous T cell lymphoma by Magro C, doi: 10.1002/9780470053461.ch2, publisher: John Wiley and Sons, USA, 2007. 2. Clinical and Basic Immunodermatology. Chapter: Cutaneous T-cell lymphoma by Kim EJ, Introcaso CE, Richardson S, Rook AH, pp: 411-437, publisher: Springer, London, 2008. 367

3. Hematopoietic Stem Cell Transplantation. Chapter: Stem Cell transplantation for Hodgkin’s and non-Hodgkin’s Lymphoma by Sweetenham J, pp: 105-136, publisher: Humana Press, 2008. 4. Protocol for: Phase II Study of non-myeloablative allogeneic transplantation using TLI and ATG in patients with cutaneous T cell lymphoma. Stanford Cancer Center. PI: Weng WK, 2009. A Phase II Study of Non-myeloablative Allogeneic Transplantation Using Total Lymphoid Irradiation (TLI) and Antithymocyte Globulin (ATG) In Patients with Cutaneous T Cell Lymphoma. Coordinating Center: Stanford Cancer Center 875 Blake Wilbur Drive Stanford, CA 94305. Principal Investigator: Wen-Kai Weng, MD, PhD, http://cutaneouslymphoma.stanford.edu/documents/MF_SS%20HSCT%20Final %20protocol.pdf 5. Thomas Hematopoietic Cell Transplantation: 4 th Edition. Chapter 70: Hematopoietic cell transplantation for rare hematologic malignancies by Pullarkat V, Forman SJ, publisher: Wiley Blackwell, Oxford, UK, 2009. 6. Evidence Based Dermatology, 2nd Edition, publisher: Chapter 30: Primary cutaneous T cell lymphoma by Whittaker S, pp: 272Blackwell Publishing, 2008 7. Neoplastic Hematopathology. Chapter: Treatment of Cutaneous T Cell Lymphomas by Cox K, pp: 449-457, publisher: Humana Press, 2010. 8. Allogeneic Stem Cell transplantation. Chapter: Non Hodgkin’s Lymphoma: Allogeneic reduced intensity conditioning by Smith S, pp:109-125, publisher: Humana Press, 2010. 9. Best Practice Onkologie. Chapter: Maligne lymphoma der Haut-Update zu Diagnostik und Therapie by Hallermann C, pp: 4-21, publisher: Springer Verlag, 2010. 10. Galper S. Diagnosis and management of mycosis fungoides. www.physicianspractice.com 11. Hellman, and Rosenberg's Cancer: Principles & Practice of Oncology ov idsp.tx.ov id.com/sp-3.7.1b/ov idweb.cgi 1/33 Editors: DeVita, Vincent T.; Lawrence, Theodore S.; Rosenberg, Steven A. Title: DeVita, Hellman, and Rosenberg's Cancer: Principles & Practice of Oncology, 9th Edition Copyright ©2011 Lippincott Williams & Wilkins, Part Eight - Practice of Oncology > Section 12 - Lymphomas in Adults > Chapter 128 - Cutaneous Lymphomas by Foss F, Edelson RL, Wilson LN, 368

12. Schlaak M. Allogeneic Stem Cell Transplantation versus Conventional Therapy for Advanced Primary Cutaneous T-Cell Lymphoma. The Cochrane Library, 29 Aug 2013, doi: 10.1002/14651858.cd008908.pub3 13. Lymphoma. Chapter: Cutaneous T Cell lymphomas: Mycosis Fungoides and Sezary Syndrome by Duvic M, pp: 287-329, publisher: Humana Press, 2013. 14. T Cell lymphomas. Chapter: Autologous and Allogeneic Stem Cell Transplantation for T cell Lymphomas by Rodriguez J, pp: 229-242, publisher: Humana Press, 2013. 15. T Cell lymphomas. Chapter: Cutaneous T-Cell Lymphomas by Abdullah F, pp:155-177, publisher: Humana Press, 2013. 16. Rare Lymphomas. Chapter: Cutaneous T-Cell Lymphoma by Zain J, pp:133-167, publisher: Springer Berlin Heidelberg, 2014.

17. Atlas of Cutaneous Lymphomas. Classification and Differential Diagnosis by Joi B. Carter, Amrita Goyal, Lyn McDivitt Duncan (eds). Chapter: Sézary Syndrome by Amrita Goyal M.D., Joi B. Carter M.D., Aliyah R. Sohani M.D., Jeffrey A. Barnes M.D., Ph.D., Mai P. Hoang M.D., Lyn McDivitt Duncan MD, pp:61, 2015, Springer International Publishing ISBN: 978-3-319-17216-3

18. Non-Hodgkin Lymphoma. Pathology, Imaging, and Current Therapy by Andrew M. Evens, Kristie A. Blum (eds). Chapter: Allogeneic Hematopoietic Cell Transplantation in Non-Hodgkin’s Lymphomas by Ibrahim Aldoss, Auayporn Nademanee, pp:329, 2015, Springer International Publishing, ISBN: 978-3-319- 13149-8 19. Primary skin lymphomas by Eugenia Piliotis, Kevin Imrie, Neil Shear, Scott Walsh & Matthew Cheung, updated May 2007, http://sunnybrook.ca/uploads/Primary_Skin_Lymphomas.pdf 20. Jacobsen, E. D. (2015) Stem cell transplantation for mycosis fungoides/Sézary syndrome, in Clinical Guide to Transplantation in Lymphoma (eds B. N. Savani and M. Mohty), John Wiley & Sons, Ltd, Chichester, UK. doi: 10.1002/9781118863282.ch23

B. Citations from Journals Α/Α Όνοµα Συγγραφέως Περιοδικό Τόµος Σελίδα Έτος 1 Schmitz N Semin Hematol 51 67 2014 2 De Masson A Haematologica 99 327 2014

3 Atalla A Annes Brasileiros de 88 216 2013 Dermatologia 369

4 Illidge T Br J Cancer 109 2566 2013 5 Schlaak M Critical Reviews in 85 21 2013 Oncology/Hematology 6 Brocolli A Leukemia Lymphoma 54 1792 2013

7 Poligone B Seminars in Cutaneous 31 25 2012 medicine and Surgery 8 Julia A J Egyptian Womens 9 1 2012 Dermatologic Society 9 Izu-Belloso RM Actas Dermo-Sifiliografica 103 694 2012

10 Blum T Current Treatment Options in 13 102 2012 Oncology 11 Paralkar VR Bone Marrow Transplant 47 940 2012

12 Delioukina M Bone Marrow Transplant 47 65 2012

13 Fukushima, T. International Journal of 88 596 2009 Hematology 14 Di LuccaChrisment Annales de Dermatologie et de 136 800 2009 Venereologie 15 Yonekura, K Biotherapy 23 441 2009 16 Zic, J.A. Dermatologic Therapy 22 407 2009 17 Wu, P.A. Biology of Blood and Marrow 15 982 2009 Transplantation 18 Samant, R.S British Journal of Radiology 82 e122 2009 19 van Besien, K. Biology of Blood and Marrow 15 554 2009 Transplantation 20 Gardner, J.M. Current Opinion in Oncology 21 131 2009 21 Cudillo, L Bone Marrow Transplantation 43 347 2009 22 Kahata, K. Acta Haematologica 120 14 2008 23 Pérez-Barrio, S. Actas Dermo-Sifiliograficas 99 560 2008 24 Capriotti, E. Leukemia and Lymphoma 49 1190 2008 25 Yonekura, K. Bone Marrow Transplantation 41 1029 2008 26 Duarte, R.F. Journal of the American 41 597 2008 Academy of Dermatology 27 Introcaso, C.E. Journal of the American 58 592 2008 Academy of Dermatology 28 Horwitz, S.M. JNCCN 6 436 2008 29 Introcaso, C.E. Journal of the American 58 645 2008 Academy of Dermatology 30 Smith, B.D. Current Problems in Cancer 32 43 2008 31 Heald, P Expert Review of Dermatology 3 99 2008 32 Zinzani, P.L. Critical Reviews in 65 172 2008 Oncology/Hematology 33 Fukusima T Ind J Hematol 88 596 2008 34 Quereux G Clinical Advances in 6 7 2008 Hematology&Oncology 35 Guillermo-Villanova V Gac Med Mex 143 249 2007 370

36 Liu, V. New England Journal of 357 2496 2007 Medicine 37 Guillermo-Villanueva, Gaceta Medica de Mexico 143 249 2007 V.A. 38 Gabriel, I.H. Bone Marrow Transplantation 40 401 2007 39 Whittaker, S.J. Cancer Treatment Reviews 33 146 2007 40 Ko, C.J Advances in Dermatology 22 259 2006 41 Duvic, M. British Journal of Cancer 95 S13 2006 (supp. 1) 42 Querfeld, C. Community Oncology 3 10 2006 SUPP 43 Kim, E.J. Current Oncology Reports 8 376L. 5 2006 44 Smith, S.M. Current Treatment Options in 7 295 2006 Oncology 45 Cetkovská, P Cesko-Slovenska 81 69 2006 Dermatologie 46 Scarisbrick J Expert Review of Dermatology 1 569 2006

47 Latkowski JA J Clin Aesth Dermatol 2 2009 48 Prince HM Blood 114 4337 2009 49 Zain J Exp Rev Hematol 3 187 2010 50 Duvic M J Clin Oncol 28 2365 2010 51 Galper SL Oncology 24 2010 52 Porcu P Clin Lymphoma Myeloma 10 S109 2010 (suppl 2) 53 Devine SM Clin Lymphoma Myeloma 10 S96 2010 (suppl 2) 54 Beylot-Barry M Annales de Deratologie et de 137 611 2010 Venereologie 55 Hallermann C Best Practice Onkologie 5 4 2010 56 Duarte RF J Clin Oncol 28 4492 2010 57 Tsuji H J Dermatol 37 1040 2010 58 Costello R Hematologie 17 411 2011 59 Herbert K Leuk Lymphoma 52 935 2011 60 Olsen EA J Am Acad Dermatol 64 352 2011 61 Jurkovicova J Medicina Clinica 136 317 2011 62 Ramsdale E Leuk Lymphoma 52 938 2011 63 Zain J Leuk Lymphoma 52 1463 2011 64 Van Besien K Current Opinion in Oncol 23 681 2011 65 Bucher S Journal of the Dermatology 3 18 2011 Nurses’ Association 66 Bucher S Journal of the Dermatology 3 75 2011 Nurses’ Association 67 Schlaak M Transplant Immunology 25 163 2011 68 Lechowicz, M.J Bone Marrow Transplantation 49 1360 2014 69 Moriarty B Expert Review of Hematology 8 159 2015 70 Aldoss I Cancer Treatment and 165 329 2015 Research 371

71 Panchal MR OncoTargets and Therapy 8 367 2015

72 Pawar R Case Reports in Hematology Volume 2014 ID: 2014 743856, †: doi: 10.3324/haematol.2013.098145

• PANGALIS GA, KYRTSONIS MC, KONTOPIDOU FN, SIAKANTARIS MP, DIMOPOULOU MN, VASSILAKOPOULOS TP, TZENOU T, KOKORIS S, DIMITRIADOU E, KALPADAKIS C, TSALIMALMA K, TSAFTARIDIS P, PANAYIOTIDIS P, ANGELOPOULOU MK . Differential diagnosis of Waldenstrom's Macroglobulinemia and other B-cell disorders. Clinical Lymphoma, 5(4): 235-240, 2005. Α. Citations from Books, Medical sites and other Literature 1. ΑΙΜΑΤΟΛΟΓΙΑ ΣΤΗΝ ΚΛΙΝΙΚΗ ΠΡΑΞΗ , Πάγκαλης ΓΑ , Εκδόσεις Π.Χ. Πασχαλίδης , Αθήνα 2008, ISBN 978-960-399-776-4 ( Κεφ . 54: Μακροσφαιριναιµία του Waldenstrom, σελ . 815-821). 2. Λεµφώµατα Οριακής Ζώνης . Κλινική και Εργαστηριακή Μελέτη . Χριστίνα Καλπαδάκη , ∆ιδακτορική ∆ιατριβή , Ιατρική Σχολή Εθνικού και Καποδιστριακού Πανεπιστηµίου Αθηνών , Αθήνα , 2008. 3. Sheila Aparecida Coelho Siqueira. Thesis: Contribuicao da imuno- histoquimica para a classificacao dos linfomas de pequenas celulas B. Sao Paulo 2005. 4. Molecular Pathology of Haematolymphoid diseases, Molecular Pathology, Library 4. Dunphy CH (ed.). Springer Science + Business Media, LLC 2010 (Chapter 18: Lymphoplasmacytic lymphoma, by Lin P, DOI: 10.1007/978-1- 4419-5698-9_18, pp 233-239). 5. Kyrtsonis MC, Koulieris E, Bartzis V, Pessah I, Nikolaou E, Karali V, Maltezas D, Panayiotidis P, Harding SJ. Chapter 2: Monoclonal Immunoglobulin. http://dx.doi.org/10.5772/55855 . INTECH, pp. 13-37, 2013.

B. Citations from Journals Α/Α Όνοµα Συγγραφέως Περιοδικό Τόµος Σελίδα Έτος 1 Bryce AH Am J Hematol 81 511 2006 2 McMaster ML Am J Hum Genet 79 695 2006 3 Pangalis GA Haematologica /The HJ 92(6S2 74 2007 4 Adam Z Vnitrni Lekarstvi 53 1325 2007 5 Adam Z Vnitrni Lekarstvi 54 68 2008 6 Kimby E Haematologica /The HJ 2 294 2008 7 Leleu X Cancer Lett 270 95 2008 8 Leleu X Eur J Haematol 82 1 2009 9 Cavaco R Rev Portug Pneumol 14 869 2008 10 Mohamed G Rev Med Intern 30 279 2009 11 Wang H J Leuk Lymph 18 160 2009 12 Poulain S Rev Med Intern 31 385 2010 13 Kyrtsonis MC Clin Lymph Myel Leuk 11 99 2011 14 Lin P Am J Clin Patho l 136 195 2011 15 Kyrtsonis MC Am J Med Med Sci 2 136 2012 16 Levidou G Curr Angiogenesis 2 110 2013 372

17 Rizzo D Leukemia 29 337 2015 18 Coimbra S Rev Assoc Med Bras 60 490 2014 19 Kyrtsonis MC BioMED Res Intern 2015 12808 2014 20 Castillo JJ Br J Ha ematol 169 81 2015

• KORKOLOPOULOU P, THYMARA I, KAVANTZAS N, VASSILAKOPOULOS TP, ANGELOPOULOU MK , KOKORIS SI, DIMITRIADOU E, SIAKANTARIS MP, ANARGYROU K, PANAYIOTIDIS P, TSENGA A, ANDROULAKI A, DOUSSIS- ANAGNOSTOPOULOU I, PATSOURIS E, PANGALIS GA. Angiogenesis in Hodgkin's lymphoma: A morphometric approach in 286 patients with prognostic implications. Leukemia, 19(6): 894-900, 2005 Α. Citations from Books, Medical sites and other Literature 1. Antiangiogenic Cancer Therapy, Davis DW, Herbst RS, Abbruzzese JL (eds.), CRC Press, Taylor & Francis Group, New York, 2008, ISBN-13: 978-0-8493- 2799-5 (Chapter 4: Pathophysiologic role of VEGF in hematologic malignancies, by Podar K, Kumar S, Chauhan D, Anderson KC, pp 129). 2. Antiangiogenic Cancer Therapy, Davis DW, Herbst RS, Abbruzzese JL (eds.), CRC Press, Taylor & Francis Group, New York, 2008, ISBN-13: 978-0-8493- 2799-5 (Chapter 28: Antiangiogenic therapy in hematologic malignancies, by Yee KWL, Giles FL, pp 704). 3. Αγγειογένεση στο λέµφωµα Hodgkin: Μορφοµετική µελέτη και προγνωστική σηµασία επί 286 ασθενών . Ειρήνη Α. Θυµαρά . ∆ιδακτορική ∆ιατριβή , Ιατρική Σχολή Εθνικού και Καποδιστριακού Πανεπιστηµίου Αθηνών , Αθήνα , 2008. 4. Έκφραση των Πρωτεϊνών bcl-2, bax, bcl-x και fas-ligand στη νόσο Hodgkin. Συσχέτιση µε την έκφραση της πρωτεϊνης p53, την παρουσία του ιού EBV και κλινικοεργαστηριακές παραµέτρους . Ηλίας ∆ράκος , ∆ιδακτορική ∆ιατριβή , Ιατρική Σχολή Εθνικού και Καποδιστριακού Πανεπιστηµίου Αθηνών , Αθήνα , Ιούνιος 2008. 5. ΑΙΜΑΤΟΛΟΓΙΑ ΣΤΗΝ ΚΛΙΝΙΚΗ ΠΡΑΞΗ , Πάγκαλης ΓΑ , Εκδόσεις Π.Χ. Πασχαλίδης , Αθήνα 2008, ISBN 978-960-399-776-4 ( Κεφ . 35: Λέµφωµα Hodgkin, σελ . 615-639). 6. Λεµφώµατα Οριακής Ζώνης . Κλινική και Εργαστηριακή Μελέτη . Χριστίνα Καλπαδάκη , ∆ιδακτορική ∆ιατριβή , Ιατρική Σχολή Εθνικού και Καποδιστριακού Πανεπιστηµίου Αθηνών , Αθήνα , 2008. 7. Μελέτη της προγνωστικής αξίας της αγγειογένεσης του µυελού των οστών σε ασθενείς µε πολλαπλούν µυέλωµα . Κωνσταντίνος Αθ . Αναργύρου , ∆ιδακτορική ∆ιατριβή , Ιατρική Σχολή Εθνικού και Καποδιστριακού Πανεπιστηµίου Αθηνών , Αθήνα , 2008. 8. Implication des galectines-1 et -3 dans l’ angiogenese et en particulier en ce qui cencerne les lymphomes. D’ Haene Nicky, Universite Libre de Bruxelles, Laboratoire d’ Anatomie Pathologique, Hopital Erasme, 2010-2011. 9. Novak EM: Physiopathogenesis of Hematological Cancer. 2012, Bentham Science Publishers Ltd. ISBN: 978-160805588-3 (Chapter: Novak EM. Hematological neoplasia and angiogenesis: a review, pp 122-150, DOI: 10.2174/978160805259211201010122). 373

10. Ribatti D: History of research on tumor angiogenesis. 2009, Sprimger, Netherlands. ISBN: 978-140209563-4; 978-140209559-7, pp 1-125, DOI: 10.1007/978-1-4020-9563-4).

B. Citations from Journals Α/Α Όνοµα Συγγραφέως Περιοδικό Τόµος Σελίδα Έτος 1 Kadowaki I Br J Haematol 130 869 2005 2 Glimelius I Leukemia 19 2360 2005 3 Mainou -Fowler Leuk Lymphoma 47 223 2006 4 Visco C Eur J Haematol 77 387 2006 5 Birrer MJ J Clin Oncol 25 2281 20 07 6 Zini JM Bull Cancer 94 241 2007 7 Kowalska M Nowotwory 57 409 2007 8 Enblad G Hematol Oncol Clin North Am 21 805 2007 9 Nico B Histol Histopathol 23 601 2008 10 Paydas S Leuk Res 32 1424 2008 11 Passam FH Pathol Res Pract 205 11 2009 12 Paydas S Leuk Res 33 1627 2009 13 Mucci LA J Clin Oncol 27 5627 2009 14 Ocur FV Pediatr Blood Cancer 55 1272 2010 15 Dincaslan HU Pediatr Hematol Oncol 27 503 2010 16 Janjic T Medicinski Podmladak 59 37 2008 17 Wolowiec D Acta Haematol Polon 42 357 2011 18 Guarini A Curr Med Chem 19 945 2012 19 Panico L Leuk Lymphoma 54 2418 2013 20 Vadasz Z Appl Immun Mol Morphol 21 177 2013 21 Koh YW Am J Surg Pathol 37 1242 2013 22 Minoia C Br J Haematol 163 640 2013 23 Mikalsen LTG PLoS One 8 e7595 2013 24 Koh YW PLoS One 9 e8706 2014 25 Dimtsas GS Leuk Lymphoma 55 558 2014 26 Cogle CR Leukemia 28 1978 2014 27 Marinaccio C Leuk Res 38 857 2014 28 Palomero J Blood 124 2235 2014

• VASSILAKOPOULOS TP, NADALI G, ANGELOPOULOU MK , DIMOPOULOU MN, SIAKANTARIS MP, KONTOPIDOU FN, KARKANTARIS C, KOKORIS SI, DIMITRIADOU EM, CALPADAKI C, SARANTOPOULOS A, GALANI Z, SACHANAS S, KYRTSONIS M-C, TSAFTARIDIS P, VARIAMIS E, PANAYIOTIDIS P, PIZZOLO G, SARRIS AH, PANGALIS GA.

β2-microglobulin in Hodgkin’s lymphoma: Prognostic significance in patients treated with ABVD or equivalent regimens. Journal of the Balcanic Union of Oncology, 10: 59-69, 2005.

A. Citations from Journals Α/Α Όνοµα Συγγραφέως Περιοδικό Τόµος Σελίδα Έτος 1 Milanovic N J BUON 17 497 2012 374

2 Ma ya GC Medicina Laboratorio 16 411 2010

• PANGALIS GA, VASSILAKOPOULOS TP, KALPADAKIS C, KYRTSONIS M-C, KOKORIS SI, ANGELOPOULOU MK , PANAYIOTIDIS P. Treatment of indolent lymphomas: from watch and wait to high dose therapy. Hematology, 10 (Suppl.1): 6-9, 2005. Α. Citations from Books, Medical sites and other Literature 1. Μονογραφή Της Ηµερίδας Με Θέµα : ‘‘ Οζώδη Λεµφώµατα , Χρόνια Λεµφοκυτταρική Λευχαιµία και Λεµφώµατα Οριακής Ζώνης ’’ Του Τµήµατος Λεµφοϋπερπλαστικών Νόσων Της Ελληνικής Αιµατολογικής Εταιρίας , Αθήνα , 22-23 Σεπτεµβρίου 2006. ( Κεφάλαιο : Οζώδη λεµφώµατα – Θεραπεία αρχικών σταδίων νόσου . Κοκόρη ΣΙ , Αγγελοπούλου ΜΚ , Σιακαντάρη ΜΠ , Κοντοπίδου ΦΝ , Τσαφταρίδης Π, ∆ηµητριάδου ΕΜ , Πλατά Ε, Κυρτσώνη ΜΧ , Βασιλακόπουλος ΘΠ , Καλπαδάκη Χ, Σαχανάς Σ, Γαλάνη Ζ, ∆ηµοπούλου ΜΝ , Κορκολοπούλου Π, Πατσούρης Ε, Πάγκαλης ΓΑ , σελ . 30-36). 2. ΑΙΜΑΤΟΛΟΓΙΑ ΣΤΗΝ ΚΛΙΝΙΚΗ ΠΡΑΞΗ , Πάγκαλης ΓΑ , Εκδόσεις Π.Χ. Πασχαλίδης , Αθήνα 2008, ISBN 978-960-399-776-4 ( Κεφ . 38: Οζώδη λεµφώµατα , σελ . 666-675). 3. ΑΙΜΑΤΟΛΟΓΙΑ ΣΤΗΝ ΚΛΙΝΙΚΗ ΠΡΑΞΗ , Πάγκαλης ΓΑ , Εκδόσεις Π.Χ. Πασχαλίδης , Αθήνα 2008, ISBN 978-960-399-776-4 ( Κεφ . 40: Σπληνικό λέµφωµα οριακής ζώνης , σελ . 685-688). 4. ΕΣΩΤΕΡΙΚΗ ΠΑΘΟΛΟΓΙΑ , από το ∆ιδακτικό και Επιστηµονικό Προσωπικό του Τοµέως Παθολογίας , Εκδόσεις ΠΑΣΧΑΛΙ∆Η , 2 η Έκδοση , 2010, ISBN 978-960-399-951-5, Αθήνα ( Κεφάλαιο : Θ. Βασιλακόπουλος , Μ. Αγγελοπούλου , Μ. Σιακαντάρη , Γ. Πάγκαλης ,Χ. Κυρτσώνη , Σ. Κοκόρη , Χ. Καλπαδάκη , Φ. Κοντοπίδου , Ε. ∆ηµητριάδου , Μ. ∆ηµοπούλου : Κακοήθη λεµφώµατα και χρόνια λεµφογενής λευχαιµία . σελ . 1386-1403).

B. Citations from Journals

Α/Α Όνοµα Συγγραφέως Περιοδικό Τόµος Σελίδα Έτος 1 Pangalis GA Eur J Hosp Pharm Pract 12 59 2006 2 Pangalis GA Turkish J Hematol 23 (S2) 54 2006 3 Kalpadakis C Hematol Oncol 25 127 2007

• VASSILAKOPOULOS TP, KYRTSONIS M-C, PAPADOGIANNIS A, NADALI G, ANGELOPOULOU MK , TZENOU T, DIMOPOULOU MN, SIAKANTARIS MP, KONTOPIDOU FN, CALPADAKIS C, KOKORIS SI, DIMITRIADOU EM, TSAFTARIDIS P, PIZZOLO G, PANGALIS GA. Serum levels of soluble syndecan-1 in Hodgkin’s lymphoma. Anticancer Research, 25 (6C): 4743-4746, 2005. Α. Citations from Books, Medical sites and other Literature 375

1. ΑΙΜΑΤΟΛΟΓΙΑ ΣΤΗΝ ΚΛΙΝΙΚΗ ΠΡΑΞΗ , Πάγκαλης ΓΑ , Εκδόσεις Π.Χ. Πασχαλίδης , Αθήνα 2008, ISBN 978-960-399-776-4 ( Κεφ . 35: Λέµφωµα Hodgkin, σελ . 615-639). 2. Zong Fang (Thesis). Studies on syndecan-1 in mesenchymal tumors. Karolinska Instituten, 2010.

B. Citations from Journals Α/Α Όνοµα Συγγραφέως Περιοδικό Τόµος Σελίδα Έτος 1 Chakravarti R BMC Genomics 7 83 2006 2 Fears CY Matrix Biology 25 443 2006 3 Contreras HR Rev Med Chile 138 95 2010 4 Manon -Jensen T FEBS J 277 3876 2010 5 Iozzo RV J Cell Mol Med 15 1013 2011 6 Ramani VC FEBS J 280 2294 2013 7 Manon -Jensen FEBS J 280 2320 2013 8 Attia FM Comp Clin Pathol 07 Feb 2013 9 Gharbaran R J Hematol Oncol 6 62 2013 10 Szatmari T Front O ncol 3 00310 2013 11 Ibbott GS Front Oncol 3 00311 2013 12 Palailogou M Histol Histopathol 29 177 2014 13 Gharbaran R Crit Rev Oncol Hematol 2014 14 Barbouri D Font Oncol 4 4 2014 15 Kovalszky I Biochim Biophys Acta 1840 2491 2014 16 Abdelmohsen SE Comp Clin Pathol 23 855 2014 17 Gharbaran R Crit Rev Oncol Hematol 94 1 2015 18 Cigliana G J Exp Clin Cancer Res 23 Apr 2015

• VASSILAKOPOULOS TP, ANGELOPOULOU MK , SIAKANTARIS MP, KONSTANTINOU N, SYMEONIDIS A, KARMIRIS TH, REPOUSSIS P, ROUSSOU PA, DIMOPOULOS MA, KOKORIS SI, DIMITRIADOU EM, KYRTSONIS MC, DIMOPOULOU MN, TSATALAS K, KOKKINIS G, VRAKIDOU E, GRIGORAKIS V, POZIOPOULOS CH, STAMATELOU M, LIAPIS D, GEORGIOU G, PANAYIOTIDIS P, PANGALIS GA. Pure infradiaphragmatic Hodgkin’s lymphoma: Clinical features, prognostic factors and comparison with supradiaphragmatic disease. Haematologica, 91: 32-39, 2006. Α. Citations from Books, Medical sites and other Literature 1. Hodgkin Lymphoma, Hoppe RT, Mauch PT, Armitage JO, Diehl V, Weiss LM (eds.), Wolters Kluwer Health; Lippincott Williams & Wilkins, Philadelphia, 2007, ISBN-13: 978-0-7817-6422-3; ISBN-10: 0-7817-6422-X (Chapter 17: Treatment of unfavorable-prognosis, stage I-II Hodgkin Lymphoma, by Hoppe RT, Engert A, Noordijk EM, pp 241-252). 2. PEREZ AND BRADY’S PRINCIPLES AND PRACTICE OF RADIATION ONCOLOGY, 5 th Edition, Halperin EC, Perez CA, Brady LW, Wazer DE, Freeman C (eds.), Wolters Kluwer Health; Lippincott Williams & Wilkins, Philadelphia, 2008, ISBN-13: 978-0-7817-6369-1; ISBN-10: 0-7817-6369-X (Chapter 75: Hodgkin Lymphoma, by Hoppe RT, pp 1721-1738). 376

3. ΑΙΜΑΤΟΛΟΓΙΑ ΣΤΗΝ ΚΛΙΝΙΚΗ ΠΡΑΞΗ , Πάγκαλης ΓΑ , Εκδόσεις Π.Χ. Πασχαλίδης , Αθήνα 2008, ISBN 978-960-399-776-4 ( Κεφ . 35: Λέµφωµα Hodgkin, σελ . 615-639). 4. ΕΣΩΤΕΡΙΚΗ ΠΑΘΟΛΟΓΙΑ , από το ∆ιδακτικό και Επιστηµονικό Προσωπικό του Τοµέως Παθολογίας , Εκδόσεις ΠΑΣΧΑΛΙ∆Η , 2 η Έκδοση , 2010, ISBN 978-960-399-951-5, Αθήνα ( Κεφάλαιο : Θ. Βασιλακόπουλος , Μ. Αγγελοπούλου , Μ. Σιακαντάρη , Γ. Πάγκαλης ,Χ. Κυρτσώνη , Σ. Κοκόρη , Χ. Καλπαδάκη , Φ. Κοντοπίδου , Ε. ∆ηµητριάδου , Μ. ∆ηµοπούλου : Κακοήθη λεµφώµατα και χρόνια λεµφογενής λευχαιµία . σελ . 1386-1403). 5. UpToDate (www.uptodate.com ) ( Κεφάλαιο : Hoppe RT, Mauch PM: Treatment of unfavorable prognosis early (stage I-II) classical Hodgkin lymphoma, Last update 10.02.2011, συνεχίζεται έως σήµερα ). 6. British Committee for standards in Haematology. Follows GA, Ardeshna KM, Barrington SF, Culligan DJ, Hoskin PJ, Linch D, Sadullah S, Williams MV, Wimperis JZ. Guidelines for the first line management of classical Hodgkin lymphoma. February 2014

B. Citations from Journals Α/Α Όνοµα Συγγραφέως Περιοδικό Τόµος Σελίδα Έτος 1 Friedberg J Haematologica 91 1 2006 2 Kolygin BA Haema 10 147 2007 3 Pavone V Ann Oncol 19 763 2008 4 Matasar MJ Radiol Clin North America 46 175 2008 5 Bien E Scand J Immunol 70 490 2009 6 Vassilakopoulos TP Arch Hellen M ed 29 130 2012 7 Word MH Blood Lym Ca: Targ Theor 2 29 2012 8 Πάγκαλης ΓΑ ΑΙΜΑ 3 203 2012 9 Βασιλακόπουλος ΘΠ ΑΙΜΑ 3 212 2012 10 Κοντοπίδου ΦΝ ΑΙΜΑ 3 298 2012 11 Follows GA Br J Haematol 166 34 2014 12 Nakajima Y Leuk Res 39 198 2015 13 Keraliya AR Insights into Imaging 6 381 2015

• KRISHNAN A, NADEMANEE A, FUNG H, ANGELOPOULOU M , MOLINA A, GAAL K, DAGIS A, PALMER J, ALVARNAS J, SLOVAK M, KOGUT N, POPPLEWELL L, RODRIGUEZ R, SCHRIBER J, WANG S, FORMAN SJ.

Does follicularity in large cell lymphoma predict outcome after autologous stem cell transplantation? \

Biol Blood Marrow Transplant. 2006;12:641-7 A. Citations from Journals Α/Α Όνοµα Συγγραφέως Περιοδικό Τόµος Σελίδα Έτος 1 Guillem VM Leuk Lymphoma 52 1249 2011 2 Oliansky DM Biol Blood Marrow 16 443 2010 3 Bierman PJ CancerTransplant Treat Res 144 357 2009 377

4 Tan D Cancer and Chemotherap 4 199 2009 5 Papajik, T. NeoplasmaReviews 55 215 2008 6 Buske, C Leukemia and Lymphoma 49 18 2008 7 Sigal DS Expert Review of 8 535 2008 Anticancer Therapy 8 Pham RN Bone Marrow 40 1039 2007 Transplantation 9 Bierman, P.J. Current Opinion in 19 433 2007 Oncology

• LILAKOS K, VINIOU NA, MAVROGIANNIS D, VASSILAKOPOULOS TP, DIMOPOULOU MN, PLATA E, ANGELOPOULOU MK , VARIAMIS E, STAVROGIANNI N, LIAPIS D, XILOURIS I, GALANOPOULOS A, AGELOUDIS M, PANAYIOTIDIS P, VOULGSRELIS M, ROMBOS J, MELETIS J, YATAGANAS X, PANGALIS GA. FLT3 overexpression in APL patients without detectable FLT3-ITD or codon 835-836 mutations: a pilot study. Anticancer Research, 26 (2 Α): 1201-1207, 2006.

A. Citations from Journals Α/Α Όνοµα Συγγραφέως Περιοδικό Τόµος Σελίδα Έτος 1 Nin DS PLoS One 7 E3450 2012 2 Farawela HM J Cancer Res Clin Oncol 140 1323 2014

• PANGALIS GA, KYRTSONIS M-C, VASSILAKOPOULOS TP, DIMOPOULOU MN, SIAKANTARIS MP, EMMANOUILIDES C, DOUFEXIS D, SACHANAS S, KONTOPIDOU FN, KALPADAKIS C, ANGELOPOULOU MK , DIMITRIADOU EM, KOKORIS SI, PANAYIOTIDIS P. Immunotherapeutic and immunoregulatory drugs in haematologic malignancies. Current Topics in Medicinal Chemistry, 6: 1657-1686, 2006 . Α. Citations from Books, Medical sites and other Literature 1. Αλληλεπιδράσεις µυελωµατικών κυττάρων και κυττάρων στρώµατος µυελού των οστών : Συσχέτιση των ευρηµάτων µε την παθογένεια , την κλινική ετερογένεια και την πρόγνωση του πολλαπλού µυελώµατος . Αργυρούλα Ι. Παπαδόγιαννη , ∆ιδακτορική ∆ιατριβή , Ιατρική Σχολή Εθνικού και Καποδιστριακού Πανεπιστηµίου Αθηνών , Αθήνα , 2007. 2. ΑΙΜΑΤΟΛΟΓΙΑ ΣΤΗΝ ΚΛΙΝΙΚΗ ΠΡΑΞΗ , Πάγκαλης ΓΑ , Εκδόσεις Π.Χ. Πασχαλίδης , Αθήνα 2008, ISBN 978-960-399-776-4 ( Κεφ . 38: Οζώδη λεµφώµατα , σελ . 666-675). 378

3. ΑΙΜΑΤΟΛΟΓΙΑ ΣΤΗΝ ΚΛΙΝΙΚΗ ΠΡΑΞΗ , Πάγκαλης ΓΑ , Εκδόσεις Π.Χ. Πασχαλίδης , Αθήνα 2008, ISBN 978-960-399-776-4 ( Κεφ . 41: ∆ιάχυτο λέµφωµα από µεγάλα Β-κύτταρα και συναφείς οντότητες , σελ . 689-701). 4. ΑΙΜΑΤΟΛΟΓΙΑ ΣΤΗΝ ΚΛΙΝΙΚΗ ΠΡΑΞΗ , Πάγκαλης ΓΑ , Εκδόσεις Π.Χ. Πασχαλίδης , Αθήνα 2008, ISBN 978-960-399-776-4 ( Κεφ . 48: ∆ερµατικά λεµφώµατα , σελ . 753-767). 5. ΑΙΜΑΤΟΛΟΓΙΑ ΣΤΗΝ ΚΛΙΝΙΚΗ ΠΡΑΞΗ , Πάγκαλης ΓΑ , Εκδόσεις Π.Χ. Πασχαλίδης , Αθήνα 2008, ISBN 978-960-399-776-4 ( Κεφ . 83: Χρήση µονοκλωνικών αντισωµάτων στην Αιµατολογία , σελ . 1272-1279). 6. APOPTOSIS IN CARCINOGENESIS AND CHEMOTHERAPY: APOAPTOSIS IN CANCER, by Chen GG, Lai PBS, Springer Science+Business Media B.V. 2009, ISBN 978-1-4020-9596-2, e-ISBN 978- 1-4020-9597-9, DOI: 10.1007/978-1-4020-9597-9_8 (Chapter 8: Apoptosis and the tumor microenvironment in hematologic malignancies, by Yarde DN, Tao J, pp 193-218). 7. Cancer Management in Man: Chemotherapy, Biological Therapy, Hyperthermia and Supporting Measures. Cancer Growth and Progression, Springer 2011, DOI: 10.1007/978-90-481-9704-0_11 (Chapter: Targeting the tumor microenvironment for enhancing chemotherapy in hematologic malignancies, by Crespo LA, Zhang X, Tao J, vol. 13 part 1, pp 215-233). 8. Multiple Myeloma: An overview. Gupta A (ed.). InTech – Open Access Publisher 2012, ISBN 978-953-307-768-0. (Chapter 8: The contribution of prognostic factors to the better management of multiple myeloma patients, by Kyrtsonis MC, Maltezas D, Koulieris E, Bitsani K, Pessach I, Efthymiou A, Bartzis V, Tzenou T, Panayiotidis P. pp. 145-174).

B. Citations from Journals Α/Α Όνοµα Συγγραφέως Περιοδικό Τόµος Σελίδα Έτος 1 Pangalis GA Eur J Hosp Pharm Pract 12 59 2006 2 Pangalis GA Turkish J Hematol 23 (S2) 54 2006 3 Kalpadakis C Hematol Oncol 25 127 2007 4 Kashiwagi H Mol Cancer 6 48 2007 5 Van Egmond M Exp Opin Biol Ther 8 83 2008 6 Anargyrou K Haematologica /The HJ 93 451 2008 7 Cao WQ Am J Clin Pathol 129 926 2008 8 Angelopoulou MK Leuk Lymphoma 49 1817 2008 9 Iwona HUS Acta Haematol Polon 39 707 2008 10 Pascal L Exp Opin Pharmacother 10 909 2009 11 Παπαδαυίδ Ε Αίµα ( Haema) 1 72 2010 12 Kyrtsonis MC Asia -Pac J Oncol Hem 2 29 2010 13 Sachanas S Leuk Lymphoma 52 387 2011 14 Kyrtsonis MC Appl Clin Genet 3 41 2010 15 Bae JE Trends Biopharm Industr 4 63 2008 16 Seamans TC BioProcess Int March 26 2008

• VASSILAKOPOULOS TP, ANGELOPOULOU MK , PANGALIS GA. Treatment strategies for pediatric nodular lymphocyte predominant Hodgkin’s lymphoma. Leukemia and Lymphoma, 47: 1450-1451, 2006.

379

B. Citations from Journals Α/Α Όνοµα Συγγραφέως Περιοδικό Τόµος Σελίδα Έτος 1 Lee AI Oncologist 14 739 2009 2 Βασιλακόπουλος ΘΠ Haema 12 169 2009 3 Aksu G Turk Oncol Derg 22 118 2007 4 Shankar A Br J Haematol 159 288 2012 5 Κοντοπίδου ΦΝ ΑΙΜΑ 3 298 2012

• KYRTSONIS MC, VASSILAKOPOULOS TP, KAFASI N, SACHANAS S, TZENOU T, PAPADOGIANNIS A, GALANIS Z, KALPADAKIS C, DIMOU M, KYRIAKOU E, ANGELOPOULOU MK , DIMOPOULOU MN, SIAKANTARIS MP, DIMITRIADOU EM, KOKORIS SI, PANAYIOYIDIS P, PANGALIS GA. Prognostic value of serum free light chain ratio (FLCR) at diagnosis in multiple myeloma (MM). British Journal of Haematology, 137(3), 240-243, 2007. Α. Citations from Books, Medical sites and other Literature 1. Mead G. Free light chain analysis in multiple myeloma. 2007 Lymphoma & Myeloma, October 18-20, 2007, pp 29-30. 2. Bradwell AR. Serum Free Light Chain Analysis (plus Hevylite). Fifth Edition. AR Bradwell, ISBN 0704427028, 978087044227020, 2008. 3. ΑΙΜΑΤΟΛΟΓΙΑ ΣΤΗΝ ΚΛΙΝΙΚΗ ΠΡΑΞΗ , Πάγκαλης ΓΑ , Εκδόσεις Π.Χ. Πασχαλίδης , Αθήνα 2008, ISBN 978-960-399-776-4 ( Κεφ . 53: Πολλαπλούν Μυέλωµα , σελ . 795-814). 4. Killingsworth LM. Free Light Chain Assays. Test Update – Quick Facts, January 2009. 5. Sigurdur Yngvi Kristinsson. Thesis: Population-dased studies on familiality and prognosis in patients with monoclonal gammopathies. Karolinska Institutet, Stockholm, Sweden, 2009. 6. Multiple Myeloma: An overview. Gupta A (ed.). InTech – Open Access Publisher 2012, ISBN 978-953-307-768-0. (Chapter 8: The contribution of prognostic factors to the better management of multiple myeloma patients, by Kyrtsonis MC, Maltezas D, Koulieris E, Bitsani K, Pessach I, Efthymiou A, Bartzis V, Tzenou T, Panayiotidis P. pp. 145-174). 7. Rao M, Lamont JL, Chan J, Concannon TW, Comenzo R, Ratichek SJ, Avendano EE. Serum Free Light Chain Analysis for the Diagnosis, Management, and Prognosis of Plasma Cell Dyscrasias: Future Research Needs. Future Research Needs Paper No. 23. (Prepared by Tufts Evidence- based Practice Center under Contract No. 290-2007-10055-I.) AHRQ Publication No. 12-EHC135-EF. Rockville, MD: Agency for Healthcare Research and Quality. September 2012. www.effectivehealthcare.ahrq.gov/reports/final.cfm (identified through Googlescholar). 8. Kyrtsonis MC, Koulieris E, Bartzis V, Pessah I, Nikolaou E, Karali V, Maltezas D, Panayiotidis P, Harding SJ. Chapter 2: Monoclonal Immunoglobulin. http://dx.doi.org/10.5772/55855 . INTECH, pp. 13-37, 2013. 9. Renal failure: Prevention, causes and treatment. Hutchison C (ed.). Nova Science Publishers, Inc., 2013, ISBN : 978-162257824-5. (Chapter: Assessment of monoclonal proteins in patients with renal diseases: New methods and their clinical utility, by Jenner E, Hutchison C, pp 127-142). 380

10. Cohen AD, Fu R, Katzmann J. Serum free light chain analysis for the diagnosis, management, and prognosis of plasma cell dyscrasias. Effective Health Care Program. Comparative Effectiveness Review, Number 73. Agency for Healthcare Research and Quality, August 2012 (identified through GoogleScholar).

B. Citations from Journals Α/Α Όνοµα Συγγραφέως Περιοδικό Τόµος Σελίδα Έτος 1 Dispenzieri A Blood 111 785 2008 2 Pratt G Br J Haematol 141 413 2008 3 Dispenzieri A Blood 111 4908 2008 4 Dispenzieri A Haematologica /The HJ 2 279 2008 5 Beauvillain C Rev Franc Lab 38 37 2008 6 Hutchison CA BMC Nephrology 9 Art.11 2008 7 Snozek CLH Leukemia 22 1933 2008 8 Katzmann JA Clin Chem 54 1753 2008 9 Pratt G Br J Haematol 144 217 2009 10 Dispenzieri A Leukemia 23 215 2009 11 Kyrtsonis MC Semin Hematol 46 110 2009 12 Muss et L Immuno Anal Biol Spec 24 149 2009 13 Kar R Hematology 13 344 2008 14 Giarin MM Clin Chem 55 1510 2009 15 Usnarska -Zubkiewicz L Acta Haematol Polon 40 349 2009 16 Bradwell AR Clin Chem 55 1646 2009 17 Sthaneswar P Clin Chem Lab Med 47 1101 2009 18 Emile C Option/Bio 430 15 2010 19 Yegin ZA Eur J Haematol 84 406 2010 20 Khoriaty R Clin Lymph Myel Leuk 10 10 2010 21 Lonial S Cancer Treat Rev 36(S2) 12 2010 22 Knop S Arzneimitteltherapie 27 309 2009 23 Kumar S Leukemia 24 1498 2010 24 Lopez -Cor ral L Med Clin 135 368 2010 25 Davids MS Am J Hematol 85 787 2010 26 Bosmann M Clin Chem Lab Med 48 1419 2010 27 Kyrtsonis MC Asia -Pac J Oncol Hem in press 28 Scudla V Klin Biochem Metabol 16 76 2008 29 Harousseau JL Clin Lymph Myel Leuk 10 424 2010 30 Ozsan GH Exp Rev Clin Immunol 7 65 2011 31 Wirk B Bone Marrow 46 771 2011 32 Mijuskovic Z J Med Biochem 30 293 2011 33 Lab Clin Pract 25 89 2007 34 Levoguer AM CLI June 2010 35 Katzmann JA Clin Biochem Rev 30 105 2009 36 Barbosa de Carvalho NM Rev Hematol 11 199 2010 37 Lin N J Exp Hematol 17 255 2009 38 Shimazaki C Rinsho Ketsueki 51 245 2010 39 Xou Jian Chin J Pract Int Med 11 1003 2008 40 Shimazaki C Rinsho Ketsueki 51 1491 2010 41 Shao X Chin Clin Oncol 15 250 2010 42 Ya Pi ng Chin J Pract Int Med 1059 2009 43 Kraj M Acta Haematol Pol 42 273 2011 44 Kraj M Nowotwory 61 355 2011 45 Zhu G J Leuk Lymphoma 20 694 2011 46 Tuchman SA Clin Lymph Myel Leuk 11 S70 2011 47 Marjanovic S Vojnosanitetski Pregled 69 209 2012 48 Koul ieris E Exp Hematol Oncol 1 9 2012 381

49 Charafeddine KM Am J Clin Pathol 137 890 2012 50 Beauvillain C Rev Franc Lab 404 37 2008 51 Lachmann HJ Adv Chron Kidn Dis 19 287 2012 52 Yee J Adv Chron Kidn Dis 19 277 2012 53 Hart AJ Biol Bone Marrow Tr an 18 1790 2012 54 Xu Y Leuk Lymphoma 54 123 2013 55 Furtado M Br J Haematol 160 63 2013 56 Bradwell A Leukemia 27 202 2013 57 Ludwig H Leukemia 27 213 2013 58 Murng SHK Clin Exp Immunol 171 201 2013 59 Phillips DP Int J Lab Hematol 35 200 2013 60 Kyrtsonis MC Am J Med Med Sci 2 136 2012 61 Katzmann JA Leukemia 27 1 2013 62 Maltezas D Hematol Oncol 31 356 2013 63 Kyrtsonis MC World J Hematol 2 6 2013 64 Di Noto PLoS One 8 e70811 2013 65 Jenner E Clin Chim Acta 427 15 2014 66 Martin -Gomez M A Nefrologia 33 862 2013 67 Sarris K Adv Hematol 2013 359071 2013 68 Astolfi M Biochimica Clin 37 383 2013 69 Harding S Biochimica Clin 37 365 2013 70 Graziani MS Exp Rev Mol Diagn 14 55 2014 71 Bhole MV Ann Clin Biochem 31 Jan 2014 72 Matschke J J L euk 2 100012 2014 73 Mandal SK BMJ Case Reports 6 Mar 2014 74 Kiba T BMC Cancer 14 462 2014 75 Idrees M KJMS 7 108 2014 76 Rajkumar SV Lancet Oncol 15 e538 2014 77 Nikolaou E Curr Cancer Ther Rev 10 90 2014 78 Barbee MS Cancer 121 853 2015 79 Yagci M Clin Lymphoma Myel 15 98 2015 80 Iriuchishima H Eur J Haematol 94 145 2015 81 Kraj M Leuk Lymphoma 10 Apr 2014 82 Scudla V Vnitrni Lekarstvi 61 60 2015 83 Barley K Clin Lymph Myel Leuk 29 May 2015 84 El Naggar AA Egypt J Immunol 22 2015 85 Rios -Tamayo R J Leuk 3 100018 2015

• KALPADAKIS C, PANGALIS GA, DIMOPOULOU MN, VASSILAKOPOULOS TP, KYRTSONIS M-C, KORKOLOPOULOU P, KONTOPIDOU FN, SIAKANTARIS MP, DIMITRIADOU EM, KOKORIS SI, TSAFTARIDIS P, PLATA E, ANGELOPOULOU MK . Rituximab monotherapy is highly effective in splenic marginal zone lymphoma. Hematological Oncology, 25, 127-131, 2007. Α. Citations from Books, Medical sites and other Literature 1. ΑΙΜΑΤΟΛΟΓΙΑ ΣΤΗΝ ΚΛΙΝΙΚΗ ΠΡΑΞΗ , Πάγκαλης ΓΑ , Εκδόσεις Π.Χ. Πασχαλίδης , Αθήνα 2008, ISBN 978-960-399-776-4 ( Κεφ . 40: Σπληνικό λέµφωµα οριακής ζώνης , σελ . 685-688). 2. ΑΙΜΑΤΟΛΟΓΙΑ ΣΤΗΝ ΚΛΙΝΙΚΗ ΠΡΑΞΗ , Πάγκαλης ΓΑ , Εκδόσεις Π.Χ. Πασχαλίδης , Αθήνα 2008, ISBN 978-960-399-776-4 ( Κεφ . 83: Χρήση µονοκλωνικών αντισωµάτων στην Αιµατολογία , σελ . 1272-1279). 382

3. Λεµφώµατα Οριακής Ζώνης . Κλινική και Εργαστηριακή Μελέτη . Χριστίνα Καλπαδάκη , ∆ιδακτορική ∆ιατριβή , Ιατρική Σχολή Εθνικού και Καποδιστριακού Πανεπιστηµίου Αθηνών , Αθήνα , 2008. 4. ΕΣΩΤΕΡΙΚΗ ΠΑΘΟΛΟΓΙΑ , από το ∆ιδακτικό και Επιστηµονικό Προσωπικό του Τοµέως Παθολογίας , Εκδόσεις ΠΑΣΧΑΛΙ∆Η , 2 η Έκδοση , 2010, ISBN 978-960-399-951-5, Αθήνα ( Κεφάλαιο : Θ. Βασιλακόπουλος , Μ. Αγγελοπούλου , Μ. Σιακαντάρη , Γ. Πάγκαλης ,Χ. Κυρτσώνη , Σ. Κοκόρη , Χ. Καλπαδάκη , Φ. Κοντοπίδου , Ε. ∆ηµητριάδου , Μ. ∆ηµοπούλου : Κακοήθη λεµφώµατα και χρόνια λεµφογενής λευχαιµία . σελ . 1386-1403). 5. Macromolecular Anticancer Therapeutics. Cancer Drug Discovery and Development. Reddy LH, Couvreur P (eds.). Springer Science+Business Media, LLC 2010. DOI: 10.1007/978-1-4419-0507-9_15 (Chapter 15: Monoclonal antibody therapy for hematologic malignancies, by Foon KA, Boyiadzis M, Jacobs SA, pp.493-536). 6. Non-Hodgkin Lymphomas – Second Edition. Armitage JO, Mauch P, Harris NL, Coiffier B, Dalla-favera R (eds.). Wolters Kluwer Health – Lippincott Williams & Wilkins, Philadelphia 2010. (Chapter 16: Splenic Marginal Zone Lymphoma, by Thieblemont C, Berger F, Felman P, Collet-Bauchu E, Coiffier B, pp. 254-259). 7. Ferry JA: Extranodal Lymphomas. 2011, Elsevier Inc. ISBN: 978-141604579- 3 (Chapter: Sohani AR, Zukerberg LR. Lymphomas of the spleen, pp 197- 220, DOI: 10.1016/B978-1-4160-4579-3.10006-3). 8. NCCN Clinical Practice Guidelines in Oncology. Non-Hodgkin’s lymphomas, v. 2.2013 (plus 1.2013 and 3.2012). 9. Rituximab : Pharmacology, clinical uses and health effects. Lake-Bakkar G (ed.). Nova Science Publishers, Inc. 2012, ISBN: 978-162257533-6 (Chapter: Rituximab in the treatment of hematological malignancies, by Townsend WM, Goldstone AH, pp. 47-80). 10. Rare Lymphomas, (Series “Hematologic Malignancies”), Dreyling M, Williams ME (eds.), Springer Berlin, Heidelberg, 2014, Print ISBN 978-3-642-39589-5, Online 978-3-642-39590-1 (Chapter: Non-MALT Marginal Zone Lymphoma, by Thieblemont C, Bernstein S, Rodig S, Delabie J, pp. 241-251, 10.1007/978-3-642-39590-1_13). 11. Handbook of Therapeutic Antibodies, Dubel S, Reichert JM (eds.), Wiley- VCH, Verlag Gmbh & Co, 2014, Print ISBN 9783527329373, Online 9783527682423 (Chapter 70: Rituximab (Rituxan), by Bohnke A, Wenger M, pp. 1909-2022, published online 12 Aug 2014, DOI: 10.1002/9783527682423.ch70).

B. Citations from Journals Α/Α Όνοµα Συγγραφέως Περιοδικό Τόµος Σελίδα Έτος 1 Jacobs SA Exp Opin Biol Ther 7 1749 2007 2 Matutes E Leukemia 22 487 2008 3 Bennett M Hematol Oncol 26 114 2008 4 Angelopoulou MK Leuk Lymphoma 49 1817 2008 5 Landgren O Leuk Lymphoma 49 35 2008 6 Kalpadakis C Leuk Lymphoma 49 2308 2008 7 Zucca E Hem/Onc Clin North Am 22 883 2008 8 Καλπαδάκη Χ Haema Educ 219 2008 9 Abramson JS N Engl J Med 359 2707 2008 10 Niscola P Cancer Chemother Pharmacol 63 759 20 09 11 Brown JR Br J Haematol 145 741 2009 12 Kalpadakis C Anticancer Res 29 1811 2009 383

13 Lin LE J Clin Rehabil Tissue Eng Res 13 7183 2009 14 Orciuolo E Leuk Res 34 184 2010 15 Bennett M Semin Hematol 47 143 2010 16 Rocha TMBS Rev Brasil Hematol Hemo ter 31 481 2009 17 Anastasiadis A Cases J 2 6913 2009 18 Lee PP Commun Oncol 8 24 2011 19 Debiasi M Sao Paulo Med J 128 375 2010 20 Thieblemont C Curr Opin Hematol 18 273 2011 21 Li LF Clin Lymphoma Myeloma 11 253 2011 22 Traverse -Glehen A Curr Opin Oncol 23 441 2011 23 Sachanas S Leuk Lymphoma 52 387 2011 24 Hauptrock B Biologics: Targets & Therapy 2 619 2008 25 Fozza C Ann Hematol 89 113 2010 26 Miztani M Rinsho Ketsueki 48 1489 2007 27 Nishikori M Rinsho Ketsueki 50 1332 2009 28 Wang XW J Mod ern Oncol 18 2267 2010 29 Thieblemont C Oncology 26 1 2012 30 Vega J Rev Med Chile 140 236 2012 31 Lam DH J Clin Oncol 30 e151 2012 32 Else M Br J Haematol 159 322 2012 33 Olszewski AJ Am J Hematol 87 e119 2012 34 Dimopoulos K Uges Laeger 174 2383 20 12 35 Leblond V J Clin Oncol 31 301 2013 36 Kalpadakis C Oncologist 18 190 2013 37 Dreyling M Ann Oncol 24 857 2013 38 Cervetti G Ann Oncol 24 2434 2013 39 Montalban C Leuk Lymphoma 2013 40 Zinzani PL Hematology – ASH Educ Book 426 2012 41 Lengle t J Leuk Lymphoma 11 Nov 2013 42 Acevedo A Rev Colomb Hematol Oncol 1 24 2012 43 Matutes E Exp Rev Hematol 6 735 2013 44 Iman Q Open J Blood Dis 3 105 2013 45 Sohani AR J Hematopathol 2014 46 Kalpadakis C Leuk Lymphoma 55 1463 2014 47 Teixeira LS Blood Lymph Cancer Target 4 29 2014 48 Yasuyama M Japan J Geriatr 51 569 2014 49 Brisou G Hematologie 21 32 2015 50 Cohen JM Am J Dermatopathol 37 e1 2015

• ANARGYROU K, TERPOS E, VASSILAKOPOULOS TP, POULI A, SACHANAS S, TZENOU T, MASOURIDIS S, CHRISTOULAS D, ANGELOPOULOU MK , DIMITRIADOU EM, KALPADAKIS C, TSIONOS K, PANAYIOTIDIS P, DIMOPOULOS MA, PANGALIS GA, KYRTSONIS M-C. Normalization of the serum angiopoietin-1 to angiopoietin-2 ratio reflects response in refractory/resistant multiple myeloma patients treated with bortezomib. Haematologica/The Hematology Journal, 93: 451-454, 2008 Α. Citations from Books, Medical sites and other Literature 384

1. ΑΙΜΑΤΟΛΟΓΙΑ ΣΤΗΝ ΚΛΙΝΙΚΗ ΠΡΑΞΗ , Πάγκαλης ΓΑ , Εκδόσεις Π.Χ. Πασχαλίδης , Αθήνα 2008, ISBN 978-960-399-776-4 (Κεφ . 53: Πολλαπλούν Μυέλωµα , σελ . 795-814). 2. Μελέτη της προγνωστικής αξίας της αγγειογένεσης του µυελού των οστών σε ασθενείς µε πολλαπλούν µυέλωµα . Κωνσταντίνος Αθ . Αναργύρου , ∆ιδακτορική ∆ιατριβή , Ιατρική Σχολή Εθνικού και Καποδιστριακού Πανεπιστηµίου Αθηνών , Αθήνα , 2008. 3. Multiple Myeloma: An overview. Gupta A (ed.). InTech – Open Access Publisher 2012, ISBN 978-953-307-768-0. (Chapter 8: The contribution of prognostic factors to the better management of multiple myeloma patients, by Kyrtsonis MC, Maltezas D, Koulieris E, Bitsani K, Pessach I, Efthymiou A, Bartzis V, Tzenou T, Panayiotidis P. pp. 145-174). 4. NEOPLASTIC DISEASES OF THE BLOOD, by Wiernik PH et al. (eds.), Springer Science+Business Media, New York, 2013, DOI 10.1007/978-1- 4614-3764-2_27 (Chapter 27: Cytokines and signal transduction in multiple myeloma, by Chauhan D & Anderson KC, pp 535-546).

B. Citations from Journals Α/Α Όνοµα Συγγραφέως Περιοδικό Τόµος Σελίδα Έτος 1 Anargyrou K Leuk Lymphoma 49 677 2008 2 Van Meurs M Crit Care 13 207art 2009 3 Huang HH Nat Rev Cancer 10 575 2010 4 Kastritis E Br J Haematol 150 587 2010 5 Joshi S Clin Biochem 44 590 2011 6 Terpos E Int J Hematol 130 735 2012 7 Kyrtsonis MC Appl Clin Genet 3 41 2010 8 Chen H Chin J Hematol 31 654 2010* 9 Ferrarini M Curr Med Chem 18 5185 2011 10 Giuliani N Cancer Microenv 4 325 2011 11 Molnar N Microvasc Res 83 290 2012 12 Leow C C Int J Oncol 40 1321 2012 13 Khan R Ann Hematol 92 101 2013 14 Danza K Eur J Human Gen 21 824 2013 15 Eroglu Z Exp Opin Investig Drugs 22 813 2013 16 Pappa CA Cancer Invest 31 385 2013 17 Weeraratne DK J Immunol Meth 396 44 2013 18 Kawaguchi M Acta Dermato -Venereol 94 9 2014 19 Alexandrakis MG Curr Angiogenesis 2 76 2013 20 Dally N Curr Angiogenesis 3 39 2014 21 Pappa CA J Cancer Res Clin Oncol 140 1801 2014 22 Teichert M Exp Dermatol 24 424 2015 *10.3760/cma.j.issn.0253-2727.2010.10.002

• DOUSSIS-ANAGNOSTOPOULOU IA, VASSILAKOPOULOS TP, THYMARA I, KORKOLOPOULOU P, ANGELOPOULOU MK , SIAKANTARIS MP, KOKORIS SI, DIMITRIADOU EM, KALPADAKIS C, MATZOURANIS M, KAKLAMANIS L, PANAYIOTIDIS P, KYRTSONIS MC, ANDROULAKI A, PATSOURIS E, KITTAS C, PANGALIS GA. Topoisomerase II α expression as an independent prognostic factor in Hodgkin’s lymphoma. 385

Clinical Cancer Research, 14: 1759-1766, 2008 Α. Citations from Books, Medical sites and other Literature 1. ΑΙΜΑΤΟΛΟΓΙΑ ΣΤΗΝ ΚΛΙΝΙΚΗ ΠΡΑΞΗ , Πάγκαλης ΓΑ , Εκδόσεις Π.Χ. Πασχαλίδης , Αθήνα 2008, ISBN 978-960-399-776-4 ( Κεφ . 35: Λέµφωµα Hodgkin, σελ . 615-639).

B. Citations from Journals Α/Α Όνοµα Συγγραφέως Περιοδικό Τόµος Σελίδα Έτος 1 Chetaille B Blood 113 2765 2009 2 Carbone A Br J Haematol 145 46 8 2009 3 Steidl C N Engl J Med 362 875 2010 4 Steidl C Blood 116 418 2010 5 Pentheroudakis G Leuk Lymphoma 51 1260 2010 6 Oliveira -Costa JP Hum Pathol 41 1624 2010 7 Sheng LM Hepato -Gastrenterol 58 359 2011 8 Marnerides A Anticancer Res 31 3585 2011 9 Derenzini E Genome Med 3 26 2011 10 Wang JL Chin J Hematol 32 29 2011 11 Chen Z Eur J Clin Invest 42 310 2012 12 Venkataraman G Blood 121 1795 2013 13 Koh YW Mod Pathol 26 1172 2013 14 Panico L Leuk Lymphoma 54 2418 2013 15 Βασιλακόπουλος ΘΠ ΑΙΜΑ 3 212 2012 16 Kayal S Leuk Lymphoma 2013 17 Georgiadi EC Leuk Lymphoma 56 748 2015

• ANGELOPOULOU MK , PANGALIS GA, SACHANAS S, KOKORIS SI, ANARGYROU K, GALANI Z, KALPADAKIS C, VASSILAKOPOULOS TP. Outcome and toxicity in relapsed hairy cell leukemia patients treated with rituximab. Leukemia Lymphoma, 49: 1817-1820, 2008 Α. Citations from Books, Medical sites and other Literature 1. ΑΙΜΑΤΟΛΟΓΙΑ ΣΤΗΝ ΚΛΙΝΙΚΗ ΠΡΑΞΗ , Πάγκαλης ΓΑ , Εκδόσεις Π.Χ. Πασχαλίδης , Αθήνα 2008, ISBN 978-960-399-776-4 ( Κεφ . 34: Λευχαιµία εκ Τριχωτών Κυττάρων , σελ . 608-614). 2. Ferry JA: Extranodal Lymphomas. 2011, Elsevier Inc. ISBN: 978-141604579- 3 (Chapter: Sohani AR, Zukerberg LR. Lymphomas of the spleen, pp 197- 220, DOI: 10.1016/B978-1-4160-4579-3.10006-3).

B. Citations from Journals Α/Α Όνοµα Συγγραφέως Περιοδικό Τόµος Σελίδα Έτος 1 Kreitman RJ Leuk Lymphoma 50 32 2009 2 Thomas DA Leuk Lymphoma 50 27 2009 3 Malfuson JV Acta Haematol 123 110 2010 4 Robak T Cacer Treat Rev 37 3 2011 386

5 Grever MR J Clin Oncol 29 583 2011 6 Kreitman JR Curr Hematol Malign Rep 8 184 2013 7 Burotto M Clin Cancer Res 19 6313 2013 8 Sohani AR J Hematopathol 2014 9 Akinosoglou K Ann Hematol 13 Feb 2015

• KALPADAKIS C, PANGALIS GA, VASSILAKOPOULOS TP, KYRTSONIS MC, SIAKANTARIS MP, KONTOPIDOU FN, KORKOLOPOULOU P, BOBOTSIS P, SAHANAS S, TZENOU T, ANAGNOSTOU D, DIMITRIADOU E, YIAKOUMIS X, PATSOURIS E, ROUSSOU P, PANAYIOTIDIS P, PAPADAKI E, ANGELOPOULOU MK . Non-gastric MALT lymphomas – a single center experience on 76 patients. Leukemia Lymphoma, 2008;49:2308-15 Α. Citations from Books, Medical sites and other Literature 1. Βασιλακόπουλος ΘΠ , Σιακαντάρη Μ, Γιακουµή Ξ. Στοµατολογικές εκδηλώσεις σε ασθενείς µε αιµατολογικές κακοήθειες . 2ο Συνέδριο Ογκολογίας στην Πρωτοβάθµια Περίθαλψη , Αθήνα 5-6 ∆εκεµβρίου 2008, Εκπαιδευτικός Τόµος , σελ .127-134. 2. Λεµφώµατα Οριακής Ζώνης . Κλινική και Εργαστηριακή Μελέτη . Χριστίνα Καλπαδάκη , ∆ιδακτορική ∆ιατριβή , Ιατρική Σχολή Εθνικού και Καποδιστριακού Πανεπιστηµίου Αθηνών , Αθήνα , 2008. 3. Οικονοµόπουλος Θ. Κακοήθη Αιµατολογικά Νοσήµατα . Εκδόσεις Π.Χ. Πασχαλίδης 2009, Κεφάλαιο « Μη -Hodgkin’s Λεµφώµατα », σελ .165-253.

B. Citations from Journals Α/Α Όνοµα Συγγραφέως Περιοδικό Τόµος Σελίδα Έτος 1 Thieblemont C Leuk Lymphoma 49 2229 2008 2 Siakantaris MP Oncologist 14 148 2009 3 Costes V Ann Pathol 29 323 2009 4 Borie R Eur Resp J 34 1408 2009 5 Decaudin D Exp Rev Opthalmol 5 241 2010 6 Oh SY Int J Hematol 92 510 2010 7 Oh SY Cancer Sci 101 2443 2010 8 Park SH Kor J Lab Med 30 547 2010 9 Anacak Y Int J Radiat Oncol Biol Phys 82 315 2012 10 Troch M Curr Hematol Malig Rep 6 216 2011 11 Wang Hua Chin J Radiat Oncol 19 2010* 12 Petros K J Med Case Rep 5 art 380 2011 13 Wierzbicke M Otolaryngol Polska 67 61 2013 14 Pali ga A Head Neck Pathol 7 381 2013 15 Kalpadakis C Curr Hematol Malign Rep 9 262 2014 16 Teckie S Int J Radiat Oncol Phys 92 130 2015 17 Thakral B Hum Pathol 01 Jun 2015

* DOI ：10.3760/cma.j.issn.1004-4221.2010.03.015

387

• MANOLA KN, GEORGAKAKOS VN, STAVROPOULOU C, SPYRIDONIDIS A, ANGELOPOULOU MK , VLACHADAMI I, KATSIGIANNIS A, ROUSSOU P, PANTELIAS GE, SAMBANI C.

Jumping translocations in hematological malignancies: a cytogenetic study of five cases.

Cancer Genet Cytogenet. 2008;187:85-94. Α. Citations from Books, Medical sites and other Literature 1. Thesis of Wenzel SS: Functional validation of oncogenes in molecular subtypes of diffuse large B-cell lymphomas (DLBCL).University of Berlin, 2014, http://www.diss.fu- berlin.de/diss/receive/FUDISS_thesis_000000097407

B. Citations from Journals Α/Α Όνοµα Συγγραφέως Περιοδικό Τόµος Σελίδα Έτος 1 Kim, J. Cancer Genetics 194 111 2009 and Cytogenetics 2 Najfeld V Br J Haematol 151 288 2010 3 Bessenyei B Cancer Genetics 204 207 2011 4 Tanaka K Indian Journal of Science and 5 2473 2012 Technology 5 Tuborgh A Cytogenetic and Genome 141 7 2013 6 Panagopoulos I OncologyResearch Reports 30 2587 2013 7 Parihar M Pediatric Blood and Cancer 61 387 2014 8 Lizcova, L. Cancer Genetics 204 348 2011 9 Manabe M Asia-Pacific Journal of Clinical 7 315 20201 Oncology 411 10 Sarova E Cancer Genetics 207 221

11 Sanford D Clinical Lymphoma Myeloma June 2015 and Leukemia

12 Miller CR Br J Haematol 19 Apr 2015

• SIAKANTARIS MP, PANGALIS GA, DIMITRIADOU E, KONTOPIDOU FN, VASSILAKOPOULOS TP, KALPADAKIS C, SACHANAS S, YIAKOUMIS X, KORKOLOPOULOU P, KYRTSONIS MC, BOBOTSIS P, ANDROULAKIS A, PATSOURIS E, PANAYIOTIDIS P, ANGELOPOULOU MK . Early stage gastric MALT lymphoma. Is it a true localized disease? Oncologist, 2009 ; 14: 148-54 388

Α. Citations from Books, Medical sites and other Literature 1. Λεµφώµατα Οριακής Ζώνης . Κλινική και Εργαστηριακή Μελέτη . Χριστίνα Καλπαδάκη , ∆ιδακτορική ∆ιατριβή , Ιατρική Σχολή Εθνικού και Καποδιστριακού Πανεπιστηµίου Αθηνών , Αθήνα , 2008. 2. Shepherd NA , Warren BF , Williams GT , Greenson JK , Lauwers GY , Novelli MR : Morson and Dawson’s Gastrointestinal Pathology. 2012, 5 th Edition, Wiley-Blackwell. ISBN: 978-140519943-8 (Chapter 15: de Leval L. Lymphoid tumours of the stomach, pp 241-269, DOI: 10.1002/9781118399668.ch15).

B. Citations from Journals Α/Α Όνοµα Συγγραφέως Περιοδικό Τόµος Σελίδα Έτος 1 Boot H Best Pract Res Clin Gastr 24 3 2010 2 Owens SR Pathol Res Int art 19314 2011 3 Broker BM Int J Med Microbiol 304 204 2014 4 Xochelli A Blood 123 1199 2014 5 Xu X J Gastroenterol Hepatol 29 1678 2014 6 Michaeli M Front Immunol 5 264 2014 7 Papageorgiou SG Anticancer Res 34 6717 2014 8 Kalpadakis C Curr Hematol Malign Rep 9 262 2014

• KALPADAKIS C, PANGALIS GA, DIMITRIADOU E, SIAKANTARIS MP, KYRTSONIS MC, XIMERIS M, TZENOU T, SAHANAS S, YIAKOUMIS X, PAPADAKI EA, PANAYIOTIDIS P, ANGELOPOULOU MK , VASSILAKOPOULOS TP. Mutation analysis of IgVH genes in splenic marginal zone lymphomas: Correlation with clinical characteristics and outcome. Anticancer Research, 2009: 29:1811-6 Α. Citations from Books, Medical sites and other Literature 1. Λεµφώµατα Οριακής Ζώνης . Κλινική και Εργαστηριακή Μελέτη . Χριστίνα Καλπαδάκη , ∆ιδακτορική ∆ιατριβή , Ιατρική Σχολή Εθνικού και Καποδιστριακού Πανεπιστηµίου Αθηνών , Αθήνα , 2008.

B. Citations from Journals Α/Α Όνοµα Συγγραφέως Περιοδικό Τόµος Σελίδα Έτος 1 Matutes E Expert Rev Anticancer Ther 9 1185 2009 2 Watkins JA J Pathol 220 461 2010 3 Salido M Blood 116 1479 2010 4 Hockley SL Br J Haematol 158 347 2012 5 Kalpadakis C Oncologist 18 190 2013 6 Matutes E Exp Rev Hematol 6 735 2013 7 Kalpadakis C Leuk Lymphoma 55 1463 2014 8 Teixeira LS Blood Lymph Cancer Target 4 29 2014 9 Gebhart J Thr omb Res 21 Aug 2014 389

10 Petrikkos L BioMed Res Int 2014 80910 2014 11 Songlin Chu Chin J Hematol 35 1034 2014

• TSOPRA O, ZIROS PG, LAGADINOU ED, SYMEONIDIS A, KOU- RAKLIS-SYMEONIDIS A, THANOPOULOU E, ANGELOPOULOU MK, VASSILAKOPOULOS TP, PANGALIS GA, ZOUMBOS NC. Disease-related anemia in chronic lymphocytic leukemia is not due to intrinsic defects of erythroid precursors: a possible pathogenetic role for tumour necrosis factor-α. Acta Haematologica, 2009: 121:187-95 ΒΙΒΛΙΟΓΡΑΦΙΚΕΣ ΑΝΑΦΟΡΕΣ A. Citations from Journals Α/Α Όνοµα Συγγραφέως Περιοδικό Τόµος Σελίδα Έτος 1 Morceau F Med Inflam 405016 2009 2 Molica S Cancer Manag Res 3 211 2011 3 Penna G Med Oncol 28 1549 2011 4 Fecteau JF Front Biosci S4 61 2012 5 Wasik -Szczepanek Acta He matol Polon 43 146 2012 6 Romanenko NA Terap Arkhiv 85 81 2013 7 Stiehl T J Roy Soc Interface 11 20140 2014

• ANARGYROU K, VASSILAKOPOULOS TP, ANGELOPOULOU MK , TERPOS E.

Incorporating novel agents in the treatment of myelodysplastic syndromes.

Leuk Res. 2010;34:6-17 Α. Citations from Books, Medical sites and other Literature 1. Ruhm S. GVHD (graft-versus-host disease) prediction and diagnosis through molecular methods in HSCT (hematopoietic stem cell transplantation). Diplomarbeit, Universitat Wien, April 2010. 2. Myelodysplastic syndromes: From pathogenesis to diagnosis and therapy. Sayar H (ed.). Nova Science Publishers, Inc., 2013, ISBN: 978-162417574-9 (Chapter: Epigenetic changes in the pathogenesis and therapy of myelodysplastic syndromes, by Fuchs O, Jonasova A, Neuwirtova R, pp. 105- 126).

B. Citations from Journals Α/Α Όνοµα Συγγραφέως Περιοδικό Τόµος Σελίδα Έτος 1 Fenaux P Leuk Res 33(Suppl2) S7 2009 2 Paydas S Leuk Res 34 409 2010 3 Lindsey M Clin J Oncol Nursing 14 545 2010 4 Xia o Z Leuk Res 35 61 2011 390

5 Vigna E Expert Opin Invest Drugs 20 465 2011 6 Stintzing S J Biomed Biotechnol 214143 2011 7 Rodriquez JNR Cuadernos Hematologia 1 2010 8 Wei W Leuk Res 36 715 2012 9 Abel GA Am J Hematol 87 634 2012 10 Meng Y J Intern Pha rm Res 41 419 2014

• TSAGARAKIS NJ, KENTROU NA, PAPADIMITRIOU KA, PAGONI M, KOKKINI G, PAPADAKI H, PAPPA V, MARINAKIS T, ANAGNOSTOPOULOS NI, VADIKOLIA C,ANAGNOSTOPOULOS A, ANGELOPOULOU MK , TERPOS E, POZIOPOULOS C, ANARGYROU K, RONTOGIANNI D, PAPADAKI T, PSARRA A, KONTOPIDOU FN, SKOUMI D, PAPADHIMITRIOU SI, PATERAKIS G, for the Hellenic Dendritic Cell Leukemia Study Group. Acute lymphoplasmacytoid dendritic cell (DC2) leukemia: Results from the Hellenic Dendritic Cell Leukemia Study Group. Leuk Res. 2010;34:438-446 A. Citations from Books, Medical sites and other Literature

1. Book: Flow Cytometry of Hematologic Malignancies, by Ortolani C, Publisher: Blackwell Publishing, 2011.

2. Les lymphomes cutanés. Sous l’égide du Groupe français d’étude des lymphomes cutanés by Bagot M (ed). Chapter: Tumeur à cellules dendritiques plasmocytoïdes blastiques by Dalle S, Petrella T, pp:239, 2013, Springer Paris, ISBN: 978-2-8178-0353-1

B. Citations from Journals Α/Α Όνοµα Συγγραφέως Περιοδικό Τόµος Σελίδα Έτος 1 Jegalian AG Haematologica 95 18 73 2010 2 Sandes AF J Hematopathol 4 123 2011 3 Vassilakopoulos TP Archives of Hellenic Medicine 28 718 2011 4 Dietrich S Biol Blood Marrow Transplant 17 1250 2011 5 Vassilakopoulos TP Archives of Hellenic Medicine 28 718 2011 6 Rauh MJ Leukemia Research 36 81 2012 7 Dantas FER Acta Oncologica 51 139 2012 8 Wang H Acta Hematologica 127 124 2012 9 Hashikawa K Journal of the American 66 278 2012 Academy of Dermatology 10 Cronin DMP American Journal of Clinical 137 267 2012 Pathology 11 Pinto-Almeida, T. Annals of Dermatology 24 235 2012 391

12 Piccaluga PP Expert Review on 5 353 2012 Hematology 13 Endo K Annals of Hematology 92 269 2013 14 Pagano L Haematologica 98 239 2013 15 Fan XS Chinese Journal of Pathology 42 131 2013 16 An HJ Annals of Hematology 92 351 2013 17 Kharfan-Dabaja Biol Blood Marrow Transplant 19 1006 2013 18 M.A Julia F Br J Deramtology 169 579 2013 19 Gruson B Br J Haematology 163 543 2013 20 Sakashita K Pediatric Blood and Cancer 60 E140 2013 21 Goren-Sahin D Case reports in Hematology Article ID 471628 2013 22 Chu G Leuk Lymphoma 55 2405 2014† 23 Sangle NA Modern Pathology 27 1137 2014 24 Stenzinger A Oncotarget 5 6404 2014 25 Sapienza MR Leukemia 28 1606 2014 26 Handler MZ Journal of the European Academy of 7 APR 2015 Dermatology and Venereology 27 Dunlap QA Allergy Rhinol (Providence) 5 e50 2014 28 Jabbour R Kansas Journal of Medicine 7 71 2014 29 Paluri R Hematolo gical Oncology 21 MAY 2014

†: DOI: 10.3109/10428194.2014.883074

• SACHANAS S, PANGALIS GA, VASSILAKOPOULOS TP, KORKOLOPOULOU P, KONTOPIDOU FN, ATHANASOULIA M, YIAKOUMIS X, KALPADAKIS C, GEORGIOU G, MASOURIDIS S, MOSCHOGIANNIS M, TSIRKINIDIS P, PAPPIS V, KOKORIS SI, SIAKANTARIS MP, PANAYIOTIDIS P, ANGELOPOULOU MK . Combination of rituximab with chlorambucil as first line treatment in patients with mantle cell lymphoma: a highly effective regimen. Leukemia and Lymphoma , 52: 387-393, 2011

A. Citations from Journals Α/Α Όνοµα Συγγραφέως Περιοδικό Τόµος Σελίδα Έτος 1 Dreyling M Leuk Lymphoma 52 351 2011 2 Harel S Semin Hematol 48 194 2011 3 Clavel CM Angew Chem Int 50 7124 2011 4 Gunellini Adv Hematol 2012 523842 2012 5 Gupta P Blood 119 3767 2012 6 Iannitto E Hematology Educ EHA 17 6 429 2012 7 McKay P Br J Haematol 159 405 2012 8 Kalpadakis C Oncologist 18 190 2013 9 Dreyling M Ann Oncol 24 857 2013 10 Walewski J Acta Haematol Pol 44 104 2013 392

11 Caballero D Ann Hematol 92 1151 2013 12 Clavel CM Chem Sci 2014 13 Kelkitli E Case Rep Hematol 621017 2014 14 Gill H Ann Oncol 25 1391 2014 15 Kanellopoulos A Int J Hematol 99 777 2014 16 Dreyling M Ann Oncol 25 83 2014 17 Campo E Blood 125 48 2015 18 Nazeef M Curr Treat Opt Oncol 16 Jun 2015

• KYRTSONIS MC, LEVIDOU G, KORKOLOPOULOU P, KOULIERIS E, BARTZI V, MALTEZAS D, PANGALIS GA, KALPADAKIS C, DIMOU M, GEORGIOU G, VASSILAKOPOULOS TP, ANGELOPOULOU MK , SALPEAS V, TSAFTARIDIS P, PATSOURIS E, PANAYIOTIDIS P, TZENOU TK. CD138 expression helps distinguishing Waldenstrom’s macroglobulinemia (WM) from splenic marginal zone lymphoma (SMZL). Clinical Lymphoma Myeloma Leukemia, 11: 99-102, 2011.

A. Citations from Journals Α/Α Όνοµα Συγγραφέως Περιοδικό Τόµος Σελίδα Έτος 1 Shaheen SP Adv Anat Pathol 19 11 2012 2 Gertz MA Am J Hematol 87 504 2012 3 Treon SP N Engl J Med 367 826 2012 4 Demberg T J Virol 86 12591 2012 5 Kyrtsonis MC Am J Med Med Sci 2 136 2012 6 deTute RM Clin Lymphoma Myel Leuk 13 211 2013 7 Gertz MA Am J Hematol 20 Jun 2013

• MARNERIDIS A*, VASSILAKOPOULOS TP*, BOLTETSOU E, LEVIDOU G, ANGELOPOULOU MK, THYMARA I, KYRTSONIS MC, PAPPI V, TSOPRA O, PANAYIOTIDIS P, PANGALIS GA, BERIS PH, PATSOURIS E, KORKOLOPOULOU P. Immunohistochemical expression and prognostic significance of CCND3, MCM2 and MCM7 in Hodgkin lymphoma. Anticancer Research, 31: 3585-3594, 2011. * equal contribution

A. Citations from Journals Α/Α Όνοµα Συγγραφέως Περιοδικό Τόµος Σελίδα Έτος 1 Zhou YM Liver Int 32 1505 2012 2 Tyleckova J Int J Mol Sci 13 15536 2012 3 Chen S Am J Chin Med 41 665 2013 4 Chen J J Mol Neurosci 51 82 2013 393

5 Zhu L Chin J Clin Oncol 40 951 2013 6 Sun W World Chinese Journal 22 553 2014 of Digestology 7 Li Yi J Intern Oncol 41 348 2014 8 Kang W Oncology Rep 31 2071 2014 9 Zhong X Tumor Biol 35 7155 2014 10 Zhong X Oncol Lett 27 Mar 2014

• GEORGIOU G, EFTHYMIOU A, VARDOUNIOTI I, BOUTSIKAS G, ANGELOPOULOU MK , VASSILAKOPOULOS TP, KYRTSONIS MC, PLATA E, TOFAS P, BITSANI A, BARTZI V, PESSACH I, DIMOU M, PANAYIOTIDIS P. Development of acute myeloid leukaemia with NPM mutation, in Ph- negative clone, during treatment of CML with imatinib. Leukemia,26: 824-826, 2012.

A. Citations from Journals Α/Α Όνοµα Συγγραφέως Περιοδικό Τόµος Σελίδα Έτος 1 Watkins DP Leukemia 27 489 2013 2 Schmidt M Leukemia 28 2292 2014 3 Amor-Vigil AM Rev Cub Hem Immun 31 2015 4 Skalska-Sadowska J PediatrHemot Blood Cancer 62 1070 2015

• VASSILAKOPOULOS TP, PANGALIS GA, KATSIGIANNIS A, PAPAGEORGIOU S, CONSTANTINOU N, TERPOS E, ZORBALA A, VRAKIDOU E, REPOUSSIS P, POZIOPOULOS C, GALANI Z, DIMOPOULOU MN, KOKORIS SI, SACHANAS S, KALPADAKIS C, DIMITRIADOU EM, SIAKANTARIS MP, KYRTSONIS MC, DERVENOULAS J, DIMOPOULOS MA, MELETIS J, ROUSSOU P, PANAYIOTIDIS P, BERIS P, ANGELOPOULOU MK . Rituximab, cyclophosphamide, doxorubicine, vincristine and prednisone with or without radiotherapy in primary mediastinal large B-cell lymphoma: The emerging standard therapy. Oncologist, 17: 239-249, 2012. Α. Citations from Books, Medical sites and other Literature 1. ΑΤΛΑΝΤΑΣ ΟΓΚΟΛΟΓΙΑΣ ΘΩΡΑΚΑ , Συρίγος Κ, Γκιόζος Γ, Χαρπίδου Α, Εκδόσεις ΠΑΡΙΣΙΑΝΟΥ , 2012, ISBN 978-960-394-838-4, Αθήνα ( Κεφάλαιο 43: Θ. Βασιλακόπουλος , Α. Ζορµπαλά : Λεµφώµατα µεσοθωρακίου . σελ . 541- 563). 2. Gouliamos AD, Andreou J, Kosmidis P: Imaging in Clinical Oncology. 2014, Springer-Verlag Italia. ISBN print 978-88-470-5384-7, ISBN online 978-88- 470-5385-4 (Chapter 33: Vassilakopoulos TP, Prassopoulos V. The role of 394

18FDG-PET/CT in malignant lymphomas: Clinical implications, pp 249-265, DOI: 10.1007/978-88-470-5385-4_35). 3. National Cancer Institute, U.S. National Institutes of Health, www.cancer.gov . Adult Non-Hodgkin Lymphoma Treatment (PDQ R). Health Professional Version. Last updated: 01/08/2014. 4. NCCN Clinical Practice Guidelines in Oncology. Non-Hodgkin’s lymphomas, v. 4.2014.

B. Citations from Journals Α/Α Όνοµα Συγγραφέως Περιοδικό Τόµος Σελίδα Έτος 1 Perez CA Case Rep Hematol ArtID 197347 2012 2 Xu LM Leuk Lymphoma 54 1684 2013 3 Xu LM Int J Radiat Oncol Biol Phys 85 1289 2013 4 Papageorgiou S Hematol Oncol 31 10 2013 5 Dunleavy K N Engl J Med 368 1408 2013 6 Foppoli M Rec Prog Med 104 203 2013 7 Wilson W EHA18 Educational Book 7 175 2013 8 Glauser TA J Cancer Educ 28 591 2013 9 Sweetenham J Clin Oncol at a glance 8 2013 10 Filippi AR Int J Radiat Oncol Biol Phys 87 311 2013 11 Mo C Int J Hematol O ncol 2 351 2013 12 Soumerai JD Leuk Lymphoma 55 538 2014 13 Dunleavy K Oncology (United States) 28 2014 14 Barnes JA Acta Haematol 131 153 2014 15 Hamlin P J Clin Oncol 32 1751 2014 16 Ferenc M Lege Artis Med 24 191 2014 17 Dabrowska -Iwanicka Curr Hematol Malig Rep 9 273 2014 18 Jingjing W Chin J Hematol 35 491 2014 19 Papageorgiou SG Anticancer Res 34 6717 2014 20 Brown A Curr Respir Care Rep 3 187 2014 21 Aoki T Haematologica/THJ 99 1817 2014 22 Dunleavy K Clin Cancer Res 20 5182 2014 23 Ka hnamuie AF J Ardabil Univ Med Sci 14 424 2014 24 Magyari S Pathol Oncol Res 21 213 2015 25 Nagle SJ Cancer Med 4 7 2015 26 Pytlik J Leuk Lymphoma 56 57 2015 27 Cheah CY Leuk Lymphoma 56 49 2015 28 Vassilakopoulos TP Leuk Lymphoma 56 3 20 15 29 Zinzani PL Hematol Oncol 25 Sep 2014 30 Martelli M Exp Rev Hematol 8 173 2015 31 Pinnix CC Int J Radiat Oncol Biol Phys 92 113 2015 32 Higashide Y Japan J Cancer Chemother 42 119 2015 33 Yang SH J Chin Med Assoc 05 Feb 2015 34 Bhatt VR Curr Treat Rev 2015 35 Vassilakopoulos TP Leukemia 14 May 2015 36 Vassilakopoulos TP MEMO 2015

• DIMOU M, ANGELOPOULOU MK , PANGALIS GA, GEORGIOU G, KALPADAKIS C, PAPPI V, TSOPRA O, KOUTSOUKOS K, ZOGRAFOS E, BOUTSIKAS G, MOSCHOGIANNI M, VARDOUNIOTI I, PETEVI K, KARALI V, KANELLOPOULOS A, DALAGEORGOS T, YIAKOUMIS X, BARTZI V, BITSANI C, PESSACH E, EFTHIMIOU A, KORKOLOPOULOU P, RASSIDAKIS 395

GZ, KYRTSONIS M-C, PATSOURIS E, MELETIS J, PANAYIOTIDIS P, VASSILAKOPOULOS TP. Autoimmune hemolytic anemia and autoimmune thrombocytopenia at diagnosis and during follow-up of Hodgkin lymphoma. Leukemia and Lymphoma, 53: 1481-1487, 2012.

Α. Citations from Books, Medical sites and other Literature 1. Fazel FB. Hodgkin’s lymphoma in adults at Chris Hani-Baragwanath Hospital: A fifteen year review. Johanessburg, 2012.

B. Citations from Journals Α/Α Όνοµα Συγγραφέως Περιοδικό Τόµος Σελίδα Έτος 1 Salmeron G Case Rep Hematol 567289 2013 2 Συµεωνίδης Α ΑΙΜΑ 3 307 2012 3 Lechner K Semin Thromb Hemostas 40 359 2014 4 Elsayed AA Pathol Int 64 336 2014 5 Black AC Proc UCLA Healthcare 18 2014 6 Kuter DJ Oncology (United States) 29 17p 2015

• KYRTSONIS MC, KOULIERIS E, MALTEZAS D, TZENOU T, HARDING S, KASTRITIS E, KAFASSI N, BARTZIS V, EFTHYMIOU A, BITSANIS K, GAVRIATOPOULOU M, TERPOS E, KALPADAKIS C, ANGELOPOULOU MK , VASSILAKOPOULOS TP, BRADWELL AR, BERIS PH, PANGALIS GA, PANAYIOTIDIS P, DIMOPOULOS MA. Prognostic contribution of the new immunoglobulin (Ig) biomarkers (Freelite TM and Heavylite TM ) in Waldenstrom’s Macroglobulinemia (WM). American Journal of Medicine and Medical Sciences, 2: 136-143, 2012. Α. Citations from Books, Medical sites and other Literature 1. Kyrtsonis MC, Koulieris E, Bartzis V, Pessah I, Nikolaou E, Karali V, Maltezas D, Panayiotidis P, Harding SJ. Chapter 2: Monoclonal Immunoglobulin. http://dx.doi.org/10.5772/55855 . INTECH, pp. 13-37, 2013.

• PAPAGEORGIOU S, DIAMANTOPOULOS P, LEVIDOU G, ANGELOPOULOU MK , ECONOMOPOULOU P, EFTHIMIOU A, CONSTANTINOU N, KATSIGIANNIS A, KORKOLOPOULOU P, PAPPA V, ECONOMOPOULOU C, GERGIOU G, DIMOU M, TSIRIGOTIS P, KYRTSONIS MC, KOTSIANIDIS I, KALPADAKIS C, DIMOPOULOS MA, BERIS F, MELETIS J, PANGALIS GA, DERVENOULAS J, PANAYIOTIDIS P, VASSILAKOPOULOS TP. Isolated central nervous system relapses in primary mediastinal large B- cell lymphoma after CHOP-like chemotherapy with or without rituximab. 396

Hematological Oncology, 31: 10-17, 2013. Α. Citations from Books, Medical sites and other Literature 1. Dreyling M, Williams ME: Rare Lymphomas. 2014, Springer-Verlag Italia. ISBN print 978-3-642-39590-1 (Chapter: Johnson P, Delabie J, Rodig S, Martelli M. Primary mediastinal large B-cell lymphoma, pp 195-206).

B. Citations from Journals Α/Α Όνοµα Συγγραφέως Περιοδικό Τόµος Σελίδα Έτος 1 Pytli k R Onkologie (Switz ) 7 129 2013 2 Krawszyk K Polskie Arch Med Wewn 123 589 2013 3 Ferreri AJM Lancet Oncol 15 159 2014 4 Cheah CY Int J Hematologic Oncol 3 189 2014 5 Dabrowska -Iwanicka Curr Hematol Malig Rep 9 273 2014 6 Papageorgiou SG Anticancer Res 34 6717 2014 7 Cheah CY Curr Oncol Rep 17 2015 8 Yoon JH Kor J Intern Med 30 362 2015 9 Bhatt VR Curr Treat Rev 2015

• KALPADAKIS C, PANGALIS GA, ANGELOPOULOU MK , SACHANAS S, KONTOPIDOU FN, YIAKOUMIS X, KOKORIS SI, DIMITRIADOU EM, DIMOPOULOU MN, MOSCHOGIANNIS M, TSAFTARIDIS P, PLATA E, PAPADAKI HE, VASSILAKOPOULOS TP. Treatment of splenic marginal zone lymphoma with rituximab monotherapy: Progress report and comparison with splenectomy. Oncologist, 18: 190-197, 2013.

A. Citations from Journals Α/Α Όνοµα Περιοδικό Τόµος Σελίδα Έτος Συγγραφέως 1 Wu Z World J Gatrenterol 19 3854 2013 2 Matutes E Exp Rev Hematol 6 735 2013 3 Olszewski AJ Ann Hematol 93 449 2014 4 Lenglet J Leuk Lymphoma 55 1854 2014 5 Montalban C Leuk Lymphoma 55 929 2014 6 Angelopoulou MK Leuk Lymphoma 55 1240 2014 7 Kalpadakis C Leuk Lymphoma 55 1463 2014 8 Kalpadakis C Leuk Lymphoma 55 2640 2014 9 Teixeira LS Blood Lymph Cancer 4 29 2014 10 Von Hohenstaufen SchweizerTarget Ther Krebsbulletin 34 171 2014 11 SonglinAK Chu Chin J Hematol 35 1034 2014 12 Tarella C Clin Lymphoma Myel 15 75 2015 13 Vannata B CancerLeuk Treat Res 165 227 2015 14 Brisou G Hematologie 21 32 2015 397

15 Ohta M World J Surg 13 67 2015 16 Parry M Clin Cancer Res 16 Mar 2015 17 Ian nitto E Leuk Lymphoma 19 Mar 2015 2015 • VASSILAKOPOULOS TP, ANGELOPOULOU MK . Advanced and relapsed/refractory Hodgkin lymphoma: What has been achieved during the last 50 years. Semin Hematol, 50: 4-14, 2013.

A. Citations from Journals Α/Α Όνοµα Συγγραφέως Περιοδικό Τόµος Σελίδα Έτος 1 Vassilakopoulos TP Transl Pediatrics 11 Jun 2013 2 Βασιλακόπουλος ΘΠ ΑΙΜΑ 3 212 2012 3 Βασιλακόπουλος ΘΠ ΑΙΜΑ 3 328 2012 4 Kanellopoulos A Arch Hellen Med 30 647 2013 5 Grever MR Hematology Am Soc HEPB 2013 24 2013 6 Balink H J Med Case Rep 8 212 2014 7 Garfin PM Biol Blood Marrow Transpl 21 326 2015

• MALTEZAS D, DIMOPOULOS MA, KATODRITOU I, REPOUSIS P, POULI A, TERPOS E, PANAYIOTIDIS P, DELIMPASI S, MICHALIS E, ANARGYROU K, GAVRIATOPOULOU M, STEFANOUDAKI A, TZENOU T, KOULIERIS E, SACHANAS S, DIMOU M, VASSILAKOPOULOS TP, ANGELOPOULOU MK , PANGALIS GA, KYRTSONIS MC. Reevaluation of prognostic markers including staging, serum free light chains (sFLC) or their ratio (sFLCR), and serum lactate dehydrogenase (LDH) in multiple myeloma (MM) patients receiving novel agents. Hematological Oncology, 2012 Sep 7. doi: 10.1002/hon.2026. [Epub ahead of print]. Α. Citations from Books, Medical sites and other Literature

1. Kyrtsonis MC, Koulieris E, Bartzis V, Pessah I, Nikolaou E, Karali V, Maltezas D, Panayiotidis P, Harding SJ. Chapter 2: Monoclonal Immunoglobulin. http://dx.doi.org/10.5772/55855 . INTECH, pp. 13-37, 2013. 2. Bhatnagar B, Badros AZ. Controversies in autologous stem cell transplantation fort he treatment of multiple myeloma (Chapter 8). In: Demirer T. Innovations in stem cell transplantation. ISBN 978-953-51-0980-8, DOI: 10.5772/54115, 2013.

B. Citations from Journals Α/Α Όνομα Συγγραφέως Περιοδικό Τόμος Σελίδα Έτος 1 Bhole MV Ann Clin Biochem 51 528 2014 2 Kuroda J Int J Hematol 99 441 2014 3 Banchi G J Clin Oncol 32 2125 2014 398

4 Tuchman SA Clin Lymphoma Myeloma 15 103 2015 5 Iriuchisima H Eur J Haematol 94 145 2015 6 Kyrtsonis MC Eur J Haematol 94 95 2015

• DIAMANTOPOULOS PT, KALOTYCHOU V, POLONYFI K, SOFOTASIOU M, ANASTASOPOULOU A, GALANOPOULOS A, SPANAKIS N, VASSILAKOPOULOS T, ANGELOPOULOU M , SIAKANTARIS M, VARIAMI E, POZIOPOULOS C, TERPOS E, KOLLIA P, VINIOU NA. Correlation of Fc-gamma RIIA Polymorphisms with Latent EBV infection and LMP1 Expression in Patients with Low Grade B-Cell Lymphomas. Leukemia and Lymphoma, 54: 2030-2034, 2013

A. Citations from Journals Α/Α Όνοµα Συγγραφέως Περιοδικό Τόµος Σελίδα Έτος 1 Ghesquieres H Leuk Lymphoma 2013 2 Papadopoulou V Leuk Lymphoma 55 1904 2014 3 Li X Curr Top Microbiol Immunol 382 275 2014 4 Kushekhar K Cancer Epidemiol Biom 23 2737 2014 5 Ghesquieres H LeukPrev Lymphoma 2013 6 Houldcroft CJ Rev Med Virol 25 71 2015

• PAPANIKOLAOU X, REPOUSIS P, TZENOU T, MALTEZAS D, KOTSOPOULOU M, MEGALAKAKI K, ANGELOPOULOU M, DIMITRAKOLOULOU E, KOULIERIS E, BARTZIS V, PANGALIS G, PANAYOTIDIS P, KYRTSONIS MC. Incidence, clinical features, laboratory findings and outcome of patients with multiple myeloma presenting with extramedullary relapse. Leuk Lymphoma. 54:1459-1464, 2013

A. Citations from Journals Α/Α Όνοµα Συγγραφέως Περιοδικό Τόµος Σελίδα Έτος 1 Moreau P Leukemia and Lymphoma 54 1349 2013 2 Rasche L Annals of Hematology 93 1207 2014 3 Li X National Medical Journal of 94 1258 2014 4 Wang J ChineseChina Journal of Clinical 41 639 2014 Oncology 5 Zhang J World Journal of Surgical 12 234 2014 Oncology 399

6 Hung Y-P J. Cancer Res. Pract. 1 39 2014 7 Deng S Clinical Lymphoma, 15 286 2015 Myeloma and Leukemia

• LEVIDOU G, SIAKANTARIS M, PAPADAKI T, PAPADAVID E, VASSILAKOPOULOS TP, ANGELOPOULOU MK , MARINOS L, NIKOLAOU V, ECONOMIDI A, ANTONIOU C, PATSOURIS E, KORKOLOPOULOU P. A comprehensive immunohistochemical approach of AKT/MTOR pathway and p-STAT3 in mycosis fungoides. Journal of the American Academy of Dermatology, 69: 375-384, 2013.

A. Citations from Journals Α/Α Όνοµα Συγγραφέως Περιοδικό Τόµος Σελίδα Έτος 1 Papadavid E Exp Dermatol 23 931 2014 2 El-Habr EA Virchows Archiv 465 473 2014 3 Zhao H Med Oncol 07 Dec 2014

• SACHANAS S, LEVIDOU G, ANGELOPOULOU MK , MOSCHOYIANNIS M, YIAKOUMIS X, KALPADAKIS C, VASSILAKOPOULOS TP, KONTOPIDOU F, TSIRKINIDIS P, DIMITRAKOPOULOU A, KOKORIS S, DIMITRIADOU E, KYRTSONIS MC, PANAYIOTIDIS P, PAPADAKI H, PATSOURIS E, KORKOLOPOULOU P, PANGALIS GA. Apoptotic and proliferative characteristics of proliferation centers in lymph node sections of chronic lymphocytic leukemia patients. Leukemia and Lymphoma, 55:571-582, 2014

A. Citations from Journals Α/Α Όνοµα Συγγραφέως Περιοδικό Τόµος Σελίδα Έτος 1 Levidou G Biomed Res Intern 25147 2014 2 Purroy N Leukem ia 28 1993 2014 3 Potzsch B Res Cancer Tumor 3 6 2014

• GAMALETSOU MN, WALSH TJ, ZAOUTIS T, PAGONI M, KOTSOPOULOU M, VOULGARELIS M, PANAYIOTIDIS P, VASSILAKOPOULOS T, ANGELOPOULOU MK , MARANGOS M, SPYRIDONIDIS A, KOFTERIDIS D, POULI A, SOTIROPOULOS D, 400

MATSOUKA P, ARGYROPOULOU A, PERLORETZOU S, LECKERMAN K, MANAKA A, OIKONOMOPOULOS P, DAIKOS G, PETRIKKOS G, SIPSAS NV. A prospective cohort, multicentre study of candidaemia in hospitalized adult patients with haematologic malignancies. Clinical Microbiology and Infection,Clin Microbiol Infect. 20:O50-57, 2014. A. Citations from Books, Medical sites and other Literature

1. Walsh TJ, Gamaletsou MN. Treatment of fungal disease in the setting of neutropenia. Hematology 2013; Am Soc Hematol Educ Programm Book. 2013; 423-427.

B. Citations from Journals Α/Α Όνοµα Συγγραφέως Περιοδικό Τόµος Σελίδα Έτος 1 Gamaletsou MN Int J Antimicrob Agents 30 June 2014 2 Sherry L BMC Microbiol 14 182 2014 3 Nucci M Blood 124 3858 2014 4 Gamaletsou MN Curr Fungal Inf ect Rep 8 262 2014 5 Corzo -Leon DE Mycoses 58 325 2015 6 Puig -Asensio M Clin Microbiol Infect 21 491 2015 7 Cuervo G Clin Microbiol Infect 21 684.e1 2015

• ANGELOPOULOU MK , KALPADAKIS C, PANGALIS GA, KYRTSONIS MC, VASSILAKOPOULOS TP. Nodal marginal zone lymphoma. Leukemia and Lymphoma;55: 1240-1250, 2014 . A. Citations from Journals Α/Α Όνοµα Συγγραφέως Περιοδικό Τόµος Σελίδα Έτος 1 Meyer AH Ann Oncol 25 210 2014 2 Olszewski AJ Leuk Lymphoma 56 942 2015 3 Gebauer N Acta Haematol 133 214 2015 4 Angelopoulou MK Acta Haematol 133 212 2015 5 Vannata B Cancer Treat Res 165 227 2015

• KALPADAKIS C, PANGALIS GA, VASSILAKOPOULOS TP, SACHANAS S, ANGELOPOULOU MK . Treatment of splenic marginal zone lymphoma: Should splenectomy be abandoned? 401

Leukemia and Lymphoma;55: 1463-1470, 2014 A. Citations from Journals Α/Α Όνοµα Συγγραφέως Περιοδικό Τόµος Σελίδα Έτος 1 Kalpadakis C Leuk Lymphoma 55 2640 2014 2 Behdad A Arch Pathol Lab Med 138 1295 2014 3 Songlin Chu Chin J Hematol 35 1034 2014 4 Vannata B Cancer Treat Res 165 227 2015 5 Baliakas K Leuk Lymphoma 56 301 2015 6 Xing KH Br J Haematol 169 520 2015

• XOCHELLI A, KALPADAKIS C, GARDINER A, BALIAKAS P, VASSILAKOPOULOS TP, MOULD S, DAVIS Z, STALIKA E, KANELLIS G, ANGELOPOULOU MK , McIVER-BROWN N, IBBOTSON R, SACHANAS S, KORKOLOPOULOU P, ATHANASIADOU A, ANAGNOSTOPOULOS A, PAPADAKI HA, PAPADAKI T, STAMATOPOULOS K, PANGALIS GA, OSCIER D. Clonal B-cell lymphocytosis exhibiting immunophenotypic features consistent with a marginal zone origin: is this a distinct entity? Blood;123:1199-1206, 2014

A. Citations from Journals Α/Α Όνοµα Συγγραφέως Περιοδικό Τόµος Σελίδα Έτος 1 Ponzoni M Blood 123 1118 2014 2 Xochelli A Cancer Genet 207 281 2014 3 Teixeira LS Blood Lymph Cancer 4 29 2014 4 Kalpadakis C BioMedTa rget Ther Res Intern 2014 5 Bruscaggin A Br J Haematol 167 718 2014 6 Ganapathi KA Haematologica/THJ 99 1421 2014 7 Arcaini L Haematologica/THJ 07 Nov 2014 8 Donaldson SL J Rheumatol 41 24962014 2014 9 Kim H Int J Hematol 101 612 2014 10 Kostopoulos IV Gen Chromosom Cancer 54 210 2015 11 Parry M Clin Cancer Res 16 Mar 2015 12 Malecka A Haematologica / THJ 22 May 2015

• DIAMANTOPOULOS PT, POLONYFI K, SOFOTASIOU M, PAPADOPOULOU V, KALALA F, ILIKIS T, ZERVAKIS K, TSILIMIDOS G, KOUZIS P, KYRTSONIS MC, VASSILAKOPOULOS T, ANGELOPOULOU M, SIAKANTARIS M, VAYOPOULOS G, KOLLIA P, PANGALIS G, VINIOU NA. 402

Rituximab in the treatment of EBV-positive low-grade B-cell lymphoma. Anticancer Research,33: 5693-5698, 2013.

A. Citations from Journals Α/Α Όνοµα Συγγραφέως Περιοδικό Τόµος Σελίδα Έτος 1 Hornig J Exp Opin Drug Disc 9 891 2014

• KALPADAKIS C, PANGALIS GA, ANGELOPOULOU MK , SACHANAS S, KONTOPIDOU F, MOSCHOGIANNIS M, XIMERI M, TSIRKINIDIS P, YIAKOUMIS X, PAPADAKI HA, VASSILAKOPOULOS TP.

Validation of the simplified prognostic score for splenic marginal zone lymphoma of the Splenic Marginal Zone Lymphoma Study Group. Leukemia and Lymphoma, 55: 2640-2642, 2014.

A. Citations from Journals Α/Α Όνοµα Συγγραφέως Περιοδικό Τόµος Σελίδα Έτος 1 Polati R Electrophoresis 02 Apr 2015

• KALPADAKIS C, PANGALIS GA, VASSILAKOPOULOS TP , KYRIAKAKI S, YIAKOUMIS X, SACHANAS S, MOSCHOGIANNIS M, TSIRKINIDIS P, KORKOLOPOULOU P, PAPADAKI H, ANGELOPOULOU MK.

Clinical aspects of MALT lymphomas. Current Hematologic Malignancy Report, 9: 262-272, 2014.

A. Citations from Journals Α/Α Όνοµα Συγγραφέως Περιοδικό Τόµος Σελίδα Έτος 1 Sachanas S Leuk Lymphoma 13 APR 2015

• VASSILAKOPOULOS TP , PANGALIS GA, CHATZIIOANNOU S, PAPAGEORGIOU S, ANGELOPOULOU MK, GALANI Z, KOURTI G, PRASSOPOULOS V, LEONIDOPOULOU T, TERPOS E, DIMOPOULOU MN, SACHANAS S, KALPADAKIS C, KONSTANTINIDOU P, BOUTSIS D, STEFANOUDAKI E, KYRIAZOPOULOU L, SIAKANTARIS MP, KYRTSONIS MC, VARIAMI E, KOTSIANIDIS I, SYMEONIDIS A, MICHALI E, KATODRITOU I, KOKKINI G, TSATALAS C, PAPADAKI H , DIMOPOULOS MA, SOTIROPOULOS V, PAPPA V, KARMIRIS T, MELETIS J, APOSTOLIDIS J, 403

DATSERIS I, PANAYIOTIDIS P, KONSTANTOPOULOS K, ROUSSOU P, RONDOGIANNI P. PET/CT in patients with primary mediastinal large B-cell lymphoma

responding to rituximab-CHOP: An analysis of 106 patients regarding prognostic significance and implications for subsequent radiotherapy. Leukemia, 2015, accepted article preview 14 May 2015; doi: 10.1038/leu.2015.120.

A. Citations from Journals Α/Α Όνοµα Συγγραφέως Περιοδικό Τόµος Σελίδα Έτος 1 Vassilakopoulos TP MEMO 2015

• KYRTSONIS MC, SARRIS K, KOULIERIS E, MALTEZAS D, NIKOLAOU E, ANGELOPOULOU MK , BARTZIS V, TZENOU T, DIMOU M, SIAKANDARIS MP, VINIOU NA, SACHANAS S, KALPADAKIS C, SFIKAKIS PP, PANGALIS GA, PANAYIOTIDIS P.

Serum soluble TACI, a BLyS receptor, is a powerful prognostic marker of outcome in chronic lymphocytic leukemia .

Biomed Research International. 2014;2014: 159632 .

A. Citations from Journals Α/Α Όνοµα Συγγραφέως Περιοδικό Τόµος Σελίδα Έτος 1 Zhang Y Journal of Immunology 247426 2015 Research

404

II. CITATIONS OF MEETING ABSTRACTS AND PAPERS IN MEETING PROCEEDINGS

• VASSILAKOPOULOS TP, ANGELOPOULOU MK , GRIGORAKIS V, BOUSSIOTIS VA, KITTAS CH, PAPAVASSILIOU K, FESSAS PH, PANGALIS GA Clinical features of 455 patients with Hodgkin’s disease. A 15 year experience of a single haematology Unit. Third International Symposium on Hodgkin’s Lymphoma, Koln, Germany, p.122, 1995. A. Citations from Journals Α/Α Όνοµα Συγγραφέως Περιοδικό Τόµος Σελίδα Έτος 1 Angelopoulou MK Leuk Lymphoma 37 131 2000

• VASSILAKOPOULOS TP, BARBOUNIS A, ANGELOPOULOU MK , BOUSSIOTIS VA, HATZIIOANNOU M, KONTOPIDOU F, FESSAS PH, KITTAS CH, PANGALIS GA. Prognostic factors for advanced stage Hodgkin’s disease. British Journal of Haematology, 93(Suppl.2):106, 1996. A. Citations from Journals Α/Α Όνοµα Συγγραφέως Περιοδικό Τόµος Σελίδα Έτος 1 Vassilakopoulos TP Haematologica 86 274 2001

• VASSILAKOPOULOS THP, ANGELOPOULOU MK , GRIBABIS DA, SIAKANTARIS MP, BOUSSIOTIS VA, PANGALIS GA Immunoglobulin disorders at diagnosis and course of B-chronic lymphocytic leukemia (B-CLL) patients. British Journal of Haematology, 93(Suppl.2): 117, 1996. A. Citations from Books, Medical sites and other Literature 1. Μονογραφή Της ∆ιηµερίδας Με Θέµα : Λεµφώµατα Χαµηλής Κακοηθείας , Χρόνιες Λεµφοκυτταρικές Λευχαιµίες , Του Τµήµατος Λεµφοϋπερπλαστικών Νόσων Της Ελληνικής Αιµατολογικής Εταιρίας , Αθήνα , 30 Σεπτεµβρίου -1 405

Οκτωβρίου 2000. ( Κεφάλαιο : Β-Χρόνια Λεµφογενής Λευχαιµία . Αγγελοπούλου ΜΚ , Βασιλακόπουλος ΘΠ , ∆ηµοπούλου ΜΝ , Σιακαντάρη ΜΠ , Κοντοπίδου ΦΝ , Γιαννακάκη ΑΛ , Κίττας Χ, Πάγκαλης ΓΑ , σελ .28-35). 2. Μελέτη κλωνικότητος σε ασθενείς µε χρόνια λεµφογενή λευχαιµία και συσχέτιση µε κλινικά και βιολογικά δεδοµένα . Ευαγγελία Μ. ∆ηµητριάδου , Thesis, Ιατρική Σχολή Εθνικού και Καποδιστριακού Πανεπιστηµίου Αθηνών , Αθήνα , Μάιος 2007. B. Citations from Journals Α/Α Όνοµα Συγγραφέως Περιοδικό Τόµος Σελίδα Έτος 1 Pangalis GA Semin Hematol 36 104 1999 2 Angelopoulou MK Panarab Congress 50 2000 3 Pangalis GA Hematol Oncol 20 103 2002

• ANGELOPOULOU MK , VASSILAKOPOULOS THP, KONTOPIDOU F, BOUSSIOTIS VA, PANGALIS GA. Prognostic factors for early stage Hodgkin’s disease. Annals of Oncology, 7(Suppl.3):109, 1996. A. Citations from Journals Α/Α Όνοµα Συγγραφέως Περιοδικό Τόµος Σελίδα Έτος 1 Vassilakopoulos T Haema 2 90 1999

• ANGELOPOULOU MK , KONTOPIDOU F, VASSILAKOPOULOS TH, PANGALIS GA B-chronic lymphocytic leukemia: Present status. In: Postgraduate Athens Leukemia-Lymphoma course, Pangalis GA and Polliack A eds., European School of Oncology / European School of Haematology, Monograph, pp 273-303, Vouliagmeni, Attiki, Greece, 1997. A. Citations from Journals Α/Α Όνοµα Συγγραφέως Περιοδικό Τόµος Σελίδα Έτος 1 Pangalis GA Semin Hematol 36 104 1999 2 Pangalis GA Hematol Oncol 20 103 2002

406

• ANGELOPOULOU MK , VASSILAKOPOULOS THP, SIAKANTARIS MP, KONTOPIDOU F, BOUSSIOTIS VA, PAPAVASSILIOU C, KITTAS CH, PANGALIS GA EBVD combination chemotherapy plus low dose involved field radiation therapy for the treatment of early clinical stage Hodgkin’s disease. Leukemia and Lymphoma 29 (Suppl.1): P-62, 1998. A. Citations from Journals Α/Α Όνοµα Συγγραφέως Περιοδικό Τόµος Σελίδα Έτος 1 Vassilakopoulos T Haema 2 90 1999

• VASSILAKOPOULOS THP, ANGELOPOULOU MK , SIAKANTARIS MP, KONTOPIDOU F, BOUSSIOTIS VA, PANGALIS GA Hodgkin’s disease in first relapse, after complete remission achieved by chemotherapy ± radiation therapy: An analysis of outcome and prognostic factors. Leukemia and Lymphoma 29 (Suppl.1): P-156, 1998. A. Citations from Books, Medical sites and other Literature 1. Linfoma de Hodgkin na infancia e adolescensia. Um estudo das caracteristicas histologicas, clinicas, epidemiologicas e de associacao com o virus Epsein-Barr, Mario Henrique Magalhaes Barros. Dissertacao de Mestrado apresentada ao Programa de pos-graduacao em Oncologia, Instituto Nacional do Cancer, Ministerio da Saude, como parte dos requisitos necassarios a obtencao do titulo de Mestre em Oncologia. Rio de Janeiro, 2007. B. Citations from Journals Α/Α Όνοµα Συγγραφέως Περιοδικό Τόµος Σελίδα Έτος 1 Vassilakopoulos TP Eur J Haematol 67 279 2001

• ANGELOPOULOU MK , DIMOPOULOU MN, SIAKANTARIS MP, KONTOPIDOU FN, RASSIDAKIS G, VASSILAKOPOULOS THP, KITTAS CH, PANGALIS GA Mantle cell and nodal monocytoid B-cell lymphomas. In: XVth Meeting of the International Society of Haematology, African and European Division. Education and Symposium Programme, pp 182-185, Durban, South Africa, 1999. BIBLIOGRAPHICAL REFERENCES A. Citations from Journals 407

Α/Α Όνοµα Συγγραφέως Περιοδικό Τόµος Σελίδα Έτος 1 Pangalis GA Semin Hematol 36 104 1999 2 Angelopoulou MK Eur J Haematol 68 12 2002

• RASSIDAKIS GZ, VASSILAKOPOULOS THP, ANGELOPOULOU MK, BALASKAS C, SIAKANTARIS MP, DIMOPOULOU MN, GUENOVA M, DOUSSIS-ANAGNOSTOPOULOU I, GORGOULIS VG, KITTAS C, PANGALIS GA. Expression of p27 kip1 in Hodgkin’s disease: relation to proliferative activity and EBV status. The Hematology Journal, 1 (Suppl 1): 174, 2000. A. Citations from Books, Medical sites and other Literature 1. Βιολογικοί Παράγοντες και Κλινικά Χαρακτηριστικά κατά τη ∆ιάγνωση και Υποτροπή του Λεµφώµατος Hodgkin: Συσχετίσεις και Προγνωστική Σηµασία . Θεόδωρος Π. Βασιλακόπουλος , Thesis, Ιατρική Σχολή Εθνικού και Καποδιστριακού Πανεπιστηµίου Αθηνών , Αθήνα , Μάρτιος 2004. B. Citations from Journals Α/Α Όνοµα Συγγραφέως Περιοδικό Τόµος Σελίδα Έτος 1 Vassilakopoulos TP Haema 7 147 2004

• SIAKANTARIS MP, GONIS NK, ANGELOPOULOU MK, KOURTIS I, KONTOPIDOU FN, DIMOPOULOU MN, VASSILAKOPOULOS THP, KITTAS CH, PANGALIS GA Low grade gastric MALT lymphoma (LGGMALT) clinical stage I. A seemingly localized disease. Blood, 96 (Suppl1 – Part 1): 329a, 2000. A. Citations from Books, Medical sites and other Literature 1. Κλινική , Ανοσολογική και Μοριακή Μελέτητου Επιθηλιοτροπισµού και της ∆ιασποράς Λεµφοκυττάρων σε Ασθενείς µε Χρονία Λεµφογενή Λευχαιµία και Χαµηλής Κακοηθείας Λεµφώµατα τύπου MALT. Μαρίνα Π. Σιακαντάρη , Thesis, Ιατρική Σχολή Εθνικού και Καποδιστριακού Πανεπιστηµίου Αθηνών , Αθήνα , Ιούλιος 2003. 2. Μονογραφή Της Ηµερίδας Με Θέµα : ‘‘ Οζώδη Λεµφώµατα , Χρόνια Λεµφοκυτταρική Λευχαιµία και Λεµφώµατα Οριακής Ζώνης ’’ Του Τµήµατος Λεµφοϋπερπλαστικών Νόσων Της Ελληνικής Αιµατολογικής Εταιρίας , Αθήνα, 22-23 Σεπτεµβρίου 2006. ( Κεφάλαιο : Λεµφώµατα στµάχου MALT. Σιακαντάρη ΜΠ , Αγγελοπούλου ΜΚ , Κοκόρη ΣΙ , Μαυρογιάννη ∆, Κοντοπίδου 408

ΦΝ , Βασιλακόπουλος ΘΠ , Κυρτσώνη ΜΧ , Καλπαδάκη Χ, ∆ηµητριάδου ΕΜ , Σαχανάς Σ, Πλατά Ε, Τσαφταρίδης Π, Βαριάµη Ε, Βύνιου ΝΑ , Πάγκαλης ΓΑ , σελ . 84-88). B. Citations from Journals Α/Α Όνοµα Συγγραφέως Περιοδικό Τόµος Σελίδα Έτος 1 Doussis-Anagnostopoulou Haema 4 215 2001 2 Siakantaris MP Haema (17 Panh) 117 2006 3 Kalpadakis C Hematol Oncol 25 127 2007 4 Kalpadakis C Leuk Lymphoma 2008 5 Siakantaris MP Oncologist 14 148 2009

• SARRIS AH, MEDEIROS LJ, RASSIDAKIS G, NADALI G, VIVIANI S, VASSILAKOPOULOS THP, GIARDINI R, CHILOSI M, KITTAS C, ANGELOPOULOU M , HERLING M, HAGEMEISTER FB, RODRIGUEZ MA, ROMAGUERA J, MCLAUGHLIN P, FORD R, GIANNI M, BONADONNA G, PANGALIS GA, PIZZOLO G, CABANILLAS F. Bcl-2 expression in Hodgkin-Reed-Sternberg cells (HRS) of patients with classical Hodgkin’s disease is associated with lower progresion-free survival and survival. Blood, 96 (Suppl1 – Part 1): 725a, 2000. A. Citations from Journals Α/Α Όνοµα Συγγραφέως Περιοδικό Τόµος Σελίδα Έτος 1 Vassilakopoulos TP Haematologica 86 274 2001 2 Vassilakopoulos TP Haema 4 230 2001 3 Vassilakopoulos TP Eur J Haematol 67 279 2001 4 Vas silakopoulos TP Haematologica 87 701 2002 5 Vassilakopoulos TP Eur J Haematol 68 289 2002 6 Hagemeister FB Oncology -NY 16 617 2002 7 Salgami EV Haematologia 32 377 2002 8 Karmiris TD Leuk Lymphoma 44 1523 2003 9 Vassalo Leuk Lymphoma 44 483 2003

Haema 3 (Suppl.1): 98, 2000. A. Citations from Journals Α/Α Όνοµα Συγγραφέως Περιοδικό Τόµος Σελίδα Έτος 1 Ζαχάρος Ι Ιατρική 79 524 2001

• VASSILAKOPOULOS TP, NADALI G, ANGELOPOULOU MK , SIAKANTARIS MP, DIMOPOULOU MN, KONTOPIDOU FN, RASSIDAKIS GZ, DOUSSIS- ANAGNOSTOPOULOU IA, HATZIIOANNOU M, KITTAS C, SARRIS AH, PIZZOLO G, PANGALIS GA Serum soluble CD30 (sCD30) levels are an independent prognostic factor for Hodgkin’s lymphoma. Haema 3 (Suppl.1): 133, 2000. A. Citations from Books, Medical sites and other Literature 1. Βιολογικοί Παράγοντες και Κλινικά Χαρακτηριστικά κατά τη ∆ιάγνωση και Υποτροπή του Λεµφώµατος Hodgkin: Συσχετίσεις και Προγνωστική Σηµασία . Θεόδωρος Π. Βασιλακόπουλος , Thesis, Ιατρική Σχολή Εθνικού και Καποδιστριακού Πανεπιστηµίου Αθηνών , Αθήνα , Μάρτιος 2004. B. Citations from Journals Α/Α Όνοµα Συγγραφέως Περιοδικό Τόµος Σελίδα Έτος 1 Αναγνωστόπουλος Haema 4( Supl ) 81 2001 2 Ρεπούσης Π Haema 4( Supl ) 103 2001 3 Vassilakopoulos TP Haematologica 87 701 2002 4 Vassilakopoulos TP Haema 7 147 2004 5 Vassilakopoulos TP J BUON 10 59 2005

• VASSILAKOPOULOS THP, NADALI G, ANGELOPOULOU MK , SIAKANTARIS MP, DIMOPOULOU MN, PANGALIS GA.

The prognostic significance of β2-microglobulin in Hodgkin’s lymphoma. Leukemia and Lymphoma 42 (Suppl.2): P-172, 2001. A. Citations from Journals Α/Α Όνοµα Συγγραφέως Περιοδικό Τόµος Σελίδα Έτος 1 Ρεπούσης Π Haema 4(Supl) 103 2001 2 Zander T Ann Oncol 13S1 67 2002

• SIAKANTARIS MP, ANGELOPOULOU MK , VASSILAKOPOULOS TP, DIMOPOULOU MN, KYRTSONIS MC, TSAFTARIDIS P, KONTOPIDOU FN, PANGALIS GA. 410

Downstaging” Rai stage III B-Chronic Lymphocytic Leukemia patients with the administration of recombinant human erythropoietin. Blood, 98 (11-part 1): 634a, 2001. A. Citations from Books, Medical sites and other Literature 1. Recombinant Human Erythropoietin (rhEPO) in Clinical Oncology. Nowroussian MR (ed.), Springer-Verlag, Wien, 2002, ISBN: 3-211-83661-6.

• KYRTSONIS MC, ANGELOPOULOU MK , VASSILAKOPOULOS TP, SIAKANTARIS MP, KONTOPIDOU FN, DIMOPOULOU MN, KOKORIS SI, TSAFTARIDIS P, KARKANTARIS C, KORKOLOPOULOU P, KITTAS C, PANGALIS GA. Waldenstrom’s macroglobulinemia and non-IgM secreting lymphoplasmacytic lymphoma: Comparative study in 108 patients from a single institution. Second International Workshop on Waldenstrom’s macroglobulinemia, Athens 2002. A. Citations from Books, Medical sites and other Literature 1. ΑΙΜΑΤΟΛΟΓΙΑ ΣΤΗΝ ΚΛΙΝΙΚΗ ΠΡΑΞΗ , Πάγκαλης ΓΑ , Εκδόσεις Π.Χ. Πασχαλίδης , Αθήνα 2008, ISBN 978-960-399-776-4 ( Κεφ . 37: Μη οζώδη λεµφώµατα « χαµηλής κακοηθείας » καθ ’ υπεροχήν λεµφαδενικά , σελ . 659- 665). B. Citations from Journals Α/Α Όνοµα Συγγραφέως Περιοδικό Τόµος Σελίδα Έτος 1 Pangalis GA Semin Oncol 30 201 2003

• KONTOPIDOU FN, KYRTSONIS MC, ANGELOPOULOU MK , SIAKANTARIS MP, DIMOPOULOU MN, VASSILAKOPOULOS TP, KORKOLOPOULOU P, KOKORIS SI, TSAFTARIDIS P, KITTAS C, PANGALIS GA. Immunophenotypic findings in lymphoplasmacytic lymphoma, including Waldenstrom’s macroglobulinemia and non-IgM secreting cases. Second International Workshop on Waldenstrom’s macroglobulinemia, Athens 2002. A. Citations from Journals Α/Α Όνοµα Συγγραφέως Περιοδικό Τόµος Σελίδα Έτος 411

1 Pangalis GA Semin Oncol 30 201 2003

• ΒΑΣΙΛΑΚΟΠΟΥΛΟΣ ΘΠ , NADALI G, ΑΓΓΕΛΟΠΟΥΛΟΥ ΜΚ , ΣΙΑΚΑΝΤΑΡΗ ΜΠ , ΚΟΚΟΡΗ ΣΙ , ∆ΗΜΗΤΡΙΑ∆ΟΥ ΕΜ , ΚΥΡΤΣΩΝΗ ΜΧ , ΤΣΑΦΤΑΡΙ∆ΗΣ Π, ΒΑΡΙΑΜΗ Ε, ΒΥΝΙΟΥ ΝΑ , PIZZOLO G, PANGALIS GA Τα επίπεδα ιντερλευκίνης -10 και διαλυτού CD30 στον ορό ασθενών µε λέµφωµα Hodgkin προσφέρουν ανεξάρτητες προγνωστικές πληροφορίες . Haema 6 (Suppl.1): 185, 2003. A. Citations from Books, Medical sites and other Literature 1. Βιολογικοί Παράγοντες και Κλινικά Χαρακτηριστικά κατά τη ∆ιάγνωση και Υποτροπή του Λεµφώµατος Hodgkin: Συσχετίσεις και Προγνωστική Σηµασία . Θεόδωρος Π. Βασιλακόπουλος , Thesis, Ιατρική Σχολή Εθνικού και Καποδιστριακού Πανεπιστηµίου Αθηνών , Αθήνα , Μάρτιος 2004. B. Citations from Journals Α/Α Όνοµα Συγγραφέως Περιοδικό Τόµος Σελίδα Έτος 1 Βασιλακόπουλος Θ Haema Συµπλ 137 2004

• ΒΑΣΙΛΑΚΟΠΟΥΛΟΣ ΘΠ , NADALI G, ΑΓΓΕΛΟΠΟΥΛΟΥ ΜΚ , ΣΙΑΚΑΝΤΑΡΗ ΜΠ , ΚΟΚΟΡΗ ΣΙ , ∆ΗΜΟΠΟΥΛΟΥ ΜΝ , ∆ΗΜΗΤΡΙΑ∆ΟΥ ΕΜ , ΚΥΡΤΣΩΝΗ ΜΧ , ΤΣΑΦΤΑΡΙ∆ΗΣ Π, ΒΑΡΙΑΜΗ Ε, ΒΥΝΙΟΥ ΝΑ , ΚΩΝΣΤΑΝΤΟΠΟΥΛΟΣ Κ, PIZZOLO G, PANGALIS GA

Αξιολόγηση επιπέδων ιντερλευκίνης -10, διαλυτού CD30 και β2- µικροσφαιρίνης ορού σε ασθενείς µε λέµφωµα Hodgkin σε υποτροπή . Haema 6 (Suppl.1): 334, 2003. A. Citations from Books, Medical sites and other Literature 1. Βιολογικοί Παράγοντες και Κλινικά Χαρακτηριστικά κατά τη ∆ιάγνωση και Υποτροπή του Λεµφώµατος Hodgkin: Συσχετίσεις και Προγνωστική Σηµασία . Θεόδωρος Π. Βασιλακόπουλος , Thesis, Ιατρική Σχολή Εθνικού και Καποδιστριακού Πανεπιστηµίου Αθηνών , Αθήνα , Μάρτιος 2004. B. Citations from Journals Α/Α Όνοµα Συγγραφέως Περιοδικό Τόµος Σελίδα Έτος 1 Βασιλακόπουλος Θ Haema Συµπλ 137 2004

412

• ΒΑΣΙΛΑΚΟΠΟΥΛΟΣ ΘΠ , ΚΥΡΤΣΩΝΗ ΜΧ , ΠΑΠΑ∆ΟΓΙΑΝΝΗ Α, ΣΙΑΚΑΝΤΑΡΗ ΜΠ , ∆ΗΜΟΠΟΥΛΟΥ Μ, ΚΟΚΟΡΗ ΣΙ , ∆ΗΜΗΤΡΙΑ∆ΟΥ ΕΜ , ΤΣΑΦΤΑΡΙ∆ΗΣ Π, ΒΑΪΟΠΟΥΛΟΣ Γ, ΑΓΓΕΛΟΠΟΥΛΟΥ ΜΚ , ΠΑΓΚΑΛΗΣ ΓΑ Επίπεδα syndecan-1 και Transforming Growth Factor-β στον ορό ασθενών µε

λέµφωµα Hodgkin: Κλινικοεργαστηριακές και προγνωστικές συσχετίσεις .

Haema 6 (Suppl.1): 334, 2003. A. Citations from Books, Medical sites and other Literature 1. Βιολογικοί Παράγοντες και Κλινικά Χαρακτηριστικά κατά τη ∆ιάγνωση και Υποτροπή του Λεµφώµατος Hodgkin: Συσχετίσεις και Προγνωστική Σηµασία . Θεόδωρος Π. Βασιλακόπουλος , Thesis, Ιατρική Σχολή Εθνικού και Καποδιστριακού Πανεπιστηµίου Αθηνών , Αθήνα , Μάρτιος 2004. B. Citations from Journals Α/Α Όνοµα Συγγραφέως Περιοδικό Τόµος Σελίδα Έτος 1 Vassilakopoulos TP Haema 7 147 2004

• ΒΑΣΙΛΑΚΟΠΟΥΛΟΣ ΘΠ , ΚΥΡΤΣΩΝΗ ΜΧ , ΠΑΠΑ∆ΟΓΙΑΝΝΗ Α, ΣΙΑΚΑΝΤΑΡΗ ΜΠ , ΚΟΚΟΡΗ ΣΙ , ∆ΗΜΟΠΟΥΛΟΥ ΜΝ , ∆ΗΜΗΤΡΙΑ∆ΟΥ ΕΜ , ΤΣΑΦΤΑΡΙ∆ΗΣ Π, ΒΑΪΟΠΟΥΛΟΣ Γ, ΑΓΓΕΛΟΠΟΥΛΟΥ ΜΚ , ΠΑΓΚΑΛΗΣ ΓΑ Επίπεδα µεταλλοπρωτεϊνάσης -9 στον ορό ασθενών µε λέµφωµα Hodgkin: Κλινικοεργαστηριακές και προγνωστικές συσχετίσεις . Haema 6 (Suppl.1): 335, 2003. A. Citations from Books, Medical sites and other Literature 1. Βιολογικοί Παράγοντες και Κλινικά Χαρακτηριστικά κατά τη ∆ιάγνωση και Υποτροπή του Λεµφώµατος Hodgkin: Συσχετίσεις και Προγνωστική Σηµασία . Θεόδωρος Π. Βασιλακόπουλος , Thesis, Ιατρική Σχολή Εθνικού και Καποδιστριακού Πανεπιστηµίου Αθηνών , Αθήνα , Μάρτιος 2004. B. Citations from Journals Α/Α Όνοµα Συγγραφέως Περιοδικό Τόµος Σελίδα Έτος 1 Vassilakopoulos TP Haema 7 147 2004

• VASSILAKOPOULOS TP, NADALI G, ANGELOPOULOU MK , SIAKANTARIS MP, KYRTSONIS MC, PIZZOLO G, PANGALIS GA Serum beta-2 microglobulin as a prognostic factor in patients with Hodgkin’s lymphoma treated with A(E)BVD or equivalent regimens with or without radiation therapy. 413

Blood 102 (11-part2): 273b, 2003. A. Citations from Journals Α/Α Όνοµα Συγγραφέως Περιοδικό Τόµος Σελίδα Έτος 1 Vassilakopoulos TP Haema 7 147 2004

• DIMOPOULOU MN, ANGELOPOULOU MK , VASSILAKOPOULOS TP, KYRTSONIS MC, KOUMBIS D, KONTOPIDOU FN, SIAKANTARIS MP, KALPADAKIS C, KOKORIS SI, DIMITRIADOU E, PANGALIS GA. B-chronic lymphocytic leukemia (B-CLL), small lymphocytic lymphoma (SLL) and Waldenstrom’s macroglobulinemia (WM): a comparative FISH analysis. Blood , 104 (11): 283b, 2004. A. Citations from Journals

Α/Α Όνοµα Συγγραφέως Περιοδικό Τόµος Σελίδα Έτος 1 Santos FPS Cancer J 18 396 2012

• SIAKANTARIS MP, KYRTSONIS MC, TZENOU T, DIMITRIADOU EM, DIMOPOULOU MN, ANGELOPOULOU MK , KOKORIS SI, VASSILAKOPOULOS TP, KORKOLOPOULOU P, GIANNAKAKIS A, PATSOURIS E, KATSAMBAS A, PANGALIS GA. Management of primary cutaneous T- and B-cell lymphoma with interferon alpha-2b (IFN-α). A single center experience. The Hematology Journal , 5 (Suppl 2): S123, 2004. A. Citations from Journals Α/Α Όνοµα Συγγραφέως Περιοδικό Τόµος Σελίδα Έτος 1 Kyrtsonis MC Eur J Haematol 2006

• VASSILAKOPOULOS TP, ANGELOPOULOU MK , SIAKANTARIS MP, KYRTSONIS MC, DIMOPOULOU MN, KOKORIS SI, DIMITRIADOU EM, PAPAVASSILIOU C, PANGALIS GA The effect of radiation dose on relapse free survival (RFS) of patients with early clinical stage Hodgkin's lymphoma (HL) after A(E)BVD chemotherapy. European Journal of Haematology , 73 (Suppl. 65): 41 (E13), 2004. A. Citations from Journals Α/Α Όνοµα Συγγραφέως Περιοδικό Τόµος Σελίδα Έτος 1 Βασιλακόπουλος Θ Haema Συµπλ 137 2004 2 Βασιλακόπουλος ΘΠ ΑΙΜΑ 3 212 2012

414

• SIAKANTARIS MP, TZENOU T, VASSILAKOPOULOS TP, KYRTSONIS MC, ANGELOPOULOU MK , DIMOPOULOU MN, KOKORIS SI, DIMITRIADOU EM, KORKOLOPOULOU P, PATSOURIS E, TSAFTARIDIS P, VARIAMIS E, LASKARIS G, Pangalis GA. Lymphoma of the oral cavity. A rare entity with favorable prognosis. Ten- year experience of a single Hematology Unit. Blood 104: 233b, 2004. A. Citations from Books, Medical sites and other Literature 1. Βασιλακόπουλος ΘΠ , Σιακαντάρη Μ, Γιακουµή Ξ. Στοµατολογικές εκδηλώσεις σε ασθενείς µε αιµατολογικές κακοήθειες . 2ο Συνέδριο Ογκολογίας στην Πρωτοβάθµια Περίθαλψη , Αθήνα 5-6 ∆εκεµβρίου 2008, Εκπαιδευτικός Τόµος , σελ .127-134.

• SIAKANTARIS MP, KYRTSONIS MC, TZENOU T, DIMITRIADOU EM, DIMOPOULOU MN, ANGELOPOULOU MK , KOKORIS SI, VASSILAKOPOULOS TP, KORKOLOPOULOU P, GIANNAKAKIS A, PLATA E, PATSOURIS E, KATSAMBAS A, PANGALIS GA. Interferon alpha-2b (IFN-α) is an efective agent for the treatment of primary cutaneous T- and B-cell lymphoma. Blood , 104 (11): 723a, 2004. A. Citations from Journals Α/Α Όνοµα Συγγραφέως Περιοδικό Τόµος Σελίδα Έτος 1 Pangalis GA Cur Top Med Chem 6 1657 2006

• KYRTSONIS MC, VASSILAKOPOULOS TP, PAPADOGIANNIS A, TZENOU T, KALPADAKIS C, ANTONIADIS A, DIMOPOULOU MN, SIAKANTARIS MP, KOKORIS SI, DIMITRIADOU EM, ANGELOPOULOU MK , PLATA E, TSAFTARIDIS P, PANGALIS GA. Serum soluble syndecan-1 levels at diagnosis constitute an independent prognostic factor of survival in myeloma that may further differentiate patients within the ISS stages. Blood, 106: 951a, 2005 . A. Citations from Journals

Α/Α Όνοµα Συγγραφέως Περιοδικό Τόµος Σελίδα Έτος 1 Chanan -Khan AA Br J Haematol 151 3 2010

415

• DIMOPOULOU MN, KALPADAKIS C, DIMITRIADOU EM, KYRTSONIS M-C, KOKORIS SI, TSAFTARIDIS P, KONTOPIDOU FN, SIAKANTARIS MP, PLATA E, VASSILAKOPOULOS TP, ANGELOPOULOU MK , PANGALIS GA. Rituximab treatment for splenic marginal zone B-cell lymphomas (SMZL). Haematologica/The Hematology Journal , 90 (Suppl. 2): 272, 2005. A. Citations from Journals Α/Α Όνοµα Συγγραφέως Περιοδικό Τόµος Σελίδα Έτος 1 Pangalis GA Hematology 10(S1) 6 2005 2 Pangalis GA Cur Top Med Chem 6 1657 2006 3 Πάγκαλης ΓΑ MED Review Oncology 1 23 2006 4 Pangalis GA Turkish J Hematol 23 (S2) 54 2006

• VASSILAKOPOULOS TP, ANGELOPOULOU MK , SACHANAS S, ZORBALA A, SIAKANTARIS MP, KOKORIS SI, DIMITRIADOU EM, DIMOPOULOU MN, KALPADAKI C, KYRTSONIS M-C, TSAFTARIDIS P, MICHAIL P, PANAYIOTIDIS P, PANGALIS GA. Conventional prognostic factors in clinical stage IA/IIA Hodgkin's lymphoma (HL) after treatment with ABVD-based combined modality therapy (CMT). Haematologica/The Hematology Journal , 90 (Suppl. 2): 141, 2005. A. Citations from Journals

Α/Α Όνοµα Συγγραφέως Περιοδικό Τόµος Σελίδα Έτος 1 Βασιλακόπουλος ΘΠ ΑΙΜΑ 3 212 20 12

• KALPADAKIS C, SIAKANTARIS MP, KYRTSONIS M-C, VASSILAKOPOULOS TP, TZENOU T, DIMOPOULOU MN, KOKORIS SI, DIMITRIADOU EM, ANGELOPOULOU MK , MITROPOULOS F, KORKOLOPOULOU P, PANGALIS GA Non-gastrointestinal extranodal marginal zone B-cell lymphomas (EMZL) : A single center experience. Haematologica/The Hematology Journal, 90 (Suppl 2): 272, 2005. A. Citations from Journals Α/Α Όνοµα Συγγραφέως Περιοδικό Τόµος Σελίδα Έτος 1 Pangalis GA Hematology 10(S1) 6 2005

• VASSILAKOPOULOS TP, ANGELOPOULOU MK , GALANI Z, SACHANAS S, KATSIGIANNIS A, DIMOPOULOU MN, KOKORIS SI, MICHALI E, 416

DIMITRIADOU EM, SIAKANTARIS MP, KONTOPIDOU F, KALPADAKI C, SARANTOPOULOS A, KORKOLOPOULOU P, ROUSSOU P, PANGALIS GA. Primary mediastinal (thymic) large B-cell lymphoma (PMLBCL): Excellent outcome with the combination of rituximab-CHOP (R-CHOP) and radiotherapy (RT). Haematologica/The Hematology Journal , 90 (Suppl. 2): 103, 2005. A. Citations from Books, Medical sites and other Literature 1. ΑΙΜΑΤΟΛΟΓΙΑ ΣΤΗΝ ΚΛΙΝΙΚΗ ΠΡΑΞΗ , Πάγκαλης ΓΑ , Εκδόσεις Π.Χ. Πασχαλίδης , Αθήνα 2008, ISBN 978-960-399-776-4 ( Κεφ . 83: Χρήση µονοκλωνικών αντισωµάτων στην Αιµατολογία , σελ . 1272-1279). B. Citations from Journals Α/Α Όνοµα Συγγραφέως Περιοδικό Τόµος Σελίδα Έτος 1 Πάγκαλης ΓΑ MED Review Oncology 1 23 2006 2 Lancet Oncology 6 451 2005 3 Vassilakopoulos TP Oncologist 17 239 2012

• VASSILAKOPOULOS TP, ANGELOPOULOU MK , SIAKANTARIS MP, KOKORIS SI, DIMITRIADOU EM, DIMOPOULOU MN, KYRTSONIS M-C, TSAFTARIDIS P, KALPADAKI C, PRASSAS E, VARIAMIS E, VYNIOU NA, ROMBOS Y, PANAYIOTIDIS P, MICHAIL P, PANGALIS GA. Very late relapses in patients with Hodgkin's lymphoma. Haematologica/The Hematology Journal , 90 (Suppl. 2): 72, 2005. A. Citations from Journals Α/Α Όνοµα Συγγραφέως Περιοδικό Τόµος Σελίδα Έτος 1 Vassilakopoulos TP Haema 10 (S2) 90 2007 2 Gaudio F Adv Hematol 707542 2011

• KALPADAKIS C, SIAKANTARIS MP, KYRTSONIS M-C, VASSILAKOPOULOS TP, TZENOU T, DIMOPOULOU MN, DIMITRIADOU EM, KOKORIS SI, ANGELOPOULOU MK , MITROPOULOS F, KORKOLOPOULOU P, PANGALIS GA. Retrospective analysis of 41 consecutive patients with non-gastrointestinal (GI) extranodal marginal zone B-cell lymphoma (EMZL): Correlation of clinical characteristics and outcome with disease localization. Blood , 106 (11): 276b, 2005. A. Citations from Journals Α/Α Όνοµα Συγγραφέως Περιοδικό Τόµος Σελίδα Έτος 1 Pangalis GA Cur Top Med Chem 6 1657 2006 417

• VASSILAKOPOULOS TP, ANGELOPOULOU MK , GALANI Z, SACHANAS S, KATSIGIANNIS A, DIMOPOULOU MN, KOKORIS SI, MICHALIS E, DIMITRIADOU EM, SIAKANTARIS MP, KONTOPIDOU FN, KALPADAKI C, SARANTOPOULOS A, KORKOLOPOULOU P, ROUSSOU P, PANGALIS GA. Excellent outcome with rituximab-CHOP (R-CHOP) combined with radiotherapy (RT) in primary mediastinal large B-cell lymphoma (PMLBCL). Blood , 106: 275a, 2005. A. Citations from Books, Medical sites and other Literature 1. Non-Hodgkin Lymphomas – Second Edition. Armitage JO, Mauch P, Harris NL, Coiffier B, Dalla-favera R (eds.). Wolters Kluwer Health – Lippincott Williams & Wilkins, Philadelphia 2010. (Chapter 21: Primary Mediastinal Large B-Cell Lymphoma, by Zinzani PL, Harris NL, Mauch PM, Dalla-Favera R, pp. 327-333).

Β. Citations from Journals Α/Α Όνοµα Συγγραφέως Περιοδικό Τόµος Σελίδα Έτος 1 De Sanctis V Int J Radiat Oncol Biol Phys 72 1154 2008 2 Zinzani PL Clin Lymphoma Myeloma 9 381 2009 3 Zinzani PL Curr Oncol Rep 13 407 2011 4 Aviles A Int J Radiat Oncol Biol Phys 83 1227 2012 5 Foppoli M Rec Prog Med 104 203 2013

• KYRTSONIS MC, SACHANAS S, VASSILAKOPOULOS TP, KAFASSI N, TZENOU T, PAPADOGIANNIS A, KALPADAKIS C, ANTONIADIS AG, DIMOPOULOU MN, ANGELOPOULOU MK , SIAKANTARIS MP, DIMITRIADOU EM, KOKORIS SI, PLATA E, TSAFTARIDIS P, PANAYIOTIDIS P, PANGALIS GA. Bortezomib in patients with relapsed-refractory multiple myeloma (MM). Clinical observations. Blood , 106 (11): 382b, 2005. A. Citations from Books, Medical sites and other Literature 1. Bradwell AR. Serum Free Light Chain Analysis (plus Hevylite). Fifth Edition. AR Bradwell, ISBN 0704427028, 978087044227020, 2008. B. Citations from Journals Α/Α Όνοµα Συγγραφέως Περιοδικό Τόµος Σελίδα Έτος 1 Pangalis GA Cur Top Med Chem 6 1657 2006

418

• VASSILAKOPOULOS TP, ANGELOPOULOU MK , GALANI Z, SACHANAS S, KATSIGIANNIS A, VRAKIDOU E, CONSTANTINOU N, DIMOPOULOU MN, KOKORIS SI, MICHALI E, DIMITRIADOU EM, SIAKANTARIS MP, PANAYIOTIDIS P, ROUSSOU P, PANGALIS GA. Rituximab-CHOP and radiotherapy for primary mediastinal large B-cell lymphoma: An update. Haematologica/The Hematology Journal , 91 (Suppl 1): 260, 2006. A. Citations from Books, Medical sites and other Literature 1. ΑΙΜΑΤΟΛΟΓΙΑ ΣΤΗΝ ΚΛΙΝΙΚΗ ΠΡΑΞΗ , Πάγκαλης ΓΑ , Εκδόσεις Π.Χ. Πασχαλίδης , Αθήνα 2008, ISBN 978-960-399-776-4 ( Κεφ . 41: ∆ιάχυτο λέµφωµα από µεγάλα Β-κύτταρα και συναφείς οντότητες , σελ . 689-701). B. Citations from Journals Α/Α Όνοµα Συγγραφέως Περιοδικό Τόµος Σελίδα Έτος 1 Pangalis GA Cur Top Med Chem 6 1657 2006 2 Zinzani PL Haematologica /The HJ 2008 3 Medina RC Rev Cub Med 50 157 2011

• VASSILAKOPOULOS TP, ANGELOPOULOU MK , GALANI Z, SACHANAS S, KATSIGIANNIS A, VRAKIDOU E, POZIOPOULOS C, CONSTANTINOU N, REPOUSSIS P, DIMOPOULOU MN, KOKORIS SI, MICHALI E, DIMITRIADOU EM, SIAKANTARIS MP, KONTOPIDOU FN, KALPADAKI C, VINIOU NA, KYRIAKOU E, KORKOLOPOULOU P, PANAYIOTIDIS P, ROUSSOU P, PANGALIS GA. Rituximab-CHOP (R-CHOP) and radiotherapy (RT) for primary mediastinal large B-cell lymphoma (PMLBCL). Blood 108: Abstr 2745, 2006. A. Citations from Books, Medical sites and other Literature

NCCN Clinical Practice Guidelines in Oncology. Non-Hodgkin’s lymphomas, v. 2.2013 (plus 1.2013 and 3.2012).

Β. Citations from Journals Α/Α Όνοµα Συγγραφέως Περιοδικό Τόµος Σελίδα Έτος 1 Fietz T Ann Hematol 88 433 2009 2 Poire X Exp Rev Hematol 2 31 2009 3 Reiger M Ann Oncol 22 664 2011 4 Zelenetz AD J Nat Compr Cancer 9 484 2011 5 Pohlen M Am J Hematol 86 E61 2011 6 Coiffier B Hematol Meeting Rep 1 27 2007

419

• TSIRKINIDIS P, VASSILAKOPOULOS TP, MOSCHOGIANNIS M, GALANI Z, ANARGYROU K, MASOURIDIS S, KONTOPIDOU F, SACHANAS S, DIMITRIADOU E, KALOTYCHOU V, KALPADAKIS C, ANTONIADIS A, PRASSAS E, CHASIOTIS D, VARIAMI E, VINIOU NA, KOKORIS S, SIAKANTARIS M, ROMBOS Y, PANGALIS GA, ANGELOPOULOU M. ESHAP vs GIN as salvage and mobilizing regimens in relapsed or refractory HL. Haematologica/The Hematology Journal , 92 (Suppl 1): 65, 2007. A. Citations from Books, Medical sites and other Literature 1. Μονογραφή Της Ηµερίδας Με Θέµα : ‘‘ Λέµφωµα Hodgkin: Πρόσφατες Εξελίξεις ’’ Του Τµήµατος Λεµφοϋπερπλαστικών Νόσων Της Ελληνικής Αιµατολογικής Εταιρίας , Αθήνα , 31 Ιανουαρίου 2009. ( Κεφάλαιο : Θεραπεία διάσωσης στο λέµφωµα Hodgkin. Αγγελοπούλου ΜΚ , Βασιλακόπουλος ΘΠ , Πάγκαλης ΓΑ , σελ . 40-51).

• GALANI H, VASSILAKOPOULOS TP, TSIRKINIDIS P, MOSCHOGIANNIS M, BOUTSIS D, ANARGYROU K, MASOURIDIS S, SACHANAS S, KALPADAKIS C, SARANTOPOULOS A, DIMITRIADOU E, DIMOPOULOU M, STAVROGIANNIS N, KALOTYCHOU V, VARIAMIS E, VINIOU NA, KOKORIS SI, SIAKANTARIS MP, KYRTSONIS MC, ROMBOS I, VAIOPOULOS G, PANGALIS GA, ANGELOPOULOU M. High dose therapy and autologous stem cell transplantation in 58 patients with Hodgkin’s lymphoma. Outcome and prognostic factors. Haematologica/The Hematology Journal , 92 (Suppl 1): 144, 2007. A. Citations from Books, Medical sites and other Literature 1. Μονογραφή Της Ηµερίδας Με Θέµα : ‘‘ Λέµφωµα Hodgkin: Πρόσφατες Εξελίξεις ’’ Του Τµήµατος Λεµφοϋπερπλαστικών Νόσων Της Ελληνικής Αιµατολογικής Εταιρίας , Αθήνα , 31 Ιανουαρίου 2009. ( Κεφάλαιο : Θεραπεία διάσωσης στο λέµφωµα Hodgkin. Αγγελοπούλου ΜΚ , Βασιλακόπουλος ΘΠ , Πάγκαλης ΓΑ , σελ . 40-51).

• KYRTSONIS MC, TZENOU T, VASSILAKOPOULOS TP, KALPADAKIS C, SACHANAS S, VOGIATZAKIS F, ANGELOPOULOU MK , SIAKANTARIS MP, DIMOPOULOU MN, KOKORIS SI, DIMITRIADOU EM, PANAYIOTIDIS P, PANGALIS GA. Serum soluble syndecan-1 is increased in WM/LPL and SMZL. Haematologica/The Hematology Journal, 92 (6, Suppl 2): 223, 2007. 420

A. Citations from Journals Α/Α Όνοµα Συγγραφέως Περιοδικό Τόµος Σελίδα Έτος 1 Αγγελοπούλου ΜΚ Haema Educ 138 2008 2 Kyrtsonis MC Clin Lymph Myel Leuk 11 99 2011

• TZENOU T, KYRTSONIS MC, KALPADAKIS C, VASSILAKOPOULOS TP, SACHANAS S, VOGIATZAKIS F, ANGELOPOULOU MK , SIAKANTARIS MP, DIMOPOULOU MN, KOKORIS SI, DIMITRIADOU EM, PANAYIOTIDIS P, PANGALIS GA. Differing serum cytokine levels in LPL and WM. Haematologica/The Hematology Journal, 92 (6, Suppl 2): 223, 2007. A. Citations from Journals Α/Α Όνοµα Συγγραφέως Περιοδικό Τόµος Σελίδα Έτος 1 Αγγελοπούλου ΜΚ Haema Educ 138 2008

• PANGALIS GΑ, TZENOU T, KALPADAKIS C, VASSILAKOPOULOS TP, DIMITRIADOU EM, SACHANAS S, PETRIKKOS L, ANGELOPOULOU MK , SIAKANTARIS MP, DIMOPOULOU MN, KOKORIS SI, TSAFTARIDIS P, PANAYIOTIDIS P, KYRTSONIS MC Biologic and clinical overlap of IgM-secreting lymphomas; focus on Waldenstrom’s macroglobulinemia. Haematologica/The Hematology Journal, 92 (6, Suppl 2): 74-77, 2007. A. Citations from Books, Medical sites and other Literature 1. ΑΙΜΑΤΟΛΟΓΙΑ ΣΤΗΝ ΚΛΙΝΙΚΗ ΠΡΑΞΗ , Πάγκαλης ΓΑ , Εκδόσεις Π.Χ. Πασχαλίδης , Αθήνα 2008, ISBN 978-960-399-776-4 ( Κεφ . 54: Μακροσφαιριναιµία του Waldenstrom, σελ . 815-821). 2. Λεµφώµατα Οριακής Ζώνης . Κλινική και Εργαστηριακή Μελέτη . Χριστίνα Καλπαδάκη , Thesis, Ιατρική Σχολή Εθνικού και Καποδιστριακού Πανεπιστηµίου Αθηνών , Αθήνα , 2008. 3. Kyrtsonis MC, Koulieris E, Bartzis V, Pessah I, Nikolaou E, Karali V, Maltezas D, Panayiotidis P, Harding SJ. Chapter 2: Monoclonal Immunoglobulin. http://dx.doi.org/10.5772/55855 . INTECH, pp. 13-37, 2013. Β. Citations from Journals

Α/Α Όνοµα Συγγραφέως Περιοδικό Τόµος Σελίδα Έτος 1 Louw VJ Transf Apher Sci 42 19 3 2010 2 Kyrtsonis MC Appl Clin Genet 3 41 2010 421

• KYRTSONIS MC, VASSILAKOPOULOS TP, KAFASI N, ANAGNOSTOPOULOS A, DELIMPASI S, TERPOS E, REPOUSSIS P, SACHANAS S, TZENOU T, GALANIS Z, MASOURIDIS S, KALPADAKIS C, DIMOU M, ANGELOPOULOU MK, DIMOPOULOU MN, SIAKANTARIS MP, DIMITRIADOU EM, KOKORIS SI, PANAYIOTIDIS P, ZERVAS K, DIMOPOULOS MA, PANGALIS GA. The addition of sFLCR improves ISS prognostication in multiple myeloma (MM). Haematologica/The Hematology Journal , 92 (6, Suppl 2): 207, 2007. A. Citations from Journals Α/Α Όνοµα Συγγραφέως Περιοδικό Τόµος Σελίδα Έτος 1 Pika T Biomed Papers Olom 152 61 2008

• KYRTSONIS MC, VASSILAKOPOULOS TP, KAFASI N, MALTEZAS D, ANAGNOSTOPOULOS A, TERPOS E, ELEFTERAKIS-PAPAIAKOVOU E, POULI A, REPOUSSIS P, DELIMPASSI S, ANARGYROU K, STAFANOUDAKI C, MICHALIS E, SACHANAS S, TZENOU T, MASOURIDIS S, DIMOU M, ANGELOPOULOU MK , DIMOPOULOU MN, SIAKANTARIS MP, DIMITRIADOU EM, KOKORIS SI, KALPADAKIS C, PANAYIOTIDIS P, DIMOPOULOS MA, PANGALIS GA. The addition of sFLCR improves ISS prognostication in multiple myeloma (MM). Blood , 110: Abstr 1490, 2007. A. Citations from Books, Medical sites and other Literature 1. Bradwell AR. Serum Free Light Chain Analysis (plus Hevylite). Fifth Edition. AR Bradwell, ISBN 0704427028, 978087044227020, 2008. 2. Multiple Myeloma: An overview. Gupta A (ed.). InTech – Open Access Publisher 2012, ISBN 978-953-307-768-0. (Chapter 8: The contribution of prognostic factors to the better management of multiple myeloma patients, by Kyrtsonis MC, Maltezas D, Koulieris E, Bitsani K, Pessach I, Efthymiou A, Bartzis V, Tzenou T, Panayiotidis P. pp. 145-174).

B. Citations from Journals Α/Α Όνοµα Συγγραφέως Περιοδικό Τόµος Σελίδα Έτος 1 Pika T Biomed Papers Olom 152 61 2008 2 Kyrtsonis MC World J Hematol 2 6 2013

422

• ANGELOPOULOU MK , ANARGYROU K, SACHANAS S, KOKORIS S, VASSILAKOPOULOS TP, GALANI Z, DIMOPOULOU MN, KONTOPIDOU FN, PLATA E, TSAFTARIDIS P, DIMITRIADOU E, SIAKANTARIS MP, PANGALIS GA. Long term follow up of hairy cell leukemia patients (pts) treated with interferon-α. The importance of maintenance. Haematologica/The Hematology Journal , 92 (6, Suppl 1): 42, 2007. A. Citations from Journals

Α/Α Όνοµα Συγγραφέως Περιοδικό Τόµος Σελίδα Έτος 1 Ramakrishna R Asia -Pac J Clin Oncol 6 210 2010

• DIMOPOULOU MN, VASSILAKOPOULOS TP, SIAKANTARIS MP, KYRTSONIS MC, KONTOPIDOU FN, KOKORIS SI, MASOURIDIS S, DIMITRIADOU EM, PLATA E, TSAFTARIDIS P, ANGELOPOULOU MK , PANGALIS GA. Cytogenetic Differences between B-Chronic lymphocytic leukemia (B-CLL) and small lymphocytic lymphoma (SLL). Leukemia Lymphoma, 48 (Suppl 1): S142, 2007. A. Citations from Books, Medical sites and other Literatures

1. Bone Marrow Pathology, 4 th Edition. Bain BJ, Clark DM, Wilkins BS (eds.), Wiley-Balckwell, 2010, ISBN 978-1-4051-6825-0 (Chapter 6: Lymphoproliferative disorders, pp. 300-420).

• TZENOU T, KYRTSONIS MC, KALPADAKIS C, VASSILAKOPOULOS TP, SACHANAS S, SACHANAS S, GALANIS Z, MASOURIDIS S, DIMOPOULOU MN, KOKORIS SI, DIMITRIADOU EM, KORKOLOPOULOU P, SIAKANTARIS MP, ANGELOPOULOU M, PANAYIOTIDIS P, PANGALIS GA. The follicular lymphoma International Prognostic Index is applicable in lymphoplasmacytic lymphoma / Waldenstrom’s macroglobulinemia. Haematologica/The Hematology Journal, 92 (Suppl 1): 266, 2007. A. Citations from Journals

Α/Α Όνοµα Συγγραφέως Περιοδικό Τόµος Σελίδα Έτος 1 Kyrtsonis MC Am J Med Med Sci 2 136 2012

423

• VASSILAKOPOULOS TP, PANGALIS G, GALANI Z, SACHANAS S, KATSIGIANNIS A, VRAKIDOU E, POZIOPOULOS C, CONSTANTINOU N, REPOUSSIS P, DIMOPOULOU M, KOKORIS S, MICHALI E, DIMITRIADOU E, MASOURIDIS S, SIAKANTARIS M, KALPADAKIS C, KYRTSONIS M, PANAYIOTIDIS P, ROUSSOU P, ANGELOPOULOU M. Addition of Rituximab to CHOP greatly improves the outcome of patients with primary mediastinal large B-cell lymphoma (PMLBCL). Ann Oncol, 19 (Suppl.4): 188, 2008. A. Citations from Journals

Α/Α Όνοµα Συγγραφέως Περιοδικό Τόµος Σελίδα Έτος 1 Giza A Hematologia 1 180 2010

• KALPADAKIS C, PANGALIS GA, VASSILAKOPOULOS TP, DIMOPOULOU MN, KYRTSONIS M, KORKOLOPOULOU P, KONTOPIDOU F, SIAKANTARIS M, DIMITRIADOU E, PANAYIOTIDIS P, PAPADAKI H, ANGELOPOULOU M . Rituximab monotherapy is the treatment of choice of splenic marginal zone lymphoma (SMZL). Ann Oncol, 19 (Suppl.4): 191, 2008. A. Citations from Books, Medical sites and other Literature 1. Λεµφώµατα Οριακής Ζώνης . Κλινική και Εργαστηριακή Μελέτη . Χριστίνα Καλπαδάκη , Thesis, Ιατρική Σχολή Εθνικού και Καποδιστριακού Πανεπιστηµίου Αθηνών , Αθήνα , 2008. 2. Advances in Malignant Hematology. Saba HI and Mufti GJ (eds.), 2011 Wiley- Blackwell, Oxford, UK. ISBN: 978-140519626-0 (Chapter 18: Non-Hodgkin lymphomas, by Fowler N, McLaughlin P, pp 274-295, doi: 10.1002/9781444394016.ch18).

B. Citations from Journals

Α/Α Όνοµα Συγγραφέως Περιοδικό Τόµος Σελίδα Έτος 1 Kalpadakis C Oncologist 2013 2 Kalpadakis C Leuk Lymphoma 20 Sep 2013

• VASSILAKOPOULOS TP, MASOURIDIS S, ANGELOPOULOU MK , KOKORIS SI, SAHANAS S, KALPADAKIS C, DIMITRIADOU EM, TSIRKINIDIS P, MOSCHOYIANNIS M, TSAFTARIDIS P, GALANIS Z, VARIAMIS E, GOULIAMOS A, PRASSOPOULOS V, GOGOU L, EFTHIMIADOU R, ANDREOU I, DATSERIS K, PAPAVASSILIOU C, PANGALIS GA. 424

PET/CT findings in patients with Hodgkin's lymphoma (HL) after ABVD combination chemotherapy: Clinical and prognosic significance. Haematologica/The Hematology Journal , 93 (Suppl 1): 247, 2008. A. Citations from Books, Medical sites and other Literature 1. Μονογραφή Της Ηµερίδας Με Θέµα : ‘‘ Λέµφωµα Hodgkin: Πρόσφατες Εξελίξεις ’’ Του Τµήµατος Λεµφοϋπερπλαστικών Νόσων Της Ελληνικής Αιµατολογικής Εταιρίας , Αθήνα , 31 Ιανουαρίου 2009. ( Κεφάλαιο : Λέµφωµα Hodgkin: Θεραπεία περιορισµένων σταδίων . Βασιλακόπουλος ΘΠ , Αγγελοπούλου ΜΚ , Πάγκαλης ΓΑ , σελ . 29-39). B. Citations from Journals Α/Α Όνοµα Συγγραφέως Περιοδικό Τόµος Σελίδα Έτος 1 Βασιλακόπουλος ΘΠ Haema 12 (S2) 169 2009 2 Kalpadakis C Oncologist 2013

• ANGELOPOULOU MK , VASSILAKOPOULOS TP, TSIRKINIDIS P, MASOURIDIS S, MOSCHOYIANNIS M, KORKOLOPOULOU P, KOKORIS S, SIAKANTARIS M, SACHANAS S, GALANI Z, DIMITRIADOU E, KALPADAKIS C, ANARGYROU K, DIMOPOULOU MN, KYRTSONIS MC, PATSOURIS E, VAIOPOULOS G, PANGALIS GA. Nodal peripheral T-cell lymphomas: Treatment outcome and prognostic factors. Haematologica/The Hematology Journal, 93 (Suppl 1): 310, 2008.

A. Citations from Journals

Α/Α Όνοµα Συγγραφέως Περιοδικό Τόµος Σελίδα Έτος 1 Αγγελοπούλου ΜΚ Αίµα (Haema) 1 42 2010

• KYRTSONIS MC, VASSILAKOPOULOS TP, TZENOU T, KAFASI N, SACHANAS S, KOULIERIS E, MALTEZAS D, DIMOPOULOU M, KOKORIS SI, DIMITRIADOU E, SIAKANTARIS MP, ANGELOPOULOU MK , PANAYIOTIDIS P, PANGALIS GA. Serum free light chains in Waldenstrom’s macroglobulinemia (WM) patients at diagnosis. Haematologica/The Hematology Journal , 93 (Suppl 1): 263, 2008. A. Citations from Journals

Α/Α Όνοµα Συγγραφέως Περιοδικό Τόµος Σελίδα Έτος 1 Leleu X Clin Lymph Myel Leuk 11 164 2011 2 Kyrtsonis MC Am J Med Med Sci 2 136 2012

425

• VASSILAKOPOULOS TP, PANGALIS GA, ANASTASOPOULOU A, ANGELOPOULOU MK , DIMOU M, STAVROULAKI E, KARAKATSANIS S, KALPADAKIS C, SACHANAS S, KYRTSONIS MC, KOKORIS SI, SIAKANTARIS MP, YIAKOUMIS X, ROUSSOU P, PANAYIOTIDIS P, PAPADAKI H, CONSTANTINOU N. Rituximab-CHOP (R-CHOP) in the treatment of 441 diffuse large B-cell lymphoma patients: Outcome and prognostic factors focusing to the Revised International Prognostic Index (R-IPI). Haematologica/The Hematology Journal , 94 (Suppl 2): 163, 2009. A. Citations from Journals

Α/Α Όνοµα Συγγραφέως Περιοδικό Τόµος Σελίδα Έτος 1 Vassilakopoulos TP Oncologist 17 239 2012

• M.K. ANGELOPOULOU , T.P. VASSILAKOPOULOS, P. TSIRKINIDIS,O. TSOPRA, Z. GALANI, V. PAPPI, M. MOSCHOGIANNIS, E. DIMITRIADOU,K. ANARGYROY, C. KALPADAKIS, S. MASOURIDIS, D. BOUTSIS,S. SACHANAS, M. DIMOPOULOU, E. VARIAMIS, N.-A. VYNIOU,S. KOKORIS, M.P. SIAKANTARIS, M.-C. KYRTSONIS, P. PANAYIOTIDIS, Y. ROMBOS, G.A. PAMGALIS, P. BERIS High-dose therapy and autologous stem cell transplantation (HDT/ ASCT) in relapsed/refractory Hodgkin’s lymphoma. Outcome and prognostic factors 36 th Annual Meeting of the European Group for Blood and Marrow Transplantation, Vienna, Austria, March 21-24 2010.Bone Marrow Transplant. 2010;45(Suppl 2s): P837 A. Citations from Journals

Α/Α Όνοµα Συγγραφέως Περιοδικό Τόµος Σελίδα Έτος 1 Αγγελοπούλου ΜΚ ΑΙΜΑ 3 239 2012

• TSIRKINIDIS P, VASSILAKOPOULOS T, TSOPRA O, PAPPIS V, MOSCHOGIANNI M, GALANI Z, ANARGYROU K, VARDOUNIOTI I, DIMITRAKOPOULOU A, MASOURIDIS S, KYRTSONIS MC, PANAYIOTIDIS P, PANGALIS G, BERIS P, ANGELOPOULOU M. ESHAP vs IGEV as salvage and mobilizing regimens in relapsed or refractory Hodgkin Lymphoma (HL). 15 th Congress of the European Haematology Association, June 10- 13, 2010, Barcelona, Spain. Haematologica/The Hematology Journal, 95 (Suppl 2): 885, 2010. . Haematologica/The Hematology Journal, 95 (Suppl 2): 885, 2010. A. Citations from Journals

Α/Α Όνοµα Συγγραφέως Περιοδικό Τόµος Σελίδα Έτος 1 Αγγελοπούλου ΜΚ ΑΙΜΑ 3 239 2012

426

• PAPPI V, ANGELOPOULOU M , TSOPRA O, DIMOU M, KYRTSONIS M, SIAKANTARIS M, YIAKOUMIS X, GASIAMIS A, PANAYIOTIDIS P, PANGALIS G, BERIS P, VASSILAKOPOULOS T. Baseline serum C-Reactive Protein levels (CRP) in Hodgkin Lymphoma (HL) and alterations during ABVD chemotherapy: Correlation with clinical, laboratory features and prognostic significance. Haematologica/The Hematology Journal, 95 (Suppl 2): 887, 2010. A. Citations from Journals

Α/Α Όνοµα Συγγραφέως Περιοδικό Τόµος Σελίδα Έτος 1 Πάγκαλης ΓΑ ΑΙΜΑ 3 203 2012

• MALTEZAS M, TZENOU T, KAFASSI N, KOULIERIS E, BARTZIS V, DIMOU M, EFTHYMIOU A, GEORGIOU G, VASSILAKOPOULOS TP, ANGELOPOULOU MK , TSAFTARIDIS P, BERIS P, KYRTSONIS MC. Clinical Impact of Increased Serum Free Light Chains (sFLCs) or their Ratio (FLCR) in WM at diagnosis and during disease course. Proceedings of the 6th International Workshop on Waldenstrom’s Macroglobulinemia, Venice, pp. 105, 2010. A. Citations from Journals

Α/Α Όνοµα Συγγραφέως Περιοδικό Τόµος Σελίδα Έτος 1 Kyrtsonis MC Am J Med Med Sci 2 136 2012 2 Kyrtsonis MC World J Hematol 2 6 2013

• VASSILAKOPOULOS TP, PANGALIS GA, BOUTSIKAS G, KOKORIS S, GALANI Z, SIAKANTARIS M, DIMITRIADOU E, DIMOPOULOU M, GEORGIOU G, DIMOU M, KALPADAKI C, KONTOPIDOU F, KYRTSONIS MC, PAPPIS V, TSOPRA O, TSIRKINIDIS P, KOUTSOUKOS K, ZOGRAFOS E, VARIAMIS E, VINIOU NA, PANAYIOTIDIS P, MELETIS J, ANGELOPOULOU M. Hodgkin Lymphoma (HL) in patients ≥60 years old: Clinical and laboratory features, outcome after anthracycline-based treatment and comparison with younger patients: A single center experience. Haematologica/The Hematology Journal , 96 (Suppl 2): 320, 2011. A. Citations from Journals

Α/Α Όνοµα Συγγραφέως Περιοδικό Τόµος Σελίδα Έτος 1 Vassilakopoulos TP Semin Hematol 50 4 2013 2 Πυροβολάκη Κ ΑΙΜΑ 3 321 2012

• . VASSILAKOPOULOS TP, ANGELOPOULOU MK , RONDOGIANNI P, GALANI Z, DADAKARIDOU M, DIMOU M, PRASSOPOULOS V, CHATZIIOANNOU S, PAPPIS V, TSOPRA O, SACHANAS S, TSIRKINIDIS P, KONTOPIDOU F, VARIAMI E, KOUTSOUKOS K, 427

ZOGRAFOS E, REPOUSSIS P, PANGALIS GA, PANAYIOTIDIS P, DATSERIS I, MELETIS J. Interim PET-Scan for early response assessment and potential modification of treatment plan after 2 ABVD cycles in advanced stage Hodgkin Lymphoma (HL). 16 th Congress of the European Haematology Association, June 9- 12, 2011, London, UK. Haematologica/The Hematology Journal, 96 (Suppl 2): 322, 2011. A. Citations from Books, Medical sites and other Literature

1. Gouliamos AD, Andreou J, Kosmidis P: Imaging in Clinical Oncology. 2014, Springer-Verlag Italia. ISBN print 978-88-470-5384-7, ISBN online 978-88-470-5385- 4 (Chapter 33: Vassilakopoulos TP, Prassopoulos V. The role of 18FDG-PET/CT in malignant lymphomas: Clinical implications, pp 249-265, DOI: 10.1007/978-88-470- 5385-4_35).

B. Citations from Journals

Α/Α Όνοµα Συγγραφέως Περιοδικό Τόµος Σελίδα Έτος 1 Βασιλακόπουλος ΘΠ ΑΙΜΑ 3 212 2012

• VASSILAKOPOULOS TP, PANGALIS G, MASOURIDIS S, PRASSOPOULOS V, KATSIGIANNIS A, TERPOS E, KALPADAKIS C, RONDOGIANNI P, GALANI Z, PAPAGEORGIOU S, POZIOPOULOS C, CHATZIIOANNOU S, BOUTSIS D, CONSTANTINOU N, VRAKIDOU E, SACHANAS S, GEORGIOU G, KOKORIS S, SIAKANTARIS M, DIMOU M, YIAKOUMIS X, VINIOU N, CHRISTOULAS D, KYRTSONIS MC, DATSERIS I, PAPADAKI H, DIMOPOULOS MA, PANAYIOTIDIS P, ROUSSOU P, ANGELOPOULOU M, MELETIS I. PET-Scan for response assessement after Rituximab-CHOP (R- CHOP) in primary mediastinal large B-cell lymphoma (PMLBCL): Prognostic significance and implications for subsequent radiotherapy (RT). 16 th Congress of the European Haematology Association, June 9- 12, 2011, London, UK. Haematologica/The Hematology Journal, 96 (Suppl 2): 391, 2011. A. Citations from Books, Medical sites and other Literatures

• KALPADAKIS C, PANGALIS GA, VASSILAKOPOULOS TP, SACHANAS S, KONTOPIDOU F, YIAKOUMIS X, KOKORIS S, DIMITRIADOU E, MOSCHOYIANNIS M, KORKOLOPOULOU P, KYRTSONIS MC, TSIRKINIDIS P, SIAKANTARIS M, PAPADAKI H, ANGELOPOULOU M. 428

Treatment of splenic marginal zone lymphoma with rituximab monotherapy vs splenectomy. Haematologica/The Hematology Journal , 96 (Suppl 2): 438, 2011 (oral presentation). A. Citations from Journals

Α/Α Όνοµα Συγγραφέως Περιοδικό Τόµος Σελίδα Έτος 1 Iannitto E Hematology Educ EHA 17 6 429 2012

• VASSILAKOPOULOS TP, ANGELOPOULOU MK , PRASSOPOULOS V, ET AL. Comparative assessment of bone marrow involvement by bone marrow biopsy or positron emission tomography in Hodgkin lymphoma. 13 th International Myeloma Workshop, Paris, France, May 3-6, 2011. Hematol Oncol 31(Suppl 1):189 (abstr. 276) . A. Citations from Books, Medical sites and other Literatures

• M ANGELOPOULOU , M MOSCHOGIANNIS, P RONDOGIANNI, V PAPPIS, P TSIRKINIDIS, O TSOPRA, Z GALANI, S SACHANAS, X YIAKOUMIS, S MASOURIDI, G BOUTSIKAS, C KALPADAKIS, E DIMITRIADOU, M DIMOPOULOU, V TELONIS, P FLEVARI, G GAINAROU, T NTALAGIORGOS, D EXARCHOS, I DATSERIS, A GOULIAMOS, MC KYRTSONIS, P PANAYIOTIDIS, G PANGALIS, I MELETIS, T VASSILAKOPOULOS. THE PROGNOSTIC SIGNIFICANCE OF PET SCAN BEFORE AND AFTER HIGH-DOSE THERAPY AND AUTOLOGOUS STEM CELL TRANSPLANTATION (ASCT) IN RELAPSED/REFRACTORY HODGKIN LYMPHOMA (HL) PATIENTS. 17 th Congress of the European Haematology Association, June 14- 17, 2012, Amsterdam The Netherlands. Haematologica/The Hematology Journal, 97 (Suppl 1): 443, 2012. A. Citations from Books, Medical sites and other Literatures

B. Citations from Journals

Α/Α Όνοµα Συγγραφέως Περιοδικό Τόµος Σελίδα Έτος 1 Αγγελοπούλου ΜΚ ΑΙΜΑ 3 239 2012 429

• KALPADAKIS C, PANGALIS G, ANGELOPOULOU M, SACHANAS S, KORKOLOPOULOU P, MAVROUDI E, KONTOPIDOU F, LEVIDOU G, DIMITRAKOPOULOU A, KYRTSONIS M, DIMITRIADOU E, KOKORIS S, YIAKOUMIS X, TSIRKINIDIS P, MOSCHOYIANNIS M, RONTOGIANNI D, PANAYIOTIDIS P, PAPADAKI H, VASSILAKOPOULOS T. CD5- MONOCLONAL B-CELL LYMPHOPROLIFERATION (MBL): CLINICAL CHARACTERISTICS AND OUTCOME. 17 th Congress of the European Haematology Association, June 14- 17, 2012, Amsterdam The Netherlands. Haematologica/The Hematology Journal, 97 (Suppl 1): 215, 2012. A. Citations from Journals

Α/Α Όνοµα Συγγραφέως Περιοδικό Τόµος Σελίδα Έτος 1 Angelopoulou MK Leuk Lymphoma 2013

• T VASSILAKOPOULOS, G PANGALIS, G BOUTSIKAS, P RONTOGIANNI, S MASOURIDIS, V PRASSOPOULOS, M DIMOU, Z GALANI, S SACHANAS, M MOSCHOGIANNIS, P TSIRKINIDIS, S CHATZIIOANNOU, O TSOPRA, G GEORGIOU, C KALPADAKIS, E DIMITRIADOU, E SINNI, A BILALIS, K PETEVI, A KANELLOPOULOS, G GAINARU, P FLEVARI, L PAPAGEORGIOU, E PESSACH, V BARTZI, A EFTHIMIOU, NA VINIOU, E VARIAMIS, MC KYRTSONIS, P BERIS, I DATSERIS , P PANAYIOTIDIS , I MELETIS , M ANGELOPOULOU . PROGNOSTIC FACTORS IN PATIENTS WITH HODGKIN LYMPHOMA (HL) AND A NEGATIVE PET/CT AFTER ABVD CHEMOTHERAPY: POTENTIAL APPLICATIONS FOR THE DESIGN OF FOLLOW-UP STRATEGIES. 17 th Congress of the European Haematology Association, June 14-17, 2012, Amsterdam The Netherlands. Haematologica/The Hematology Journal, 97 (Suppl 1): 218, 2012. A. Citations from Books, Medical sites and other Literatures

B. Citations from Journals

Α/Α Όνοµα Συγγραφέως Περιοδικό Τόµος Σελίδα Έτος 1 Vassilakopoulos TP Semin Hematol 50 4 2013 2 Βασιλακόπουλος ΘΠ ΑΙΜΑ 3 212 2012

• T VASSILAKOPOULOS, P RONTOGIANNI, G PANGALIS, G BOUTSIKAS, V PRASSOPOULOS, S MASOURIDIS, S KOKORIS, M 430

DIMOU, Z GALANI, S CHATZIIOANNOU, M MOSCHOGIANNIS, S SACHANAS, X YIAKOUMIS, V PAPPI, E SINNI, T TZENOU, K PETEVI, A KANELLOPOULOS, T NTALAGIORGOS, I VARDOUNIOTI, K KOUTSI, L PAPAGEORGIOU, E PESSACH, V TELONIS, E VARIAMIS, MC KYRTSONIS, M DIMOPOULOU, M SIAKANTARIS, P BERIS, I DATSERIS, P PANAYIOTIDIS, I MELETIS, M ANGELOPOULOU . OUTCOME AND PROGNOSTIC FACTORS IN PATIENTS WITH HODGKIN LYMPHOMA (HL) WHO REMAIN PET/CT-POSITIVE AFTER ABVD COMBINATION CHEMOTHERAPY: POTENTIAL APPLICATIONS FOR THE DESIGN OF SUBSEQUENT TREATMENT. 17 th Congress of the European Haematology Association, June 14- 17, 2012, Amsterdam The Netherlands. Haematologica/The Hematology Journal, 97 (Suppl 1): 1404, 2012. A. Citations from Books, Medical sites and other Literature

B. Citations from Journals

Α/Α Όνοµα Συγγραφέως Περιοδικό Τόµος Σελίδα Έτος 1 Βασιλακόπουλος ΘΠ ΑΙΜΑ 3 212 2012

• Θ.Π. Βασιλακόπουλος , Ε. Ζωγράφος , Κ. Πετέβη , Γ. Μπούτσικας , Α. Κανελλόπουλος , Γ. Χειλάς , Μ. ∆ήµου , Γ. Γκαινάρου , Ε. Σίννη , Μ-Χ. Κυρτσώνη , Β. Παππή , Τ. Τζένου , Α. Μπιλάλης , Α. Ευθυµίου , Ι. Βαρδουνιώτη , Η. Πεσσάχ , Π. Φλέβαρη , Λ. Παπαγεωργίου , Β. Τελώνης , Κ. Κούτση , Μ. Πάνος , Π. Τσαφταρίδης , Π. Παναγιωτίδης , Μ.Κ. Αγγελοπούλου , Φ. Μπερής , Ι. Μελέτης ΕΠΙΠΕ∆Α ΠΡΟΚΑΛΣΙΤΟΝΙΝΗΣ (PCT) ΚΑΤΑ ΤΗ ∆ΙΑΓΝΩΣΗ ΑΣΘΕΝΩΝ ΜΕ ΛΕΜΦΩΜΑ HODGKIN (ΗL) ΚΑΙ ΕΜΠΥΡΕΤΟ Ή/ΚΑΙ ΑΥΞΗΜΕΝΑ ΕΠΙΠΕ∆Α C-ΑΝΤΙ∆ΡΩΣΑΣ ΠΡΩΤΕΙΝΗΣ (CRP) ΟΡΟΥ . 23 ο Πανελλήνιο Αιµατολογικό Συνέδριο , Θεσσαλονίκη , 24-26 Νοεµβρίου 2012, Αίµα 2012; 2(4): Περίληψη 144 A. Citations from Journals

Α/Α Όνοµα Συγγραφέως Περιοδικό Τόµος Σελίδα Έτος 1 Πάγκαλης ΓΑ ΑΙΜΑ 3 203 2012

• Α. Κανελλόπουλος , Μ.Κ. Αγγελοπούλου , Γ. Μπούτσικας , Κ. Πετέβη , Γ. Γαινάρου , Ζ. Γαλάνη , Ε. Σίννη , Μ.Π. Σιακαντάρη , Μ. Μοσχογιάννη , Π. Τσαφταρίδης , Β. Κοµνηνάκα , Ξ. Γιακουµή , Π. 431

Τσιρκινίδης , Π. Φλέβαρη , Λ. Παπαγεωργίου , Β. Τελώνης , Κ. Κούτση , Γ.Α. Πάγκαλης , Ι. Μελέτης , Θ.Π. Βασιλακόπουλος ΟΙ ΛΕΜΦΟΚΥΤΤΑΡΙΚΟΙ ΙΣΤΟΛΟΓΙΚΟΙ ΥΠΟΤΥΠΟΙ ΤΟΥ ΛΕΜΦΩΜΑΤΟΣ HODGKIN (HL): ΚΛΙΝΙΚΑ ΧΑΡΑΚΤΗΡΙΣΤΙΚΑ ΚΑΙ ΜΑΚΡΟΧΡΟΝΙΑ ΠΡΟΓΝΩΣΗ ΜΙΑΣ ΣΕΙΡΑΣ 61 ΑΣΘΕΝΩΝ . 23 ο Πανελλήνιο Αιµατολογικό Συνέδριο , Θεσσαλονίκη , 24-26 Νοεµβρίου 2012, Αίµα 2012; 2(4): Περίληψη 143. A. Citations from Journals

Α/Α Όνοµα Συγγραφέως Περιοδικό Τόµος Σελίδα Έτος 1 Κοντοπίδου ΦΝ ΑΙΜΑ 3 298 2012